<DOC>
<DOCNO> FR941219-2-00001 </DOCNO>
<PARENT> FR941219-2-00001 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4703 -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 242&blank;/&blank;Monday, December 19, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 242
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Monday, December 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00002 </DOCNO>
<PARENT> FR941219-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=50 g=1 f=1 -->
DEPARTMENT OF COMMERCE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->
Bureau of Export Administration
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Action Affecting Export Privileges; Rajeev Sharma, Individually and Formerly Doing Business as Libra Electronics,
Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In the Matter of: Rajeev Sharma, individually and formerly doing business as Libra Electronics, Inc.; Respondent.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Order
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Export Enforcement, Bureau of Export Administration, United States Department of Commerce (Department),
having notified Rajeev Sharma, individually and formerly doing business as Libra Electronics, Inc. (hereinafter
collectively referred to as Sharma), of its intention to initiate an administrative proceeding against him pursuant
to Section 13(c) of the Export Administration Act of 1979, as amended (50 U.S.C.A. app. &sect;&sect;2401&hyph;2420
(1991, Supp. 1993, and Pub. L. No. 103&hyph;277, July 5, 1994)) (the Act),
<FOOTCITE>1</FOOTCITE>
 and Part 788 of the Export Administration Regulations (the Regulations), based on allegations that, on four separate
occasions between approximately May 4, 1988 and approximately July 13, 1988, Sharma exported U.S.-origin computers
and accessories from the United States to Australia, without obtaining the validated licenses required by Section
772.1(b) of the Regulations;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Act expired on August 20, 1994. Executive Order 12934 (59 FR 43437 (1994)) continued the Export Administration
Regulations (currently codified at 15 CFR Parts 768&hyph;799 (1994)) in effect under the International Emergency
Economic Powers Act (50 U.S.C.A. &sect;&sect;1701&hyph;1706 (1991)).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department and Sharma having entered into a Consent Agreement whereby the Department and Sharma have agreed to
settle this matter in accordance with the terms and conditions set forth therein and the terms of the Consent Agreement
having been approved by me;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is therefore ordered, that, first, a civil penalty of $20,000 is assessed against Sharma. Payment of the $20,000
civil penalty shall be suspended in its entirety for a period of two years beginning on the date of entry of this Order,
and shall thereafter be waived provided that, during the period of suspension, Sharma has committed no violation
of the Act or any regulation, order, or license issued under the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second, Rajeev Sharma, individually and formerly doing business as Libra Electronics, Inc., 5255 Via Cartagena,
Yorba Linda, California 92687, shall, for a period of two years from the date of entry of this Order, be denied all privileges
of participating, directly or indirectly, in any manner or capacity, in any transaction in the United States or abroad
involving any commodity or technical data exported or to be exported from the United States and subject to the Regulations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. All outstanding individual validated export licenses in which Sharma appears or participates, in any manner or
capacity, are hereby revoked and shall be returned forthwith to the Office of Export Licensing for cancellation.
Further, all of Sharma's privileges of participating, in any manner or capacity, in any special licensing procedure,
including, but not limited to, distribution licenses, are hereby revoked.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Without limiting the generality of the foregoing, participation, either in the United States or abroad, shall
include participation, directly or indirectly, in any manner or capacity: (i) As a party or as a representative of
a party to any export license application submitted to the Department; (ii) in preparing or filing with the Department
any export license application or request for reexport authorization, or any document to be submitted therewith;
(iii) in obtaining from the Department or using any validated or general export license, reexport authorization,
or other export control document; (iv) in carrying on negotiations with respect to, or in receiving, ordering, buying,
selling, delivering, storing, using, or disposing of, in whole or in part, any commodities or technical data exported
or to be exported from the United States and subject to the Regulations; and (v) in financing, forwarding, transporting,
or other servicing of such commodities or technical data.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00003 </DOCNO>
<PARENT> FR941219-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
C. After notice and opportunity for comment as provided in &sect;788.3(c) of the Regulations, any person, firm, corporation,
or business organization related to Sharma by affiliation, ownership, control, or position of responsibility in
the conduct of trade or related services may also be subject to the provisions of this Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. As provided by &sect;787.12(a) of the Regulations, without prior disclosure of the facts to and specific authorization
of the Office of Export Licensing, in consultation with the Office of Export Enforcement, no person may directly or
indirectly, in any manner or capacity: (i) Apply for, obtain, or use any license, Shipper's Export Declaration, bill
of lading, or other export control document relating to an export or reexport of commodities or technical data by,
to, or for another person then subject to an order revoking or denying his export privileges or then excluded from practice
before the Bureau of Export Administration; or (ii) order, buy, receive, use, sell, deliver, store, dispose of, forward,
transport, finance, or otherwise service or participate: (a) In any transaction which may involve any commodity
or technical data exported or to be exported from the United States; (b) in any reexport thereof; or (c) in any other
transaction which is subject to the Regulations, if the person denied export privileges may obtain any benefit or
have any interest in, directly or indirectly, any of these transactions.
<!-- PJG 0012 frnewline -->
Third, the proposed Charging Letter, the Consent Agreement and this Order shall be made available to the public, and
this Order shall be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register. 
<!-- PJG 0012 frnewline -->
This Order is effective immediately.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Entered this 9th day of December, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
John Despres,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Assistant Secretary for Export Enforcement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;31154 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 3510&hyph;DT&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00004 </DOCNO>
<PARENT> FR941219-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=4 -->

<USBUREAU>International Trade Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=4 -->

<RINDOCK>[A&hyph;583&hyph;810]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=4 -->
Chrome-Plated Lug Nuts From Taiwan; Preliminary Results of Antidumping Duty Administrative Review and Partial
Termination 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Import Administration, International Trade Administration, Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Preliminary Results of Antidumping Duty Administrative Review and Partial Termination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In response to a request by a petitioner and a respondent, the Department of Commerce (the Department) is conducting
an administrative review of the antidumping duty order on chrome-plated lug nuts from Taiwan. The review covers seven
firms and the period September 1, 1992, through August 31, 1993. The review indicates the existence of margins for
the firms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As a result of this review, we preliminarily determine to assess antidumping duties equal to the difference between
United States price and foreign market value. 
<!-- PJG 0012 frnewline -->
Interested parties are invited to comment on these preliminary results.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
December 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Todd Peterson or Thomas Futtner, Office of Antidumping Compliance, Import Administration, International Trade
Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW, Washington, DC. 20230; telephone
(202) 482&hyph;4195 or 482&hyph;3814, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 20, 1991, the Department published the antidumping duty order on chrome-plated lug nuts from Taiwan.
The Department published a notice of ``Opportunity to Request Administrative Review'' on September 7, 1993 (58 FR
47116). The petitioner, Consolidated International Automotive, Inc. (Consolidated), and a respondent, Gourmet
Equipment (Taiwan) Corporation (Gourmet), requested that we conduct an administrative review for the period September
1, 1992, through August 31, 1993. We published a notice of ``Initiation of Antidumping and Countervailing Duty Administrative
Review'' on October 18, 1993 (58 FR 53710), for the following firms: Buxton International, Gourmet, Chu Fong Metallic
Industrial Corporation (Chu Fong), San Chien Electric Industrial Works, Ltd. (San Chien), Everspring Plastic Corp.
(Everspring), Kuang Hong Industries Co., Ltd. (Kuang), and Transcend International Co. (Transcend). Questionnaires
were sent to Buxton, Everspring, Kuang, Transcend, Gourmet, Chu Fong, and San Chien. Everspring responded that it
has never sold the subject merchandise. Only Gourmet and Buxton responded to the questionnaire. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department has now conducted the administrative review in accordance with section 751 of the Tariff Act of 1930,
as amended (the Tariff Act). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Scope of the Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The merchandise covered by this review is one-piece and two-piece chrome-plated lug nuts, finished or unfinished,
which are more than 11/16 inches (17.45 millimeters) in height and which have a hexagonal (hex) size of at least 3/4
inches (19.05 millimeters). The term ``unfinished'' refers to unplated and/or unassembled chrome-plated lug nuts.
The subject merchandise is used for securing wheels to cars, vans, trucks, utility vehicles, and trailers. Zinc-plated
lug nuts, finished or unfinished, and stainless-steel capped lug nuts are not in the scope of this review. Chrome-plated
lock nuts are also not in the scope of this review. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
During the period of review (POR), chrome-plated lug nuts were provided for under subheading 7318.16.00.10 of the
Harmonized Tariff Schedule (HTS). Although the HTS subheading is provided for convenience and Customs purposes,
our written description of the scope of this review is dispositive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Use of Best Information Available (BIA)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In deciding what to use as BIA, the Department's regulations provide that the Department may take into account whether
a party refuses to provide requested information (19 CFR 353.37(b)). Thus, the Department determines, on a case-by-case
basis, what constitutes BIA. For the purposes of these preliminary results, we applied the following two-tier BIA
analysis where we were unable to use a company's response for purposes of determining a dumping margin (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
see Final Results of Antidumping Duty Administrative review of Antifriction Bearings and Parts Thereof from France,
et al., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
58 FR 39739, July 26, 1993):
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. When a company refuses to cooperate with the Department or otherwise significantly impedes these proceedings,
we used as BIA the higher of (1) the highest of the rates found for any firm for the same class or kind of merchandise in
the same country of origin in the less than fair value investigation (LTFV) or prior administrative reviews; or (2)
the highest rate found in this review for any firm for the same class or kind of merchandise in the same country of origin.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00005 </DOCNO>
<PARENT> FR941219-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
2. When a company substantially cooperates with our requests for information and, substantially cooperates in verification,
but fails to provide the information requested in a timely manner or in the form required or was unable to substantiate
it, we used as BIA the higher of (1) the highest rate ever applicable to the firm for the same class or kind of merchandise
from either the LTFV investigation or a prior administrative review or if the firm has never before been investigated
or reviewed, the all others rate from the LTFV investigation; or (2) the highest calculated rate in this review for
the class or kind of merchandise for any firm from the same country of origin.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chu Fong, Kuang, Transcend, and San Chien failed to respond to the Department's questionnaire. Accordingly, for
these companies we applied the first-tier BIA rate of 10.67 percent, which is the highest rate the Department found
in the original LTFV investigation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gourmet and Buxton provided us with responses to our questionnaires. However, the Department determined that the
data Gourmet submitted could not be reconciled to its audited financial statements. Reliance on the accounting system
used for the preparation of the audited financial statements is a key and vital part of the Department's determination
that a company's sales and constructed value data are credible. An ``in-house'' system which has not been audited
and is not used for the preparation of the financial statements or for any purpose other than internal deliberations
of the company does not assure the Department that such costs have been stated in accordance with generally accepted
accounting principles, or that all sales and costs have been appropriately captured by the ``in-house'' system (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
see Final Determination at Less Than Fair Value: Certain Hot-Rolled Carbon Steel Flat Products, Certain Cold-Rolled
Carbon Steel Flat Products and Certain Cut-To-Length Carbon Steel Plate from Korea
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 58 FR 37186 (July 9, 1993)). Because their submissions were unreconcilable to their audited financial statements,
we have determined to apply BIA to Gourmet and Buxton, (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
see
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Use of BIA memo to Holly Kuga, Director, Office of Antidumping Compliance). Accordingly, we applied the second-tier
BIA rate of 6.47 percent to Gourmet and 6.93 percent to Buxton. These rates represent the highest rates ever applicable
to each firm.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Everspring responded that it never sold the subject merchandise, and we have no information to contradict this claim.
If Everspring begins to sell the subject merchandise, it entries will receive the ``all other rate'' cash deposit
rate until we conduct an administrative review upon request.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00006 </DOCNO>
<PARENT> FR941219-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Preliminary Results of Review
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have preliminarily determined that the following margins exist for the period September 1, 1992, through August
31, 1993:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,s25,6 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer/exporter 
<!-- PJG 007 0150 intable -->
1Margin (percent) 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Gourmet Equipment (Taiwan) Corporation 
<!-- PJG 007 0104 intable -->
6.47
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Buxton International 
<!-- PJG 007 0104 intable -->
6.93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chu Fong Metallic Industrial Work Co., Ltd 
<!-- PJG 007 0104 intable -->
10.67
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Transcend International 
<!-- PJG 007 0104 intable -->
10.67
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kuang Hong Industrial Works 
<!-- PJG 007 0104 intable -->
10.67
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
San Chien Industrial Works, Ltd 
<!-- PJG 007 0104 intable -->
10.67
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Everspring Corporation 
<!-- PJG 007 0104 intable -->
6.93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department shall determine and the Customs Service shall assess, antidumping duties on all appropriate entries.
Upon completion of this review, the Department will issue appraisement instructions concerning these respondents
directly to the U.S. Customs Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Furthermore, the following deposit requirements will be effective for all shipments of the subject merchandise,
entered, or withdrawn from warehouse, for consumption on or after the publication date of the final results of this
administrative review, as provided for by section 751(a)(1) of the Tariff Act: (1) the cash deposit rate for the reviewed
firms will be those firms' rates established in the final results of this administrative review; (2) for previously
reviewed or investigated companies not listed above, the cash deposit rate will continue to be the company-specific
rate published for the most recent period; (3) if the exporter is not a firm covered in this review, a previous review,
or the original LTFV investigation, but the manufacturer is, the cash deposit rate will be the rate established for
the most recent period for the manufacturer of the merchandise; and (4) the ``all others'' rate will remain at 6.93
percent as established in the LTFV investigation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On May 25, 1993, the Court of International Trade, in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Floral Trade Council
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Slip Op. 93&hyph;79, and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Federal-Mogul Corporation and the Torrington Company
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Slip Op. 93&hyph;83, decided that once an ``all other'' rate is established for a company, it can only be changed through
an administrative review. The Department has determined that in order to implement these decisions, it is appropriate
to apply the original ``all others'' rate from the LTFV investigation (or that rate as amended for correction of clerical
errors or as a result of litigation) in proceedings governed by antidumping duty orders for the purposes of establishing
cash deposit in all current and future administrative reviews. The ``all others'' rate in the LTFV investigation
was 6.93 percent.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These deposit requirements, when imposed, shall remain in effect until publication of the final results of the next
administrative review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested parties may request disclosure within five days of the date of publication of this notice, and a hearing
within 10 days of the date of publication. Any hearing requested will be held as early as convenient for parties but
not later than 44 days after date of publication, or the first workday thereafter. Case briefs, or other written comments,
from interested parties may be submitted not later than 30 days after the date of publication of this notice. Rebuttal
briefs and rebuttal comments, limited to issues raised in the case briefs, may be filed not later than 37 days after
the date of publication. The Department will publish the final results of review, including its results of its analysis
of issues raised in any such written comments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This notice serves as a preliminary reminder to importers of their responsibility under 19 CFR 353.26 to file a certificate
regarding the reimbursement of antidumping duties prior to liquidation of the relevant entries during this review
period. Failure to comply with this requirement could result in the Secretary's presumption that reimbursement
of antidumping duties occurred and the subsequent assessment of double antidumping duties.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This administrative review and notice are in accordance with section 751(a)(1) of the Tariff Act (19 U.S.C. 1675(a)(1))
and 19 CFR 353.22.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Susan G. Esserman,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Import Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31138 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00007 </DOCNO>
<PARENT> FR941219-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[A&hyph;614&hyph;801]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Fresh Kiwifruit From New Zealand; Amended Final Results of Antidumping Administrative Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Date: December 8, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Import Administration, International Trade Administration, Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Amendment of Final Results of Antidumping Duty Administrative Review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
We are amending the final results of the administrative review of the antidumping duty order on fresh kiwifruit from
New Zealand published on September 22, 1994, to reflect the correction of ministerial errors made in the margin calculations
in those final results. We are publishing this amendment to the final results in accordance with 19 CFR 353.28(c).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
December 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ann Ngo or Thomas F. Futtner, Office of Antidumping compliance, Import Administration, International Trade Administration,
U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230; telephone (202) 482&hyph;5346
or 482&hyph;3814, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The review covers one exporter, the New Zealand Kiwifruit Marketing Board (NZKMB), and the period November 27, 1991,
through May 31, 1993. The Department of Commerce (the Department) published the preliminary results on May 6, 1994
(59 FR 23691) and the final results on September 22, 1994 (59 FR 48596) of its administrative review of the antidumping
duty order on fresh kiwifruit from New Zealand.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Scope of the Review
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The product covered by the order under review is fresh kiwifruit. Processed kiwifruit, including fruit jams, jellies,
pastes, purees, mineral waters, or juices made from or containing kiwifruit, are not covered under the scope of the
order. The subject merchandise is currently classifiable under subheading 0810.90.20.60 of the Harmonized Tariff
Schedule (HTS). Although the HTS number is provided for convenience and customs purposes, our written description
of the scope of this review is dispositive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Amendment of Final Results
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 18, 1994, NZKMB alleged that the Department made clerical errors in its final results of review. First,
NZKMB argued that the Department used an incorrect data set when calculating third-country weighted-average prices.
Second, NZKMB argued that in calculating foreign market value the Department used an incorrect amount for third-country
packing costs. Third, NZKMB argued that the Department failed to use the correct quantity adjustment information
for U.S. sales in its calculations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Petitioners, the California Kiwifruit Commission, have argued that the respondent's allegation of clerical errors
submitted on October 18, 1994, was untimely because it was based on a computer program provided at the disclosure on
October 5, 1994 (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
see
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 19 CFR 353.28(b)).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We disagree with petitioners that the respondent's submission alleging clerical error was untimely. The disclosure
documents released by the Department to the respondent on October 5, 1994, did not include the computer program for
the calculation of the weighted-average third-country price and therefore were incomplete. This computer program
was then provided to the respondent on October 11, 1994. Thus, full disclosure occurred on October 11, 1994. Therefore,
in accordance with 19 CFR 353.28(6), the deadline for submission of allegations of clerical errors regarding our
calculations was 
<!-- PJG 0012 frnewline -->
October 18, 1994. We received the respondent's allegation of clerical errors in a timely fashion on October 18, 1994,
and have therefore analyzed it and amended our calculations accordingly. Specifically, we: (1) Amended the calculations
to use the correct data set in the calculation of third-country weighted-average prices, (2) revised third-country
packing costs, (3) corrected the results for the quantity adjustment information for U.S. sales.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00008 </DOCNO>
<PARENT> FR941219-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Final Results of Review
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Upon review of comments submitted, the Department has determined that the following margin exists for the period
November 27, 1991, through May 31, 1993:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,s25,6 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer/Exporter
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Margin (percent)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
New Zealand Kiwifruit Marketing Board 
<!-- PJG 007 0104 intable -->
10.18
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Customs Service shall assess antidumping duties on all appropriate entries. Individual differences between
U.S. price and foreign market value may vary from the percentage stated above. The Department will issue appraisement
instructions concerning the respondent directly to the U.S. Customs Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Furthermore, the following deposit requirements will be effective for all shipments of the subject merchandise,
entered, or withdrawn from warehouse, for consumption on or after the publication date of these amended final results
of administrative review, as provided for by section 751(a)(1) of the Tariff Act of 1930, as amended (the Act): (1)
The cash deposit rate for the reviewed firm will be 10.18%; and (2) the cash deposit rate for merchandise exported by
all other manufacturers and exporters who are not covered by this review will be the ``all others'' rate of 98.60 percent
established in the less-than-fair-value investigation, in accordance with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Floral Trade Council
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 822 F.Supp. 766 (1993), and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Federal Mogul Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 822 F.Supp. 782 (1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These deposit requirements shall remain in effect until publication of the final results of the next administrative
review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This notice serves as the final reminder to importers of their responsibility under 19 CFR 353.26 to file a certificate
regarding the reimbursement of antidumping duties prior to liquidation of the relevant entries during this review
period. Failure to comply with this requirement could result in the Secretary's presumption that reimbursement
of antidumping duties occurred and the subsequent assessment of double antidumping duties.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This notice also serves as a reminder to parties subject to administrative protective order (APO) of their responsibility
concerning the disposition of proprietary information disclosed under APO in accordance with 19 CFR 353.34(d).
Timely written notification or conversion to judicial protective order is hereby requested. Failure to comply with
the regulations and the terms of the APO is a sanctionable violation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This administrative review and notice are in accordance with section 751(f) of the Act (19 U.S.C. 1673(d)) and 19 CFR
353.28(c).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Paul L. Joffe,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Assistant Secretary for Import Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31140 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00009 </DOCNO>
<PARENT> FR941219-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[A&hyph;122&hyph;050]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Racing Plates (Aluminum Horseshoes) From Canada; Preliminary Results of Antidumping Duty Administrative Review
</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Import Administration/International Trade Administration, Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Preliminary Results of Antidumping Duty Administrative Review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In response to a request by a respondent, the Department of Commerce has conducted an administrative review of the
antidumping finding on racing plates from Canada. The review covers one firm and the period February 1, 1993, through
January 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have preliminarily determined that sales have been made below the foreign market value (FMV). If these preliminary
results are adopted in our final results of administrative review, we will instruct U.S. Customs to assess antidumping
duties equal to the difference between the United States price (USP) and the FMV.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested parties are invited to comment on these preliminary results.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
December 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Todd Peterson or Thomas Futtner, Office of Antidumping Compliance, Import Administration, International Trade
Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230; telephone
(202) 482&hyph;4195 or 482&hyph;3814, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On February 27, 1974 (39 FR 7579), the Department of Treasury published the antidumping finding of racing plates (aluminum
horseshoes) from Canada. The Department of Commerce (the Department) published a notice of ``Opportunity to Request
Administrative Review'' on February 4, 1994 (59 FR 5390). The respondent, Equine Forgings Limited, requested that
we conduct an administrative review for the period February 1, 1993, through January 31, 1994. We published a notice
of ``Initiation of Antidumping and Countervailing Duty Administrative Review'' on March 14, 1994 (59 FR 11769) for
Equine Forgings Limited. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department has now conducted the administrative review in accordance with section 751 of the Tariff Act of 1930,
as amended (the Tariff Act). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Scope of the Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Imports covered by the review are shipments of racing plates (horseshoes) that are made of aluminum, may have cleats
or caulks, and come in a variety of sizes. They are used on race horses, polo, jumping, hunting, and other performing
horses, as differentiated from pleasure and work horses. During the review period such merchandise was classifiable
under Harmonized Tariff Schedule (HTS) item number 7616.90.00. This HTS item number is provided for convenience
and customs purposes. The written description remains dispositive. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
United States Price 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In calculating USP, the Department used purchased price, as defined in section 772 of the Tariff Act, since sales to
the first unrelated purchaser were made prior to the date of importation. Purchase price was based on the packed f.o.b.
price to unrelated purchasers in the United States. We made deductions, where appropriate, for inland freight, U.S.
duty, and brokerage/handling charges. We adjusted USP for taxes in accordance with our practice as outlined in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Silicomanganse from Venezuela, Preliminary Determination of Sales at Less Than Fair Value 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(59 FR 31204, June 17, 1994). No other adjustments were claimed or allowed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Foreign Market Value 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In calculating FMV, we used home market price, as defined in section 773 of the Tariff Act, since sufficient quantities
of such or similar merchandise were sold in the home market to provide a basis for comparison. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Home market price was based upon the packed f.o.b. price to unrelated purchasers in Canada, with appropriate deductions
for rebates. We adjusted for Canadian value-added tax in accordance with our decision 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Silicomanganese from Venezuela, Preliminary Determination of Sales at Less Than Fair Value 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(59 FR 31204, June 17, 1994). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In accordance with the Court of Appeals for the Federal Circuit's decision in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The Ad Hoc Committee of AZ&hyph;NM&hyph;TX&hyph;FL Producers of Grey Portland Cement v. United States, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No. 93&hyph;1239, (January 5, 1994), we no longer deduct home market movement expenses from FMV pursuant to the Department's
inherent power to fill in gaps in the antidumping statute. Accordingly, we now adjust for such expenses under the circumstance-of-sale
provision of 19 CFR 352.56 and the ESP offset provision of 19 CFR 353.56(b)(1)(2), as appropriate. As a result, we have
not adjusted for Equine Forging's reported home market inland freight as movement expenses. Rather, we have treated
Equine Forging's reported post-sale inland freight as a direct selling expense, which we have deducted from FMV.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00010 </DOCNO>
<PARENT> FR941219-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Preliminary Results of Review
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have preliminarily determined that the following margin exists for the period February 1, 1993, through January
31, 1994:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,s25,6 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer/Exporter
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Margin (percent)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Equine Forgings Limited
<!-- PJG 007 0104 intable -->
0.01
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department shall determine, and the Customs Service shall assess, antidumping duties on all appropriate entries.
Upon completion of this review, the Department will issue appraisement instructions directly to the U.S. Customs
Service. 
<!-- PJG 0012 frnewline -->
Furthermore, the following deposit requirements will be effective for all shipments of the subject merchandise,
entered, or withdrawn from warehouse, for consumption on or after the publication date of the final results of this
administrative review, as provided for by section 751(a)(1) of the Tariff Act: (1) The cash deposit rate for the reviewed
firm will be that firm's rate established in the final results of this administrative review. If the rate in the final
results of review for Equine Forgings Limited is 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 there will be no cash deposits required on shipments from this firm. (2) For previously reviewed or investigated companies
not listed above, the cash deposit rate will continue to be the company-specific rate published for the most recent
period. (3) If the exporter is not a firm covered in this review, a previous review, or the original less than fair value
(LTFV) investigation, but the manufacturer is, the cash deposit rate will be the rate established for the most recent
period for the manufacturer of the merchandise.
<!-- PJG 0012 frnewline -->
On May 25, 1993, the Court of International Trade, in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Floral Trade Council 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Slip Op. 93&hyph;79, and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Federal-Mogul Corporation and the Torrington Company
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Slip Op. 93&hyph;83, decided that once an ``all others'' rate is established for a company, it can only be changed through
an administrative review. The Department has determined that in order to implement these decisions, it is appropriate
to apply the original ``all others'' rate from the LTFV investigation (or that rate as amended for correction of clerical
errors or as a result of litigation) in proceedings governed by antidumping duty orders for the purposes of establishing
cash deposits in all current and future administrative reviews. In proceedings governed by antidumping findings,
unless we are able to ascertain the ``all others'' rate from the Treasury LTFV investigation, the Department has determined
that it is appropriate to adopt the ``new shipper'' rate established in the first final results of administrative
review published by the Department (or that rate amended for correction of clerical errors or as a result of litigation)
as the ``all others'' rate for the purpose of establishing cash deposits in all current and future administrative
reviews.
<!-- PJG 0012 frnewline -->
Because this proceeding is governed by an antidumping finding and we are unable to ascertain the ``all others'' rate
from the Treasury LTFV investigation, the ``all others'' rate for purposes of this review will be 6.77 percent, the
``new shipper'' rate established in the final results of administrative review published by the Department (47 FR
51779, November 17, 1982). 
<!-- PJG 0012 frnewline -->
These deposit requirements, when imposed, shall remain in effect until publication of the final results of the next
administrative review.
<!-- PJG 0012 frnewline -->
Interested parties may request disclosure within 5 days of the date of publication of this notice, and a hearing within
10 days of the date of publication. Any hearing requested will be held as early as convenient for parties but no later
than 44 days after the date of publication, or the first workday thereafter. Case briefs, or other written comments,
from interested parties may be submitted not later than 30 days after the date of publication of this notice. Rebuttal
briefs and rebuttal comments, limited to issues raised in the case briefs, may be filed not later than 37 days after
the date of publication. The Department will publish the final results of review, including its results of its analysis
of issues raised in any such written comments or at a hearing.
<!-- PJG 0012 frnewline -->
This notice serves as a preliminary reminder to importers of their responsibility under 19 CFR 353.26 to file a certificate
regarding the reimbursement of antidumping duties prior to liquidation of the relevant entries during this review
period. Failure to comply with this requirement could result in the Secretary's presumption that reimbursement
of antidumping duties occurred and the subsequent assessment of double antidumping duties.
<!-- PJG 0012 frnewline -->
This administrative review and notice are in accordance with section 751(a)(1) of the Tariff Act (19 U.S.C. 1675(a)(1))
and 19 CFR 353.22.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Susan G. Esserman,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Import Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31139 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00011 </DOCNO>
<PARENT> FR941219-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[C&hyph;614&hyph;701]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Determination Not To Revoke Countervailing Duty Order; Certain Steel Wire Nails From New Zealand </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Import Administration, International Trade Administration, Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Determination Not To Revoke Countervailing Duty Order. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Department of Commerce (the Department) is notifying the public of its determination not to revoke the countervailing
duty order on steel wire nails from New Zealand. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 December 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Brian Albright, Office of Countervailing Compliance, Import Administration, International Trade Administration,
U.S. Department of Commerce, 14th Street and Constitution Avenue, NW, Washington, DC 20230; telephone: (202) 482&hyph;2786.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 29, 1994, the Department published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (59 FR 49643) its intent to revoke the countervailing duty order on steel wire nails from New Zealand (52 FR 37196; October
5, 1987). Under 19 CFR 355.25(d)(4)(iii), the Secretary of Commerce will conclude that an order is no longer of interest
to interested parties and will revoke the order if no domestic interested party objects to revocation and no interested
party requests an administrative review by the last day of the fifth anniversary month. 
<!-- PJG 0012 frnewline -->
Within the specified time frame, we received objections from domestic interested parties to our intent to revoke
this countervailing duty order. Therefore, because the requirements of 19 CFR 355.25(d)(4)(iii) have not been met,
we will not revoke this order. 
<!-- PJG 0012 frnewline -->
This determination is in accordance with 19 CFR 355.25(d)(4). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph A. Spetrini,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Assistant Secretary 
<!-- PJG 0012 frnewline -->
for Compliance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31141 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00012 </DOCNO>
<PARENT> FR941219-2-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>CORPORATION FOR NATIONAL AND COMMUNITY SERVICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Members of the Performance Review Board</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Corporation for National and Community Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
List of Performance Review Board Members.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Corporation publishes the revised list of positions which comprise the Performance Review Board established
under the Civil Service Reform Act.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Phyllis D. Beaulieu, Director of Personnel, Corporation for National and Community Service (CNCS), 1201 New York
Avenue, NW., Room 7309, Washington, DC 20525, (202) 606&hyph;5000, extension 321.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Civil Service Reform Act requires that each agency establish one or more Performance Review Boards to review and
evaluate the initial appraisals of senior executives' performance, make recommendations to the appointing authority
concerning their performance, to include performance bonuses and to make recommendations for recertification.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The incumbents of the following positions will serve as members of the CNCS Performance Review Board.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. Chief Operating Officer_Chairman
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Comptroller
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. General Counsel
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Eli Segal,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief Executive Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31153 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6050&hyph;28&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00013 </DOCNO>
<PARENT> FR941219-2-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Establishment, Amendment and Adjustment of Import Limits and Amendment of a Restraint Period for Certain Cotton,
Man-Made Fiber, Silk Blend and Other Vegetable Fiber Textile Products Produced or Manufactured in Bangladesh</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Committee for the Implementation of Textile Agreements (CITA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Issuing a directive to the Commissioner of Customs establishing, amending and adjusting limits and amending a restraint
period.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
December 20, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ross Arnold, International Trade Specialist, Office of Textiles and Apparel, U.S. Department of Commerce, (202)
482&hyph;4212. For information on the quota status of these limits, refer to the Quota Status Reports posted on the
bulletin boards of each Customs port or call (202) 927&hyph;5850. For information on embargoes and quota re-openings,
call (202) 482&hyph;3715.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Executive Order 11651 of March 3, 1972, as amended; section 204 of the Agricultural Act of 1956, as amended (7 U.S.C.
1854).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Bilateral Textile Agreement of December 10, 1994 between the Governments of the United States and the People's
Republic of Bangladesh establishes limits for the periods February 1, 1994 and through December 31, 1994 and December
1, 1994 through December 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the letter published below, the Chairman of CITA directs the Commissioner of Customs to amend the current limits
for certain categories for the new restraint period beginning on February 1, 1994 and extending through December
31, 1994. These amended limits include special carryforward, as well as flexibility previously applied. Also, the
new limit established for Categories 352/652 for the period December 1, 1994 through December 31, 1994 has been adjusted
for carryforward and special carryforward. As a result of the amendments to Categories 340/640 and 634, these limits,
which are currently filled, will re-open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A description of the textile and apparel categories in terms of HTS numbers is available in the CORRELATION: Textile
and Apparel Categories with the Harmonized Tariff Schedule of the United States (see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice 58 FR 62645, published on November 29, 1993). Also see 59 FR 4039, published on January 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The letter to the Commissioner of Customs and the actions taken pursuant to it are not designed to implement all of the
provisions of the bilateral agreement, but are designed to assist only in the implementation of certain of its provisions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Committee for the Implementation of Textile Agreements
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=34 g=1 f=1 -->
December 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Commissioner of Customs,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Department of the Treasury, Washington, DC 20229.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dear Commissioner: This directive amends, but does not cancel, the directive issued to you on January 24, 1994, by
the Chairman, Committee for the Implementation of Textile Agreements. That directive concerns imports of certain
cotton, man-made fiber, silk blend and other vegetable fiber textiles and textile products, produced or manufactured
in Bangladesh and exported during the twelve-month period which began on February 1, 1994 and extends through January
31, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Effective on December 20, 1994, you are directed, pursuant to the Bilateral Textile Agreement of December 10, 1994
between the Governments of the United States and the People's Republic of Bangladesh, to amend the current restraint
period to end on December 31, 1994 at the adjusted limits listed below. Also, you are directed to establish a limit at
1,210,000 dozen
<FOOTCITE>1</FOOTCITE>
 for Categories 352/652 for the period December 1, 1994 through December 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=3 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=3 -->
The limit has not been adjusted to account for any imports exported after November 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<TABLE>

<!-- PJG tableformat 2,L2,i1,s70,r78 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Category
<!-- PJG 007 0150 intable -->
1Adjusted eleven-month limit
<!-- PJG ITAG l=28 g=5 f=1 -->
a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
237
<!-- PJG 007 0104 intable -->
386,680 dozen
<!-- PJG 0012 frnewline -->
331
<!-- PJG 007 0104 intable -->
979,638 dozen pairs.
<!-- PJG 0012 frnewline -->
334
<!-- PJG 007 0104 intable -->
122,843 dozen.
<!-- PJG 0012 frnewline -->
335
<!-- PJG 007 0104 intable -->
211,811 dozen.
<!-- PJG 0012 frnewline -->
336/636
<!-- PJG 007 0104 intable -->
364,124 dozen. 
<!-- PJG 0012 frnewline -->
338/339
<!-- PJG 007 0104 intable -->
1,001,185 dozen.
<!-- PJG 0012 frnewline -->
340/640
<!-- PJG 007 0104 intable -->
2,602,866 dozen.
<!-- PJG 0012 frnewline -->
341
<!-- PJG 007 0104 intable -->
2,156,239 dozen.
<!-- PJG 0012 frnewline -->
342/642
<!-- PJG 007 0104 intable -->
315,315 dozen.
<!-- PJG 0012 frnewline -->
347/348
<!-- PJG 007 0104 intable -->
1,932,163 dozen.
<!-- PJG 0012 frnewline -->
351/651
<!-- PJG 007 0104 intable -->
592,500 dozen.
<!-- PJG 0012 frnewline -->
363
<!-- PJG 007 0104 intable -->
23,149,740 numbers.
<!-- PJG 0012 frnewline -->
369&hyph;S
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0104 intable -->
1,354,399 kilograms.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
634
<!-- PJG 007 0104 intable -->
432,778 dozen.
<!-- PJG 0012 frnewline -->
635
<!-- PJG 007 0104 intable -->
280,390 dozen.
<!-- PJG 0012 frnewline -->
638/639
<!-- PJG 007 0104 intable -->
1,094,804 dozen.
<!-- PJG 0012 frnewline -->
641
<!-- PJG 007 0104 intable -->
946,407 dozen.
<!-- PJG 0012 frnewline -->
645/646
<!-- PJG 007 0104 intable -->
281,880 dozen.
<!-- PJG 0012 frnewline -->
647/648
<!-- PJG 007 0104 intable -->
1,018,307 dozen.
<!-- PJG 0012 frnewline -->
847
<!-- PJG 007 0104 intable -->
704,828 dozen.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
The limits have not been adjusted to account for any imports exported after January 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=1 -->
b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Category 369&hyph;S: only HTS number 6307.10.2005.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Textile products in Categories 352/652 which have been exported to the United States prior to December 1, 1994 shall
not be subject to this directive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Textile products in Categories 352/652 which have been released from the custody of the U.S. Customs Service under
the provisions of 19 U.S.C. 1448(b) or 1484(a)(1) prior to the effective date of this directive shall not be denied
entry under this directive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Committee for the Implementation of Textile Agreements has determined that these actions fall within the foreign
affairs exception to the rulemaking provisions of 5 U.S.C. 553(a)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sincerely,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31223 Filed 12&hyph;15&hyph;94; 2:19 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DR&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00014 </DOCNO>
<PARENT> FR941219-2-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF DEFENSE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Marine Mammals 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Advanced Research Projects Agency.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of public hearing on draft environmental impact statement; change in public comment period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Advanced Research Projects Agency (ARPA), in cooperation with the National Marine Fisheries Service (NMFS),
and the University of California, San Diego (UCSD) as the state lead agency, announced notice on December 2, 1994 (59
FR 61882) of a public hearing on a draft environmental impact statement/environmental impact report EIS/EIR) for
the California Acoustic Thermometry of Ocean Climate (ATOC) Project and its associated Marine Mammal Research Program.
This notice is to extend the public comment period to January 31, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Advanced Research Projects Agency, Attn: Dr. Ralph W. Alewine, III, (703) 696&hyph;2246.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31033 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00015 </DOCNO>
<PARENT> FR941219-2-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirement Submitted to the Office of Management and Budget (OMB) for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The Department of Defense has submitted to OMB for clearance, the following proposal for collection of information
under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Title; Applicable Forms; and OMB Control Number: Freight Carrier Qualification Statement/Required Documents;
MT Forms 377&hyph;R, 380&hyph;R, and 381&hyph;R; OMB Control Number 0702&hyph;0088
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Type of Request: Reinstatement
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Number of Respondents: 1,400
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Responses per Respondent: 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Annual Responses: 1,400
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Average Burden per Response: 8.5 hours
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Annual Burden Hours: 11,900
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Needs and Uses: The information collected hereby, enables the Military Traffic Management Command (MTMC) to determine
the capability of carriers to perform quality service transporting Department of Defense freight. The information
which the carriers furnish MTMC assists in determining if individuals or associated companies are affiliated with
government-debarred carriers, as well as in determining carriers' financial stability
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Affected Public: Businesses or other for-profit; Small businesses or organizations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Frequency: On occasion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Respondent's Obligation: Required to obtain or retain a benefit
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
OMB Desk Officer: Mr. Edward C. Springer. Written comments and recommendations on the proposed information collection
should be sent to Mr. Springer at the Office of Management and Budget, Desk Officer for DoD, Room 10236, New Executive
Office Building, Washington, DC 20503
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
DOD Clearance Officer: Mr. William Pearce. Written requests for copies of the information collection proposal should
be sent to Mr. Pearce WHS/DIOR, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202&hyph;4302.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31031 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00016 </DOCNO>
<PARENT> FR941219-2-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirement Submitted to OMB for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Defense has submitted to OMB for clearance the following proposal for collection of information
under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Title: National Civic Outreach Program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Type of Request: New collection
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Average Burden Hours/Minutes per Response: 10 minutes
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Responses per Respondent: 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Number of Respondents: 2,500
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Annual Burden Hours: 417
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Annual Responses: 2,500
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Needs and Uses: This information collection is used to analyze and determine the effectiveness of the National Civic
Outreach Program. Since our customers are the public (civic organizations, business leaders, etc.) these surveys
provide the most accurate source of information to evaluate this program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Affected Public: Individuals or households, businesses or other for-profit, small businesses or organizations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Frequency: On occasion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Respondent's Obligation: Voluntary
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
OMB Desk Officer: Mr. Edward C. Springer. Written comments and recommendations on the proposed information collection
should be sent to Mr. Springer at the Office of Management and Budget, Desk Officer for DoD, Room 10236, New Executive
Office Building, Washington, DC 20503
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
DOD Clearance Officer: Mr. William P. Pearce. Written requests for copies of the information collection proposal
should be sent to Mr. Pearce, WHS/DIOR, 1215 Jefferson Davis Highway, Suite 1204, Arlington, Virginia 22202&hyph;4302.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31032 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00017 </DOCNO>
<PARENT> FR941219-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Army</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Army Science Board; Open Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (P.L. 92&hyph;463), announcement is made
of the following Committee Meeting:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Name of Committee: Army Science Board (ASB).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Date of Meeting: 12 January 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Time of Meeting: 0930&hyph;1700.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Place: Pentagon, Washington, DC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Agenda: The Army Science Board (ASB) Study Panel to monitor the Army's implementation of the ASB 1994 Summer Study
``Technical Architecture for C4I'' will have a working session in the Pentagon on the above mentioned date. This meeting
will be open to the public. Any interested person may attend, appear before, or file statements with the committee
at the time and in the manner permitted by the committee. The ASB Administrative Officer, Sally Warner, may be contacted
for further information at (703) 695&hyph;3039/7046.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sally A. Warner,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrative Officer, Army Science Board.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31155 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3710&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00018 </DOCNO>
<PARENT> FR941219-2-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF EDUCATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CFDA NO: 84.217]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Ronald E. McNair Postbaccalaureate Achievement Program; Notice Inviting Applications for New Awards for Fiscal
Year (FY) 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Purpose of Program:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The purpose of this program is to provide 
<!-- PJG 0012 frnewline -->
grants for higher education institutions to prepare low-income, 
<!-- PJG 0012 frnewline -->
first-generation college students, and students from groups 
<!-- PJG 0012 frnewline -->
underrepresented in graduate education, for doctoral study. This program supports the National Education Goals
by funding projects designed to increase the number of United States undergraduate and graduate students, especially
minorities, who complete advanced degrees in numerous disciplines, including the fields of mathematics and science.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligible Applicants:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Institutions of higher education and combinations of those institutions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Deadline for Transmittal of Applications:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 February 3, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Deadline for Intergovernmental Review:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 April 4, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Applications Available:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 December 23, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Available Funds:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 $17,900,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimated Range of Awards:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 $190,000_$250,000 per year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimated Average Size of Awards:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 $195,000 per year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimated Number of Awards:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 92. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Project Period:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Up to 60 months. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: The Department is not bound by any estimates in this notice, except as otherwise provided by statute. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Applicable Regulations:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (a) The Education Department General 
<!-- PJG 0012 frnewline -->
Administrative Regulations (EDGAR) in 34 CFR parts 74, 75, 77, 79, 82, 85, and 86; and (b) The regulations for this program
in 34 CFR part 647 as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on August 25, 1994 (59 FR 43986&hyph;92). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
For Applications or Information Contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Eileen S. Bland, Special Services Branch, Division of Student Services, U.S. Department of Education, 600 Independence
Avenue, S.W., Washington, D.C. 20202&hyph;5249. Telephone: (202) 708&hyph;4804. Individuals who use a telecommunications
device for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 
<!-- PJG 0012 frnewline -->
1&hyph;800&hyph;877&hyph;8339 between 8 a.m. and 8 p.m. Eastern Standard Time, Monday through Friday. 
<!-- PJG 0012 frnewline -->
Information about the Department's funding opportunities, including copies of application notices for discretionary
grant competitions, can be viewed on the Department's electronic bulletin board (ED Board), telephone (202) 260&hyph;9950;
or on the Internet Gopher Server at GOPHER.ED.GOV (under Announcements, Bulletins, and Press Releases). However,
the official application notice for a discretionary grant competition is the notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Program Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 20 U.S.C. 1070a&hyph;11 and 1070a&hyph;15.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David A. Longanecker, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary 
<!-- PJG 0012 frnewline -->
for Postsecondary Education. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31099 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4000&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00019 </DOCNO>
<PARENT> FR941219-2-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Federal Interagency Coordinating Council Meeting (FICC)</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Interagency Coordinating Council, Education.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of public meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice describes the schedule and agenda of a forthcoming meeting of the Federal Interagency Coordinating Council.
Notice of this meeting is required under section 685(c) of the Individuals with Disabilities Education Act, as amended,
and is intended to notify the general public of their opportunity to attend the meeting. The meeting will be accessible
to individuals with disabilities.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATE AND TIME: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 26, 1995, from 1 p.m. to 4:30 p.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Hubert H. Humphrey Building, Room 703A/727A, 200 Independence Avenue, SW., Washington, DC 20202.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Connie Garner, U.S. Department of Education, 600 Independence Avenue, SW., Room 3127, Switzer Building, Washington,
DC 20202&hyph;2644. Telephone: (202) 205&hyph;8124. Individuals who use a telecommunications device for the deaf
(TDD) may call (202) 205&hyph;8170.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Federal Interagency Coordinating Council (FICC) is established under section 685 of the Individuals with Disabilities
Education Act, as amended (20 U.S.C. 1484a). The Council is established to: (1) Minimize duplication across Federal,
State and local agencies of programs and activities relating to early intervention services for infants and toddlers
with disabilities and their families and preschool services for children with disabilities; (2) ensure effective
coordination of Federal early intervention and preschool programs, including Federal technical assistance and
support activities; and (3) identify gaps in Federal agency programs and services and barriers to Federal interagency
cooperation. To meet these purposes, the FICC seeks to: (1) Identify areas of conflict, overlap, and omissions in
interagency policies related to the provision of services to infants, toddlers, and preschoolers with disabilities;
(2) develop and implement joint policy interpretations on issues related to infants, toddlers, and preschoolers
that cut across Federal agencies, including modifications of regulations to eliminate barriers to interagency
programs and activities; and (3) coordinate the provision of technical assistance and dissemination of best practice
information. The FICC is chaired by the Assistant Secretary for Special Education and Rehabilitative Services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At this meeting the FICC plans to: (1) Update the membership on the reauthorization IDEA; and (2) finalize the FICC
strategic plan.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The meeting of the FICC is open to the public. Written public comment will be accepted at the conclusion of the meeting.
These comments will be included in the summary minutes of the meeting. The meeting will be physically accessible with
meeting materials provided in both braille and large print. Interpreters for persons who are hearing impaired will
be available. Individuals with disabilities who plan to attend and need other reasonable accommodations should
contact the contact person named above in advance of the meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Summary minutes of the FICC meetings will be maintained and available for public inspection at the U.S. Department
of Education, 600 Independence Avenue, SW., Room 3127, Switzer Building, Washington, DC 20202&hyph;2644, from
the hours of 9 a.m. to 5 p.m., weekdays except Federal holidays.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Judith E. Heumann,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Special Education and Rehabilitative Services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31144 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4000&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00020 </DOCNO>
<PARENT> FR941219-2-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Issuance of Proposed Decisions and Orders During the Week of November 14 through November 18, 1994 </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->
Office of Hearings and Appeals
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the week of November 14 through November 18, 1994, the proposed decisions and orders summarized below were
issued by the Office of Hearings and Appeals of the Department of Energy with regard to applications for exception.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the procedural regulations that apply to exception proceedings (10 C.F.R. Part 205, Subpart D), any person
who will be aggrieved by the issuance of a proposed decision and order in final form may file a written notice of objection
within ten days of service. For purposes of the procedural regulations, the date of service of notice is deemed to be
the date of publication of this Notice or the date an aggrieved person receives actual notice, whichever occurs first.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The procedural regulations provide that an aggrieved party who fails to file a Notice of Objection within the time
period specified in the regulations will be deemed to consent to the issuance of the proposed decision and order in
final form. An aggrieved party who wishes to contest a determination made in a proposed decision and order must also
file a detailed statement of objections within 30 days of the date of service of the proposed decision and order. In
the statement of objections, the aggrieved party must specify each issue of fact or law that it intends to contest in
any further proceeding involving the exception matter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the full text of these proposed decisions and orders are available in the Public Reference Room of the Office
of Hearings and Appeals, Room 1E&hyph;234, Forrestal Building, 1000 Independence Avenue, S.W., Washington, D.C.
20585, Monday through Friday, between the hours of 1:00 p.m. and 5:00 p.m., except federal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
George B. Breznay, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Hearings and Appeals.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Farm, Fuel &amp; Feed, Kuna, Idaho, LEE&hyph;0164, Reporting Requirements 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Farm, Fuel &amp; Feed filed an Application for Exception from the Energy Information Administration (EIA) requirement
that it file Form EIA&hyph;782B, the ``Resellers'/Retailers' Monthly Petroleum Product Sales Report.'' In considering
this request, the DOE found that the firm was not suffering a gross inequity or serious hardship. Accordingly, on November
14, 1994, the DOE issued a Proposed Decision and Order determining that the exception request should be denied. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Hood River, Supply Association, Hood River, OR, LEE&hyph;0134, Reporting Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Hood River Supply Association filed an Application for Exception from the Energy Information Administration (EIA)
requirement that it file Form EIA&hyph;782B, the ``Resellers'/Retailers' Monthly Petroleum Product Sales Report.''
In considering this request, the DOE found that the firm was not suffering a serious hardship or gross inequity. Accordingly,
on November 14, 1994, the DOE issued a Proposed Decision and Order determining that the exception request should be
denied. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31134 Filed 12&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00021 </DOCNO>
<PARENT> FR941219-2-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Oak Ridge Operations Office; Financial Assistance Award; United States Automotive Materials Partnership</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of intent to award an unsolicited application financial assistance award.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The U.S. Department of Energy (DOE), Oak Ridge Operations Office, announces that pursuant to 10 CFR 600.6(a)(2),
it is making a discretionary financial assistance award based on acceptance of an unsolicited application meeting
the criteria of 10 CFR 600.14(e)(1) under Cooperative Agreement Number DE&hyph;FC05&hyph;950R22363 to the United
States Automotive Materials Partnership (USAMP). USAMP is a consortium of Chrysler Corporation, Ford Motor Company,
and General Motors Corporation. The proposed cooperative agreement will provide estimated funding in the amount
of $1,660,000 by the DOE for a project entitled, ``Automotive Lightweight Materials Program''. The purpose of this
effort is to define and conduct pre-competitive, vehicle-related research and development (R&amp;D) in materials
and materials processing which will improve the competitiveness of the U.S. automotive industry. USAMP goals are
to develop several families of automotive materials that will impact strategic needs of the industry. These funds
will be matched equally by USAMP under this cooperative agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Please write the U.S. Department of Energy, ORNL Site Office, Energy Programs Division, ATTN: Mary H. Rawlins, ER&hyph;11,
Bethel Valley Road, Oak Ridge, TN 37831&hyph;6269.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The DOE has determined in accordance with 10 CFR 600.14(f), that the unsolicited application for financial assistance
submitted by USAMP, is meritorious based on the general evaluation required by 10 CFR 600.14(d) and that the proposed
project represents a unique idea, that would not be eligible for financial assistance under a recent, current, or
planned solicitation. The applicant is a consortium of the three largest automotive manufacturers in the United
States. These competitive companies have come together as several consortia under the United States Council for
Automotive Research (USCAR) to work together to jointly advance ``precompetitive'' automotive technologies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The anticipated term of the proposed cooperative agreement is one year from the effective date of the award. This award
will not be made for at least 14 days after publication to allow for public comment.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Oak Ridge, Tennessee, on December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Peter D. Dayton,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Procurement and Contracts Division, Oak Ridge Operations Office.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31136 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00022 </DOCNO>
<PARENT> FR941219-2-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Energy Information Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Agency Information Collection Under Review by the Office of Management and Budget </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Energy Information Administration, Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of request submitted for review by the Office of Management and Budget. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Energy Information Administration (EIA) has 
<!-- PJG 0012 frnewline -->
submitted the energy information collection(s) listed at the end of this notice to the Office of Management and Budget
(OMB) for 
<!-- PJG 0012 frnewline -->
review under provisions of the Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->
(Pub. L. No. 96&hyph;511, 44 U.S.C. 3501 et seq.). The listing does not include collections of information contained
in new or revised regulations which are to be submitted under section 3504(h) of the Paperwork Reduction Act, nor management
and procurement assistance requirements collected by the Department of Energy (DOE). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Each entry contains the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The sponsor of the collection (the DOE component or Federal Energy Regulatory Commission (FERC)); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Collection number(s); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Current OMB docket number (if applicable); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Collection title; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Type of request, e.g., new, revision, extension, or reinstatement; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) Frequency of collection; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) Response obligation, i.e., mandatory, voluntary, or required to obtain or retain benefit; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(8) Affected public; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(9) An estimate of the number of respondents 
<!-- PJG 0012 frnewline -->
per report period; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(10) An estimate of the number of responses per respondent annually; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(11) An estimate of the average hours per response; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(12) The estimated total annual respondent burden; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(13) A brief abstract describing the proposed collection and the respondents. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be filed on or before January 18, 1995. If you anticipate that you will be submitting comments but find
it difficult to do so within the time allowed by this notice, you should advise the OMB DOE Desk Officer listed below
of your intention to do so as soon as possible. The Desk Officer may be telephoned at (202) 395&hyph;3084. (Also, please
notify the EIA contact listed below.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Address comments to the Department of Energy Desk 
<!-- PJG 0012 frnewline -->
Officer, Office of Information and Regulatory Affairs, Office of 
<!-- PJG 0012 frnewline -->
Management and Budget, 726 Jackson Place NW., Washington, D.C. 
<!-- PJG 0012 frnewline -->
20503. (Comments should also be addressed to the Office of 
<!-- PJG 0012 frnewline -->
Statistical Standards at the address below.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Requests for additional information or copies of the forms and instructions should be directed to 
<!-- PJG 0012 frnewline -->
Herbert Miller, Office of Statistical Standards, (EI&hyph;73), Forrestal Building, U.S. Department of Energy,
Washington, D.C. 
<!-- PJG 0012 frnewline -->
20585. Mr. Miller may be telephoned at (202) 254&hyph;5346. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The energy information collection submitted to OMB for review was: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. Energy Information Administration 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. EIA&hyph;890 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. 1905&hyph;0189 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Clean City Vehicle Fleet Survey 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Revision 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. On occasion 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Voluntary 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. State or local governments; Businesses or other for-profit; Non-profit institutions; Small businesses or organizations

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. 30,000 respondents 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. 1 response 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. .048 hours per response 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. 1,430 hours respondent burden 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. EIA&hyph;890 will be used to collect data on private and local government fleets of motor vehicles. Data will be
used to meet the objectives of the Energy Policy Act. Respondents will consist of a sample of all fleets in 5 metropolitan
areas. (The Atlanta area was surveyed in 1994 and the Denver area has been selected as the second metropolitan area
for this survey.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Statutory Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sec. 2(a) of the Paperwork Reduction Act of 1980, (Pub. L. No. 96&hyph;511), which amended Chapter 35 of Title 44 United
States Code (See 44 U.S.C. &sect;3506(a) and (c)(1). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, D.C., December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Yvonne M. Bishop, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Statistical Standards, Energy Information Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31135 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00023 </DOCNO>
<PARENT> FR941219-2-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP95&hyph;33&hyph;001]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Williston Basin Interstate Pipeline Company; Notice of Compliance Tariff Filing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 9, 1994, Williston Basin Interstate Pipeline Company (Williston Basin), tendered for
filing in response to the November 30, 1994, Letter Order issued in the above-referenced docket, Substitute First
Revised Sheet No. 243 to Second Revised Volume No. 1 of its FERC Gas Tariff. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Williston Basin states that in the November 30 Letter Order, the Commission rejected Williston Basin's proposed
deletion of certain language in First Revised Sheet No. 243. Williston Basin states that on the apparent assumption
that the only change contained in First Revised Sheet No. 243 was the deletion of that language, the Letter Order rejected
the entirety of the sheet. However, it states, that sheet also contained changes that were necessitated by the changes
made to the tariff sheets that were accepted by the Letter Order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Williston Basin states that it is resubmitting the tariff sheet in question with the previously stricken language
included along with the changes necessary to conform Sheet No. 243 with the accepted tariff sheets. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, N.E., Washington, D.C. 20426, in accordance with Rule 211 of the Commission's Rules of Practice
and Procedure (18 CFR 385.211). All such protests should be filed on or before December 20, 1994. Protests will be considered
by the Commission in determining the appropriate action to be taken, but will not serve to make the protestants parties
to the proceeding. Copies of the filing are on file with the Commission and are available for public inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31053 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00024 </DOCNO>
<PARENT> FR941219-2-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. GT94&hyph;68&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Alabama-Tennessee Natural Gas Company; Notice of Report of Refunds</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on September 9, 1994, Alabama-Tennessee Natural Gas Company (Alabama-Tennessee), tendered for
filing its report concerning refunds it received from its historical, upstream natural gas pipeline supplier, Tennessee
Gas Pipeline Company (Tennessee), in connection with Tennessee's settlement of various matters in Docket No. RP91&hyph;203&hyph;000,
et al. 
<!-- PJG 0012 frnewline -->
Alabama-Tennessee states that the refund includes principal amounts for the period prior to Tennessee's Restructuring
under Order No. 636 (February 1, 1993 through August 31, 1993) and interest through June 3, 1994 at the FERC interest
rate in accordance with Section 154.67(c)(2) of the Commission's Regulations. 
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, N.E., Washington, D.C. 20426, in accordance with Rule 211 of the Commission's Rules of Practice
Procedure 18 CFR 385.211. All such protests should be filed on or before December 20, 1994. Protests will be considered
by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties
to the proceeding. Copies of this filing are on file with the Commission and are available for public inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31049 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00025 </DOCNO>
<PARENT> FR941219-2-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. CP95&hyph;109&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>CNG Transmission Corporation; Application</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 2, 1994, CNG Transmission Corporation (CNG), 445 West Main Street, Clarksburg, West
Virginia 26031, filed in an abbreviated application pursuant to Section 7(c) of the Natural Gas Act for a certificate
of public convenience and necessity authorizing CNG to construct and operate, for the transmission of natural gas,
4.73 miles of 30-inch underground pipeline in Rotterdam Township, Schenectady County, New York, all as more fully
set forth in the application which is one file with the Commission and open to public inspection. The construction
cost is estimated by CNG to be $7,991,600 dollars. The proposed facility, designated CNG's TL&hyph;450 Extension
5, is needed by CNG to continue to maintain pressure requirements and meet post Order No. 636 obligations for Niagara
Mohawk Power Corporation's distribution system serving the Albany, New York area.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to make any protest with reference to said application should on or before January
3, 1995, file with the Federal Energy Regulatory Commission, Washington, D.C., 20426, a motion to intervene or a protest
in accordance with the requirements of the Commission's Rules of Practice and Procedure (18 CFR 385.214 or 385.211)
and the Regulations under the Natural Gas Act (18 CFR 157.10). All protests filed with the Commission will be considered
by it in determining the appropriate action to be taken, but will not serve to make the protestants parties to the proceedings.
Any person wishing to become a party to a proceeding or to participate as a party in any hearing therein must file a motion
to intervene in accordance with the Commission's Rules.
<!-- PJG 0012 frnewline -->
Take further notice that, pursuant to the authority contained in and subject to the jurisdiction conferred upon the
Federal Energy Regulatory Commission by Sections 7 and 15 of the Natural Gas Act and Commission's Rules of Practice
and Procedure, a hearing will be held without further notice before the Commission or its designee on this application
if no motion to intervene is filed within the time required herein, if the Commission on its own review of the matter
finds that a grant of the certificate is required by the public convenience and necessity. If a motion for leave to intervene
is timely filed, or if the Commission on its own motion believes that a formal hearing is required, further notice of
such hearing will be duly given.
<!-- PJG 0012 frnewline -->
Under the procedure herein provided for, unless otherwise advised, it will be unnecessary for CNG to appear or be represented
at the hearing.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31050 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00026 </DOCNO>
<PARENT> FR941219-2-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;219&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Columbia Gulf Transmission Company; Notice of Informal Settlement Conference </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that an informal settlement conference will be convened in this proceeding on December 20, 1994, at 10:00
a.m., at the offices of the Federal Energy Regulatory Commission, 810 First Street, N.E., Washington, D.C., for the
purpose of exploring the possible settlement of the above-referenced docket. 
<!-- PJG 0012 frnewline -->
Any party, as defined by 18 CFR 385.102(c), or any participant as defined by 18 CFR 385.102(b), is invited to attend.
Persons wishing to become a party must move to intervene and receive intervenor status pursuant to the Commission's
regulations (18 CFR 385.214). 
<!-- PJG 0012 frnewline -->
For additional information, contact Edith A. Gilmore at (202) 208&hyph;2158 or Hollis J. Alpert at (202) 208&hyph;0783.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31051 Filed 12&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00027 </DOCNO>
<PARENT> FR941219-2-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP95&hyph;85&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Mississippi River Transmission Corporation; Notice of Proposed Change in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 7, 1994, Mississippi River Transmission Corporation (MRT), submitted for filing as
part of its FERC Gas Tariff, Third Revised Volume No. 1, First Revised Sheet NO. 9A, proposed to be effective November
1, 1994.
<!-- PJG 0012 frnewline -->
MRT states that the purpose of the filing is to retire Original Sheet No. 9A which provided for the billing of certain
Account Nos. 191 and 858 costs during October, 1994, and reserve Sheet No. 9A for future use.
<!-- PJG 0012 frnewline -->
MRT states that a copy of the filing has been mailed to all of its former jurisdictional sales customers and the State
Commissions of Arkansas, Illinois and Missouri.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, DC 20426, in accordance with Sections
385.211 and 385.214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). All such motions
or protests should be filed on or before December 20, 1994. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing
to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available
for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31052 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00028 </DOCNO>
<PARENT> FR941219-2-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. ER94&hyph;284&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Wisconsin Public Service Corporation, et al.; Electric Rate and Corporate Regulation Filings </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Wisconsin Public Service Corporation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket Nos. ER94&hyph;284&hyph;000, ER94&hyph;1007&hyph;000 and ER94&hyph;1047&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on October 31, 1994, Wisconsin Public Service Corporation tendered for filing a supplement to its

<!-- PJG 0012 frnewline -->
March 15, 1994 filing in the above-referenced dockets. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. Consolidated Edison Company of New York, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER95&hyph;258&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 5, 1994, Consolidated Edison Company of New York, Inc. (Con Edison), tendered for filing
an agreement with Orange &amp; Rockland Utilities, Inc. (O&amp;R) to provide for the sale of energy and capacity subject
to cost based ceiling rates. The ceiling rate for energy is 100 percent of the incremental energy cost plus up to 10 percent
of the SIC (where such 10 percent is limited to 1 mill per KWhr, plus transmission costs, where the SIC in the hour reflects
a purchased power resource). The ceiling rate for capacity sold by Con Edison is $7.70 per megawatt hour. The ceiling
rate for capacity sold by O&amp;R is $14.79 per megawatthour. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Con Edison states that a copy of this filing has been served by mail upon O&amp;R. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. Tucson Electric Power Company 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER95&hyph;259&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 1, 1994, Tucson Electric Power Company (Tucson), tendered for filing an Amendment No.
1 (the Amendment) to the Economy Energy Agreement dated April 26, 1994 between Tucson and the Colorado River Commission
of the State of Nevada (CRC). The Amendment makes an administrative change to the billing provisions of the Agreement.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tucson requests an effective date of December 1, 1994, and therefore requests waiver of the Commission's regulations
with respect to notice of filing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing have been served upon all parties affected by this proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
4. Southern Company Services, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER95&hyph;260&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 5, 1994, Southern Company Services, Inc. (SCS), acting on behalf of Alabama Power Company,
Georgia Power Company, Gulf Power Company, Mississippi Power Company and Savannah Electric and Power Company (collectively
referred to as Southern Companies) filed a Service Agreement dated as of November 14, 1994 between Louis Dreyfus Electric
Power Inc. and SCS (as agent for Southern Companies) for service under the Short-Term Non-Firm Transmission Service
Tariff of Southern Companies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
5. Pacific Gas and Electric Company 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER95&hyph;262&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 6, 1994, Pacific Gas and Electric Company (PG&amp;E), tendered for filing as an initial
rate schedule, a Control Area and Transmission Service Agreement (Agreement) covering rates, terms and conditions
for services rendered by PG&amp;E to Destec Power Services, Inc. (DPS). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Agreement: (1) Identifies the types of suppliers from which DPS can purchase, describes the types loads it can
service, and provides the equations for accounting for balancing of such loads and resources; (2) establishes DPS
control area reliability obligations, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, load following, spinning reserve and power deviation requirements, and gives DPS options to satisfy these obligations
by purchasing services from PG&amp;E, purchasing services from third parties, or satisfying these obligations
using its own resources; and (3) provides flexible network transmission service on both a firm short term and annual
basis among specified generation ``Input'' points and load ``Output'' points. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PG&amp;E is requesting any necessary waivers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were served upon DPS and the California Public Utilities Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 27, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 20426, in accordance with Rules
211 and 214 
<!-- PJG 0012 frnewline -->
of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such motions or protests
should be filed on or before the comment date. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31048 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00029 </DOCNO>
<PARENT> FR941219-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 3721&hyph;001; Project No. 4270&hyph;001; Project No. 4282&hyph;001; Project No. 4312&hyph;001;
Project No. 4628&hyph;001; Project No. 4738&hyph;002; Project No. 9231&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Puget Sound Power &amp; Light Company, et al., Intent To Hold a Public Meeting in Bellingham, WA, To Discuss the Draft
Environmental Impact Statement (DEIS) for Seven Proposed Projects in the Nooksack River Basin</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On December 2, 1994, the Notice of Availability of the Nooksack River Basin DEIS was issued in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (59 FR 61894). The DEIS evaluates the potential environmental and engineering impacts of constructing, operating,
and maintaining seven proposed hydroelectric projects in Whatcom County, Washington.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The DEIS evaluated three alternatives for the seven projects: (1) No action (deny licenses); (2) issue licenses for
the projects as proposed in the license applications; and (3) issue licenses for the projects with additional mitigation
measures proposed by the Commission's staff.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The public meeting, which will be recorded by an official stenographer, is scheduled to begin at 7:00 p.m. on Wednesday,
January 11, 1995, at the County Council Chambers, Whatcom County Courthouse, 311 Grand Avenue, Bellingham, Washington.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
At the meeting, resource agency personnel and other interested persons will have the opportunity to provide oral
and written comments and recommendations regarding the DEIS for the Commission's public record.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Persons choosing not to speak at the meeting, but who have views on the issues or information relevant to the issues,
may submit written statements for inclusion in the public record. Written comments may be filed with the Secretary,
Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, D.C. 20426, until January 30,
1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All written correspondence should clearly show the following caption on the first page: Nooksack River Basin Docket
No. EL85&hyph;19&hyph;118.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further, parties are reminded of the Commission's Rules of Practice and Procedure, requiring parties filing documents
with the Commission, to serve a copy of the document on each person whose name appears on the offical service list.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information, please call Tom Dean at (202) 219&hyph;2778.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31047 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00030 </DOCNO>
<PARENT> FR941219-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 3913&hyph;001; </RINDOCK>
<!-- PJG 0012 frnewline -->
Project No. 4376&hyph;001; 
<!-- PJG 0012 frnewline -->
Project No. 4437&hyph;006; 
<!-- PJG 0012 frnewline -->
Project No. 6984&hyph;000; 
<!-- PJG 0012 frnewline -->
Project No. 9787&hyph;000; 
<!-- PJG 0012 frnewline -->
Project No. 10100&hyph;000; 
<!-- PJG 0012 frnewline -->
Project No. 10269&hyph;002; 
<!-- PJG 0012 frnewline -->
Project No. 10311&hyph;002; 
<!-- PJG 0012 frnewline -->
Project No. 10416&hyph;003] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Puget Sound Power &amp; Light Company, et al.; Intent To Hold a Public Meeting in Mount Vernon, Washington, To Discuss
the Draft Environmental Impact Statement (DEIS) for Nine Proposed Projects in the Skagit River Basin </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On December 2, 1994, the Notice of Availability of the Skagit River Basin DEIS was issued in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (59 FR 61894). The DEIS evaluates the potential environmental impacts of constructing, operating, and maintaining
nine proposed hydroelectric projects in Skagit and Whatcom Counties, Washington. 
<!-- PJG 0012 frnewline -->
The DEIS evaluated three alternatives for the nine projects: (1) No action (deny licenses); (2) issue licenses for
the projects as proposed in the license applications; and (3) issue licenses for the projects with additional mitigation
measures proposed by the Commission's staff. 
<!-- PJG 0012 frnewline -->
The public meeting, which will be recorded by an official stenographer, is scheduled to begin at 7:00 p.m. on Thursday,
January 12, 1995, in Ford Hall (Room 101), Skagit Valley College, Mount Vernon, Washington. 
<!-- PJG 0012 frnewline -->
At the meeting, resource agency personnel and other interested persons will have the opportunity to provide oral
and written comments and recommendations regarding the DEIS for the Commission's public record. 
<!-- PJG 0012 frnewline -->
Persons choosing not to speak at the meeting, but who have views on the issues or information relevant to the issues,
may submit written statements for inclusion in the public record. Written comments may be filed with the Secretary,
Federal Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 20426, until January 30,
1995. 
<!-- PJG 0012 frnewline -->
All written correspondence should clearly show the following caption on the first page: Skagit River Basin DEIS,
FERC Docket No. EL85&hyph;19&hyph;119. 
<!-- PJG 0012 frnewline -->
Further, parties are reminded of the Commission's Rules of Practice and Procedure, requiring parties filing documents
with the Commission, to serve a copy of the document on each person whose name appears on the official service list.

<!-- PJG 0012 frnewline -->
For further information, please call John McEachern at (202) 219&hyph;3056.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31046 Filed 12&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00031 </DOCNO>
<PARENT> FR941219-2-00025 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Cases Filed; The Office of Hearings and Appeals, Week of October 10 Through October 14, 1994 </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
During the Week of October 10 through October 14, 1994, the appeals and applications for exception or other relief
listed in the Appendix to this Notice were filed with the Office of Hearings and Appeals of the Department of Energy.
Submissions inadvertently omitted from earlier lists have also been included. 
<!-- PJG 0012 frnewline -->
Under DOE procedural regulations, 10 C.F.R. Part 205, any person who will be aggrieved by the DOE action sought in these
cases may file written comments on the application within ten days of service of notice, as prescribed in the procedural
regulations. For purposes of the regulations, the date of service of notice is deemed to be the date of publication
of this Notice or the date of receipt by an aggrieved person of actual notice, whichever occurs first. All such comments
shall be filed with the Office of Hearings and Appeals, Department of Energy, Washington, D.C. 20585.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
George B. Breznay, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Hearings and Appeals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00032 </DOCNO>
<PARENT> FR941219-2-00025 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 4,L2,i1,s50,r150,xls72,r200 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
List of Cases Received by the Office of Hearings and Appeals 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[Week of October 10 through October 14, 1994] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date 
<!-- PJG 007 0150 intable -->
1Name and location of applicant 
<!-- PJG 007 0150 intable -->
1Case No. 
<!-- PJG 007 0150 intable -->
1Type of submission
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
7/7/94 
<!-- PJG 007 0104 intable -->
Cantu Shell, Hardin, KY 
<!-- PJG 007 0104 intable -->
RR315&hyph;10 
<!-- PJG 007 0104 intable -->
Request for Modification/Rescission in the Shell Refund Proceeding. If granted: The March 1, 1991 Dismissal Letter,
Case Number RF315&hyph;10007, issued to Cantu Shell regarding the firm's Application for Refund submitted in the
Shell refund proceeding would be modified. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9/13/94 
<!-- PJG 007 0104 intable -->
Westside Gas, Eugene, OR 
<!-- PJG 007 0104 intable -->
RR321&hyph;169 
<!-- PJG 007 0104 intable -->
Request for Modification/Rescission in the Texaco Refund Proceeding. If granted: The September 9, 1994 Dismissal
Letter, Case Number RF321&hyph;19684, issued to Westside Gas regarding the firm's Application for Refund submitted
in the Texaco refund proceeding would be modified. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10/11/94 
<!-- PJG 007 0104 intable -->
Arrow Lakes Dairy, Memphis, TN 
<!-- PJG 007 0104 intable -->
RR300&hyph;260 
<!-- PJG 007 0104 intable -->
Request for Modification/Rescission in the Gulf Refund Proceeding. If granted: The August 11, 1994 Decision and
Order, Case Number 15606, issued to Arrow Lakes Dairy would be modified regarding the firm's Application for Refund
submitted in the Gulf refund proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10/12/94 
<!-- PJG 007 0104 intable -->
Citizen Action, Washington, DC 
<!-- PJG 007 0104 intable -->
VFA&hyph;0002 
<!-- PJG 007 0104 intable -->
Appeal of an Information Request Denial. If granted: The September 21, 1994 Freedom of Information Request Denial
issued by the Office of Energy Markets and End Use would be rescinded, and Citizen Action would receive access to copies
of the Energy Information Administration study entitled ``The Short-Term Impact of Lower World Oil Prices on the
United States Economy'' which was prepared sometime between 1984 and 1986. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10/12/94 
<!-- PJG 007 0104 intable -->
Jane Affleck, Kent, England 
<!-- PJG 007 0104 intable -->
VFA&hyph;0003 
<!-- PJG 007 0104 intable -->
Appeal of an Information Request Denial. If granted: The June 6, 1994 Freedom of Information Request Denial issued
by the Office of Intergovernmental and External Affairs would be rescinded, and Jane Affleck would receive access
from the Department of Defense to updated information concerning the Concept Paper by Tom Starke regarding Non-Lethal
Weapons from the Los Alamos National Laboratory. Jane Affleck would receive a waiver of all fees incurred in the processing
of this information request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10/12/94 
<!-- PJG 007 0104 intable -->
Vulcan Power Company, Boston, MA 
<!-- PJG 007 0104 intable -->
VFA&hyph;0004 
<!-- PJG 007 0104 intable -->
Appeal of an Information Request Denial. If granted: The August 3, 1994 Freedom of Information Request Denial issued
by the Bonneville Power Administration would be rescinded, and Vulcan Power Company would receive access to certain
Department of Energy Information. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10/13/94 
<!-- PJG 007 0104 intable -->
Albuquerque Operations Office, Albuquerque, NM 
<!-- PJG 007 0104 intable -->
VSO&hyph;0004 
<!-- PJG 007 0104 intable -->
Request for Hearing under 10 CFR Part 710. If granted: An individual employed by a sub-contractor at the Los Alamos
National Laboratory would receive a hearing under 10 CFR Part 710.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,s100,r200,xls72 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Refund Applications Received 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[10/10/94&hyph;10/14/94] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date received
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Name of refund proceeding/name of refund applicant
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Case No.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
10/13/94 
<!-- PJG 007 0104 intable -->
Graff's Arco 
<!-- PJG 007 0104 intable -->
RF304&hyph;15461 
<!-- PJG 0012 frnewline -->
10/13/94 
<!-- PJG 007 0104 intable -->
Pride Companies, L.P 
<!-- PJG 007 0104 intable -->
RF345&hyph;32 
<!-- PJG 0012 frnewline -->
10/17/94 
<!-- PJG 007 0104 intable -->
Harvey, IL 
<!-- PJG 007 0104 intable -->
RF272&hyph;99152
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;31131 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00033 </DOCNO>
<PARENT> FR941219-2-00026 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=4 -->

<DOCTITLE>Cases Filed; </DOCTITLE>
<!-- PJG 0012 frnewline -->
Office of Hearings and Appeals, 
<!-- PJG 0012 frnewline -->
Week of October 31 through November 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
During the Week of October 31 through November 4, 1994, the appeals and applications for exception or other relief
listed in the Appendix to this Notice were filed with the Office of Hearings and Appeals of the Department of Energy.
Submissions inadvertently omitted from earlier lists have also been included. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Under DOE procedural regulations, 10 CFR Part 205, any person who will be aggrieved by the DOE action sought in these
cases may file written comments on the application within ten days of service of notice, as prescribed in the procedural
regulations. For purposes of the regulations, the date of service of notice is deemed to be the date of publication
of this Notice or the date of receipt by an aggrieved person of actual notice, whichever occurs first. All such comments
shall be filed with the Office of Hearings and Appeals, Department of Energy, Washington, D.C. 20585.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
George B. Breznay, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Director, 
<!-- PJG 0012 frnewline -->
Office of Hearings and Appeals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00034 </DOCNO>
<PARENT> FR941219-2-00026 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 4,L2,i1,s50,r142,xls72,r188 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
List of Cases Received by the Office of Hearings and Appeals 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[Week of October 31 to November 4, 1994] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date 
<!-- PJG 007 0150 intable -->
1Name and location of applicant 
<!-- PJG 007 0150 intable -->
1Case No. 
<!-- PJG 007 0150 intable -->
1Type of submission 
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
11/01/94 
<!-- PJG 007 0104 intable -->
Rocky Flats Field Office, Golden, Colorado 
<!-- PJG 007 0104 intable -->
VSO&hyph;0006 
<!-- PJG 007 0104 intable -->
Request for a Hearing under 10 C.F.R. Part 710. If granted: An individual employed at Rocky Flats Field Office would
receive a hearing under 10 C.F.R. Part 710. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/01/94 
<!-- PJG 007 0104 intable -->
Rocky Flats Field Office, Golden, Colorado 
<!-- PJG 007 0104 intable -->
VSO&hyph;0007 
<!-- PJG 007 0104 intable -->
Request for a Hearing under 10 C.F.R. Part 710. If granted: An individual employed at Rocky Flats Field Office would
receive a hearing under 10 C.F.R. Part 710. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/01/94 
<!-- PJG 007 0104 intable -->
Rocky Flats Field Office, Golden, Colorado 
<!-- PJG 007 0104 intable -->
VSO&hyph;0008 
<!-- PJG 007 0104 intable -->
Request for Hearing under 10 C.F.R. Part 710. If granted: An individual employed at Rocky Flats Field Office would
receive a hearing under 10 C.F.R. Part 710. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/01/94 
<!-- PJG 007 0104 intable -->
Sause Brothers Ocean Towing Co., Inc., Portland, Oregon 
<!-- PJG 007 0104 intable -->
RR272&hyph;183 
<!-- PJG 007 0104 intable -->
Request for Modification/Rescission in the Crude Oil Refund Proceeding. If granted: The August 26, 1994 Decision
and Order, Case number RF272&hyph;90161, issued to Sause Brothers Ocean Towing Company Incorporated would be modified
regarding the firm's application for refund submitted in the Crude Oil Refund Proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/02/94 
<!-- PJG 007 0104 intable -->
Headquarters, Washington, D.C. 
<!-- PJG 007 0104 intable -->
VSO&hyph;0009 
<!-- PJG 007 0104 intable -->
Request for Hearing under 10 C.F.R. Part 710. If granted: An individual employed at the Department of Energy Headquarters
would receive a hearing under C.F.R. Part 710 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/02/94 
<!-- PJG 007 0104 intable -->
PSI Energy, Inc., Plainfield, Indiana 
<!-- PJG 007 0104 intable -->
VEA&hyph;0001 
<!-- PJG 007 0104 intable -->
Appeal from Special Assessment to the Uranium Enrichment Decontamination and Decommissioning Fund. If granted:
The written determination issued by the Department of Energy on October 3, 1994 would be rescinded and PSI Energy,
Inc. (PSI) would receive a refund of payments made to the Decontamination and Decommissioning Fund, all future obligations
of PSI would be cancelled and PSI's assessment would be adjusted to zero. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/02/94 
<!-- PJG 007 0104 intable -->
Weed Associates, Easton, Maryland 
<!-- PJG 007 0104 intable -->
VFA&hyph;0009 
<!-- PJG 007 0104 intable -->
Appeal of an Information Request Denial. If granted: The September 27, 1994 Freedom of Information Request Denial
issued by the Office of Procurement and Assistance Management would be rescinded, and Weed Associates would receive
access to withheld portions of a contractor's Technical Proposal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/04/94 
<!-- PJG 007 0104 intable -->
Eric Engberg, Washington, D.C. 
<!-- PJG 007 0104 intable -->
VFA&hyph;0010 
<!-- PJG 007 0104 intable -->
Appeal of an Information Request Denial. If granted: The October 25, 1994 Freedom of Information Request Denial issued
by the Office of Intergovernmental and External Affairs would be rescinded, and Eric Engberg would receive access
to the names of DOE employees deleted from copies of DOE Travel Authorizations released to him. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/04/94 
<!-- PJG 007 0104 intable -->
Savannah River Operations Office, Aiken, South Carolina 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
VSO&hyph;0010 
<!-- PJG 007 0104 intable -->
Request for Hearing under 10 C.F.R. Part 710. If granted: An individual employed at Savannah River Operations Office
would receive a hearing under 10 C.F.R. Part 710. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/28/93 
<!-- PJG 007 0104 intable -->
St. Bernard Parish School Board, Paris, Tennessee 
<!-- PJG 007 0104 intable -->
RR272&hyph;184 
<!-- PJG 007 0104 intable -->
Request for Modification/ Rescission in the Crude Oil Refund Proceeding. If granted: The December 17, 1993 Dismissal
letter, Case Number RF272&hyph;88449, issued to St. Bernard Parish School Board would be modified regarding the
firm's application for refund submitted in the Crude Oil Refund Proceeding. 
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,s100,r200,xls72  -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Refund Applications Received 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[Week of October 31, 1994 to November 4, 1994] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date received 
<!-- PJG 007 0150 intable -->
1Name of refund proceeding/name of refund applicant 
<!-- PJG 007 0150 intable -->
1Case No. 
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
10/31/94 
<!-- PJG 007 0104 intable -->
Petro, Ltd 
<!-- PJG 007 0104 intable -->
RF349&hyph;19 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/01/94 
<!-- PJG 007 0104 intable -->
Baker's Texaco 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
2 
<!-- PJG 007 0104 intable -->
RF321&hyph;21040 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
05/20/91 
<!-- PJG 007 0104 intable -->
Melton Gulf 
<!-- PJG 007 0104 intable -->
RF300&hyph;21813 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/04/94 
<!-- PJG 007 0104 intable -->
Spiro Karamalegos 
<!-- PJG 007 0104 intable -->
RF321&hyph;21041 
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31133 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00035 </DOCNO>
<PARENT> FR941219-2-00027 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Hearings and Appeals</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Issuance of Proposed Decision and Order During the Week of October 10 through October 14, 1994 </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the week of October 10 through October 14, 1994, the proposed decision and order summarized below was issued
by the Office of Hearings and Appeals of the Department of Energy with regard to an application for exception. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the procedural regulations that apply to exception proceedings (10 CFR part 205, subpart D), any person who
will be aggrieved by the issuance of a proposed decision and order in final form may file a written notice of objection
within ten days of service. For purposes of the procedural regulations, the date of service of notice is deemed to be
the date of publication of this Notice or the date an aggrieved person receives actual notice, whichever occurs first.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The procedural regulations provide that an aggrieved party who fails to file a Notice of Objection within the time
period specified in the regulations will be deemed to consent to the issuance of the proposed decision and order in
final form. An aggrieved party who wishes to contest a determination made in a proposed decision and order must also
file a detailed statement of objections within 30 days of the date of service of the proposed decision and order. In
the statement of objections, the aggrieved party must specify each issue of fact or law that it intends to contest in
any further proceeding involving the exception matter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the full text of this proposed decision and order are available in the Public Reference Room of the Office
of Hearings and Appeals, Room 1E&hyph;234, Forrestal Building, 1000 Independence Avenue, SW., Washington, DC 20585,
Monday through Friday, between the hours of 1 p.m. and 5 p.m., except federal holidays. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
 George B. Breznay 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Hearings and Appeals. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Quint Cities Petroleum Company, Moline, IL 
<!-- PJG 0012 frnewline -->
LEE&hyph;0154, Reporting Requirements 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Quint Cities Petroleum Company filed an Application for Exception from the Energy Information Administration (EIA)
requirement that it file Form EIA&hyph;782B, the ``Resellers'/Retailers' Monthly Petroleum Product Sales Report.''
In considering this request, the DOE found that the firm was not suffering a gross inequity or serious hardship. Accordingly,
on October 12, 1994, the DOE issue a Proposed Decision and Order determining that the exception request should be denied.

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=3 -->
[FR Doc. 94&hyph;31143 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00036 </DOCNO>
<PARENT> FR941219-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=3 -->

<DOCTITLE>Proposed Implementation of Special Refund Procedures </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Hearings and Appeals, 
<!-- PJG 0012 frnewline -->
Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed implementation of special refund procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Office of Hearings and Appeals (OHA) of the Department of Energy (DOE) announces the proposed procedures for disbursement
of a total of $10,700,000, plus accrued interest, in alleged crude oil overcharges obtained pursuant to a Consent
Order entered into with Murphy Oil Corp., Murphy Oil USA, Inc., and Murphy Exploration and Production Co., Case No.
VEF&hyph;0003 (Murphy). The OHA has tentatively determined that the funds obtained from Murphy, plus interest accrued,
will be distributed in accordance with the DOE's Modified Statement of Restitutionary Policy in Crude Oil Cases.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES AND ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be filed in duplicate on or before January 18, 1995, and should be addressed to the Office of Hearings
and Appeals, 1000 Independence Avenue SW., Washington, DC 20585. All comments should be marked with the reference
number VEF&hyph;0003.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Thomas O. Mann, Deputy Director, Office of Hearings and Appeals, 1000 Independence Avenue SW., Washington, DC 20585,
(202) 586&hyph;2094.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with 10 CFR 205.282(b), notice is hereby given of the issuance of the Proposed Decision and Order set
out below. The Proposed Decision and Order sets forth the procedures that the DOE has tentatively formulated to distribute
a total of $10,700,000, plus accrued interest, obtained by the DOE under the terms of the Consent Order entered into
with Murphy on July 15, 1994. These funds were paid towards the settlement of alleged violations of the DOE petroleum
price and allocation regulations that were in effect from August 19, 1973, through January 28, 1981. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The OHA has proposed to distribute these funds in accordance with the DOE's Modified Statement of Restitutionary
Policy in Crude Oil Cases, 51 FR 27,899 (August 4, 1986)(the MSRP). Under the MSRP, crude oil overcharge monies are
divided between the federal government, the states, and injured purchasers of refined petroleum products. Refunds
to the states would be distributed in proportion to each state's consumption of petroleum products during the price
control period. Refunds to eligible purchasers would be based on the volume of petroleum products they purchased
and the degree to which they can demonstrate injury. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Any member of the public may submit written comments regarding the proposed refund procedures. Commenting parties
are requested to provide two copies of their submissions. Comments must be submitted within 30 days of publication
of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and should be sent to the address set forth at the beginning of this notice. All comments received in this proceeding
will be available for public inspection between the hours of 1 p.m. and 3 p.m., Monday through Friday, except Federal
holidays, in the Public Reference Room of the Office of Hearings and Appeals, located in Room 1E&hyph;234, 1000 Independence
Avenue SW., Washington, DC 20585.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
George B. Breznay, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, 
<!-- PJG 0012 frnewline -->
Office of Hearings and Appeals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00037 </DOCNO>
<PARENT> FR941219-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Proposed Decision and Order of the Department of Energy, 
<!-- PJG 0012 frnewline -->
Implementation of Special Refund Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Name of Firm: Murphy Oil Corp. / Murphy Oil USA, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Date of Filing: October 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Case Number: VEF&hyph;0003 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 25, 1994 the Economic Regulatory Administration (ERA) of the Department of Energy (DOE) filed a Petition
for the Implementation of Special Refund Procedures with the Office of Hearings and Appeals (OHA), to distribute
$10,700,000 remitted by Murphy Oil Corp., Murphy Oil USA, Inc., and Murphy Exploration &amp; Production Co. (collectively
referred to as ``Murphy''), pursuant to the Consent Order entered into between Murphy and the DOE on July 15, 1994.
In accordance with the procedural regulations codified at 10 CFR part 205, subpart V (Subpart V), the ERA requests
in its Petition that the OHA establish special procedures to make refunds in order to remedy the effects of alleged
regulatory violations which were resolved by the present Consent Order. This Proposed Decision and Order sets forth
the OHA's plan to distribute these funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Murphy is a major integrated refiner which produced and sold crude oil and a full range of refined petroleum products
during the period of federal price controls. As such, it was subject to the federal petroleum price and allocation
regulations. During that time, the ERA conducted an extensive audit of Murphy and issued an issue letter to Murphy
on September 29, 1976. ERA issued a Notice of Probable Violation to Murphy on January 28, 1981. ERA issued a Proposed
Remedial Order (PRO) to Murphy on December 15, 1986, which Murphy contested before the OHA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 On February 9, 1987, Murphy and the DOE entered into a Consent Order which resolved disputes regarding Murphy's refined
petroleum product operations during the period the petroleum price and allocation regulations were in effect. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Murphy Oil Corp.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 17 DOE &para;85,782 (1987) (the first Consent Order). The first Consent Order left the issue of Murphy's alleged violations
as a producer of crude oil unresolved. Those issues were decided by the OHA on June 17, 1992 when the OHA issued a modified
version of ERA's PRO as a Remedial Order (RO). 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Murphy Oil Corp.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 22 DOE &para;83,005 (1992). Murphy subsequently appealed the OHA's determination to the Federal Energy Regulatory
Commission (FERC). On January 24, 1994 a FERC Administrative Law Judge issued a Decision and Proposed Order (D&amp;PO)
which modified the RO. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Ocean Drilling &amp; Exploration Co., et al.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 66 FERC &para;63,002 (1994). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 On July 15, 1994, Murphy and the DOE entered into the present Consent Order, the second between Murphy and the DOE. This
second Consent Order, which does not modify or affect the terms of the first Consent Order, resolves all existing or
potential civil and administrative claims against Murphy for alleged violations of the federal petroleum price
and allocation regulations left unresolved by the first Consent Order. Under the terms of this second Consent Order,
Murphy has remitted $10,700,000 to the DOE, and all outstanding or potential claims by the DOE against Murphy have
been extinguished. These funds are being held in an interest-bearing escrow account maintained at the Department
of the Treasury pending a determination regarding their proper distribution. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Jurisdiction and Authority 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subpart V regulations set forth general guidelines which may be used by the OHA in formulating and implementing
a plan of distribution for funds received as a result of an enforcement proceeding. The DOE policy is to use the Subpart
V process to distribute such funds. For a more detailed discussion of Subpart V and the authority of the OHA to fashion
procedures to distribute refunds, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
see
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Petroleum Overcharge Distribution and Restitution Act of 1986 (PODRA), 15 U.S.C. 4501&hyph;07; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office of Enforcement,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 9 DOE &para;82,508 (1981); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office of Enforcement, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8 DOE &para;82,597 (1981). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 We have considered the ERA's Petition that we implement a Subpart V proceeding with respect to the second Murphy Consent
Order fund and have determined that such a proceeding is appropriate. This Proposed Decision and Order sets forth
the OHA's tentative plan to distribute this fund. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Proposed Refund Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Crude Oil Refund Policy 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We propose to distribute the Murphy funds in accordance with the DOE's Modified Statement of Restitutionary Policy
in Crude Oil Cases, 51 FR 27899 (August 4, 1986) (the MSRP). The MSRP was issued as a result of a court-approved Settlement
Agreement. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
In re: The Department of Energy Stripper Well Exemption Litigation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 653 F. Supp. 108 (D. Kan.), 6 Fed. Energy Guidelines &para;90,509 (1986) (the Stripper Well Settlement Agreement).
The MSRP establishes that 40 percent of the crude oil overcharge funds will be remitted to the federal government,
another 40 percent to the states, and up to 20 percent may be initially reserved for the payment of claims by injured
parties. The MSRP also specifies that any monies remaining after all valid claims by injured purchasers are paid be
disbursed to the federal government and the states in equal amounts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The OHA has utilized the MSRP in all Subpart V proceedings involving alleged crude oil violations. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Order Implementing the MSRP, 51 FR 29689 (August 20, 1986). This Order provided a period of 30 days for the filing of
comments or objections to our proposed use of the MSRP as the groundwork for evaluating claims in crude oil refund proceedings.
Following this period, the OHA issued a Notice evaluating the numerous comments which it received pursuant to the
Order Implementing the MSRP. This Notice was published at 52 FR 11737 (April 10, 1987) (the April 10 Notice). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The April 10 Notice contained guidance to assist potential claimants wishing to file refund applications for crude
oil monies under the Subpart V regulations. Generally, all claimants would be required to (1) document their purchase
volumes of petroleum products during the August 19, 1973 through January 27, 1981 crude oil price control period,
and (2) prove that they were injured by the alleged crude oil overcharges. We also specified that end-users of petroleum
products whose businesses are unrelated to the petroleum industry will be presumed to have been injured by the alleged
crude oil overcharges and need not submit any additional proof of injury beyond documentation of their purchase volumes.

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See City of Columbus, Georgia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 16 DOE &para;85,550 (1987). Additionally, we stated that crude oil refunds would be calculated on the basis of a per
gallon (or ``volumetric'') refund amount, which is obtained by dividing the crude oil refund pool by the total consumption
of petroleum products in the United States during the crude oil price control period. The OHA has adopted the refund
procedures outlined in the April 10 Notice in numerous cases. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See, e.g., Texaco, Inc,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 19 DOE &para;85,200 (1989); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Shell Oil Co.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 17 DOE &para;85,204 (1988) (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Shell
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Mountain Fuel Supply Co.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 14 DOE &para;85,475 (1986) (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Mountain Fuel
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Refund Claims 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We propose to adopt the DOE's standard crude oil refund procedures to distribute the monies remitted by Murphy. We
have chosen initially to reserve 20 percent of the fund, plus accrued interest, for direct refunds to claimants in
order to ensure that sufficient funds will be available for injured parties. This reserve figure may later be reduced
if circumstances warrant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The OHA will evaluate crude oil refund claims in a manner similar to that used in Subpart V proceedings to evaluate claims
based on alleged refined product overcharges. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Mountain Fuel,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 14 DOE at 88,869. Under these procedures, claimants will be required to document their purchase volumes of petroleum
products and prove they were injured as a result of the alleged violations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00038 </DOCNO>
<PARENT> FR941219-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We will adopt a presumption that the alleged crude oil overcharges were absorbed, rather than passed on, by applicants
which were (1) end-users of petroleum products, (2) unrelated to the petroleum industry, and (3) not subject to the
regulations promulgated under the Emergency Petroleum Allocation Act of 1973 (EPAA), 15 U.S.C. 751&hyph;760h.
In order to receive a refund, end-user claimants need not submit any evidence of injury beyond documentation of their
purchase volumes. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Shell,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 17 DOE at 88,406. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Petroleum retailer, reseller, and refiner applicants must submit detailed evidence of injury, and they may not rely
upon the injury presumptions utilized in refined product cases. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 These applicants, however, may use econometric evidence of the type found in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
OHA Report on Stripper Well Overcharges,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 6 Fed. Energy Guidelines &para;90,507 (1985). 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See also
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 PODRA &sect;3003(b)(2), 15 U.S.C. 4502(b)(2). If a claimant has executed and submitted a valid waiver pursuant to
one of the escrows established by the Stripper Well Settlement Agreement, it has waived its rights to file an application
for Subpart V crude oil refund monies. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See Mid-America Dairymen
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Herrington,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 878 F.2d 1448 (Temp. Emer. Ct. App.), 3 Fed. Energy Guidelines &para;26,617 (1989); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
In re: Department of Energy Stripper Well Exemption Litigation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 707 F. Supp. 1267 (D. Kan.), 3 Fed Energy Guidelines &para;26,613 (1987). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 As has been stated in prior Decisions, a crude oil refund applicant will only be required to submit one application
for its share of all available crude oil overcharge funds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See, e.g., A. Tarricone, Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 15 DOE &para;85,495 (1987). A party that has already submitted a claim to any other crude oil refund proceeding implemented
by the DOE need not file another claim. The prior application will be deemed to be filed in all crude oil refund proceedings
finalized to date. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The DOE had previously established June 30, 1994 as the final deadline for filing an Application for Refund from the
crude oil funds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 58 FR 26318 (May 3, 1993). Although that date has passed, it has been decided to re-open the crude proceeding. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 59 Fed. Reg. 55656 (November 8, 1994). The new closing date for this proceeding has been tentatively set for June 3,
1996. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 It is the policy of the DOE to pay all crude oil refund claims at the rate of $.0008 per gallon. While we anticipate that
applicants that filed their claims before June 30, 1988 will receive a supplemental refund payment, we will decide
in the future whether claimants that filed later applications should receive additional refunds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
See, e.g., Seneca Oil Co.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 21 DOE &para;85,327 (1991). Notice of any additional amounts available in the future will be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Payments to the Federal Government and the States 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the terms of the MSRP, we propose that the remaining eighty percent of the alleged crude oil overcharge amounts
subject to this Proposed Decision, plus accrued interest, should be disbursed in equal shares to the states and the
federal government for indirect restitution. Refunds to the states will be in proportion to the consumption of petroleum
products in each state during the period of price controls. The share or ratio of the funds which each state will receive
is contained in Exhibit H of the Stripper Well Settlement Agreement, 6 Fed. Energy Guidelines &para;90,509 at 90,687.
When disbursed, these funds will be subject to the same limitations and reporting requirements as all other crude
oil monies received by the states under the Stripper Well Settlement Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 It Is Therefore Ordered That: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The funds remitted by Murphy Oil Corp., Murphy Oil USA, Inc., and Murphy Exploration &amp; Production Co. pursuant
to the Consent Order entered into with the DOE on July 15, 1994 will be distributed in accordance with the foregoing
Decision.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31132 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00039 </DOCNO>
<PARENT> FR941219-2-00029 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRI&hyph;5124&hyph;8]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Proposed Settlement Agreement; PM&hyph;10 SIP for the State of Arizona
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Agency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Environmental Protection Agency (EPA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed settlement agreement; request for public comment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Summary: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with Section 113(g) of the Clean Air Act (``Act''), notice is hereby given of a proposed settlement agreement
concerning litigation instituted against the Environmental Protection Agency (``EPA'') by Edward M. Ober, through
his counsel David S. Baron of the Arizona Center for Law in the Public Interest (hereafter ``ACLPI''). The lawsuit
concerns EPA's alleged failure to perform a nondiscretionary duty with respect to promulgating a PM&hyph;10 final
implementation plan (``FIP'') for the Phoenix, Arizona Planning Area. The proposed settlement agreement provides
that EPA shall sign a Notice of Final Rulemaking (``NFRM'' regarding the moderate nonattainment area PM&hyph;10
State implementation plan (``SIP'') submitted by the State of Arizona for the Phoenix Planning Area, respecting
which a Notice of Proposed Rulemaking (``NPRM'') was published at 59 FR 38402 (July 28, 1994), no later than March 1,
1995. If final rulemaking action by EPA results in disapproval of the SIP, in whole or in part, EPA would agree to sign
a NFRM promulgating a FIP that corrects the disapproved portions of the SIP no later than March 1, 1996, unless prior
to that date EPA has fully approved a SIP revision that corrects the deficiency that formed the basis for the disapproval
action. If EPA takes final rulemaking action approving the SIP, in whole or in part, the parties will file a joint motion
to stay litigation in the district court pending the outcome of appellate review. Additionally, it after appellate
review EPA's approval is vacated, the parties will file a joint motion to lift the stay, and plaintiffs would be free
to pursue litigation of their original FIP claims without being required to file an addtional 60-day notice of intent
to sue or a new complaint. If, however, EPA is upheld on appellate review, plaintiffs shall, within 30 days, file a motion
to dismiss or withdraw their complaint. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For a period of thirty [30] days following the date of publication of this notice, the Agency will receive written comments
relating to the settlement agreement. EPA or the Department of Justice may withhold or withdraw consent to the proposed
settlement agreement in the comments disclose facts or circumstances that indicate that such consent is inappropriate,
improper, inadequate, or inconsistent with the requirements of the Act. 
<!-- PJG 0012 frnewline -->
Copies of the settlement agreement are available from Phyllis Cochran, Air and Radiation Division (2344), Office
of General Counsel, U.S. Environmental Protection Agency, 401 M Street, SW., Washington, D.C. 20460, (202) 260&hyph;7606.
Written comments should be sent to Michael A. Prosper at the above address and must be submitted on or before January
18, 1995. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean C. Nelson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
General Counsel. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31108 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00040 </DOCNO>
<PARENT> FR941219-2-00030 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;5124&hyph;9] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Arizona: Final Determination of Adequacy of State Municipal Solid Waste Permit Program </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Final Determination of Full Program Adequacy for Arizona's Application. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Section 4005(c)(1)(B) of the Resource Conservation and Recovery Act (RCRA), as amended by the Hazardous and Solid
Waste Amendments (HSWA) of 1984, 42 U.S.C. 6945 (c)(1)(B), requires States to develop and implement regulatory programs
to ensure that municipal solid waste landfill facilities (MSWLFs) which may receive hazardous household waste or
small quantity generator hazardous waste will comply with the revised federal MSWLF criteria, codified at 40 CFR
Part 258 (the Federal MSWLF Criteria). Section 4005(c)(1)(C) of RCRA, 42 U.S.C. 6945(c)(1)(C), requires the Environmental
Protection Agency (EPA) to determine whether States have adequate regulatory programs for MSWLFs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Approved State MSWLF programs provide interaction between the State and MSWLF owners and operators regarding site-specific
approval conditions. Only owners or operators located in States with approved programs can use the site-specific
flexibility provided by 40 CFR Part 258 to the extent the state program allows such flexibility. EPA notes that the
Federal MSWLF Criteria apply to all MSWLFs, regardless of the approval status of any state program or individual facility.

<!-- PJG 0012 frnewline -->
Arizona applied for a determination of adequacy under Section 4005 of RCRA. EPA reviewed Arizona's application and
issued for public comment a tentative determination that Arizona's program is adequate to ensure compliance with
the revised MSWLF criteria. Based on a thorough review of Arizona's MSWLF program and the fact that the only comments
EPA received supported the tentative determination, EPA is today issuing a final determination that Arizona's MSWLF
program is adequate.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The determination of adequacy for Arizona shall be effective on December 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 U.S. EPA Region IX, 75 Hawthorne Street, San Francisco, California, 94105. Attn: Ms. Donna J. Orebic, mail code H&hyph;W&hyph;3,
telephone (415) 744&hyph;2092. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
A. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 9, 1991, EPA promulgated the Federal MSWLF Criteria, codified at 40 CFR part 258. Subtitle D of RCRA, 42 U.S.C.
6941&hyph;6949(a), as amended by the Hazardous and Solid Waste Amendments of 1984 (HSWA), requires States to develop
regulatory programs to ensure that MSWLFs comply with the Federal MSWLF Criteria. Section 4005 of RCRA, 42 U.S.C.
6945, also requires that EPA determine the adequacy of State MSWLF programs to ensure that facilities comply with
the Federal MSWLF Criteria. To facilitate this requirement, the Agency has drafted and is in the process of proposing
a State and Tribal Implementation Rule (STIR) that will provide procedures by which EPA will approve, or partially
approve, State and Tribal landfill regulatory programs. 
<!-- PJG 0012 frnewline -->
EPA has approved, and will continue to approve, State MSWLF programs prior to the promulgation of the STIR. Prior to
the promulgation of the STIR, adequacy determinations will continue to be made on the basis of statutory authorities
and requirements. EPA interprets the statutory requirements for States to develop ``adequate'' regulatory programs
to impose several minimum standards. First, each State must have enforceable standards for new and existing MSWLFs
that are technically comparable to EPA's revised MSWLF criteria. Next, the State must have the authority to issue
a permit or other notice of prior approval to all new and existing MSWLFs in its jurisdiction. The State also must provide
for public participation in facility approval and enforcement as required in Section 7004(b) of RCRA, 42 U.S.C. 6974(b).
Finally, the State must show that it has sufficient compliance monitoring and enforcement authorities to take specific
action against any owner or operator that fails to comply with an approved MSWLF program. 
<!-- PJG 0012 frnewline -->
EPA Regions will determine whether a State has submitted an ``adequate'' program based on the interpretation outlined
above. EPA expects States to meet all of the criteria for all elements of a MSWLF program before it gives full approval
to a MSWLF program. In addition, States may use the draft STIR as an aid in interpreting these requirements. 
<!-- PJG 0012 frnewline -->
On May 6, 1994, Arizona submitted an application for program adequacy determination. On September 15, 1994, EPA published
a tentative determination of adequacy for all portions of Arizona's program. Further background on the tentative
determination of adequacy appears at 59 FR 47332 (September 15, 1994). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00041 </DOCNO>
<PARENT> FR941219-2-00030 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Along with the tentative determination, EPA announced the availability of the application for public comment. EPA
received two comments supporting the determination, but no requests for a public meeting. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
B. Decision 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the tentative determination, EPA proposed to fully approve Arizona's MSWLF program. Arizona's application for
adequacy determination meets all of the statutory and regulatory requirements established by RCRA. The State of
Arizona has the authority to enforce the requirements of its MSWLF program at all MSWLFs in the State, with the exception
of those located on Tribal Lands. Accordingly, Arizona is granted a determination of adequacy for all portions of
its MSWLF program. 
<!-- PJG 0012 frnewline -->
In addition to enforcement by the States, Section 4005(a) of RCRA provides that citizens may use the citizen suit provisions
of Section 7002 of RCRA to enforce the Federal MSWLF Criteria at 40 CFR part 258 independent of any state enforcement
program. As EPA explained in the preamble to the final MSWLF criteria, EPA expects that any owner or operator complying
with provisions in a state program approved by EPA should be considered to be in compliance with the federal criteria.
See 56 FR 50978, 50995 (October 9, 1991). 
<!-- PJG 0012 frnewline -->
Today's action takes effect on the date of publication. EPA believes it has good cause under section 553(d) of the Administrative
Procedure Act, 5 U.S.C 553(d), to put this action into effect less than 30 days after publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. All of the requirements and obligations in the State's MSWLF program are already in effect as a matter of state law.
EPA's action today does not impose any new requirements on the regulated community, nor do these requirements become
enforceable by EPA as federal law. Consequently, EPA finds that it does not need to give notice prior to making its approval
effective. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Compliance With Executive Order 12291
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Management and Budget has exempted this rule from the requirements of Section 6 of Executive Order 12866.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Certification Under the Regulatory Flexibility Act
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to the provisions of 5 U.S.C. 605(b), I hereby certify that this approval will not have a significant economic
impact on a substantial number of small entities. It does not impose any new burdens on small entities. This rule, therefore,
does not require a regulatory flexibility analysis.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
This notice is issued under the authority of Sections 2002, 4005 and 4007 of the Solid Waste Disposal Act, as amended,
42 U.S.C. 6912, 6945, 6947.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 6, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Nora McGee, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31107 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00042 </DOCNO>
<PARENT> FR941219-2-00031 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;60052; FRL&hyph;4920&hyph;6] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Intent To Suspend Certain Pesticide Registrations</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of issuance of notices of intent to suspend. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This Notice, pursuant to section 6(f)(2) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), 7 U.S.C.
136 et seq., announces that EPA has issued Notices of Intent to Suspend pursuant to sections 3(c)(2)(B) and 4 of FIFRA.
The Notices were issued following issuance of Section 4 Reregistration Requirements Notices by the Agency and the
failure of registrants subject to the Section 4 Reregistration Requirements Notices to take appropriate steps to
secure the data required to be submitted to the Agency. This Notice includes the text of a Notice of Intent to Suspend,
absent specific chemical, product, or factual information. Table A of this Notice further identifies the registrants
to whom the Notices of Intent to Suspend were issued, the date each Notice of Intent to Suspend was issued, the active
ingredient(s) involved, and the EPA registration numbers and names of the registered product(s) which are affected
by the Notices of Intent to Suspend. Moreover, Table B of this Notice identifies the basis upon which the Notices of
Intent to Suspend were issued. Finally, matters pertaining to the timing of requests for hearing are specified in
the Notices of Intent to Suspend and are governed by the deadlines specified in section 3(c)(2)(B). As required by
section 6(f)(2), the Notices of Intent to Suspend were sent by certified mail, return receipt requested, to each affected
registrant at its address of record.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Francisca Liem, Office of Compliance, Agriculture and Ecosystems Division, Mail Code 2225A, Environmental Protection
Agency, 401 M St., SW., Washington, DC 20460, (202) 564&hyph;2365.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
I. Text of a Notice of Intent to Suspend
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The text of a Notice of Intent to Suspend, absent specific chemical, product, or factual information, follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=74 g=1 f=1 -->
United States Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=72 g=1 f=1 -->
Office of Prevention, Pesticides and Toxic Substances
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Washington, DC 20460 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Certified Mail 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=3 -->
Return Receipt Requested
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
SUBJECT: Suspension of Registration of Pesticide Product(s) Containing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
 for Failure to Comply with the Section 4 Phase 5 Reregistration Eligibility Document Data Call-In Notice for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=7 f=2 -->
XXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
 Dated 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dear Sir/Madam:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This letter gives you notice that the pesticide product registrations listed in Attachment I will be suspended 30
days from your receipt of this letter unless you take steps within that time to prevent this Notice from automatically
becoming a final and effective order of suspension. The Agency's authority for suspending the registrations of your
products is section 3(c)(2)(B) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Upon becoming
a final and effective order of suspension, any violation of the order will be an unlawful act under section 12(a)(2)(J)
of FIFRA.
<!-- PJG 0012 frnewline -->
You are receiving this Notice of Intent to Suspend because you have failed to comply with the terms of the Phase 5 Registration
Eligibility Document Data Call-In Notice imposed pursuant to section 4(g)(2)(b) and section 3(c)(2)(B) of FIFRA.

<!-- PJG 0012 frnewline -->
The specific basis for issuance of this Notice is stated in the Explanatory Appendix (Attachment III) to this Notice.
Affected products and the requirements which you failed to satisfy are listed and described in the following three
attachments:
<!-- PJG 0012 frnewline -->
Attachment I Suspension Report - Product List
<!-- PJG 0012 frnewline -->
Attachment II Suspension Report - Requirement List
<!-- PJG 0012 frnewline -->
Attachment III Suspension Report - Explanatory Appendix
<!-- PJG 0012 frnewline -->
The suspension of the registration of each product listed in Attachment I will become final unless at least one of the
following actions is completed.
<!-- PJG 0012 frnewline -->
1. You may avoid suspension under this Notice if you or another person adversely affected by this Notice properly request
a hearing within 30 days of your receipt of this Notice. If you request a hearing, it will be conducted in accordance
with the requirements of section 6(d) of FIFRA and the Agency's procedural regulations in 40 CFR part 164.
<!-- PJG 0012 frnewline -->
Section 3(c)(2)(B), however, provides that the only allowable issues which may be addressed at the hearing are whether
you have failed to take the actions which are the bases of this Notice and whether the Agency's decision regarding the
disposition of existing stocks is consistent with FIFRA. Therefore, no substantive allegation or legal argument
concerning other issues, including but not limited to the Agency's original decision to require the submission of
data or other information, the need for or utility of any of the required data or other information or deadlines imposed,
and the risks and benefits associated with continued registration of the affected product, may be considered in the
proceeding. The Administrative Law Judge shall by order dismiss any objections which have no bearing on the allowable
issues which may be considered in the proceeding.
<!-- PJG 0012 frnewline -->
Section 3(c)(2)(B)(iv) of FIFRA provides that any hearing must be held and a determination issued within 75 days after
receipt of a hearing request. This 75&hyph;day period may not be extended unless all parties in the proceeding stipulate
to such an extension. If a hearing is properly requested, the Agency will issue a final order at the conclusion of the
hearing governing the suspension of your products.
<!-- PJG 0012 frnewline -->
A request for a hearing pursuant to this Notice must (1) include specific objections which pertain to the allowable
issues which may be heard at the hearing, (2) identify the registrations for which a hearing is requested, and (3) set
forth all necessary supporting facts pertaining to any of the objections which you have identified in your request
for a hearing. If a hearing is requested by any person other than the registrant, that person must also state specifically
why he asserts that he would be adversely affected by the suspension action described in this Notice. Three copies
of the request must be submitted to: Hearing Clerk, Mail Code 1900, U.S. Environmental Protection Agency, 401 M St.,
SW., Washington, DC 20460, and an additional copy should be sent to the signatory listed below. The request must be

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
received
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 by the Hearing Clerk by the 30th day from your receipt of this Notice in order to be legally effective. The 30&hyph;day
time limit is established by FIFRA and cannot be extended for any reason. Failure to meet the 30&hyph;day time limit
will result in automatic suspension of your registration(s) by operation of law and, under such circumstances, the
suspension of the registration for your affected product(s) will be final and effective at the close of business 30
days after your receipt of this Notice and will not be subject to further administrative review.
<!-- PJG 0012 frnewline -->
The Agency's Rules of Practice at 40 CFR 164.7 forbid anyone who may take part in deciding this case, at any stage of the
proceeding, from discussing the merits of the proceeding 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ex parte
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 with any party or with any person who has been connected with the preparation or presentation of the proceeding as an
advocate or in any investigative or expert capacity, or with any of their representatives. Accordingly, the following
EPA offices, and the staffs thereof, are designated as judicial staff to perform the judicial function of EPA in any
administrative hearings on this Notice of Intent to Suspend: The Office of the Administrative Law Judges, the Office
of the Judicial Officer, the Administrator, the Deputy Administrator, and the members of the staff in the immediate
offices of the Administrator and Deputy Administrator. None of the persons designated as the judicial staff shall
have any 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ex parte
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 communication with trial staff or any other interested person not employed by EPA on the merits of any of the issues
involved in this proceeding, without fully complying with the applicable regulations.
<!-- PJG 0012 frnewline -->
2. You may also avoid suspension if, within 30 days of your receipt of this Notice, the Agency determines that you have
taken appropriate steps to comply with the Section 4 Phase 5 Reregistration Eligibility Document Data Call-In Notice
requirements. In order to avoid suspension under this option, you must satisfactorily comply with Attachment II,
Requirement List, for each product by submitting all required supporting data/information described in Attachment
II and in the Explanatory Appendix (Attachment III) to the following address (preferably by certified mail):
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Office of Compliance, Agriculture and Ecosystems Division, Mail Code 2225A, Environmental Protection Agency,
401 M St., SW., Washington, DC 20460. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For you to avoid automatic suspension under this Notice, the Agency must also determine within the applicable 30&hyph;day
period that you have satisfied the requirements that are the bases of this Notice and so notify you in writing. You should
submit the necessary data/information as quickly as possible for there to be any chance the Agency will be able to make
the necessary determination in time to avoid suspension of your product(s).
<!-- PJG 0012 frnewline -->
The suspension of the registration(s) of your company's product(s) pursuant to this Notice will be rescinded when
the Agency determines you have complied fully with the requirements which were the bases of this Notice. Such compliance
may only be achieved by submission of the data/information described in the attachments to the signatory below.
<!-- PJG 0012 frnewline -->
Your product will remain suspended, however, until the Agency determines you are in compliance with the requirements
which are the bases of this Notice and so informs you in writing.
<!-- PJG 0012 frnewline -->
After the suspension becomes final and effective, the registrant subject to this Notice, including all supplemental
registrants of product(s) listed in Attachment I, may not legally distribute, sell, use, offer for sale, hold for
sale, ship, deliver for shipment, or receive and (having so received) deliver or offer to deliver, to any person, the
product(s) listed in Attachment I.
<!-- PJG 0012 frnewline -->
Persons other than the registrant subject to this Notice, as defined in the preceding sentence, may continue to distribute,
sell, use, offer for sale, hold for sale, ship, deliver for shipment, or receive and (having so received) deliver or
offer to deliver, to any person, the product(s) listed in Attachment I.
<!-- PJG 0012 frnewline -->
Nothing in this Notice authorizes any person to distribute, sell, use, offer for sale, hold for sale, ship, deliver
for shipment, or receive and (having so received) deliver or offer to deliver, to any person, the product(s) listed
in Attachment I in any manner which would have been unlawful prior to the suspension.
<!-- PJG 0012 frnewline -->
If the registrations of your products listed in Attachment I are currently suspended as a result of failure to comply
with another Section 4 Data Requirements Notice or Section 3(c)(2)(B) Data Call-In Notice, this Notice, when it becomes
a final and effective order of suspension, will be in addition to any existing suspension, i.e., all requirements
which are the bases of the suspension must be satisfied before the registration will be reinstated.
<!-- PJG 0012 frnewline -->
You are reminded that it is your responsibility as the basic registrant to notify all supplementary registered distributors
of your basic registered product that this suspension action also applies to their supplementary registered products
and that you may be held liable for violations committed by your distributors. If you have any questions about the requirements
and procedures set forth in this suspension notice or in the subject Section 4 Data Requirements Notice, please contact
Francisca Liem at (202) 564&hyph;2365.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Sincerely yours,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Director, Agriculture and Ecosystem Division
<!-- PJG 0012 frnewline -->
Attachments: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Attachment I - Product List 
<!-- PJG 0012 frnewline -->
Attachment II - Requirement List
<!-- PJG 0012 frnewline -->
Attachment III - Explanatory Appendix 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Registrants Receiving and Affected by Notices of Intent To Suspend; Date of Issuance; Active Ingredient and Products
Affected 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following is a list of products for which a letter of notification has been sent:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s50,15,r40,r47,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table A._List of Products
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Registrant Affected
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Registration Number
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Active Ingredient
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Name of Product
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date Issued
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lA &amp; V, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01201400044
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPoolcare/Spacare Dichlor Plus Granules
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01201400056
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPoolcare Alga-Kill
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAbbott Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00027500078
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lReceptal Saf-Gard Liner System with Germicide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAlex C. Fergusson, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00083300044
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAfco Super-Chlor Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAlpha Chemical Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01063400003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlpha San 200
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01063400019
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlpha San 300
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAn-Fo Manufacturing Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00131700065
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSani-Du Chlorine Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00131700080
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDu-Clor Swimming Pool Chlorine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAqua Clear Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04530900021
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAqua Clear Iso-Gran
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lArco Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00886600024
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lArco Concentrated Pool Chlorine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00886600025
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lArco Chlorinating Concentrated Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBetz Entec, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03457100014
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBetz Entec 362
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBirko Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01014700010
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSynchlorozene For Hide-Brine Curing
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCalgon Vestal Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00104300101
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCs-420 Wash Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCapo Industries, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l05499800002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConcentrated Stabilized Chlorine Granules
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCarefree Chemical Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l05389200009
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSpa Granules
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChemtreat, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01530000017
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Treatment C-2181
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01530000021
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Treatment C-2185
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lColgate Palmolive Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00458200065
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAjax Disinfecting Cleanser
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00458200066
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCpl Institutional Ajax Disinfectant Cleanser
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00458200067
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAjax Disinfecting Cleanser 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCoughlan Products Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00229200096
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBacta Clean Sanitizer Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCustom Pools of Houston
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l06304100001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSta-Clear Jumbo Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDespo Chemicals Int'l., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04892500001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAltasan 16
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lEcolab, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00167700141
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBonchem Bon-A-Chlor 100
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lFitzpatrick Bros., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00646600012
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKitchen Klenzer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lGarratt Callahan Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00854000014
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGarratt-Callahan Formula 36
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lGreat Lakes Biochemical Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400045
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Chlorine Concentrate Granular
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400046
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Algae Out
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400060
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Spa/hot Tub Products Chlorinating Conce
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400041
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Chlorination Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400042
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Quick Shock Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400043
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Chlorination Tablets - Float Canister
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400044
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Chlorination Tablets - Feeder Canister
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400049
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Replacement Chlorinating Canister
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400051
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex Chlorination Sticks
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00736400057
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTabex One-Half Ounce Chlorination Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lH.B. Fuller Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00452400040
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMonoklor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lHoffman, J.l. Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00213600033
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHoffman's Stabilized Dry Pool Chlorinator
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lJersey Chemicals, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01007900003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNat-Chlor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lKing Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l05373500002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSani-King P-Max 8 Cartridge
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lLuseaux Laboratories, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00352200018
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLuseaux Chlo-Rins-Tabs
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMiami Products &amp; Chemical Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00027800050
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSanygen Granular Chlorinating Compound
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lN. Jonas &amp; Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200012
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaxi-Clor Stabilized Chlorine Power Concentrate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200037
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPow Supe Chlorinator
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200050
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiamond Sani - Spa
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200023
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4lb Continuous Chlorinator
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200024
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaxi Clor Chlorine Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200035
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaxi-Clor Giant Chlorine Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200036
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaxi Chlor Chlorinating Sticks
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200044
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuper 90 Chlorinating Powder
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200051
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOn Guard Maxi-Clor Super Chlorinating Sticks
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00343200061
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOnguard Maxi-Clor 3 Inch Super Chlorinating Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNisso America, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00803300005
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNisso Sdic-60
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00803300004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNisso Tcca - 90
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00803300006
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNisso Sdic-55
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lOakite Products, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00102000004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOakite Chlor-Tergent
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lOccidental Chemical Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500058
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMwss 60 Wash And Surface Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500047
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMwws 56 Wash And Surface Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500050
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaws 56 Acid Wash Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500054
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMds 56 Detergent Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500055
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMfds 56 Fabric And Diaper Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00093500057
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMwss 56 Wash And Surface Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lOlde Tyme Products, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l06328700001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMr. O's Sanitizing Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPace International, L.P.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l06486400006
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSanit C-16 Bactericide-Deodorizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l06486400009
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMaster Cax A Heavy Duty Cleaner-Sanitizer-Deo
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPazianos Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chlor 90
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chlor 90 Granular
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000005
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chlor One Inch Tablet
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000006
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chloro Three Inch Tablet
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chlor 60
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l03398000003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNeo-Chlor 55
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPenetone Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l01019000002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSalubrite ``Chlorinated Detergent''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPhoenix Chemical Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04852000010
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lModern Stabilized Chlorinating Giant Tabs
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04852000011
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lModern Stabilized Chlorinating Tiny Tabs
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04852000012
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lModern Stabilized Chlorinating Stix
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPride Mfg., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l06249800001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPool Pride Granular 62
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPurdy Products Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00017800009
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lStera-Sheen Green Label Sanitizer &amp; Cleaner
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPuritan/Churchill Chemical Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00054100173
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPuritan #285 Germicide Concentrate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lRichardson Chemical Products Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00088100012
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSC Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSaratoga Specialties
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00940900001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMorrell Chemicals H. D. Sanitizer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSavolite, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00179100040
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKlearsol 64
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lScientific Water Systems
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04538700015
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClor Mor Dy-Chlor 62
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04538700017
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClor Mor Chlorinated Tablets, ``1''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04538700018
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClor Mor Chlorinated Tablets, 3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSteelcrete Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04170200007
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAztec Small Tablets Stabilized Pool Chlorinating Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSteelcrete Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04170200008
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAztec Large Tablets Stabilized Pool Chlorinating Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04170200009
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAztec Sticks Stabilized Pool Chlorinating Concentrate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04170200006
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAztec Granular Pool &amp; Spa Stabilized Chlorinating Concentrate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSuncoast Chemicals Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04604300002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuncoast Tri-Chlor 1 Inch Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04604300003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuncoast Tri-Chlor 3 Inch Tablets
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSwimchem, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04352100003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuper Swim Brite 62
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTexo Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l00587000033
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lD.C. San
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lU.S. Army Natick RD&amp;E Center
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l04051000004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDisinfectant, Food Service (Chlorine-Iodine Type) MIL-D-1130
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lWater Technology &amp; Controls, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l05162400003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAQG-003 Algae Control
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Basis for Issuance of Notice of Intent; Requirement List
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following companies failed to submit the following requirement data or information:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,s30,r30,r55,r20,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table B._List of Requirements
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Active Ingredient
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Registrant Affected
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Requirement Name
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Guideline Reference No.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Original Due-Date
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lA &amp; V, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAbbott Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlex C. Fergusson, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlpha Chemical Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAn-Fo Manufacturing Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAqua Clear Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lArco Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBetz Entec, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBirko Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCalgon Vestal Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCapo Industries, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCarefree Chemical Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemtreat, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColgate Palmolive Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCoughlan Products Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCustom Pools of Houston
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDespo Chemicals Int'l., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lEcolab, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFitzpatrick Bros., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGarratt Callahan Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGreat Lakes Biochemical Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lH.B. Fuller Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHoffman, J.l. Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lJersey Chemicals, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKing Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLuseaux Laboratories, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMiami Products &amp; Chemical Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lN. Jonas &amp; Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNisso America, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOakite Products, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOccidental Chemical Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlde Tyme Products, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPace International, L.P.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPazianos Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPenetone Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhoenix Chemical Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPride Mfg., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPurdy Products Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPuritan/Churchill Chemical Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRichardson Chemical Products Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSaratoga Specialties
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSavolite, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lScientific Water Systems
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSteelcrete Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSteelcrete Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuncoast Chemicals Company
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSwimchem, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTexo Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lU.S. Army Natick RD&amp;E Center
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWater Technology &amp; Controls, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90-Day Response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lConfidential Statement of Formula (CSF) Form
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChemical Identity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeginning Materials &amp; Manufacturing Process
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiscussion of Formation of Impurities
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l61&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPreliminary Analysis of Product Samples
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCertification of Ingredient Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnalytical Method to Verify Certified Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lColor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhysical State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOdor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDensity, Bulk Density, or Specific Gravity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lpH
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxidizing/Reducing Action
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;14
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lViscosity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;18
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorrosion Characteristics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l63&hyph;20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Oral Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Dermal Toxicity - Rabbit/Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcute Inhalation Toxicity - Rat
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Eye Irritation - Rabbit
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimary Dermal Irritation
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDermal Sensitization
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81&hyph;6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l8/31/93
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Attachment III Suspension Report_Explanatory Appendix
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A discussion of the basis for the Notice of Intent to Suspend sent to each affected registrant follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Chlorinated Isocyanurates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On May 7, 1993, the EPA issued the Phase 5 Reregistration Eligibility Document Data Call-In Notice imposed pursuant
to section 4(g)(2)(B) and 3(c)(2)(B) of FIFRA which required registrants of products containing chlorinated isocyanurate
used as the active ingredient to develop and submit certain data. These data/information were determined to be necessary
to satisfy reregistration data requirements of section 4(g). Failure to comply with the requirements of a Phase 5
Reregistration Eligibility Document Data Call-In Notice is a basis for suspension under section 3(c)(2)(B) of FIFRA.
<!-- PJG 0012 frnewline -->
The Chlorinated Isocyanurate Phase 5 Reregistration Eligibility Document Data Call-In Notice dated May 7, 1993,
required each affected registrant to submit data/information to the Agency to address each of the data requirements.
Those data/information were required to be received by the Agency within 8 months of the registrant's receipt of the
Notice. Because you have failed to submit appropriate or adequate data/information within the time provided for
the data/information requirements listed in Attachment II, the Agency is issuing this Notice of Intent to Suspend.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Conclusions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA has issued Notices of Intent to Suspend on the dates indicated. Any further information regarding these Notices
may be obtained from the contact person noted above.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rick Colbert,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Agriculture and Ecosystem Division, Office of Compliance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31106 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00043 </DOCNO>
<PARENT> FR941219-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;50803; FRL&hyph;4925&hyph;4]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Receipt of an Application for an Experimental Use Permit Amendment for a Transgenic Plant Pesticide </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On October 20, 1994, EPA received an application from Ciba Geigy, Seed Division to amend their experimental use permit
(EUP) for a transgenic plant pesticide by adding test sites in Texas. The Agency has determined that this application
may be of regional and national significance. Therefore in accordance with 40 CFR 172.11(a), the Agency is soliciting
public comments on this application. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments must be received by January 18, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments, in triplicate, should bear the docket control number OPP&hyph;50803 and be submitted to: Public Response
and Program Resources Branch, Field Operations Division (7506C), Office of Pesticide Programs, Environmental
Protection Agency, 401 M St., SW., Washington, DC 20460. In person bring comments to: Rm. 1128, Crystal Mall #2, 1921
Jefferson Davis Highway, Crystal City, VA 22202 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information submitted in any comment concerning this notice may be claimed confidential by marking any part or all
of that information as ``Confidential Business Information'' (CBI). Information so marked will not be disclosed
except in accordance with procedures set forth in 40 CFR Part 2. A copy of the comment that does not contain CBI must be
submitted for inclusion in the public record. Information not marked confidential may be disclosed publicly by EPA
without prior notice to the submitter. Written comments will be available for public inspection in Rm. 1128 at the
address given above, from 8 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Janet L. Andersen, Acting Director, Biopesticides and Pollution Prevention Division (7501W), Office of
Pesticide Programs, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460 Office location and telephone
number: Rm. CS51B6, Westfield Building North Tower, 2800 Crystal Drive, Arlington, VA 22202 (703)308&hyph;8712

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On October 20, 1994, EPA received an application to amend an EUP from Ciba-Geigy Corporation, Seed Division (Ciba
Seeds), P.O. Box 12257, Research Triangle Park, North Carolina 27709&hyph;2257. The EUP application is assigned
EPA File Symbol 66736&hyph;EUP&hyph;1. In the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of November 2, 1994 (59 FR 54904), EPA announced issuance of an extension for this EUP. The approved EUP extension allows
the use of 197.1 grams of the Bacillus thuringiensis 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=6 f=2 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-endotoxin (produced by a bacterially derived CryIA(b) gene in corn plants) in seeds planted on 190 acres of corn to
evaluate the control of the European corn borer and other lepidopteran pests. The program is currently authorized
only in the States of California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky,
Michigan, Minnesota, Mississippi, Missouri, Nebraska, North Carolina, North Dakota, Ohio, Pennsylvania, South
Dakota, and Wisconsin and the Commonwealth of Puerto Rico. The experimental use permit extension is effective for
plantings from April 12, 1994 to March 31, 1995, and associated activities such as collection of field data and harvesting
and processing of seed after last planting. Corn grown under this permit is not permitted to enter commerce. Ciba Seeds
has applied to amend the EUP by diverting plantings of up to 45 acres of transgenic Bt corn from previously authorized
plantings in Hawaii and Illinois to Texas. Thus, the additional test sites will not increase the total acreage authorized
under the current EUP. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Upon review of the Ciba Seeds application, any comments received in response to this notice and any other relevant
information, the U.S. EPA will set conditions under which the experiments will be conducted. Any issuance of an EUP
amendment approval will be announced in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Flora Chow,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Biopesticides and Pollution Prevention Division, Office of Pesticide Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31105 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00044 </DOCNO>
<PARENT> FR941219-2-00033 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;5123&hyph;7]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Availability of Great Lakes Dredged Material Testing and Evaluation Manual and Request for Comment</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice announces the availability of and requests public comment on the draft testing manual entitled ``Great
Lakes Dredged Material Testing and Evaluation Manual (Draft)'' (draft Great Lakes Manual). The manual was prepared
by an Environmental Protection Agency (EPA)/Army Corps of Engineers (CE) workgroup comprised of staff with scientific
and/or programmatic expertise related to Great Lakes dredged material discharge activities. This manual supplements
the manual entitled ``Evaluation of Dredged Material Proposed for Discharge in Waters of the U.S._Testing Manual
(Draft)'' (draft National Manual) which was noticed for comment in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on July 21, 1994 (59 FR 37234). The draft Great Lakes manual contains more specific information for the Great Lakes
system, including detailed bioassay test protocols. Both manuals were issued pursuant to the provisions of section
404(b)(1) of the Clean Water Act and 40 CFR part 230. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments on the draft Great Lakes Manual must be postmarked or submitted by hand on or before March 21, 1995
to Marc Tuchman at the address listed below under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 A copy of the draft Great Lakes Manual can be obtained by calling or writing to Jan Miller, USACE North Central Division,
CENCD&hyph;ED&hyph;WL, 111 North Canal Street, Chicago, Ill., 60606&hyph;7205; telephone: 312&hyph;353&hyph;6354.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments on the draft Great Lakes Manual may be mailed or delivered to: 
<!-- PJG 0012 frnewline -->
Marc Tuchman, USEPA Great Lakes National Program Office_G&hyph;9J, Attention: Great Lakes Manual Comments, 77
West Jackson Street, Chicago, Ill. 60604; telephone: 312&hyph;353&hyph;1369. Commentors are requested to submit
an original and 3 copies of their written comments and enclosures. Commentors who want receipt of their comments acknowledged
should include a self-addressed, stamped envelope. No facsimiles (faxes) will be accepted. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jan Miller, USACE North Central Division, CENCD&hyph;ED&hyph;WL, 111 North Canal Street, Chicago, Ill., 60606&hyph;7205;
telephone: 312&hyph;353&hyph;6354; Marc Tuchman, USEPA Great Lakes National Program Office_G&hyph;9J, 77 West
Jackson Street, Chicago, Ill. 60604; telephone: 312&hyph;353&hyph;1369; or John Dorkin, USEPA Region 5_WS&hyph;16J,
77 West Jackson Street, Chicago, Ill. 60604; telephone: 312&hyph;886&hyph;1980. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed discharges of dredged or fill material in Great Lakes Waters must be evaluated to determine the potential
environmental impacts of such activities. Specifically, Section 404 of the Federal Water Pollution Control Act
of 1972, Public Law 92&hyph;500, as amended by the CWA, Public Law 95&hyph;217, requires that the discharge of dredged
or fill material into waters of the U.S. be permitted by the CE. EPA has the primary role in developing the environmental
guidelines_the Section 404(b)(1) Guidelines (Guidelines)_in conjunction with the CE, by which permit applications
must be evaluated. The Guidelines are published at 40 CFR Part 230. Fundamental to the Guidelines is the precept that
dredged or fill material should not be discharged into the aquatic ecosystem, unless it can be demonstrated that such
a discharge will not have an unacceptable adverse impact either individually or in combination with known and/or
probable impacts of other activities affecting the ecosystems of concern. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dredged material testing is part of the larger evaluation of a proposed discharge activity to determine its compliance
with the Guidelines. Sections 230.60 and 230.61 of the Guidelines provide the basis for certain contaminant-related
factual determinations regarding the potential environmental effects of a proposed discharge. The draft Great
Lakes Manual provides regional guidance on the testing provision of the Guidelines, supplementing the draft National
Manual which was noticed for comment in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on July 21, 1994 (59 FR 37234). The manuals detail the physical, chemical, and biological evaluation procedures outlined
in &sect;&sect;230.60 and 230.61, including technical guidance on sampling and handling, quality assurance, chemical
and physical analysis, and biological effects testing. The draft Great Lakes Manual contains more specific information
for the Great Lakes system, including detailed bioassay test protocols. Conclusions reached utilizing the manuals
will be used to make factual determinations of the potential environmental effects of a proposed discharge of dredged
material. 
<!-- PJG 0012 frnewline -->
The final Great Lakes Manual will be published in approximately 6 months after review and consideration of the comments
received on this draft and in coordination with the development of the final National Manual. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 7, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Valdas Adamkus, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Administrator, Region 5. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;30947 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00045 </DOCNO>
<PARENT> FR941219-2-00034 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;5124&hyph;3]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Water System Supervision Program Revision for the State of Montana</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Public notice is hereby given in accordance with the provisions of section 1413 of the Safe Drinking Water Act as amended,
42 U.S.C. 300g&hyph;2, and 40 CFR part 142, Subpart B_Primary Enforcement Responsibility, that the State of Montana
has revised its Public Water System Supervision (PWSS) Primacy Program. Montana's PWSS program, administered by
the Drinking Water Section of the Department of Health and Environmental Sciences, has adopted regulations for total
coliforms, Phase II (7 inorganic and 26 organic chemicals), Phase IIb (1 inorganic and 4 organic chemicals), Phase
V (5 inorganic and 18 organic chemicals), and lead and copper that correspond to the National Primary Drinking Water
Regulations (NPDWR) in 49 CFR Part 141 for total coliforms (FR Vol. 54, No. 124, June 29, 1989, Pg. 27544&hyph;27568),
Phase II (FR Vol. 56, No. 20, January 30, 1991, Pg. 3526&hyph;3597), Phase IIb (FR Vol. 56, No. 126, July 1, 1991, Pg.
30266&hyph;30281), Phase V (FR Vol. 57, No. 138, July 17, 1992, Pg. 31776&hyph;31849), and for lead and copper (FR
Vol. 56, No. 110, June 7, 1991, Pg. 26460&hyph;26564). The Environmental Protection Agency (EPA) has completed its
review of Montana's primacy revisions and has determined that they are no less stringent than the NPDWRs. EPA therefore
approves Montana's primacy revisions for Total Coliforms, Phase II, IIb, V, and Lead and Copper Rules. This determination
shall become effective January 18, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any interested parties are invited to submit written comments on this determination, and may request a public hearing
on or before January 18, 1995. If a public hearing is requested and granted, this determination shall not become effective
until such time following the hearing that the Regional Administrator issues an order affirming or rescinding this
action.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Requests for a public hearing should be addressed to: William P. Yellowtail, Regional Administrator, c/o Marty Swickard
(8WM&hyph;DW), U.S. Environmental Protection Agency, Region VIII, 999 18th Street, Suite 500, Denver, CO 80202&hyph;2466.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Frivolous or insubstantial requests for a hearing may be denied by the Regional Administrator. However, if a substantial
request is made within thirty (30) days after this notice, a public hearing will be held.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any request for a public hearing shall include the following: (1) the name, address, and telephone number of the individual,
organization, or other entity requesting a hearing; (2) a brief statement of the requesting person's interest in
the Regional Administrator's determination and of information that the requesting person intends to submit at such
hearing; and (3) the signature of the individual making the request, or, if the request is made on behalf of an organization
or other entity, the signature of the responsible official of the organization or other entity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notice of any hearing shall be given not less than fifteen (15) days prior to the time schedule for the hearing. Such
notice will be made by the Regional Administrator in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and in newspapers of general circulation in the State of Montana. A notice will also be sent to the person(s) requesting
the hearing as well as to the State of Montana. The hearing notice will include a statement of purpose, information
regarding time and location, and the address and telephone number where interested persons may obtain further information.
The Regional Administrator will issue an order affirming or rescinding his determination upon review of the hearing
record. Should the determination be affirmed, it will become effective as of the date of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Should no timely and appropriate request for a hearing be received, and the Regional Administrator does not elect
to hold a hearing on his own motion, this determination shall become effective on January 18, 1995. Please bring this
notice to the attention of any persons known by you to have an interest in this determination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All documents relating to this determination are available for inspection at the following locations: (1) U.S. EPA
Region VIII, Drinking Water Branch, 999 18th Street (4th floor), Denver, Colorado; (2) Department of Health and Environmental
Sciences, Drinking Water Section, 1400 Broadway, Room A206, Helena, Montana.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Marty Swickard, Drinking Water Branch, EPA Region VIII (8WM&hyph;DW), 999 18th Street, Suite 500, Denver, Colorado
80202&hyph;2466, telephone (303) 293&hyph;1629.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jack W. McGraw,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Administrator, EPA, Region VIII.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31109 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00046 </DOCNO>
<PARENT> FR941219-2-00035 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL COMMUNICATIONS COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirement Submitted to Office of Management and Budget for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Communications Commission has submitted the following information collection requirement to OMB for
review and clearance under the Paperwork Reduction Act of 1980 (44 U.S.C. 3507).
<!-- PJG 0012 frnewline -->
Copies of this submission may be purchased from the Commission's copy contractor, International Transcription
Service, Inc., 2100 M Street, NW., Suite 140, Washington, DC 20037, (202) 857&hyph;3800. For further information
on this submission contact Judy Boley, Federal Communications Commission, (202) 418&hyph;0214. Persons wishing
to comment on this information collection should contact Timothy Fain, Office of Management and Budget, Room 10214
NEOB, Washington, DC 20503, (202) 395&hyph;3561.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
OMB Number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 None.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Section 76.987(g), New Product Tiers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Action:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 New collection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 State, local governments and businesses or other for-profit.
<!-- PJG 0012 frnewline -->
Frequency of Response: On occasion reporting requirement.
<!-- PJG 0012 frnewline -->
Estimated Annual Burden: 33,600 responses, .5 hours average burden per response, 16,800 hours total annual burden.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Needs and Uses:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On 11/10/94, the Commission adopted a Sixth Order on Reconsideration, Fifth Report and Order, and Seventh Notice
of Proposed Rulemaking, in MM Docket No. 93&hyph;215, Implementation of Sections of the Cable Television Consumer
Protection and Competition Act of 1992, Rate Regulation. In this Order, we added rules establishing an additional
cable programming service tier (CPST) category which we refer to a new programming tier (NPT). Section 76.987(g)
requires cable operators to file with the Commission, within 30 days of offering a NPT, a copy of the new rate card that
contains the following information on the BSTs (basic service tiers), CPSTs, and NPTs: 1) the names of the programming
services contained on each tier; and 2) the price of each tier. Operators also must file with the Commission, copies
of notifications that were sent to subscribers regarding the initial offering of NPTs. After this initial filing,
cable operators must file updated rate cards and copies of customer notifications with the Commission within 30 days
of rate or service changes affecting the NPT. The information is used by FCC staff to ensure that cable operators are
complying with our conditions for NPTs, i.e., that operators are not making fundamental changes to what they offer
on their tiers of service, and that subscribers are given due notice of NPT introductions.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Federal Communications Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William F. Caton,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31093 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6712&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00047 </DOCNO>
<PARENT> FR941219-2-00036 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirement Submitted to Office of Management and Budget for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Communications Commission has submitted the following information collection requirement to OMB for
review and clearance under the Paperwork Reduction Act of 1980 (44 U.S.C. 3507).
<!-- PJG 0012 frnewline -->
Copies of this submission may be purchased from the Commission's copy contractor, International Transcription
Service, Inc., 2100 M Street, NW., Suite 140, Washington, DC 20037, (202) 857&hyph;3800. For further information
on this submission contact Judy Boley, Federal Communications Commission, (202) 418&hyph;0214. Persons wishing
to comment on this information collection should contact Timothy Fain, Office of Management and Budget, Room 10214
NEOB, Washington, DC 20503, (202) 395&hyph;3561.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
OMB Number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 3060&hyph;0595.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Updating Maximum Permitted Rates for Regulated Cable Services ``Update Form''.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form Number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 FCC Form 1210.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Revision of a currently approved collection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
State, local governments and businesses or other for-profit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On occasion reporting requirement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimated Annual Burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 33,600 responses, 11 hours average burden per response, 69,600 hours total annual burden. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Needs and Uses:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On 2/22/94, the Commission adopted a Second Order on Reconsideration, Fourth Report and Order, and Fifth Notice of
Proposed Rulemaking in MM Docket No. 92&hyph;266, Implementation of Sections of the Cable Television Consumer Protection
and Competition Act of 1992, Rate Regulation. Using a more sophisticated economic model, we have recalculated the
competitive differential to reflect a more accurate estimate of the difference between competitive and noncompetitive
cable rates. In addition, we have improved the measure of equipment and installation revenues. On 11/10/94, the Commission
adopted a Sixth Order on Reconsideration, Fifth Report and Order, and Seventh Notice of Proposed Rulemaking, referred
to as the ``Going Forward'' order. This Order further revised its rules for rate adjustments when channels are added
or deleted, or new programming service tier channels are added or deleted, or new programming service tiers are established.
To reflect the new rule sections adopted by the Commission, Section 76.922(e)(1) and (2), we are expanding the Instructions
for FCC Form 1210, to enable cable operators to implement the revised methodology reflected in these rules. It is anticipated
that these additional instructions will be used on an interim basis between January 1, 1995 and March 31, 1995, for
operators who choose to use the new methodology. A revised version of the FCC Form 1210 that is being submitted to OMB
for approval will become effective April 1, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Federal Communications Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William F. Caton,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31092 Filed 12&hyph;16&hyph;94 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6712&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00048 </DOCNO>
<PARENT> FR941219-2-00037 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL RESERVE SYSTEM</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE> The Chase Manhattan Corporation, et al.; Formations of; Acquisitions by; and Mergers of Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have applied for the Board's approval under section 3 of the Bank Holding Company
Act (12 U.S.C. 1842) and  225.14 of the Board's Regulation Y (12 CFR 225.14) to become a bank holding company or to acquire
a bank or bank holding company. The factors that are considered in acting on the applications are set forth in section
3(c) of the Act (12 U.S.C. 1842(c)).
<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing to the Reserve Bank or to the offices of the Board of Governors.
Any comment on an application that requests a hearing must include a statement of why a written presentation would
not suffice in lieu of a hearing, identifying specifically any questions of fact that are in dispute and summarizing
the evidence that would be presented at a hearing.
<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding each of these applications must be received not later than January 12,
1995.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of New York 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(William L. Rutledge, Senior Vice President) 33 Liberty Street, New York, New York 10045: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. The Chase Manhattan Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, New York, New York; to acquire 100 percent of the voting shares of Chase Savings Bank, New York, New York, a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 bank.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Richmond 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Lloyd W. Bostian, Jr., Senior Vice President) 701 East Byrd Street, Richmond, Virginia 23261:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. CCB Financial Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Durham, North Carolina; to merge with Security Capital Bancorp, Salisbury, North Carolina, and thereby indirectly
acquire Security Capital Bank, Salisbury, North Carolina, OMNIBANK, INC., SSB, Salisbury, North Carolina, Citizens
Savings, Inc., SSB, Concord, North Carolina, and Home Savings Bank, Inc., SSB, Kings Mountain, North Carolina.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
C. Federal Reserve Bank of Kansas City 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(John E. Yorke, Senior Vice President) 925 Grand Avenue, Kansas City, Missouri 64198:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Byron State, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Byron, Nebraska; to become a bank holding company by acquiring 80 percent of the voting shares of Byron State Bank,
Byron, Nebraska.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. The Estes Park Bank Restated Employee Stock Ownership 401(K) Plan &amp; Retirement Trust
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Estes Park, Colorado; to acquire 47.43 percent of the voting shares of Estes Bank Corporation, Estes Park, Colorado,
and thereby indirectly acquire The Estes Park Bank, Estes Park, Colorado.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William W. Wiles,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94-31074 Filed 12-16-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00049 </DOCNO>
<PARENT> FR941219-2-00038 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[DKT. C&hyph;3539]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
American Body Armor and Equipment, Inc.; Prohibited Trade Practices, and Affirmative Corrective Actions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order prohibits, among other things, a Florida-based company from misrepresenting that its bullet-resistant
garments are certified, approved, endorsed, or sanctioned by any government body or private organization. In addition,
the respondent is required to contact certain past purchasers and offer to provide replacement vests at a reduced
cost.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint and Order issued October 21, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130,
6th Street &amp; Pennsylvania Avenue, NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Lisa Kopchik or Joel Winston, FTC/S&hyph;4002, Washington, DC 20580. (202) 326&hyph;3139 or 326&hyph;3153.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Thursday, June 6, 1991, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 56 FR 26096, a proposed consent agreement with analysis In the Matter of American Body Armor and Equipment, Inc.,
for the purpose of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments,
suggestions or objections regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments were filed and considered by the Commission. The Commission has ordered the issuance of the complaint in
the form contemplated by the agreement, made its jurisdictional findings and entered an order to cease and desist,
as set forth in the proposed consent agreement, in disposition of this proceeding.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets or applies sec. 5, 38 Stat. 719, as amended; 15 U.S.C. 45)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31122 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00050 </DOCNO>
<PARENT> FR941219-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. 9207]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Coca-Cola Co.; Prohibited Trade Practices and Affirmative Corrective Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Modifying Order.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This order reopens the proceeding and modifies the Commission's final order issued on June 13, 1994, that required
the respondent, for ten years, to obtain Commission approval before acquiring certain brand-name soft drink concentrate
manufacturers, by eliminating a provision which had expressly defined Coca-Cola Enterprises, Inc. as a Coca-Cola
Company subsidiary or affiliate subject to this prior approval requirement.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
dates: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final Order issued June 13, 1994. Modifying Order issued December 5, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Modifying Order are available from the Commission's Public Reference Branch, H&hyph;130, 6th and PA.
Ave., NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Joseph Brownman or Ronald Rowe, FTC/S&hyph;2105, Washington, D.C. 20580. (202) 326&hyph;2605 or 326&hyph;2610.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
supplementary information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In the Matter of The Coca-Cola Company. The prohibited trade practices and/or corrective actions as set forth at 59
FR 40031, are changed, in part, as indicated in the summary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended;
15 U.S.C. 45, 18)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31123 Filed 12&hyph;16&hyph;94, 9:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00051 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[File No. 922 3021]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Gateway Educational Products, Ltd., et al.; Proposed Consent Agreement With Analysis to Aid Public Comment</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Proposed Consent Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent agreement, accepted subject to final Commission approval, would prohibit, among other things, a California-based
corporation and two officers from making reading and comprehension claims for their ``Hooked on Phonics'' reading
program or any other educational program or product without possessing and relying upon competent and reliable substantiating
evidence. In addition, it would prohibit them from representing that any endorsement represents the typical or ordinary
experience of consumers with any educational program or product without possessing and relying upon competent and
reliable substantiating evidence.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 17, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be directed to: FTC/Office of the Secretary, Room 159, 6th St. and Pa. Ave., NW., Washington, DC 20580.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Joel Winston or Toby Levin, FTC/S&hyph;4002, Washington, DC 20580. (202) 326&hyph;3153 or 326&hyph;3156.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to section 6(f) of the Federal Trade Commission Act, 38 Stat. 721, 15 U.S.C. 46 and &sect;2.34 of the Commission's
rules of practice (16 CFR 2.34), notice is hereby given that the following consent agreement containing a consent
order to cease and desist, having been filed with and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of sixty (60) days. Public comment is invited. Such comments or views will be
considered by the Commission and will be available for inspection and copying at its principal office in accordance
with &sect;4.9(b)(6)(ii) of the Commission's rules of practice (16 CFR 4.9(b)(6)(ii)).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00052 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In the matter of: Gateway Educational Products, Ltd., a corporation, and John Shanahan and John Herlihy, individually
and as officers of said corporation. File No. 9223021.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Agreement Containing Consent Order To Cease and Desist
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Trade Commission having initiated an investigation of certain acts and practices of Gateway Educational
Products, Ltd., a corporation, and John Shanahan and John Herlihy, individually and as officers of said corporation
(``proposed respondents''), and it now appearing that proposed respondents are willing to enter into an agreement
containing an order to cease and desist from the use of the acts and practices being investigated.
<!-- PJG 0012 frnewline -->
It is hereby agreed by and between Gateway Educational Products, Ltd., by its duly authorized officer, and John Shanahan
and John Herlihy, individually and as officers of said corporation, and their attorneys, and counsel for the Federal
Trade Commission that:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Proposed respondent Gateway Educational Products, Ltd., is a corporation organized, existing, and doing business
under and by virtue of the laws of the State of Delaware with its office and principal place of business located at 1050
Katella Ave., Suite D, Orange, California 92667.
<!-- PJG 0012 frnewline -->
Proposed respondents John Shanahan and John Herlihy are officers of said corporation. They formulate, direct and
control the policies, acts and practices of said corporation and their address is the same as that of said corporation.
<!-- PJG 0012 frnewline -->
2. Proposed respondents admit all the jurisdictional facts set forth in the draft of complaint.
<!-- PJG 0012 frnewline -->
3. Proposed respondents waive:
<!-- PJG 0012 frnewline -->
(a) Any further procedural steps;
<!-- PJG 0012 frnewline -->
(b) The requirement that the Commission's decision contain a statement of findings of fact and conclusions of law;
and
<!-- PJG 0012 frnewline -->
(c) All rights to seek judicial review or otherwise to challenge or contest the validity of the order entered pursuant
to this agreement.
<!-- PJG 0012 frnewline -->
4. This agreement shall not become part of the public record of the proceeding unless and until it is accepted by the
Commission. If this agreement is accepted by the Commission, it, together with the draft of complaint contemplated
thereby, will be placed on the public record for a period of sixty (60) days and information in respect thereto publicly
released. The Commission thereafter may either withdraw its acceptance of this agreement and so notify the proposed
respondents, in which event it will take such action as it may consider appropriate, or issue and serve its complaint
(in such form as the circumstances may require) and decision, in disposition of the proceeding.
<!-- PJG 0012 frnewline -->
5. This agreement is for settlement purposes only and does not constitute an admission by proposed respondents that
the law has been violated as alleged in the draft of complaint, or that the facts as alleged in the draft of complaint,
other than the jurisdictional facts, are true.
<!-- PJG 0012 frnewline -->
6. This agreement contemplates that, if it is accepted by the Commission, and if such acceptance is not subsequently
withdrawn by the Commission pursuant to the provisions of &sect;2.34 of the Commission's rules, the Commission may,
without further notice to proposed respondents, (1) issue its complaint corresponding in form and substance with
the draft of complaint and its decision containing the following order to cease and desist in disposition of the proceeding
and (2) make information public in respect thereto. When so entered, the order to cease and desist shall have the same
force and effect and may be altered, modified, or set aside in the same manner and within the same time provided by statute
for other orders. The order shall become final upon service. Delivery by the U.S. Postal Service of the complaint and
decision containing the agreed-to-order to proposed respondents' address as stated in this agreement shall constitute
service. Proposed respondents waive any right they may have to any other manner of service. The complaint may be used
in construing the terms of the order, and no agreement, understanding, representation, or interpretation not contained
in the order or the agreement may be used to vary or contradict the terms of the order.
<!-- PJG 0012 frnewline -->
7. Proposed respondents have read the proposed complaint and order contemplated hereby. They understand that once
the order has been issued, they will be required to file one or more compliance reports showing that they have fully
complied with the order. Proposed respondents further understand that they may be liable for civil penalties in the
amount provided by law for each violation of the order after it becomes final.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Order
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Definitions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this order, the following definitions shall apply:
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00053 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. ``HOP'' means the reading program known as ``Hooked on Phonics/SRA Reading Power'' marketed by Gateway Educational
Products, Ltd. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. ``Educational program or product'' means any program of product that provides instruction in any field of study,
including but not limited to any aspect of reading. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. ``Competent and reliable scientific evidence'' means tests, analyses, research, studies, or other evidence
based on the expertise of professionals in the relevant area, has been conducted and evaluated in an objective manner
by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable
results.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
I. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is ordered that respondents Gateway Educational Products, Ltd., a corporation, its successors and assigns, and
its officers, and John Shanahan and John Herlihy, individually and as officers of said corporation, and respondents'
agents, representatives, and employees, directly or through any corporation, subsidiary, division or other device,
in connection with the manufacturing, labelling, advertising, promotion, offering for sale, sale, or distribution
of HOP or any other educational program or product in or affecting commerce, as ``commerce'' is defined in the Federal
Trade Commission Act, do forthwith cease and desist from representing, in any manner, directly or by implication,
that such program or product: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Can or will quickly and easily teach persons with reading problems or disabilities to read, regardless of the nature
of the problem or disability; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Is effective for teaching persons with learning disabilities, including dyslexia and attention deficit disorders,
to read; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Can or will cause users with reading problems or disabilities to achieve significant improvement in reading levels
or classroom grades; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Is effective for teaching persons in a home setting to read, without the need for additional assistance such as a
teacher or tutor; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Is effective for teaching reading comprehension skills; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. Has helped nearly one million or any other number of students to learn to read; or 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00054 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
G. Provides any other educational benefits,
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
unless at the time of making such representation, respondents possess and rely upon competent and reliable evidence,
which when appropriate must be competent and reliable scientific evidence, that substantiates such representation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
II
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents Gateway Educational Products, Ltd., a corporation, its successors and assigns,
and its officers, and John Shanahan and John Herlihy, individually and as officers of said corporation, and respondents'
agents, representatives, and employees, directly or through any corporation, subsidiary, division or other device,
in connection with the manufacturing, labelling, advertising, promotion, offering for sale, sale, or distribution
of any educational program or product in or affecting commerce, as ``commerce'' is defined in the Federal Trade Commission
Act, do forthwith cease and desist from representing, directly or by implication, that any endorsement (as ``endorsement''
is defined in 16 CFR 255.0(b)) of the program or product represents the typical or ordinary experience of members of
the public who use the program or product, unless at the time of making such representation, respondents possess and
rely upon competent and reliable evidence, which when appropriate must be competent and reliable scientific evidence,
the substantiates such representation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents Gateway Educational Products, Ltd., a corporation, its successors and assigns,
and its officers, and John Shanahan and John Herlihy, individually and as officers of said corporation, shall for
five (5) years after the date of the last dissemination to which they pertain, maintains and upon request make available
to the Federal Trade Commission or its staff for inspection and copying:
<!-- PJG 0012 frnewline -->
A. Any advertisement making any representation covered by this order;
<!-- PJG 0012 frnewline -->
B. All materials that were relied upon by respondents in disseminating any representation covered by this order;
and
<!-- PJG 0012 frnewline -->
C. All reports, tests, studies, surveys, demonstrations or other evidence in any respondent's possession or control
that contradict, qualify, or call into question such representation, or the basis upon which respondents relied
for such representation, including complaints from consumers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00055 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
IV
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondent Gateway Educational Products, Ltd., its successors and assigns, shall:
<!-- PJG 0012 frnewline -->
A. Within thirty (30) days after service of this order, provide a copy of this order to each of its current principals,
officers, directors, and managers, and to all personnel, agents, and representatives having sales, advertising,
or policy responsibility with respect to the subject matter of this order; and
<!-- PJG 0012 frnewline -->
B. For a period of five (5) years from the date of entry of this order, provide a copy of this order to each of its principals,
officers, directors, and managers, and to all personnel, agents, and representatives having sales, advertising,
or policy responsibility with respect to the subject matter of this order within three (3) days after the person commences
his or her responsibilities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
V
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondent Gateway Educational Products, Ltd., its successors and assigns, shall notify
the Federal Trade Commission at least thirty (30) days prior to any proposed change in its corporate structure, including
but not limited to dissolution, assignment, or sale resulting in the emergence of a successor corporation, the creation
or dissolution of subsidiaries or affiliates, the planned filing of a bankruptcy petition, or any other change in
the corporation that may affect compliance obligations arising out of this order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
VI
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents John Shanahan and John Herlihy shall, for a period of ten (10) years from the
date of entry of this order, notify the Commission within thirty (30) days of the discontinuance of their present business
or employment with respondent Gateway Educational Products, Ltd., or its successors and assigns, and of their affiliation
with any new business or employment in connection with the manufacturing, labelling, advertising, promotion, offering
for sale, sale, or distribution of any educational program or product. Each notice of affiliation with any new business
or employment shall include the respondent's new business address and telephone number, current home address, and
a statement describing the nature of the business or employment and his duties and responsibilities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
VII
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents shall, within sixty (60) days after service of this order, and at such other
times as the Federal Trade Commission may require, file with the Commission a report, in writing, setting forth in
detail the manner and form in which they have complied with this order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00056 </DOCNO>
<PARENT> FR941219-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Analysis of Proposed Consent Order To Aid Public Comment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Trade Commission has accepted an agreement to a proposed consent order from Gateway Educational Products,
Ltd. (``Gateway''), and John Shanahan and John Herlihy, officers of Gateway.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent order has been placed on the public record for sixty (60) days for reception of comments by interested
persons. Comments received during this period will become part of the public record. After sixty (60) days, the Commission
will again review the agreement and comments received and will decide whether it should withdraw from the agreement
or make final the agreement's proposed order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This matter concerns the ``Hooked on Phonics'' reading program (``HOP''). The Commission's proposed complaint
alleges that the respondents represented in their advertisements and promotional materials that HOP will quickly
and easily teach persons with reading problems or disabilities to read, regardless of the nature of the problem or
disability; is effective for teaching persons with learning disabilities, including dyslexia and attention deficit
disorders, to read; will cause users with reading problems or disabilities to achieve significant improvement in
reading levels and classroom grades; is effective for teaching persons in a home setting to read, without the need
for additional assistance such as a teacher or tutor; is effective for teaching reading comprehension skills; has
helped nearly one million students to learn to read at home; and that testimonials or endorsements appearing in the
HOP advertising reflect consumers' typical or ordinary experiences using HOP. The complaint alleges that the respondents
falsely represented that they relied upon a reasonable basis for these representations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent order contains provisions designed to prevent the respondents from engaging in similar acts
and practices in the future. Part I requires respondents to possess adequate substantiation for the HOP efficacy
claims alleged in the complaint, as well as for any claims that any educational program or product will be effective
for teaching reading or provides any other educational benefit. The substantiation level required is competent
and reliable evidence, which when appropriate must be competent and reliable scientific evidence.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Part II of the proposed order prohibits the respondents, in advertising any educational program or product, from
representing that any endorsement represents the typical experience of consumers who use the program or product,
unless the claim is substantiated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Parts III through VII relate to the respondents' obligations to retain substantiation materials; to notify the Commission
of changes in corporate identity, or in the case of the individuals, employment; to distribute copies of the order
to certain employees; and to file compliance reports with the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The purpose of this analysis is to facilitate public comment on the proposed order, and it is not intended to constitute
an official interpretation of the agreement and proposed order or to modify in any way their terms.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31128 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00057 </DOCNO>
<PARENT> FR941219-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. C&hyph;3543]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Hayes Microcomputer Products, Inc.; Prohibited Trade Practices, and Affirmative Corrective Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order prohibits, among other things, a Georgia manufacturer and distributor of computer communications
products from making representations for any of its modem-related products regarding the risk of data loss or data
destruction, or data transmission problems due to any escape method, unless the respondent possesses and relies
upon competent and reliable substantiating evidence.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint and Order issued November 28, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130,
6th Street &amp; Pennsylvania Avenue, NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Linda Badger or Kerry O'Brien, FTC/San Francisco Regional Office, 901 Market St., Suite 570, San Francisco, CA. 94103.
(415) 744&hyph;7920.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Monday, May 9, 1994, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 59 FR 23864, a proposed consent agreement with analysis In the Matter of Hayes Microcomputer Products, Inc., for
the purpose of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments,
suggestions or objections regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A comment was filed and considered by the Commission. The Commission has ordered the issuance of the complaint in the
form contemplated by the agreement, made its jurisdictional findings and entered an order to cease and desist, as
set forth in the proposed consent agreement, in disposition of this proceeding.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets or applies sec. 5, 38 Stat. 719, as amended; 15 U.S.C. 45)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31124 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00058 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. 9266]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Red Apple Companies, Inc., et al.; Proposed Consent Agreement With Analysis To Aid Public Comment</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Proposed Consent Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent agreement, accepted subject to final Commission approval, would require, among other things, three
New York-based companies and their officer to divest six supermarkets, within 12 months, to a Commission-approved
acquirer or acquirers. If the respondents fail to satisfy the divestiture requirements, the proposed order would
permit the Commission to appoint a trustee to divest supermarkets to satisfy the terms of the order. The consent agreement
also would prohibit the respondents, for ten years, from acquiring, without prior Commission approval, any supermarket
or any interest in an entity that owns or operates a supermarket in New York County south of 116th Street. In addition,
the respondents, for ten years, would be prohibited from entering into or enforcing any agreement that restricts
the ability of any person acquiring any supermarket owned or operated by any respondent in New York County south of
116th Street.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 17, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be directed to: FTC/Office of the Secretary, Room 159, 6th St. and Pa. Ave., NW., Washington, DC 20580.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ronald Rowe, FTC/S&hyph;2105, Washington, DC 20580. (202) 326&hyph;2610.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to section 6(f) of the Federal Trade Commission Act, 38 Stat. 721, 15 U.S.C. 46 and &sect;3.25(f) of the Commission's
rules of practice (16 CFR 3.25(f)), notice is hereby given that the following consent agreement containing a consent
order to cease and desist, having been filed with and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of sixty (60) days. Public comment is invited. Such comments or views will be
considered by the Commission and will be available for inspection and copying at its principal office in accordance
with &sect;4.9(b)(6)(ii) of the Commission's rules of practice (16 CFR 4.9(b)(ii)).
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00059 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Agreement Containing Consent Order To Divest and to Cease and Desist
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In the matter of Red Apple Companies, Inc., a corporation; John A. Catsimatidis, an individual; Supermarket Acquisition
Corp., a corporation; and Designcraft Industries, Inc. (d/b/a Sloan's Supermarkets, Inc.), a corporation. Docket
No. 9266.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agreement herein, by and between Red Apple Companies, Inc. (``Red Apple''), a corporation, John A. Catsimatidis,
an individual, Supermarket Acquisition Corporation (``SAC''), a corporation, and Sloan's Supermarkets, Inc.
(a/k/a Designcraft Industries, Inc.) (``SSI''), a corporation, by their duly authorized officers, hereafter sometimes
referred to as ``respondents,'' and their attorney, and counsel for the Federal Trade Commission, is entered into
in accordance with the Commission's rule governing consent order procedures. In accordance therewith the parties
hereby agree that:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Respondent Red Apple is a corporation organized, existing and doing business under and by virtue of the laws of the
State of New York, with its executive offices located at 823 Eleventh Avenue, New York, New York 10019&hyph;3535.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Respondent John A. Catsimatidis is the Chairman, Chief Executive Officer, and sole shareholder of Red Apple Companies,
Inc., and Chairman, Chief Executive Officer, Treasurer, and the largest shareholder of Sloan's Supermarkets, Inc.,
with his office and principal place of business at 823 Eleventh Avenue, New York, New York 10019&hyph;3535.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Respondent SAC is a corporation organized, existing and doing business under and by virtue of the laws of the State
of New York, with its executive offices located at 823 Eleventh Avenue, New York, New York 10019&hyph;3535.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Respondent SSI is a corporation organized, existing and doing business under and by virtue of the laws of the State
of Delaware, with its executive offices located at 823 Eleventh Avenue, New York, New York 10019&hyph;3535.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Respondents have been served with a copy of the complaint issued by the Federal Trade Commission charging them with
violation of section 7 of the Clayton Act, as amended, 15 U.S.C. 18, and section 5 of the Federal Trade Commission Act,
as amended, 15 U.S.C. 45, and have filed an answer to said complaint denying said charges.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Respondents admit all the jurisdictional facts set forth in the Commission's complaint in this proceeding.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Respondents waive:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Any further procedural steps;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00060 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. The requirement that the Commission's decision contain a statement of findings of fact and conclusions of law;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. All rights to seek judicial review or otherwise to challenge or contest the validity of the order entered pursuant
to this agreement; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Any claim under the Equal Access to Justice Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. This agreement shall not become part of the public record of the proceeding unless and until it is accepted by the
Commission. If this agreement is accepted by the Commission it will be placed on the public record for a period of sixty
(60) days and information in respect thereto publicly released. The Commission thereafter may either withdraw its
acceptance of this agreement and so notify the respondents, in which event it will take such action as it may consider
appropriate, or issue and serve its decision, in disposition of the proceeding.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. This agreement is for settlement purposes only and does not constitute an admission by respondents that the law
has been violated as alleged in the complaint, or that the facts as alleged in the complaint, other than jurisdictional
facts, are true.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. This agreement contemplates that, if it is accepted by the Commission, and if such acceptance is not subsequently
withdrawn by the Commission pursuant to the provisions of &sect;3.25(f) of the Commission's rules, the Commission
may without further notice to respondents, (1) issue its decision containing the following order to divest and to
cease and desist in disposition of the proceeding, and (2) make information public in respect thereto. When so entered,
the order shall have the same force and effect and may be altered, modified or set aside in the same manner and within
the same time provided by statute for other orders. The order shall become final upon service. Delivery by the U.S.
Postal Service of the complaint and decision containing the agreed-to order to respondents' addresses as stated
in this agreement shall constitute service. Respondents waive any right they might have to any other manner of service.
The complaint may be used in construing the terms of the order, and no agreement, understanding, representation,
or interpretation not contained in the order or in the agreement may be used to vary or to contradict the terms of the
order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. Respondents have read the complaint and the order contemplated hereby. They understand that once the order has
been issued, they will be required to file one or more compliance reports showing that they have fully complied with
the order. Respondents further understand that they may be liable for civil penalties in the amount provided by law
for each violation of the order after it becomes final.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Order
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
I
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is ordered that, as used in this order, the following definitions shall apply:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. ``Commission'' means the Federal Trade Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. ``Red Apple'' means Red Apple Companies, Inc., its parents, predecessors, subsidiaries, divisions, groups and
affiliates (including Red Apple Supermarkets, Inc., Gristede's Supermarkets, Inc., and Supermarket Acquisition
Corp.), and their directors, officers, employees, agents, partners, and representatives (including John A. Catsimatidis),
and their respective successors or assigns.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. ``John A. Catsimatidis'' means John A. Catsimatidis, an individual and Chairman and Chief Executive Officer of
Red Apple Companies, Inc., and Chairman, Chief Executive Officer, and Treasurer of Sloan's Supermarkets, Inc. (a/k/a
Designcraft Industries, Inc.).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. ``SAC'' means Supermarket Acquisition Corp., its parents, predecessors, subsidiaries, divisions, groups and
affiliates, and their directors, officers, employees, agents, partners, and representatives, and their respective
successors or assigns.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. ``SSI'' means Sloan's Supermarkets, Inc. (a/k/a Designcraft Industries, Inc.), its parents, predecessors,
subsidiaries, divisions, groups and affiliates, and their directors, officers, employees, agents, partners,
and representatives, and their respective successors or assigns.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. ``Respondents'' mean Red Apple, John A. Catsimatidis, SAC, and SSI.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. ``Assets to be divested'' means the assets described in Paragraphs II. A. and II. B. of this order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00061 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
H. ``Supermarket'' means a full-line retail grocery store that carries a wide variety of food and grocery items in
particular product categories, including bread and dairy products; refrigerated and frozen food and beverage products;
fresh and prepared meats and poultry; produce, including fresh fruits and vegetables; shelf-stable food and beverage
products, including canned and other types of packaged products; staple foodstuffs, which may include salt, sugar,
flour, sauces, spices, coffee, and tea; and other grocery products, including nonfood items such as soaps, detergents,
paper goods, other household products, and health and beauty aids.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
II
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents shall divest six supermarkets in the following manner:
<!-- PJG 0012 frnewline -->
A. Respondents shall divest, absolutely and in good faith, within twelve months from the date this order becomes final,
four of the following listed supermarkets, with one supermarket located in each of the four areas identified below
within New York County, New York:
<!-- PJG 0012 frnewline -->
1. Upper East Side:
<!-- PJG 0012 frnewline -->
a. Sloan's located at 1407 Lexington Avenue (store no. 425);
<!-- PJG 0012 frnewline -->
b. Sloan's located at 1343&hyph;1347 Lexington Avenue (store no. 437); or
<!-- PJG 0012 frnewline -->
c. Gristede's located at 1356 Lexington Avenue (store no. 52).
<!-- PJG 0012 frnewline -->
2. Upper West Side:
<!-- PJG 0012 frnewline -->
a. Sloan's located at 530&hyph;34 Amsterdam Avenue (store no. 435); or
<!-- PJG 0012 frnewline -->
b. Gristede's located at 251 West 86th Street/2361 Broadway (store no. 56).
<!-- PJG 0012 frnewline -->
3. Chelsea:
<!-- PJG 0012 frnewline -->
a. Gristede's located at 188 Ninth Avenue (store no. 441, formerly under the Sloan's trade name) or the nearest alternate
supermarket owned or operated by any respondent.
<!-- PJG 0012 frnewline -->
4. Greenwich Village:
<!-- PJG 0012 frnewline -->
a. Sloan's located at 585 Hudson Street (store no. 410) or the nearest alternate supermarket owned or operated by any
respondent; or
<!-- PJG 0012 frnewline -->
b. Gristede's located at 25 University Place (store no. 82) or the nearest alternate supermarket west of Broadway
owned or operated by any respondent.
<!-- PJG 0012 frnewline -->
The assets to be divested shall consist of the grocery business operated, and all assets, leases, properties, business
and goodwill, tangible and intangible, utilized in the distribution or sale of groceries at the listed locations
that are divested.
<!-- PJG 0012 frnewline -->
B. Respondents shall also divest, absolutely and in good faith, within twelve months from the date this order becomes
final, two of the following listed supermarkets, with one supermarket from one area identified below within New York
County, New York, and the other supermarket from a different area identified below within New York County, New York:
<!-- PJG 0012 frnewline -->
1. Upper East Side: 
<!-- PJG 0012 frnewline -->
In addition to one of the three Upper East Side supermarkets listed in Paragraph II.A.1., either one other supermarket
listed in Paragraph II.A.1., or one of the following:
<!-- PJG 0012 frnewline -->
a. Sloan's located at 1245 Park Avenue (store no. 38, formerly under the Red Apple trade name);
<!-- PJG 0012 frnewline -->
b. Gristede's located at 205 East 96th Street (store no. 98);
<!-- PJG 0012 frnewline -->
c. Gristede's located at 350 East 86th Street (store no. 50);
<!-- PJG 0012 frnewline -->
d. Sloan's located at 1668 Second Avenue (store no. 434);
<!-- PJG 0012 frnewline -->
e. Gristede's located at 1644 York Avenue (store no. 53); or
<!-- PJG 0012 frnewline -->
f. Sloan's located at 1637 York Avenue (store no. 507).
<!-- PJG 0012 frnewline -->
2. Upper West Side:
<!-- PJG 0012 frnewline -->
In addition to one of the two Upper West Side supermarkets listed in Paragraph II.A.2., either one other supermarket
listed in Paragraph II.A.2., or the following:
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00062 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a. a supermarket owned or operated by any respondent and located within four blocks of either of the two supermarkets
listed in Paragraph II. A. 2.
<!-- PJG 0012 frnewline -->
3. Greenwich Village:
<!-- PJG 0012 frnewline -->
In addition to one of the four Greenwich Village supermarkets listed in Paragraph II. A. 4., either one other supermarket
listed in Paragraph II. A. 4., or one of the following:
<!-- PJG 0012 frnewline -->
a. Gristede's located at 77 Seventh Avenue (store no. 37) or the nearest alternate supermarket owned or operated by
any respondent; or 
<!-- PJG 0012 frnewline -->
b. Gristede's located at 311 Bleecker Street (store no. 83) or the nearest alternate supermarket owned or operated
by any respondent.
<!-- PJG 0012 frnewline -->
The assets to be divested shall consist of the grocery business operated, and all assets, leases, properties, business
and goodwill, tangible and intangible, utilized in the distribution or sale of groceries at the listed locations
that are divested. 
<!-- PJG 0012 frnewline -->
C. Respondents shall divest the assets to be divested only to an acquirer or acquirers that receive the prior approval
of the Commission and only in a manner that receives the prior approval of the Commission. The purpose of the divestiture
of the assets to be divested is to ensure the continuation of the assets to be divested as ongoing, viable enterprises
engaged in the supermarket business and to remedy the lessening of competition resulting from the acquisitions as
alleged in the Commission's complaint.
<!-- PJG 0012 frnewline -->
D. Pending divestiture of such assets to be divested to comply with Paragraphs II. and III. of this order, respondents
shall take such actions as are necessary to maintain the viability and marketability of such assets to be divested
to comply with Paragraphs II. and III. of this order and to prevent the destruction, removal, wasting, deterioration,
or impairment of such assets to be divested to comply with Paragraphs II. and III. of this order except in the ordinary
course of business and except for ordinary wear and tear.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that: 
<!-- PJG 0012 frnewline -->
A. If respondents have not divested, absolutely and in good faith and with the Commission's prior approval, such assets
to be divested to comply with Paragraph II. of this order within twelve months from the date this order becomes final,
the Commission may appoint a trustee to divest any of the supermarkets listed in Paragraph II. (and all assets, leases,
properties, business and goodwill, tangible and intangible, utilized in the distribution or sale of groceries at
the listed locations) that are owned or operated by any respondent at the time of the appointment of the trustee in order
to satisfy the requirements of Paragraph II. A. and II. B. of this order. In the event that the Commission or the Attorney
General brings an action pursuant to section 5(l) of the Federal Trade Commission Act, 15 U.S.C. 45(l), or any other
statute enforced by the Commission, respondents shall consent to the appointment of a trustee in such action. Neither
the appointment of a trustee nor a decision not to appoint a trustee under this Paragraph shall preclude the Commission
or the Attorney General from seeking civil penalties or any other relief available to it, including a court-appointed
trustee, pursuant to section 5(l) of the Federal Trade Commission Act, or any other statute enforced by the Commission,
for any failure by the respondents to comply with this order.
<!-- PJG 0012 frnewline -->
B. If a trustee is appointed by the Commission or a court pursuant to Paragraph III. A. of this order, respondents shall
consent to the following terms and conditions regarding the trustee's powers, duties, authority, and responsibilities:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The Commission shall select the trustee, subject to the consent of respondents, which consent shall not be unreasonably
withheld. The trustee shall be a person with experience and expertise in acquisitions and divestitures. If respondents
have not opposed, in writing, including the reasons for opposing, the selection of any proposed trustee within ten
(10) days after written notice by the staff of the Commission to respondents of the identity of any proposed trustee,
respondents shall be deemed to have consented to the selection of the proposed trustee.
<!-- PJG 0012 frnewline -->
2. Subject to the prior approval of the Commission, the trustee shall have the exclusive power and authority to divest
any of the supermarkets listed in Paragraph II (and all assets, leases, properties, business and goodwill, tangible
and intangible, utilized in the distribution or sale of groceries at the listed locations) that are owned or operated
by any respondent at the time of the appointment of the trustee in order to comply with Paragraph II. of this order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Within ten (10) days after appointment of the trustee, respondents shall execute a trust agreement that, subject
to the prior approval of the Commission and, in the case of a court-appointed trustee, of the court, transfers to the
trustee all rights and powers necessary to permit the trustee to effect the divestitures required by Paragraph II.
of this order. Such trust agreement may include a confidentiality agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The trustee shall have twelve (12) months from the date the Commission or court approves the trust agreement described
in Paragraph III. B. 3. to accomplish the divestitures, which shall be subject to the prior approval of the Commission.
If, however, at the end of the twelve-month period, the trustee has submitted a plan of divestiture or believes that
divestiture can be achieved within a reasonable time, the divestiture period may be extended by the Commission, or,
in the case of a court-appointed trustee, by the court; provided, however, the Commission may extend this 12-month
period only one (1) time for one (1) year.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00063 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. The trustee shall have full and complete access to the personnel, books, records and facilities related to any of
the supermarkets listed in Paragraph II. (and all assets, leases, properties, business and goodwill, tangible and
intangible, utilized in the distribution or sale of groceries at the listed locations) or to any other relevant information,
as the trustee may request. Respondents shall develop such financial or other information as such trustee may reasonably
request and shall cooperate with the trustee. Respondents shall take no action to interfere with or impede the trustee's
accomplishment of the divestitures. Any delays in divestiture caused by respondents shall extend the time for divestiture
under this Paragraph in an amount equal to the delay, as determined by the Commission or, for a court-appointed trustee,
by the court. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. The trustee shall use his or her best efforts to negotiate the most favorable price and terms available in each contract
that is submitted to the Commission, subject to respondents' absolute and unconditional obligation to divest at
no minimum price. The divestitures shall be made in the manner and to the acquirer or acquirers as set out in Paragraph
II. of this order; provided, however, if the trustee receives bona fide offers, for any particular supermarket to
be divested, from more than one acquiring entity, and if the Commission determines to approve more than one such acquiring
entity for such supermarket, the trustee shall divest to the acquiring entity or entities selected by respondents
from among those approved by the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. The trustee shall serve, without bond or other security, at the cost and expense of respondents, on such reasonable
and customary terms and conditions as the Commission or a court may set. The trustee shall have the authority to employ,
at the cost and expense of respondents, such consultants, accountants, attorneys, investment bankers, business
brokers, appraisers, and other representatives and assistants as are necessary to carry out the trustee's duties
and responsibilities. The trustee shall account for all monies derived from the sale and all expenses incurred. After
approval by the Commission and, in the case of a court-appointed trustee, by the court, of the account of the trustee,
including fees for his or her services, all remaining monies shall be paid at the direction of the respondents, and
the trustee's power shall be terminated. The trustee's compensation shall be based at least in significant part on
a commission arrangement contingent on the trustee's divesting the assets to be divested to satisfy Paragraph II.
of this order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Respondents shall indemnify the trustee and hold the trustee harmless against any losses, claims, damages, liabilities,
or expenses arising out of, or in connection with, the performance of the trustee's duties, including all reasonable
fees of counsel and other expenses incurred in connection with the preparation for, or defense or any claim, whether
or not resulting in any liability, except to the extent that such liabilities, losses, damages, claims, or expenses
result from misfeasance, gross negligence, willful or wanton acts, or bad faith by the trustee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. If the trustee ceases to act or fails to act diligently, a substitute trustee shall be appointed in the same manner
as provided in Paragraph III. A. of this order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. The Commission or, in the case of a court-appointed trustee, the court, may on its own initiative or at the request
of the trustee issue such additional orders or directions as may be necessary or appropriate to accomplish the divestiture
required by this order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. The trustee shall have no obligation or authority to operate or maintain the assets to be divested. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. The trustee shall report in writing to respondents and the Commission every ninety (90) days concerning the trustee's
efforts to accomplish divestiture. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
IV 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that, for a period of ten (10) years commencing on the date this order becomes final, respondents
shall not, without the prior approval of the Commission, directly or indirectly, through subsidiaries, partnerships,
or otherwise: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Acquire any stock, share capital, equity, or other interest in any supermarket or leasehold interest in any supermarket
located in New York County, New York, south of 116th Street, including any facility that has operated as a supermarket
in this area within six (6) months of the date of the proposed acquisition; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00064 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
B. Acquire any stock, share capital, equity, or other interest in: (1) Any entity that owns any interest in or operates
any supermarket located in New York County, New York, south of 116th Street, or (2) any entity that owned any interest
in or operated any supermarket located in New York County, New York, south of 116th Street with six (6) months of the
date of the proposed acquisitions.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Provided, however, that an acquisition otherwise covered by the requirements of this Paragraph shall be exempt from
the requirements of this Paragraph if it is an acquisition by John A. Catsimatidis or by a respondent corporation from
a respondent corporation or from John A. Catsimatidis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
V
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that, for a period of ten (10) years commencing on the date this order becomes final, respondents
shall neither enter into nor enforce any agreement that restricts the ability of any person (as defined in section
1(a) of the Clayton Act, 15 U.S.C. 12(a)) acquiring any supermarket owned or operated by any respondent, any leasehold
interest in any supermarket, or any interest in any retail location that formerly operated as a supermarket in New
York County, New York, south of 116th Street, to operate a supermarket or retail food store.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
VI
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Within sixty (60) days after the date this order becomes final and every sixty (60) days thereafter until respondents
have fully complied with the provisions of Paragraph II. or III. of this order, respondents shall submit to the Commission
verified written reports setting forth in detail the manner and form in which they intend to comply, are complying,
and have complied with Paragraphs II. and III. of this order. Respondents shall include in their compliance reports,
among other things that are required from time to time, a full description of the efforts being made to comply with Paragraphs
II. and III. of the order, including a description of all substantive contacts or negotiations for the divestiture
and the identity of all parties contacted. Respondents shall include in their compliance reports copies of all written
communications to and from such parties, all internal memoranda, and all reports and recommendations concerning
divestiture.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. One year (1) from the date this order becomes final, annually for the next nine (9) years on the anniversary of the
date this order becomes final, and at other times as the Commission may require, respondents shall file verified written
reports with the Commission setting forth in detail the manner and form in which they have complied and are complying
with this order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
VII
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that respondents shall notify the Commission at least thirty (30) days prior to any proposed
change in the corporate respondents such as dissolution, assignment, sale resulting in the emergency of a successor
corporation, or the creation or dissolution of subsidiaries or any other change in the corporation that may affect
compliance obligations arising out of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
VIII
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is further ordered that, for the purpose of determining or securing compliance with this order, respondents shall
permit any duly authorized representative of the Commission:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Upon five days' written notice to respondents, access, during office hours and in the presence of counsel, to inspect
and copy all books, ledgers, accounts, correspondence, memoranda and other records and documents in the possession
or under the control of any respondent relating to any matters contained in this order; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Upon five days' written notice to respondents and without restraint or interference from them, to interview respondents
or officers, directors, or employees of respondents in the presence of counsel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00065 </DOCNO>
<PARENT> FR941219-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Analysis of Proposed Consent Order To Aid Public Comment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Trade Commission (``Commission'') has accepted for public comment from Red Apple Companies, Inc., John
A. Catsimatidis, Supermarket Acquisition Corporation and Sloan's Supermarkets, Inc. (a/k/a Designcraft Industries,
Inc.) (collectively referred to as the ``Red Apple respondents'') an agreement containing a proposed consent order.
The Commission is placing the agreement containing a proposed consent order on the public record for sixty (60) days
for receipt of comments by interested persons.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments received during this period will become part of the public record. After sixty (60) days, the Commission
will again review the agreement and the comments received and will decide whether it should withdraw from the agreement
or make final the agreement's proposed order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission issued a complaint in this matter on May 27, 1994, stating that it has reason to believe that the Red Apple
respondents' acquisitions of Sloan's supermarkets between 1991 and 1993 in residential neighborhoods in New York
County, New York, located within the Upper East Side, the Upper West Side, Chelsea, and Greenwich Village would substantially
lessen competition in violation of section 7 of the Clayton Act, as amended, 15 U.S.C. 18, and section 5 of the FTC Act,
as amended, 15 U.S.C. 45. The agreement containing a proposed consent order would, if issued by the Commission, settle
the charges alleged in the Commission's complaint.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent order requires the Red Apple respondents to divest a combination of six supermarkets from two
lists of supermarkets organized by geographic market. The listed supermarkets are all located in the Upper East Side,
the Upper West Side, Chelsea, and Greenwich Village. Under the proposed consent order, the Red Apple respondents
must divest one supermarket within each of the four geographic markets and two additional supermarkets in those geographic
markets. The proposed consent order gives the Red Apple respondents 12 months to divest these supermarkets to an acquirer
or acquirers that receive the prior approval of the Commission. Under the proposed consent order, if the Red Apple
respondents fail to satisfy the divestiture provisions, the Commission may appoint a trustee to divest supermarkets
to satisfy the terms of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent order also prohibits the Red Apple respondents, for a ten-year period, from acquiring, without
prior approval from the Commission, any supermarket (or leasehold interest in a supermarket, or stock, share capital,
equity or other interest in an entity that owns or operates a supermarket) located in new York County south of 116th
Street. The word ``supermarket'' is defined in the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent order also prohibits the Red Apple respondents, for a ten-year period, from entering into or
enforcing any agreement that restricts the ability of any person acquiring any supermarket owned or operated by any
respondent in New York County south of 116th Street to operate a supermarket or retail food store.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the proposed consent order, the Red Apple respondents are required to provide to the Commission a report of compliance
with the order within sixty (60) days following the date the order becomes final, every sixty (60) days thereafter
until the divestitures are completed, and annually for a period of ten years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is anticipated that the order will resolve the competitive problems alleged in the complaint. The purpose of this
analysis is to invite public comment on the proposed consent order to aid the Commission in its determination of whether
it should make final the proposed consent order contained in the agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This analysis is not intended to constitute an official interpretation of the agreement and proposed consent order,
nor is it intended to modify the terms of the agreement and proposed consent order in any way.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31129 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00066 </DOCNO>
<PARENT> FR941219-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. C&hyph;3540]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Revco D.S., Inc.; Prohibited Trade Practices, and Affirmative Corrective Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order requires, among other things, an Ohio-based drugstore chain to divest, within twelve months,
to a Commission approved acquirer, either the pharmacy business that it owns or the pharmacy business acquired from
Hook-SupeRx, Inc. (HSI) in each of three geographic areas in Virginia. If the divestitures are not completed within
twelve months, the order requires the respondent to consent to the appointment of a trustee to divest the assets. In
addition, the consent order requires the respondent to obtain prior Commission approval, for ten years, before acquiring
any similar business interest in any of the three specified geographic areas.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint and order issued October 31, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130,
6th Street &amp; Pennsylvania Avenue, NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Laura Wilkinson or Ann Malester, FTC/S&hyph;2224, Washington, DC 20580. (202) 326&hyph;2830 or 326&hyph;2682.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Wednesday, July 27, 1994, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 59 FR 38188, a proposed consent agreement with analysis In the Matter of Revco D.S., Inc., for the purpose of soliciting
public comment. Interested parties were given sixty (60) days in which to submit comments, suggestions or objections
regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No comments having been received, the Commission has ordered the issuance of the complaint in the form contemplated
by the agreement, made its jurisdictional findings and entered an order to divest, as set forth in the proposed consent
agreement, in disposition of this proceeding.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended;
15 U.S.C. 45, 18)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31125 Filed 12&hyph;15&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00067 </DOCNO>
<PARENT> FR941219-2-00044 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. C&hyph;3542]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Roche Holding Ltd., et al.; Prohibited Trade Practices, and Affirmative Cooperative Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order, among other things, requires Roche to divest Syva's drugs of abuse testing (DAT) business within
12 months to a Commission-approved buyer, to operate the Syva assets separately from its own DAT business pending
the divestiture, and to obtain, for ten years, prior Commission approval before acquiring assets or interests of
any entity involved in the market for drugs of abuse reagent products.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint and Order issued November 22, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130,
6th Street &amp; Pennsylvania Avenue, NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Claudia Higgins or Ann Malester, FTC/S&hyph;2224, Washington, DC 20580. (202) 326&hyph;2682.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Monday, September 12, 1994, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 59 FR 46846, a proposed consent agreement with analysis In the Matter of Roche Holding Ltd., et al., for the purpose
of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments, suggestions
or objections regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No comments having been received, the Commission has ordered the issuance of the complaint in the form contemplated
by the agreement, made its jurisdictional findings and entered an order to divest, as set forth in the proposed consent
agreement, in disposition of this proceeding.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended;
15 U.S.C. 45, 18).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31126 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00068 </DOCNO>
<PARENT> FR941219-2-00045 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. 9232]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Schering Corp.; Prohibited Trade Practices, and Affirmative Corrective Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent Order.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order prohibits, among other things, a New Jersey manufacturer of the diet product, Fibre Trim, from
claiming that any food, food supplement, or drug product provides any appetite suppressant, weight loss, weight
control, or weight maintenance benefit without processing and relying upon competent and reliable scientific evidence
to substantiate the claim.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint issued September 22, 1989. Order issued October 31, 1994.
<FOOTCITE>1</FOOTCITE>

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint and the Decision and Order are available from the Commission's Public Reference Branch, H&hyph;130,
6th Street &amp; Pennsylvania Avenue, N.W., Washington, D.C. 20580.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Theodore Hoppock or Susan Cohn, FTC/S&hyph;4002, Washington, DC 20580/ (202) 326&hyph;3087 or 326&hyph;3053.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Tuesday, August 16, 1994, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 59 FR 42048, a proposed consent agreement with analysis in the Matter of Schering Corporation, for the purpose of
soliciting public comment. Interested parties were given sixty (60) days in which to submit comments, suggestions
or objections regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No comments having been received, the Commission has made its jurisdictional findings and entered an order to cease
and desist, as set forth in the proposed consent agreement, in disposition of this proceeding.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets or applies sec. 5, 38 Stat. 719, as amended; 15 U.S.C. 45, 52)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31127 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00069 </DOCNO>
<PARENT> FR941219-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>GENERAL SERVICES ADMINISTRATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Change in Solicitation Procedures Under the Small Business Competitiveness Demonstration Program</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Acquisition Policy, GSA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Title VII of the ``Business Opportunity Development Act of 1988'' (Public Law 100&hyph;656) established the Small
Business Competitiveness Demonstration Program and designated nine (9) agencies, including GSA, to conduct the
program over a four (4) year period from January 1, 1989 to December 31, 1992. The Small Business Opportunity Enhancement
Act of 1992 (Public Law 102&hyph;366) extended the demonstration program until September 1996 and made certain changes
in the procedures for operation of the demonstration program. The law designated four (4) industry groups for testing
whether the competitive capability of the specified industry groups will enable them to successfully compete on
an unrestricted basis. The four (4) industry groups are: Construction (except dredging); architectural and engineering
(A&amp;E) services (including surveying and mapping); refuse systems and related services (limited to trash/garbage
collection); and non-nuclear ship repair. Under the program, when a participating agency misses its small business
participation goal, restricted competition is reinstituted only for those contracting activities that failed
to attain the goal. The small business goal is 40 percent of the total contract dollars awarded for construction, trash/garbage
collection services, and non-nuclear ship repair and 35 percent of the total contract dollars awarded for architect-engineer
services. This notice announces modifications to GSA's solicitation practices under the demonstration program
based on a review of the agency's performance during the period from October 1, 1993 to September 30, 1994. Modifications
to solicitation practices are outlined in the Supplementary Information section below and apply to solicitations
issued on or after January 1, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 1, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Tom Wisnowzki, Office of GSA Acquisition Policy, (202) 501&hyph;1224.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Procurements of construction or trash/garbage collection with an estimated value of $25,000 or less will be reserved
for emerging small business concerns in accordance with the procedures outlined in the interim policy directive
issued by the Office of Federal Procurement Policy (58 FR 13513, March 11, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Procurements of construction or trash/garbage collection with an estimated value that exceed $25,000 by GSA contracting
activities will be made in accordance with the following procedures:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Construction Services in Groups 15, 16 and 17
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Procurements for all construction services (except solicitations issued by GSA contracting activities in Regions
1, 2, 5, 6, 7, 9 and the National Capital Region in Group 15 and Regions 1, 3, 4, 5, 7, 10 and the National Capital Region
for individual SIC code 1796) will be conducted on an unrestricted basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Procurements for construction services in Group 15 issued by GSA contracting activities in Regions 1, 2, 5, 6, 7, 9
and the National Capital Region, and in individual SIC Code 1796 in Regions 1, 3, 4, 5, 7, 10 and the National Capital
Region will be set aside for small business when there is a reasonable expectation of obtaining competition for two
or more small businesses. If no expectation exists, the procurements will be conducted on an unrestricted basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 1 encompasses the states of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 2 encompasses the states of New Jersey, New York, and the territories of Puerto Rico and the Virgin Islands.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 3 encompasses the states of Pennsylvania, Delaware, West Virginia, Maryland (except Montgomery and Prince
Georges counties), and Virginia (except the city of Alexandria and the counties of Arlington, Fairfax, Loudoun,
and Prince William).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 4 encompasses the states of Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Mississippi,
and Tennessee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00070 </DOCNO>
<PARENT> FR941219-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Region 5 encompasses the states of Illinois, Indiana, Ohio, Michigan, Minnesota, and Wisconsin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 6 encompasses the states of Iowa, Kansas, Missouri and Nebraska.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 7 encompasses the states of Arkansas, Louisiana, Oklahoma, New Mexico, and Texas.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 9 encompasses the states of Arizona, California, Hawaii, and Nevada.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 10 encompasses the states of Alaska, Idaho, Oregon, and Washington.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The National Capital Region encompasses the District of Columbia, Montgomery and Prince Georges counties in Maryland,
and the city of Alexandria and the counties of Arlington, Fairfax, Loudoun, and Prince William in Virginia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Trash/Garbage Collection Services in PSC S205
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Procurements for trash/garbage collection services in PSC S205 will be conducted on an unrestricted basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Architect-Engineer Services (All PSC Codes Under the Demonstration Program)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Procurements for all architect-engineer services (except procurements issued by contracting activities in GSA
Region 9 for service code C219) shall be conducted on an unrestricted basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Procurements for architect-engineer services issued by GSA contracting activities in GSA Region 9 for service code
C219 will be set aside for small business when there is a reasonable expectation of obtaining competition from two
or more small businesses. If no expectation exists, the procurement will be conducted on an unrestricted basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Region 9 encompasses the states of Arizona, California, Hawaii, and Nevada.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Non-nuclear Ship Repair
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
GSA does not procure non-nuclear ship repairs.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ida M. Ustad,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Acquisition Policy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31156 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;61&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00071 </DOCNO>
<PARENT> FR941219-2-00047 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Notice of Meeting of the Commission on Research Integrity
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Pursuant to P.L. 92&hyph;463, notice is hereby given of the meeting of the Commission on Research Integrity, on Thursday,
January 5, 1995, from 8:30 a.m. to 5 p.m., at the Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington,
VA 22202. The meeting will be open to the public. The meeting is subject to availability of funds and other constraints.
Therefore, interested parties are advised to call the Executive Secretary shortly before scheduled meetings to
verify the date and place.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The mandate of the Commission is to develop recommendations for the Secretary of Health and Human Services and the
Congress on the administration of Section 493 of the Public Health Service Act, as amended by and added to, by Section
161 of the NIH Revitalization Act of 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The purpose of this meeting will be to continue the dialogue with professional societies on their role to ensure research
integrity and to discourage research misconduct, including existing or planned codes of ethics that address such
issues. The Commission will also continue its discussion on a new model assurance for institutions, a definition
of research integrity, a more rigorous approach to whistleblower protection, and other issues on which the Commission
is planning to make recommendations. Discussion items may include, but will not be limited to, the issues noted above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Commission members will prepare questions to guide representatives in their presentations. The questions will
be forwarded to witnesses by the Executive Secretary. More detailed statements from witnesses on the concerns of
the specific society may be submitted in writing to the Executive Secretary before or at the meeting. Each statement
will be reviewed by Commission Members.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Henrietta D. Hyatt-Knorr, Executive Secretary, Commission on Research Integrity, at Rockwall II, Suite 700, 5515
Security Lane, Rockville MD 20852, (301) 443&hyph;5300, will furnish the meeting agenda, the Committee charter,
and a roster of the Committee members upon request. Members of the public wishing to make presentations should contact
the Executive Secretary. Depending on the number of presentations and other considerations, the Executive Secretary
will allocate a reasonable timeframe for each speaker.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Henrietta D. Hyatt-Korr,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Executive Secretary, Commission on Research Integrity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31078 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;17&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00072 </DOCNO>
<PARENT> FR941219-2-00048 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Inspector General</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Program Exclusions: November 1994</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Inspector General, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of program exclusions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the month of November 1994, the HHS Office of Inspector General imposed exclusions in the cases set forth below.
When an exclusion is imposed, no program payment is made to anyone for any items or services (other than an emergency
item or service not provided in a hospital emergency room) furnished, ordered or prescribed by an excluded party under
the Medicare, Medicaid, Maternal and Child Health Services Block Grant and Block Grants to States for Social Services
programs. In addition, no program payment is made to any business or facility, e.g., a hospital, that submits bills
for payment for items or services provided by an excluded party. Program beneficiaries remain free to decide for themselves
whether they will continue to use the services of an excluded party even though no program payments will be made for
items and services provided by that excluded party. The exclusions have national effect and also apply to all other
Federal non-procurement programs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,s50,9 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Subject, city, state
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Effective date 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
PROGRAM-RELATED CONVICTIONS 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
BANDY, GRACE A., BECKLEY, WV
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
BERNARD, GERALD, BRONX, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BUENAVENTURA, ANGELINA R., VALLEJO, CA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
DEES, MICHAEL ANTHONY, WASHINGTON, DC
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
DUVIDOVSKY, LYUDMILLA, BROOKLYN, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
EAST AMBULANCE SERVICES, LTD., WEST HOMESTEAD, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
HOLYWAY, CRAIG, DETROIT, MI
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
KHAWAJA, SHAHID, STATEN ISLAND, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
LEE, WILLIAM B., LOMPOC, CA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
MAHAJAN, SHYAM S., STROUDSBURG, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
MCDONOUGH, JAMES JOSEPH, JR., ST LOUIS PARK, MN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
MMK, INC., STATEN ISLAND, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
MUSTAFIZ, ALI, BRONX, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
PENNINGTON, SANDRA D., ST PAUL, MN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
PETERSON, WARREN COON RAPIDS, MN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
RICH, JAMES L., NEW YORK, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
RIDLEY, MARY G., SOUTH PORTLAND, ME
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
SCHLEIFER, THEODORE III, WEST HOMESTEAD, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
SILLS, KIM MCCARTER, MANSFIELD, TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
SIMANI, FARSHAD FRED, KEW GARDENS, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
THOMAS, BARBARA, WALDORF, MD
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
TINO, PHILLIP G., GREENEVILLE, TN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
VEREB, PATRICK R., NEW CASTLE, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
WATTMAN, EDWIN Z., PROVIDENCE, RI
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
PATIENT ABUSE/NEGLECT CONVICTIONS 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
BANKSTON, THELMA JOE, CARTWRIGHT, OK
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
GOULART, JEFFREY A., BRISTOL, RI
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
GREGOIRE, STUART R., BRANDON, VT
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
HARRIS, JAMES LEE, JR., KINGSLAND, AR
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
HARTMAN, EDWARD L., KEYSER, WV
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
HAVENS, CAMI M., SPOKANE, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
HINDS, ROBERT S., MESA, AZ
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
HUANTE, MARTHA, SAN ANTONIO, TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
MCCAA, BEVERLY, BIRMINGHAM, AL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
MEAD, HEIDI L., MONTROSE, IA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
REMY, MARY K., FORT SMITH, AR
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
REMY, CALVIN, FORT SMITH, AR
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
RODRIGUEZ, IRENE A., CASHION, AZ
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
SEAMSTER, MARY HELEN, MINDEN, LA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
WEBB, MARGURETTE, FORT SMITH, AR
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
WILSON, CHRISTINE, CHARLOTTE, NC
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
CONVICTION FOR HEALTH CARE FRAUD
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
DEBIASE, ROBERT, BROOKLYN, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
SCANNAPIECO, ANNE, PHILADELPHIA, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
CONTROLLED SUBSTANCE CONVICTIONS
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
KASTIGAR, BERNARD PAUL, EL SEGUNDO, CA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
WELTMAN, HAROLD S., KINGSTON, PA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
LICENSE REVOCATION/SUSPENSION/
<!-- PJG 0012 frnewline -->
SURRENDER 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
ALEXANDER, ZANDRINA, TAMPA, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
BARTOLAZO, NAPOLEON A., SEMINOLE, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
BAY SHORE PODIATRIC SVCS PC, HICKVILLE, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BIRCH, JAMES T., JR., NORFOLK, VA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
BISLA, RANHIT S., PHOENIX, AZ
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94
<!-- PJG 0012 frnewline -->
BLACKANN, ROBERT L., INDEPENDENCE, MO
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BONE, KATHLEEN, WALLINGFORD, CT
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BROADWAY MALL PODIATRIC SVCS, HICKSVILLE, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BUJNOWSKI, REGINA, NEW BRITAIN, CT
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
BUSSEY, WILLIAM J., FT COLLINS, CO
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
COOKE, FRANCIS W., GUTHRIE, OK
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
CRAWFORD, GENE OLIVER, FORT WASHINGTON, MD
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
DAVIDSON, DONNA, HARMONY, RI
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
DAVIS, ROGER W., COLORADO SPRINGS, CO
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
FARZANFAR, MOHAMMAD R., BALTIMORE, MD 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94
<!-- PJG 0012 frnewline -->
GRANNIS, JILL F., CAYUCOS, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
HICKSVILLE PODIATRIC SVCS, PC, HICKVILLE, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
HILLGARD, ELSE, VIENNA, VA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
HOBBS, WILLIAM D., MILES CITY, MT 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
KASDIN, JACK, RICHMOND, VA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
KLINGENSTEIN, KEITH G., COLLEGE PARK, MD 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
KOSTEK, DEBORAH L., FARGO, ND 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
LEHMKUHLE, JOSEPH, GRAND JUNCTION, CO 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
MARRY, SUSAN M., READING, MA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
MARTIN-JOHNSON, TRACIE, CONVENTRY, RI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
MASSOUDA, ROBERT A., PROVIDENCE, RI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
NAMIHAS, IVAN C., TUSTIN, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
NAVRKAL, HARVEY, FT COLLINS, CO 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
RANES, RAYMOND D., OCALA, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
SAEED, MUHAMMAD A., LAHORE, PAKISTAN 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
SOUTH SHORE MALL PODIATRIC SVC, HICKSVILLE, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
STATESCU, OVIDIU I., CARLSBAD, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
SUFFOLK COUNTY PODIATRIC SVCS, HICKVILLE, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
SURGICAL CARE PROVIDER, DPM, PC, HICKVILLE, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
TUCKER, DAVID O., KEENE, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
TUCKER, THOMAS WALTER, BIRMINGHAM, AL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
URCIULLO, SHARON, EAST HARTFORD, CT 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
VANCE, JUDITH K., PANHANDLE, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
FEDERAL/STATE EXCLUSION/
<!-- PJG 0012 frnewline -->
SUSPENSION 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
BELT, LANA CRABTREE, CHANUTE, KS 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
CAPUCHINO, ROSEMARIE LYNN, FORT WORTH, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
QUALITY OF CARE VIOLATIONS 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
VEST, T. BRUCE, ALTON, IL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/8/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
OWNED/CONTROLLED BY CONVICTED/
<!-- PJG 0012 frnewline -->
EXCLUDED 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
CLEARWATER FAMILY SERVICES, BELLEVUE, WA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
FRANK S. HORNG, M.D., P.C., LURAY, VA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
LIFECARE MEDICAL SALES &amp; RENT, GREENEVILLE, TN 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
LIFECARE MEDICAL SALES &amp; RENT, GREENEVILLE, TN 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
VASU CLINICS, LTD, GRUNDY, VA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
VILLAGE DRUG PHARMACY, EL SEGUNDO, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
DEFAULT ON HEAL LOAN 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
BETHEA-OWENS, CARROLL R., IRVING, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/10/94 
<!-- PJG 0012 frnewline -->
BLISH, JON J., MOUND, MN 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
BOULWARE, SUSAN L., SAUSALITO, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
BUCKENDAHL, WILLIAM G., BUELLTON, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
CABALLERO, JORGE R., LOS ANGELES, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
CARRANCEJIE, MONICA, TAMPA, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
CATALFO, CHRISTOPHER L., ORLANDO, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
CRIDER, WALTER D., SCOTTSDALE, AZ 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
DICKEY, JERRY P., RICHARDSON, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
DIFIORE, WILLIAM E., JR., SANTA ANA, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
DIGIOIA, DONNA M., CAMBRIDGE, MA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
ELOFSON, OLOF R., ISSAQUAH, WA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
FLANAGAN, JOHN T., JR., CHICAGO, IL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
GARCIA, JOSE E., ALTAMONTE SPRINGS, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
GOLDSTEIN, DAVID W., CHERRY HILL, NJ 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
GREGORY, TODD A., SANTA MARIA, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
HARDWICK, JAMES F., ALTAMONTE SPRINGS, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
HASSIOTTI, LEONE L., EAST ORANGE, NJ 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94
<!-- PJG 0012 frnewline -->
HERRON, WOODIE D., ABERDEEN, MS 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
HERZLICH, DOUGLAS B., BRONX, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
HOWE, JOHN B., POMPTON LAKES, NJ 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
JENNINGS, PEGGY J., GAINESVILLE, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
KERN, MARK S., FORT MYERS, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
KESSINGER, ANDREW JACKSON, IV., SEYMOUR, MO 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
KUZYK, DONALD IRVIN, NEWBURY PARK, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
LANDEMARE, HENRY M., MOSS BEACH, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
MCGEE, BILLIE J., SIMI VALLEY, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
MILLON, JEFFREY M., LITHONIA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
MURPHY, DEBORAH C., OJAI, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
MURPHY, RICHARD T., HENDERSON, NV 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
OLAH, DIAN M., CLEARWATER, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
OPPENHEIMER, JAHN H., ST PETERSBURG, FL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
RAZAVI, MAHMOOD K., LOS ANGELES, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
REDD, TIMOTHY J., SAN DIMAS, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
RESENDIZ, MARIO G., DANBURY, CT 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
RITER, CECIL F., HONOLULU, HI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
ROBINSON, HAROLD L., TUMWATER, WA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
ROSHY, GARY L., LUDINGTON, MI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
SCHUCKMAN, GARY A., WILMINGTON, NC 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
SCHWARZ, BERNARD CHARLES, CENTER LINE, MI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
SIMOVICH, PAUL N., HUNTINGTON BEACH, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
SPEER, JAMES D., CORPUS CHRISTI, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
STEELE, DAVID L., TEXARKANA, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
SUTANTO, SUGENG, DOWNERS GROVE, IL 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
TARVER, DONALD EUGENE, SAN FRANCISCO, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
TROUTMAN, WILLIAM D., JR., ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/5/94 
<!-- PJG 0012 frnewline -->
WARFORD, MARK A., ROSEVILLE, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
WARNER, NATHAN G., HOUSTON, MO 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 0012 frnewline -->
WHITTLESEY, JAMES B., NOVATO, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
WILLIAMS, WILLIAM E., OAKLAND, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/4/94 
<!-- PJG 0012 frnewline -->
WOODS, DAEMON S., FT DRUM, NY 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94 
<!-- PJG 0012 frnewline -->
WRIGHT, LYNNEA S., KANSAS CITY, MO 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/7/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
SECTION 1128Aa
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
ATLANTA MEDICAL EQUIPMENT, INC., ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8/31/94 
<!-- PJG 0012 frnewline -->
ATLANTA MEDICARE EQUIPMENT, INC., ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8/31/94 
<!-- PJG 0012 frnewline -->
BAGEL, LEE, ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8/31/94 
<!-- PJG 0012 frnewline -->
BAGEL, SHERRY, ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8/31/94 
<!-- PJG 0012 frnewline -->
NORTHSIDE MEDICAL EQUIPMENT, INC., ATLANTA, GA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8/31/94 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
PEER REVIEW ORGANIZATIONS CASES 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
SPENCER, WILLIAM A., OSAGE, IA 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/9/94 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Dated: December 9, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
James F. Patton, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Director, Health Care Administrative Sanctions, Office of Civil Fraud and Administrative Adjudication. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;31111 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 4150&hyph;04&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00073 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=2 -->

<DOCTITLE>Publication of OIG Special Fraud Alerts </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Inspector General, HHS. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 notice sets forth the 5 previously-developed Special Fraud Alerts issued directly to the health care provider community
by the HHS Office of Inspector General (OIG). In keeping with the OIG's goal and intent of publicizing its concern about
possible widespread and abusive health care industry practices, and seeking wider dissemination of this information
to the general public, we are republishing the main content of these Special Fraud Alerts in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
. This notice also serves to alert the general public of our intention to publish all future OIG Special Fraud Alerts
in this same manner, in addition to the current method used to distribute this material to Medicare and State health
care program providers.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Joel J. Schaer, Legislation, Regulations and Public Affairs Staff, (202) 619&hyph;0089.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
The Use of Fraud Alerts by the OIG 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Over the years, the OIG has used fraud alerts as a vehicle to identify fraudulent and abusive practices within the health
care industry. The majority of these fraud alerts are disseminated internally to the OIG's Office of Investigations
and other agencies within the Department. However, the OIG has also developed and issued Special Fraud Alerts intended
for extensive distribution directly to the health care provider community. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Special Fraud Alerts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since 1988, the OIG has issued 5 ``Special Fraud Alerts'' addressing specific trends of health care fraud and certain
practices of an industry-wide character. Specifically, the OIG Special Fraud Alerts have served to provide general
guidance to the health care industry on violations of Federal law (including various aspects of the anti-kickback
statute), as well as to provide additional insight to the Medicare carrier fraud units in identifying health care
fraud schemes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In developing these Special Fraud Alerts, the OIG relies on a number of sources, such as studies or management and program
evaluations conducted by the OIG's Office of Evaluation and Inspections. In addition, the OIG may consult with experts
in the subject field, including those within the OIG, other agencies of the Department, other Federal and State agencies,
and from those in the health care industry. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
The Nature of Past Special Fraud Alerts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the most part, the OIG Special Fraud Alerts have been reserved for national trends in health care fraud and have
addressed potential violations of the Medicare and State health care programs' anti-kickback statute. The Special
Fraud Alerts have addressed the following topic areas that could violate the anti-kickback statute: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Joint venture arrangements;
<!-- PJG 0012 frnewline -->
&bull;Routine waiver of Medicare Part B copayments and 
<!-- PJG 0012 frnewline -->
deductibles;
<!-- PJG 0012 frnewline -->
&bull;Hospital incentives to referring physicians;
<!-- PJG 0012 frnewline -->
&bull;Prescription drug marketing practices;
<!-- PJG 0012 frnewline -->
&bull;Arrangements for the provision of clinical laboratory services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Federal Register Publication of Special Fraud Alerts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the past, the OIG has always printed and distributed copies of these Special Fraud Alerts directly to all Medicare
program providers. While the OIG Special Fraud Alerts have been designed to be available to all affected program providers,
we believe it is useful to publicize these various issues and concerns involving potential abusive health care industry
practices to a more widespread audience. For this reason, we are using this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice as a vehicle to reprint the substance of the 5 previously-issued Special Fraud Alerts cited above. 
<!-- PJG 0012 frnewline -->
It is our intention to use this same 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 form for publishing future Special Fraud Alerts developed by the OIG. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because each of the previously-developed Special Fraud Alerts contained a similar brief narrative as to the nature
of the OIG and a description of the Medicare and Medicaid anti-kickback statute, we will first summarize and set out
this material in one section, as it is germane to all 5 subject issuances. Following that will be the main body and content
of each of the Special Fraud Alerts. Lastly, we have provided the general information set forth in each of these Special
Fraud Alerts addressing information on how to report information on suspected violations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
The OIG Special Fraud Alerts
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
A. General Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Inspector General was established at the Department of Health and Human Services by Congress in 1976
to identify and eliminate fraud, abuse and waste in Health and Human Services programs and to promote efficiency and
economy in departmental operations. The OIG carries out this mission through a nationwide program of audits, investigations
and inspections. To help reduce fraud in the Medicare and Medicaid programs, the OIG is actively investigating violations
of the Medicare and Medicaid anti-kickback statute, 42 U.S.C. Section 1320a-7b(b).
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00074 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
What Is the Medicare and Medicaid Anti-Kickback Law?
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Among its provisions, the anti-kickback statute penalizes anyone who knowingly and willfully solicits, receives,
offers or pays remuneration in cash or in kind to induce, or in return for: 
<!-- PJG 0012 frnewline -->
A. Referring an individual to a person for the furnishing, or arranging for the furnishing, of any item or service payable
under the Medicare or Medicaid program; or 
<!-- PJG 0012 frnewline -->
B. Purchasing, leasing or ordering , or arranging for or recommending purchasing, leasing or ordering, any goods,
facility, service or item payable under the Medicare or Medicaid program. 
<!-- PJG 0012 frnewline -->
Violators are subject to criminal penalties, or exclusion from participation in the Medicare and Medicaid programs,
or both. In 1987, section 14 of the Medicare and Medicaid Patient and Program Protection Act, PL 100&hyph;93, directed
this Department to promulgate ``safe harbor'' regulations, in order to provide health care providers a mechanism
to assure them that they will not be prosecuted under the anti-kickback statute for engaging in particular practices.
The Department published 11 final ``safe harbor'' regulations on July 29, 1991 (42 CFR 1001.952, 56 FR 35952), and
two more on November 5, 1992 (42 CFR 1001.952, 57 FR 52723). The scope of the anti-kickback statute is not expanded by
the ``safe harbor'' regulations; these regulations give those in good faith compliance with a ``safe harbor'' the
assurance that they will not be prosecuted under the anti-kickback statute. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
B. Special Fraud Alert: Joint Venture Arrangements
<!-- PJG 0012 frnewline -->
(Issued August 1989)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Inspector General has become aware of a proliferation of arrangements between those in a position to
refer business, such as physicians, and those providing items or services for which Medicare or Medicaid pays. Some
examples of the items or services provided in these arrangements include clinical diagnostic laboratory services,
durable medical equipment (DME), and other diagnostic services. Sometimes these deals are called ``joint ventures.''
A joint venture may take a variety of forms: it may be a contractual arrangement between two or more parties to cooperate
in providing services, or it may involve the creation of a new legal entity by the parties, such as a limited partnership
or closely held corporation, to provide such services. Of course, there may be legitimate reasons to form a joint venture,
such as raising necessary investment capital. However, the Office of Inspector General believes that some of these
joint ventures may violate the Medicare and Medicaid anti-kickback statute.
<!-- PJG 0012 frnewline -->
Under these suspect joint ventures, physicians may become investors in a newly formed joint venture entity. The investors
refer their patients to this new entity, and are paid by the entity in the form of ``profit distributions.'' These subject
joint ventures may be intended not so much to raise investment capital legitimately to start a business, but to lock
up a stream of referrals from the physician investors and to compensate them indirectly for these referrals. Because
physician investors can benefit financially from their referrals, unnecessary procedures and tests may be ordered
or performed, resulting in unnecessary program expenditures.
<!-- PJG 0012 frnewline -->
The questionable features of these suspect joint ventures may be reflected in three areas: 
<!-- PJG 0012 frnewline -->
(1) The manner in which investors are selected and retained; 
<!-- PJG 0012 frnewline -->
(2) The nature of the business structure of the joint venture; and 
<!-- PJG 0012 frnewline -->
(3) The financing and profit distributions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Suspect Joint Ventures: What To Look For 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To help you identify these suspect joint ventures, the following are examples of questionable features, which separately
or taken together may result in a business arrangement that violates the anti-kickback statute. Please note that
this is not intended as an exhaustive list, but rather gives examples of indicators of potentially unlawful activity.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Investor 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;Investors are chosen because they are in a position to make referrals. 
<!-- PJG 0012 frnewline -->
&bull;Physicians who are expected to make a large number of referrals may be offered a greater investment opportunity
in the joint venture than those anticipated to make fewer referrals. 
<!-- PJG 0012 frnewline -->
&bull;Physician investors may be actively encouraged to make referrals to the joint venture, and may be encouraged
to divest their ownership interest if they fail to sustain an ``acceptable'' level of referrals. 
<!-- PJG 0012 frnewline -->
&bull;The joint venture tracks its sources of referrals, and distributes this information to the investors. 
<!-- PJG 0012 frnewline -->
&bull;Investors may be required to divest their ownership interest if they cease to practice in the service area,
for example, if they move, become disabled or retire. 
<!-- PJG 0012 frnewline -->
&bull;Investment interests may be nontransferable. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Business Structure 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;The structure of some joint ventures may be suspect. For example, one of the parties may be an ongoing entity
already engaged in a particular line of business. That party may act as the reference laboratory or DME supplier for
the joint venture. In some of these cases, the joint venture can be best characterized as a ``shell.'' 
<!-- PJG 0012 frnewline -->
&bull;In the case of a shell laboratory joint venture, for example:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_It conducts very little testing on the premises, even though it is Medicare certified. 
<!-- PJG 0012 frnewline -->
_The reference laboratory may do the vast bulk of the testing at its central processing laboratory, even though it
also serves as the ``manager'' of the shell laboratory. 
<!-- PJG 0012 frnewline -->
_Despite the location of the actual testing, the local ``shell'' laboratory bills Medicare directly for these tests.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00075 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;In the case of a shell DME joint venture, for example: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_It owns very little of the DME or other capital equipment; rather the ongoing entity owns them. 
<!-- PJG 0012 frnewline -->
_The ongoing entity is responsible for all day-to-day operations of the joint venture, such as delivery of the DME
and billing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Financing and Profit Distribution 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;The amount of capital invested by the physician may be disproportionately small and the returns on investment
may be disproportionately large when compared to a typical investment in a new business enterprise. 
<!-- PJG 0012 frnewline -->
&bull;Physician investors may invest only a nominal amount, such as $500 to $1500. 
<!-- PJG 0012 frnewline -->
&bull;Physician investors may be permitted to ``borrow'' the amount of the ``investment'' from the entity, and pay
it back through deductions from profit distributions, thus eliminating even the need to contribute cash to the partnership.

<!-- PJG 0012 frnewline -->
&bull;Investors may be paid extraordinary returns on the investment in comparison with the risk involved, often
well over 50 to 100 percent per year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
C. Special Fraud Alert: Routine Waiver of Copayments or Deductibles Under Medicare Part B 
<!-- PJG 0012 frnewline -->
(Issued May 1991) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To help reduce fraud in the Medicare program, the Office of Inspector General is actively investigating health care
providers, practitioners and suppliers of health care items and services who (1) are paid on the basis of charges
<FOOTCITE>1</FOOTCITE>
 and (2) routinely waive (do not bill) Medicare deductible and copayment charges to beneficiaries for items and services
covered by the Medicare program. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This fraud alert is not intended to address the routine waiver of copayments and deductibles by providers, practitioners
or suppliers who are paid on the basis of costs or diagnostic related groups. The fact that these types of services are
not discussed in this fraud alert should not be interpreted to legitimize routine waiver of deductibles and copayments
with respect to these payment methods. Also, it does not apply to a waiver of any copayment by a Federally qualified
health care center with respect to an individual who qualifies for subsidized services under a provision of the Public
Health Service Act. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
What Are Medicare Deductible and Copayment Charges? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Medicare ``deductible'' is the amount that must be paid by a Medicare beneficiary before Medicare will pay for
any items or services for that individual. Currently, the Medicare Part B deductible is $100 per year. 
<!-- PJG 0012 frnewline -->
``Copayment'' (``coinsurance'') is the portion of the cost of an item or service which the Medicare beneficiary must
pay. Currently, the Medicare Part B coinsurance is generally 20 percent of the reasonable charge for the item or service.
Typically, if the Medicare reasonable charge for a Part B item or service is $100, the Medicare beneficiary (who has
met his [or her] deductible) must pay $20 of the physician's bill, and Medicare will pay $80. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Why Is it Illegal for ``Charged-Based'' Providers, Practitioners and Suppliers to Routinely Waive Medicare Copayment
and Deductibles? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Routine waiver of deductibles and copayments by charge-based providers, practitioners or suppliers is unlawful
because it results in (1) false claims, (2) violations of the anti-kickback statute, and (3) excessive utilization
of items and services paid for by Medicare. 
<!-- PJG 0012 frnewline -->
A ``charge-based'' provider, practitioner or supplier is one who is paid by Medicare on the basis of the ``reasonable
charge'' for the item or service provided. 42 U.S.C. 1395u(b)(3); 42 CFR 405.501. Medicare typically pays 80 percent
of the reasonable charge. 42 U.S.C. 1395l(a)(1). The criteria for determining what charges are reasonable are contained
in regulations, and include an examination of (1) the actual charge for the item or service, (2) the customary charge
for the item or service, (3) the prevailing charge in the same locality for similar items or services. The Medicare
reasonable charge cannot exceed the actual charge for the item or service, and may generally not exceed the customary
charge or the highest prevailing charge for the item or service. In some cases, the provider, practitioner or supplier
will be paid the lesser of his [or her] actual charge or an amount established by a fee schedule. 
<!-- PJG 0012 frnewline -->
A provider, practitioner or supplier who routinely waives Medicare copayments or deductibles is misstating its
actual charge. For example, if a supplier claims that its charge for a piece of equipment is $100, but routinely waives
the copayment, the actual charge is $80. Medicare should be paying 80 percent of $80 (or $64), rather than 80 percent
of $100 (or $80). As a result of the supplier's misrepresentation, the Medicare program is paying $16 more than it should
for this item. 
<!-- PJG 0012 frnewline -->
In certain cases, a provider, practitioner or supplier who routinely waives Medicare copayments or deductibles
also could be held liable under the Medicare and Medicaid anti-kickback statute. 42 U.S.C. 1320a&hyph;7b(b). The
statute makes it illegal to offer, pay, solicit or receive anything of value as an inducement to generate business
payable by Medicare or Medicaid. When providers, practitioners or suppliers forgive financial obligations for
reasons other than genuine financial hardship of the particular patient, they may be unlawfully inducing that patient
to purchase items or services from them. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00076 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At first glance, it may appear that routine waiver of copayments and deductibles helps Medicare beneficiaries. By
waiving Medicare copayments and deductibles, the provider of services may claim that the beneficiary incurs no costs.
In fact, this is not true. Studies have shown that if patients are required to pay even a small portion of their care,
they will be better health care consumers, and select items or services because they are medically needed, rather
than simply because they are free. Ultimately, if Medicare pays more for an item or service than it should, or if it pays
for unnecessary items or services, there are less Medicare funds available to pay for truly needed services. 
<!-- PJG 0012 frnewline -->
One important exception to the prohibition against waiving copayments and deductibles is that providers, practitioners
or suppliers may forgive the copayment in consideration of a particular patient's financial hardship. This hardship
exception, however, must not be used routinely; it should be used occasionally to address the special financial needs
of a particular patient. Except in such special cases, a good faith effort to collect deductibles and copayments must
be made. Otherwise, claims submitted to Medicare mat violate the statutes discussed above and other provisions of
the law. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
What Penalties Can Someone Be Subject to for Routinely Waiving Medicare Copayments or Deductibles? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Whoever submits a false claim to the Medicare program (for example, a claim misrepresents an actual charge) may be
subject to criminal, civil or administrative liability for making false statements and/or submitting false claims
to the Government. 18 U.S.C. 287 and 1001; 31 U.S.C. 3729; 42 CFR 1320a&hyph;7a). Penalties can include imprisonment,
criminal fines, civil damages and forfeitures, civil monetary penalties and exclusion from Medicare and the State
health care programs. 
<!-- PJG 0012 frnewline -->
In addition, anyone who routinely waives copayments or deductibles can be criminally prosecuted under 42 U.S.C.
1320a&hyph;7b(b), and excluded from participating in Medicare and the State health care programs under the anti-kickback
statute. 42 U.S.C. 1320a&hyph;7(b)(7). 
<!-- PJG 0012 frnewline -->
Finally, anyone who furnishes items or services to patient substantially in excess of the needs of such patients can
be excluded from Medicare and the State health care programs. 42 U.S.C. 1320a&hyph;7(b)(6)(B). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Indications of Improper Waiver of Deductibles and Copayments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To help you identify charge-based providers, practitioners or suppliers who routinely waive Medicare deductibles
and copayments, listed below are some suspect marketing practices. Please note that this list is not intended to be
exhaustive but, rather, to highlight some indicators of potentially unlawful activity. 
<!-- PJG 0012 frnewline -->
&bull;Advertisements which state: ``Medicare Accepted As Payment in Full,'' ``Insurance Accepted As Payment in
Full,'' or ``No Out-Of-Pocket Expense.'' 
<!-- PJG 0012 frnewline -->
&bull;Advertisements which promise that ``discounts'' will be given to Medicare beneficiaries. 
<!-- PJG 0012 frnewline -->
&bull;Routine use of ``Financial hardship'' forms which state that the beneficiary is unable to pay the coinsurance/deductible
(i.e., there is no good faith attempt to determine the beneficiary's actual financial condition). 
<!-- PJG 0012 frnewline -->
&bull;Collection of copayments and deductibles only where the beneficiary has Medicare supplemental insurance
(``Medigap'') coverage (i.e., the items or services are ``free'' to the beneficiary). 
<!-- PJG 0012 frnewline -->
&bull;Charges to Medicare beneficiaries which are higher than those made to other persons for similar services and
items (the higher charges offset the waiver of coinsurance.) 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00077 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;Failure to collect copayments or deductibles for a specific group of Medicare patients for reasons unrelated
to indigency (e.g., a supplier waives coinsurance or deductible for all patients from a particular hospital, in order
to get referrals). 
<!-- PJG 0012 frnewline -->
&bull;``Insurance programs'' which cover copayments or deductibles only for items or services provided by the entity
offering the insurance. The ``insurance premium'' paid by the beneficiary is insignificant and can be as low as $1
a month or even $1 a year. These premiums are not based upon actuarial risks, but instead are a sham used to disguise the
routine waiver of copayments and deductibles. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
D. Special Fraud Alert: Hospital Incentives to Physicians 
<!-- PJG 0012 frnewline -->
(Issued May 1992) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Why Do Hospitals Provide Economic Incentives to Physicians? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As many hospitals have become more aggressive in their attempts to recruit and retain physicians and increase patient
referrals, physician incentives (sometimes referred to as ``practice enhancements'') are becoming increasingly
common. Some physicians actively solicit such incentives. These incentives may result in reductions in the physician's
professional expenses or an increase in his or her revenues. In exchange, the physician is aware that he or she is often
expected to refer the majority, if not all, of his or her patients to the hospital providing the incentives. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Why Is it Illegal for Hospitals to Provide Financial Incentives to Physicians for Their Referrals? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Inspector General has become aware of a variety of hospital incentive programs used to compensate physicians
(directly or indirectly) for referring patients to the hospital. These arrangements are implicated by the anti-kickback
statute because they can constitute remuneration offered to induce, or in return for, the referral of business paid
for by Medicare or Medicaid. In addition, they are not protected under the existing ``safe harbor'' regulations.

<!-- PJG 0012 frnewline -->
These incentive programs can interfere with the physician's judgment of what is the most appropriate care for a patient.
They can inflate costs to the Medicare program by causing physicians to overuse inappropriately the services of a
particular hospital. The incentives may result in the delivery of inappropriate care to Medicare beneficiaries
and Medicaid recipients by inducing the physician to refer patients to the hospital providing financial incentives
rather than to another hospital (or non-acute care facility) offering the best or most appropriate care for that patient.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Suspect Hospital Incentive Arrangements_What To Look For 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To help identify suspect incentive arrangements, examples of practices which are often questionable are listed
[below]. Please note that this list is not intended to be exhaustive but, rather, to suggest some indicators of potentially
unlawful activity. 
<!-- PJG 0012 frnewline -->
&bull;Payment of any sort of incentive by the hospital each time a physician refers a patient to the hospital. 
<!-- PJG 0012 frnewline -->
&bull;The use of free or significantly discounted office space or equipment (in facilities usually located close
to the hospital). 
<!-- PJG 0012 frnewline -->
&bull;Provision of free or significantly discounted billing, nursing or other staff services. 
<!-- PJG 0012 frnewline -->
&bull;Free training for a physician's office staff in such areas as management techniques, CPT coding and laboratory
techniques. 
<!-- PJG 0012 frnewline -->
&bull;Guarantees which provide that, if the physician's income fails to reach a predetermined level, the hospital
will supplement the remainder up to a certain amount. 
<!-- PJG 0012 frnewline -->
&bull;Low-interest or interest-free loans, or loans which may be ``forgiven'' if a physician refers patients (or
some number of patients) to the hospital. 
<!-- PJG 0012 frnewline -->
&bull;Payment of the cost of a physician's travel and expenses for conferences. 
<!-- PJG 0012 frnewline -->
&bull;Payment for a physician's continuing education courses. 
<!-- PJG 0012 frnewline -->
&bull;Coverage on hospitals' group health insurance plans at an inappropriately low cost to the physician. 
<!-- PJG 0012 frnewline -->
&bull;Payment for services (which may include consultations at the hospital) which require few, if any, substantive
duties by the physician, or payment for services in excess of the fair market value of services rendered. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00078 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Financial incentive packages which incorporate these or similar features may be subject to prosecution under the
Medicare and Medicaid anti-kickback statute, if one of the purposes of the incentive is to influence the physician's
medical decision as to where to refer his or her patients for treatment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
E. Special Fraud Alert: Prescription Drug Marketing Schemes 
<!-- PJG 0012 frnewline -->
(Issued August 1994) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
How Does the Anti-Kickback Law Relate to Prescription Drug Marketing Schemes? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In recent years, prescription drug companies in the United States have increased their marketing activities among
providers, patients and suppliers such as pharmacies. Many prescription drug marketing activities go far beyond
traditional advertising and educational contacts. Physicians, suppliers and, increasingly, patients are being
offered valuable, non-medical benefits in exchange for selecting specific prescription drug brands. Traditionally,
physicians and pharmacists have been trusted to provide treatments and recommend products in the best interest of
the patient. In an era of aggressive drug marketing, however, patients may now be using prescription drug items, unaware
that their physician or pharmacist is being compensated for promoting the selection of a specific product. Prescription
drugs supplied under one of these programs are often reimbursed under Medicaid. Among the specific activities, which
the OIG has identified, are the following actual cases: 
<!-- PJG 0012 frnewline -->
&bull;A ``product conversion'' program which resulted in 96,000 brand-name conversions. In this scenario, for
instance, Drug Company A offered a cash award to pharmacies for each time a drug prescription was changed from Drug
Company B's product to Drug Company A's product. The pharmacies were induced to help persuade physicians, who were
unaware of the pharmacies' financial interest, to change prescription. 
<!-- PJG 0012 frnewline -->
&bull;A ``frequent flier'' campaign in which physicians were given credit toward airline frequent flier mileage
each time the physician completed a questionnaire for a new patient placed on the drug company's product. 
<!-- PJG 0012 frnewline -->
&bull;A ``research grant'' program in which physicians were given substantial payments for de minimis recordkeeping
tasks. The physician administered the drug manufacturer's product to the patient and made brief notes, sometimes
a single word, about the treatment outcome. Upon completion of a limited number of such ``studies,'' the physician
received payment from the manufacturer. 
<!-- PJG 0012 frnewline -->
If one purpose of any of these marketing schemes is to induce the provision of a prescription drug item reimbursable
by Medicaid, then the criminal anti-kickback statute is implicated. There is no statutory exception or ``safe harbor''
to protect such activities. Thus a physician, pharmacy or other practitioner or supplier receiving payment under
these activities may be subject to criminal prosecution and exclusion from participation in the Medicare and Medicaid
programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00079 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A marketing program that is illegal under the anti-kickback statute may pose a danger to patients because the offering
or payment of remuneration may interfere with a physician's judgment in determining the most appropriate treatment
for a patient. Further, where the patient is a Medicaid beneficiary, these drug marketing practices may increase
the Federal government's costs of reimbursing suppliers for the products. The OIG is investigating various drug
marketing schemes, and enforcing the anti-kickback laws where these practices affect the Federal health care programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
What To Look For
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Generally, a payment or gift may be considered improper under 42 U.S.C. 1320a&hyph;7b(b) if it is:
<!-- PJG 0012 frnewline -->
&bull;Made to a person in a position to generate business for the paying party;
<!-- PJG 0012 frnewline -->
&bull;Related to the volume of business generated; and
<!-- PJG 0012 frnewline -->
&bull;More than nominal in value and/or exceeds fair market value of any legitimate service rendered to the payer,
or is unrelated to any service at all other than referral of patients.
<!-- PJG 0012 frnewline -->
OIG investigation may be warranted where one or more of the following features is present in prescription drug marketing
activities:
<!-- PJG 0012 frnewline -->
&bull;Any prize, gift or cash payment, coupon or bonus (e.g., airline discounts and related travel premiums), offered
to physicians and/or suppliers (including pharmacies, mail order prescription drug companies and managed care
organizations) in exchange for, or based on, prescribing or providing specific prescription products. These items
are particularly suspect if based on value or volume of business generated for the drug company.
<!-- PJG 0012 frnewline -->
&bull;Materials which offer cash or other benefits to pharmacists (or others in a position to recommend prescription
drug products) in exchange for performing marketing tasks in the course of pharmacy practice related to Medicare
or Medicaid. The marketing tasks may include sales-oriented ``educational'' or ``counseling'' contacts, or physician
and/or patient outreach, etc.
<!-- PJG 0012 frnewline -->
&bull;Grants to physicians and clinicians for studies of prescription products when the studies are of questionable
scientific value and require little or no actual scientific pursuit. The grants may nonetheless offer substantial
benefits based on, or related to, use of the product.
<!-- PJG 0012 frnewline -->
&bull;Any payment, including cash or other benefit, given to a patient, provider or supplier for changing a prescription,
or recommending or requesting such a change, from one product to another, unless the payment is made fully consistent
with a ``safe harbor'' regulation, 42 CFR 1001.952, or other Federal provision governing the reporting of prescription
drug prices.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00080 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
F. Special Fraud Alert: Arrangements for the Provision of Clinical Lab Services
<!-- PJG 0012 frnewline -->
(Issued October 1994)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
How Does the Anti-Kickback Statute Relate to Arrangements for the Provision of Clinical Lab Services?
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Many physicians and other health care providers rely on the services of outside clinical laboratories to which they
may refer high volumes of patient specimens every day. The quality, timeliness and cost of these services are of obvious
concern to Medicare and Medicaid patients and to the programs that finance their health care services. Since the physician,
not the patient, generally selects the clinical laboratory, it is essential that the physician's decision regarding
where to refer specimens is based only on the best interests of the patient.
<!-- PJG 0012 frnewline -->
Whenever a laboratory offers or gives to a source of referrals anything of value not paid for at fair market value, the
inference may be made that the thing of value is offered to induce the referral of business. The same is true whenever
a referral source solicits or receives anything of value from the laboratory. By ``fair market value'' we mean value
for general commercial purposes. However, ``fair market value'' must reflect an arms length transaction which has
not been adjusted to include the additional value which one or both of the parties has attributed to the referral of
business between them.
<!-- PJG 0012 frnewline -->
The office of Inspector General has become aware of a number of practices engaged in by clinical laboratories and health
care providers that implicate the anti-kickback statute in this manner. Below are some examples of lab services arrangements
that may violate the anti-kickback statute.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Provision of Phlebotomy Services to Physicians
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
When permitted by State law, a laboratory may make available to a physician's office a phlebotomist who collects specimens
from patients for testing by the outside laboratory. While the mere placement of a laboratory employee in the physician's
office would not necessarily serve as an inducement prohibited by the anti-kickback statute, the statute is implicated
when the phlebotomist performs additional tasks that are normally the responsibility of the physician's office
staff. These tasks can include taking vital signs or other nursing functions, testing for the physician's office
laboratory, or performing clerical services.
<!-- PJG 0012 frnewline -->
Where the phlebotomist performs clerical or medical functions not directly related to the collection or processing
of laboratory specimens, a strong inference arises that he or she is providing a benefit in return for the physician's
referrals to the laboratory. In such a case, the physician, the phlebotomist, and the laboratory may have exposure
under the anti-kickback statute. This analysis applies equally to the placement of phlebotomists in other health
care settings, including nursing homes, clinics and hospitals.
<!-- PJG 0012 frnewline -->
Furthermore, the mere existence of a contract between the laboratory and the health care provider that prohibits
the phlebotomist from performing services unrelated to specimen collection does not eliminate the OIG's concern,
where the phlebotomist is not closely monitored by his [of her] employer or where the contractual prohibition is not
rigorously enforced.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Lab Pricing at Renal Dialysis Centers
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Medicare program pays for laboratory tests provided to patients with end stage renal disease (ESRD) in two different
ways. Some laboratory testing is considered routine and payment is included in the composite rate paid by Medicare
to the ESRD facility which in turn pays the laboratory. Some laboratory testing required by the patient is not included
in the composite rate, and these additional tests are billed by the laboratory directly to Medicare and paid at the
usual laboratory fee schedule price.
<!-- PJG 0012 frnewline -->
The OIG is aware of cases where a laboratory offers to perform the tests encompassed by the composite rate at a price
below fair market value of the tests performed. In order to offset the low charges on the composite rate tests, the ESRD
facility agrees to refer all or most of its non-composite rate tests to the laboratory. This arrangement appears to
be an offer of something of value (composite rate tests below fair market value) in return for the ordering of additional
tests which are billed directly to the Medicare program.
<!-- PJG 0012 frnewline -->
If offered or accepted in return for referral of additional business, the lab's pricing scheme is illegal remuneration
under the anti-kickback statute. The statutory exception and ``safe harbor'' for ``discounts'' does not apply to
immunize parties to this type of transaction, since discounts on the composite rate tests are offered to induce referral
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
other 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
tests. See 42 CFR 1001.952(h)(3)(ii).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Waiver of Charges To Managed Care Patients
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Managed care plans may require a physician or other health care provider to use only the laboratory with which the plan
has negotiated a fee schedule. In such situations, the plan usually will refuse to pay claims submitted by other laboratories.
The provider, however, may use a different laboratory and may wish to continue to use that laboratory for non-managed
care patients. In order to retain the provider as a client, the laboratory that does not have the managed care contract
may agree to perform the managed care work free of charge.
<!-- PJG 0012 frnewline -->
The status of such agreements under the anti-kickback statute depends in part on the nature of the contractual relationship
between the managed care plan and its providers. Under the terms of many managed care contracts, a provider receives
a bonus or other payment if utilization of ancillary services, such as laboratory testing, is kept below a particular
level. Other managed care plans impose financial penalties if the provider's utilization of services exceeds pre-established
levels. When the laboratory agrees to write off charges for the physician's managed care work, the physician may realize
a financial benefit from the managed care plan created by the appearance that utilization of tests has been reduced.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00081 </DOCNO>
<PARENT> FR941219-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In cases where the provision of free services results in a benefit to the provider, the anti-kickback statute is implicated.
If offered or accepted in return for the referral of Medicare or State health care plan business, both the laboratory
and the physician may be violating the anti-kickback statute. There is no statutory exception or ``safe harbor''
to immunize any party to such a practice because the Federal programs do not realize the benefit of these ``free'' services.
See 42 CFR 1001.952(h)(3)(iii).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Other Inducements
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following are additional examples of inducements offered by clinical laboratories which may implicate the anti-kickback
statute:
<!-- PJG 0012 frnewline -->
&bull;Free pick-up and disposal of bio-hazardous waste products (such as sharps) unrelated to the collection of
specimens for the outside laboratory.
<!-- PJG 0012 frnewline -->
&bull;Provision of computers or fax machines, unless such equipment is integral to, and exclusively used for, performance
of the outside laboratory's work.
<!-- PJG 0012 frnewline -->
&bull;Provision of free laboratory testing for health care providers, their families and their employees.
<!-- PJG 0012 frnewline -->
When one purpose of these arrangements is to induce the referral of program-reimbursed laboratory testing, both
the clinical laboratory and the health care provider may be liable under the statute and may be subject to criminal
prosecution and exclusion from participation in the Medicare and Medicaid programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
G. Reporting Information
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
What To Do If You Have Information About Suspect Activities or Arrangements
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If you have information about health care providers, practitioners, entities or other persons engaging in these
types of activities or arrangements described above, contact any of the regional offices of the Office of Investigations
of the Office of Inspector General, U.S. Department of Health and Human Services, at the following locations:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,s50,r150,12 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Regions
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1States served
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Telephone
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Boston 
<!-- PJG 007 0104 intable -->
MA, VT, NH, ME, RI, CT 
<!-- PJG 007 0104 intable -->
617&hyph;565&hyph;2660
<!-- PJG 0012 frnewline -->
New York 
<!-- PJG 007 0104 intable -->
NY, NJ, PR, VI 
<!-- PJG 007 0104 intable -->
212&hyph;264&hyph;1691
<!-- PJG 0012 frnewline -->
Philadelphia 
<!-- PJG 007 0104 intable -->
PA, MD, DE, WV, VA 
<!-- PJG 007 0104 intable -->
215&hyph;596&hyph;6796
<!-- PJG 0012 frnewline -->
Atlanta 
<!-- PJG 007 0104 intable -->
GA, KY, NC, SC, FL, TN, AL, MS (No. District) 
<!-- PJG 007 0104 intable -->
404&hyph;331&hyph;2131
<!-- PJG 0012 frnewline -->
Chicago 
<!-- PJG 007 0104 intable -->
IL, MN, WI, MI, IN, OH, IA, MO 
<!-- PJG 007 0104 intable -->
312&hyph;353&hyph;2740
<!-- PJG 0012 frnewline -->
Dallas 
<!-- PJG 007 0104 intable -->
TX, NM, OK, AR, LA, MS (So. District) 
<!-- PJG 007 0104 intable -->
214&hyph;767&hyph;8406
<!-- PJG 0012 frnewline -->
Denver 
<!-- PJG 007 0104 intable -->
CO, UT, WY, MT, ND, SD, NE, KS 
<!-- PJG 007 0104 intable -->
303&hyph;844&hyph;5621
<!-- PJG 0012 frnewline -->
Los Angeles 
<!-- PJG 007 0104 intable -->
AZ, NV (Clark Co.), So. CA 
<!-- PJG 007 0104 intable -->
714&hyph;836&hyph;2372
<!-- PJG 0012 frnewline -->
San Francisco 
<!-- PJG 007 0104 intable -->
No. CA, NV, AZ, HI, OR, ID, WA 
<!-- PJG 007 0104 intable -->
415&hyph;556&hyph;8880
<!-- PJG 0012 frnewline -->
Washington, DC 
<!-- PJG 007 0104 intable -->
DC and Metropolitan areas of VA and MD 
<!-- PJG 007 0104 intable -->
202&hyph;619&hyph;1900
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 2, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
June Gibbs Brown,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Inspector General.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31157 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4150&hyph;04&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00082 </DOCNO>
<PARENT> FR941219-2-00050 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;94&hyph;3850]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Administration, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed information collection requirement described below has been submitted to the Office of Management
and Budget (OMB) for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments
on the subject proposal.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit comments regarding this proposal. Comments must be received within thirty
(30) days from the date of this Notice. Comments should refer to the proposal by name and should be sent to: Joseph F.
Lackey, Jr., OMB Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Kay F. Weaver, Reports Management Officer, Department of Housing and Urban Development, 451 7th Street, SW., Washington,
DC 20410, telephone (202) 708&hyph;0050. This is not a toll-free number. Copies of the proposed forms and other available
documents submitted to OMB may be obtained from Ms. Weaver.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department has submitted the proposal for the collection of information, as described below, to OMB for review,
as required by the Paperwork Reduction Act (44 U.S.C. Chapter 35).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Notice lists the following information:
<!-- PJG 0012 frnewline -->
(1) the title of the information collection proposal;
<!-- PJG 0012 frnewline -->
(2) the office of the agency to collect the information;
<!-- PJG 0012 frnewline -->
(3) the description of the need for the information and its proposed use;
<!-- PJG 0012 frnewline -->
(4) the agency form number, if applicable;
<!-- PJG 0012 frnewline -->
(5) what members of the public will be affected by the proposal;
<!-- PJG 0012 frnewline -->
(6) how frequently information submissions will be required;
<!-- PJG 0012 frnewline -->
(7) an estimate of the total number of hours needed to prepare the information submission including number of respondents,
frequency of response, and hours of response;
<!-- PJG 0012 frnewline -->
(8) whether the proposal is new or an extension, reinstatement, or revision of an information collection requirement;
and
<!-- PJG 0012 frnewline -->
(9) the names and telephone numbers of an agency official familiar with the proposal and of the OMB Desk Officer for
the Department.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Section 3507 of the Paperwork Reduction Act, 44 U.S.C. 3507; Section 7(d) of the Department of Housing and Urban Development
Act, 42 U.S.C. 3535(d).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David S. Cristy,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Information Resources Management Policy and Management Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00083 </DOCNO>
<PARENT> FR941219-2-00050 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proposal: Section 8 Housing Assistance Payments Program and Estimate of Required Annual Contributions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Office: Public and Indian Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Description of the Need for the Information and its Proposed Use: Public Housing Agencies use the forms to estimate
their annual contributions requirements, requisition funds, and to report actual receipt and expenditures to assure
that project costs do not exceed the amount authorized in the Annual Contribution Contract. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Form Number: HUD&hyph;52663, 52672, 52673, and 52681.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Respondents: State or Local Governments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Frequency of Submission: Annually and Quarterly.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Reporting Burden:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Number of respondents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Frequency of response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Hours per response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1=
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Burden hours 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
HUD&hyph;52672 
<!-- PJG 007 0104 intable -->
6,200 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1.5 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
9,300
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HUD&hyph;52673 
<!-- PJG 007 0104 intable -->
6,200 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1.5 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
9,300
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HUD&hyph;52663 
<!-- PJG 007 0104 intable -->
6,200 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
4 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1.0 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
24,800
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HUD&hyph;52681 
<!-- PJG 007 0104 intable -->
6,200 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
3.0 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
18,600
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Total Estimated Burden Hours: 62,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Status: Extension, no changes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Contact: Elizabeth A. Lewis, HUD, (202) 708&hyph;7424; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;7316. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31056 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00084 </DOCNO>
<PARENT> FR941219-2-00051 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;94&hyph;3617; FR&hyph;3444&hyph;N&hyph;07]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Office of Lead-Based Paint Abatement and Poisoning Prevention; Announcement of Funding Awards for the Lead-Based

<!-- PJG 0012 frnewline -->
Paint Hazard Reduction in Priority Housing 
<!-- PJG 0012 frnewline -->
Category I and Category II Grants 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of the Secretary_Office of Lead-Based Paint Abatement and Poisoning Prevention, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Announcement of funding awards.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with section 102(a)(4)(C) of the Department of Housing and Urban Development Reform Act of 1989, this
announcement notifies the public of funding decisions made by the Department in a competition for funding under the
NOFA for Lead-Based Paint Hazard Reduction in Priority Housing: Category I and Category II Grants. The announcement
contains the names and addresses of the award winners and the amounts of awards.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ellis G. Goldman, Office of Lead-Based Paint Abatement and Poisoning Prevention, 451 Seventh Street, SW., Washington,
DC 20410, telephone (202) 755&hyph;1822, ext. 112. The TDD number for the hearing impaired is (202) 708&hyph;9300
(not a toll-free number), or 1&hyph;800&hyph;877&hyph;8339.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Lead-Based Paint program is authorized by the Departments of Veterans Affairs and Housing and Urban 
<!-- PJG 0012 frnewline -->
Development, and the Independent Agencies Appropriations Act of 1993 (Pub. L. 102&hyph;389, approved October 6,
1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of the competition was to award grant funding for approximately $90,000,000 for a grant program for States
and local governments to undertake lead-based paint hazard reduction in priority housing: and Category II, for up
to $3,000,000, for grants to States for assistance in implementing a State certification program after passing enabling
legislation. The 1994 awards announced in this Notice were selected for funding in a competition announced in a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice published on June 4, 1993 (58 FR 31848). Applications were scored 
<!-- PJG 0012 frnewline -->
and selected for funding on the basis of selection criteria contained in that Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A total of $94,328,617 has been awarded, to nineteen Category I grantees, and thirteen Category II grantees. In accordance
with section 102(a)(4)(C) of the Department of Housing and Urban Development Reform Act of 1989 (Pub. L. 101&hyph;235,
approved December 15, 1989), the Department has published the names, addresses, and amounts of all Category I awards
and eight Category II awards in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on October 14, 1994 (59 FR 52184). The remaining five Category II awards, totaling $977,353 are as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2(,0,),p3,8/9,i1,s25,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
NOFA for Lead-Based Paint Hazard Reduction in Priority Housing: Category II Grants
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
State of Minnesota 
<!-- PJG 007 0104 intable -->
$189,750 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
State of Virginia 
<!-- PJG 007 0104 intable -->
200,000 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
State of Ohio 
<!-- PJG 007 0104 intable -->
187,636 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
State of Connecticut 
<!-- PJG 007 0104 intable -->
200,000 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
State of Rhode Island 
<!-- PJG 007 0104 intable -->
199,967
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: December 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
Ronald J. Morony,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Acting Director, Office of Lead-Based Paint Abatement and Poisoning Prevention.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;31055 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 4210&hyph;32&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00085 </DOCNO>
<PARENT> FR941219-2-00052 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=4 -->


<USDEPT>DEPARTMENT OF THE INTERIOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=4 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=4 -->
Section 4(e) Conditions for the Kerr Hydroelectric Project, Montana
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Extension of Public Comment Period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On November 22, 1994 (59 FR 60158), the Department of the Interior published a notice of availability and a request
for comment regarding its proposed Section 4(e) conditions for the Kerr Hydroelectric Project license. In an effort
to allow more time for public participation the Department is extending the comment period for an additional 45 days.
Pursuant to the Federal Power Act, 16 U.S.C. 797(e), the proposed conditions provide for the adequate protection
and utilization of the Flathead Indian Reservation and the Fish and Wildlife Service administered Flathead Waterfowl
Production Area.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department will consider all comments on the proposed section 4(e) conditions received on or before February
6, 1995 in the formulation of the Secretary's final section 4(e) conditions for the Kerr Hydroelectric Project.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be sent to Anne Crichton, Department of the Interior, Office of the Solicitor, 1849 C Street, NW.,
Mail Stop 6456, Washington, DC 20240.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Janice Schneider, Department of the Interior, Office of the Solicitor, 1849 C Street, NE., Mail Stop 6456, Washington,
DC 20240, 202&hyph;208&hyph;6967.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The November 22, 1994 (59 FR 60158) notice of availability and request for comment provided a 30 day period during which
the Department would receive comments regarding its proposed Section 4(e) conditions for the Kerr Hydroelectric
Project. Pursuant to the Federal Power Act, 16 U.S.C. 797(e), the proposed conditions provide for the adequate protection
and utilization of the Flathead Indian Reservation and the Fish and Wildlife Service administered Flathead Waterfowl
Production Area. The proposed conditions for the Flathead Indian Reservation provide for the imposition of a base
load operational scenario at the Kerr Project. This operational scenario precludes the use of Kerr Dam as a load regulating
or peak power generation facility, and requires minimum flows, certain restrictions on flow fluctuations (ramping
rates), and a two year ramping rate study. In addition, the proposed conditions provide for non-operational measures
designed to protect and provide for adequate utilization of the Flathead Indian Reservation in conjunction with
operational measures. The non-operational measures include the development of a Fish and Wildlife Implementation
Strategy, development of an operational rule curve, habitat acquisition, habitat development, fishery supplementation
and reintroduction, development of recreational resources, and the identification and protection of cultural
resources on the Flathead Indian Reservation. The proposed conditions for the Flathead WPA provide for the imposition
of erosion control on the north shore of Flathead Lake and the upper Flathead River, island restoration, and habitat
acquisition and development. The costs of all measures will be borne by the project licensees.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The deadline for comment on the proposed Section 4(e) conditions is extended for 45 days by this notice. The comment
period, which began on November 22, 1994, therefore, consists of a total of 75 days. All comments are due to the Department
on or before February 6, 1995. In addition, the Department will be making available two technical reports that further
support the proposed Section 4(e) conditions, the ``Kerr Hydro-electric Project Report'' by Stetson Engineers,
Inc., and ``An Evaluation of the Wildlife Components of the Kerr Dam Project Mitigation and Management Plan and Recommended
Section 4(e) Articles'' by BioSystems Analysis, Inc. The proposed conditions and the above referenced reports are
available for review and copying at the Department of the Interior, 1849 C Street, NW., Washington, DC in room 6443.
Copies of the proposed Section 4(e) conditions and the above referenced reports will be made available to all interested
parties upon request.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Willie R. Taylor,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Office of Environmental Policy and Compliance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31045 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;02&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00086 </DOCNO>
<PARENT> FR941219-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Central Utah Project Completion Act; Notice of Intent To Contract for Hydroelectric Power Development in the Diamond
Fork Area of the Central Utah Project (CUP) and the Strawberry Valley Project (SVP), UT</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of the Assistant Secretary for Water and Science, Department of the Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of intent to accept proposals, select a lessee, and contract for hydroelectric power development in the Diamond
Fork area.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Current Federal policy encourages non-Federal development of electrical power resource potential on Federal water
resource projects. The Department of the Interior (Interior), in consultation with the Department of Energy, Western
Area Power Administration (Western), will consider proposals for non-Federal development of hydroelectric power
in the Diamond Fork area of the CUP and the SVP, Utah, consisting of the area from the outlet of the Syar Tunnel to the confluence
of Diamond Fork Creek and the Spanish Fork River. Interior is considering such hydroelectric power development under
a lease of power privilege. No Federal funds will be available for such hydroelectric power development. Western
would have the first opportunity to purchase and/or market the power that would be generated by such development under
a lease of power privilege. The CUP and the SVP are Federal Bureau of Reclamation (Reclamation) projects. This notice
presents background information, proposal content guidelines, information concerning selection of a non-Federal
entity(s) to develop hydroelectric power in the Diamond Fork area of the CUP and the SVP, and power purchasing and/or
marketing considerations. Interested parties are invited to submit proposals.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 A written proposal and seven copies must be submitted on or before May 1, 1995, to: Mr. Ronald Johnston, Program Director,
CUP Completion Act Office, Department of the Interior, 302 East 1860 South, Provo, UT 84606&hyph;6154.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A copy of the proposal should also be sent to: Mr. Kenneth G. Maxey, Area Manager, Western Area Power Administration,
P.O. Box 11606, Salt Lake City, UT 84147&hyph;0606.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00087 </DOCNO>
<PARENT> FR941219-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Additional information on matters related to this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 notice can be obtained at the address and telephone number set forth below: Mr. Ronald Johnston, Program Director,
CUP Completion Act Office, Department of the Interior, 302 East 1860 South, Provo, UT 84606&hyph;6154, Telephone:
(801) 379&hyph;1103.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information related to Western's purchasing and/or marketing the power may be obtained at the address and telephone
number set forth below: Mr. Kenneth G. Maxey, Area Manager, Western Area Power Administration, P.O. Box 11606, Salt
Lake City, UT 84147&hyph;0606, Telephone: (801) 524&hyph;6372.
<!-- PJG 0012 frnewline -->
Technical data may be obtained at the address and telephone number set forth below: Mr. Reed Murray, Program Coordinator,
CUP Completion Act Office, Department of the Interior, 302 East 1860 South, Provo, UT 84606&hyph;6154, Telephone:
(801) 379&hyph;1237.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background Information
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The CUP, Bonneville Unit, located in northern Utah, was authorized for construction, including hydroelectric power,
by the Colorado River Storage Project (CRSP) Act of April 11, 1956, (70 Stat. 105) (CRSP Act) as a participating project,
and the Central Utah Project Completion Act (Titles II through VI of Public Law 102&hyph;575, 106 Stat. 4605) (CUPCA).
The United States has constructed a portion of the Bonneville Unit of the CUP (initial phase), including, among other
features, Upper Stillwater Dam, Bottle Hollow Dam, Starvation Dam, Currant Creek Dam, Jordanelle Dam, Soldier Creek
Dam for the enlarged Strawberry Reservoir, the Syar Tunnel, and the Sixth Water Aqueduct and Tunnel. The Central Utah
Water Conservancy District (District) is constructing other features of the Bonneville Unit pursuant to CUPCA.
Section 208 of the CUPCA provides that power generation facilities associated with the CUP be developed and operated
in accordance with the CRSP Act, which explicitly embodies all Reclamation law except as otherwise provided in the
CRSP Act. The District, under its contracts with the United States, has certain operation, maintenance, replacement,
and repayment responsibilities and obligations concerning the Bonneville Unit.
<!-- PJG 0012 frnewline -->
The United States constructed the SVP, comprising the Strawberry Dam and Reservoir, the Strawberry Tunnel, the Upper
Spanish Fork Powerplant and transmission lines, the High Line Canal, the Mapleton and Springville Lateral and related
collection, diversion, conveyance, and distribution works, all of which were substantially completed in approximately
the year 1915. The Strawberry Water Users Association (Association), under its contracts with the United States,
has the right to lease power privileges (subject to approval by Interior) and has operation, maintenance, replacement,
and repayment responsibilities and obligations concerning the SVP.
<!-- PJG 0012 frnewline -->
Interior, in consultation with Western, is considering only a consolidated system for hydroelectric power development
in the Diamond Fork area (Project), involving both the CUP and the SVP, through a lease of power privilege. The general
authority for lease of power privilege under Reclamation law includes the Town Sites and Power Development Act of
1906 (43 U.S.C. &sect;522) and the Reclamation Project Act of 1939 (43 U.S.C. &sect;485h(c)) (1939 Act).
<!-- PJG 0012 frnewline -->
A lease of power privilege is an alternative to Federal hydroelectric power development. The lease of power privilege
would grant to a non-Federal entity(s) the right to utilize, consistent with CUP and SVP purposes, water power head
or storage at and/or operationally in conjunction with the CUP and the SVP, for non-Federal electric power generation
and sale by the lessee(s). Any lease of power privilege in the Diamond Fork area of the CUP and SVP must accommodate pre-existing
legal rights of the District and the Association.
<!-- PJG 0012 frnewline -->
Interior would be the lead Federal agency for compliance with the National Environmental Policy Act (NEPA) for any
lease of power privilege to develop the Project. Issuance of a lease(s) of power privilege for hydroelectric power
development in the Diamond Fork area will require compliance with Federal fish, wildlife, recreation, and environmental
laws, as determined by Interior.
<!-- PJG 0012 frnewline -->
Western would have the first opportunity to purchase and/or market the power that would be generated by the Project
under a lease(s) of power privilege. Under this process, Western would either purchase and market the power as Salt
Lake City Area_Integrated Projects (SLCA&hyph;IP) power or market the power independently by first offering it
to preference entities and secondly to non-preference entities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00088 </DOCNO>
<PARENT> FR941219-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All Project study and development costs, including compliance with Federal fish, wildlife, recreation and environmental
laws, would be the expense of the lessee(s). Lease payments to the United States will be deposited in the Upper Colorado
River Basin Fund.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proposal Content Guidelines
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested parties should submit proposals explaining in as precise detail as is practicable how the Project would
be developed. Factors which a proposal(s) should consider and address include, but are not limited to, the following:
<!-- PJG 0012 frnewline -->
A. Provide qualifications of the proposing entity(s). Include information on preference status, type of organization,
length of time in business, experience in funding and design and construction of similar projects, industry rating(s)
that indicate financial soundness of the potential lessee(s), experience of key management personnel, history
of any reorganizations or mergers with other companies, and any other information that demonstrates the adequacy
of the proposal and financial ability to fund all studies, designs, and construction. The term ``preference,'' as
applied to a lease of power privilege, means an entity qualifying for preference to develop non-Federal hydroelectric
power, under Section 9(c) of the 1939 Act, as a municipality, public corporation or agency, or cooperative or other
nonprofit organization financed in whole or in part by loans made pursuant to the Rural Electrification Act of 1936.
<!-- PJG 0012 frnewline -->
B. Provide geographical locations and describe principal structures and other important features of the Project
including roads and transmission lines. Estimate and describe installed capacity and the capacity of the power facilities
under dry, average, and wet hydrological conditions. Also describe seasonal or annual generation patterns. Include
estimates of the amount of electrical energy that would be produced from each facility for each month of average, dry,
and wet water years. If capacity and energy can be delivered to another location, either by the proposing entity or
by potential wheeling agents, specify where capacity and energy can be delivered. Include concepts for power sales
and contractual arrangements, involved parties and the proposed approach to wheeling if required.
<!-- PJG 0012 frnewline -->
C. Indicate title arrangements and the ability for acquiring title to or the right to occupy and use lands necessary
for the Project, including such additional lands as may be required during construction.
<!-- PJG 0012 frnewline -->
D. Identify water rights applicable to the proper operation of the Project, the holder of such rights, and how these
rights would be acquired or perfected.
<!-- PJG 0012 frnewline -->
E. Explain studies necessary to adequately define impacts on the CUP and the SVP and the environment in order to facilitate
the decision making process. Explain any proposed use of the Project for conservation and utilization of the available
water resources in the public interest. Describe any significant environmental issues and the approach for gathering
data and handling the environmental issues to protect and enhance the quality of the environment.
<!-- PJG 0012 frnewline -->
F. Describe anticipated contractual arrangements with the District and the Association and define how the Project
would operate in harmony with the CUP and the SVP.
<!-- PJG 0012 frnewline -->
G. Provide a management plan to accomplish such activities as planning, NEPA compliance, design, construction,
operation, and maintenance. Prepare schedules of these activities as is applicable. Describe what studies are necessary
to accomplish the hydroelectric power development and how the studies would be implemented.
<!-- PJG 0012 frnewline -->
H. Estimate Project development cost. This cost should include all investment costs such as the cost of studies to
determine feasibility, NEPA compliance, design, construction, and financing as well as the amortized annual cost
of the investment; also, the annual operation, maintenance, and replacement expense for the Project and other expenses
associated with the CUP and the SVP. If there are additional transmission or wheeling expenses associated with the
development of the Project, these should be included. Identify proposed methods of financing the Project. An economic
analysis should be presented that compares the present worth of all benefits and costs of the Project. Additionally,
a financial analysis should be presented that compares monies available to the United States for use of Federal facilities
and costs to the CUP and the SVP.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Selection of Lessee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interior, in consultation with Western, will evaluate proposals received in response to this published notice.
A proposal will be ruled unacceptable if it is not complete, is not consistent with both CUP and SVP purposes, and does
not accommodate pre-existing legal rights of the District and the Association, as determined by Interior.
<!-- PJG 0012 frnewline -->
Selection of a lessee will be based on the following considerations:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00089 </DOCNO>
<PARENT> FR941219-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. First consideration will be given to preference entities. Interior will give added consideration to proposals
that (1) are especially well-adapted to developing, conserving, and utilizing the water and natural resources;
(2) are harmonious with CUP and SVP purposes; and (3) would provide significant economic benefits to the CUP, the SVP,
and the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Second consideration will be given to non-preference entities. Interior will give added consideration to proposals
that (1) are especially well-adapted to developing, conserving, and utilizing the water and natural resources;
(2) are harmonious with CUP and SVP purposes; and (3) would provide significant economic benefits to the CUP, the SVP,
and the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Power Purchasing and/or Marketing Considerations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Western would have the first opportunity to purchase and/or market the power that would be generated by the Project
under a lease(s) of power privilege. Western will consult with Interior on such power purchasing and/or marketing
considerations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Western would determine its interest in purchasing the electric power from the lessee(s) as a replacement resource
for its Salt Lake City Area Integrated Projects (SLCA/IP) under principles and processes being considered as part
of Western's Replacement Power Process under the Grand Canyon Protection Act. Western would also apply Integrated
Resource Planning principles in comparing this resource with all other potential resource purchases available
to Western. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternatively, Western may market the power available from the Project on a stand-alone basis, first to preference
entities qualified under criteria established by Western and second to non-preference entities, by developing
an individual marketing plan for this power. This marketing plan would be developed through a separate subsequent
public process beginning with a notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of Western's intent to market the power. The marketing plan would include all aspects of marketing the power, including
assignment of power to qualified preference and/or non-preference entities, pricing, transmission, and delivery
of power. Western would recover the costs it would incur in purchasing and/or marketing the power through the rates
charged for the power. Firm power rates would be established through a public process, initiated by a notice in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, separate from the marketing plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the event Western elects to not purchase and/or market the power generated by the Project or such a decision cannot
be made prior to execution of the lease of power privilege, the lessee(s) would be responsible for marketing the power
generated by the Project with priority given to preference entities as heretofore defined in PROPOSAL CONTENT GUIDELINES,
paragraph A. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Notification of Selection of Lessee and Negotiations for a Lease of Power Privilege
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
After Interior selects a lessee, Interior will notify, in writing, all entities submitting proposals of Interior's
decision regarding selection of the potential lessee(s). The selected potential lessee(s) will have five years
from the date of such notification to enter into a lease(s) of power privilege for the site or sites identified in the
proposal. Lease of power privilege negotiation sessions will be public. If Western elects to purchase and/or market
the power, such lease(s) of power privilege will state how Western will be involved in purchasing and/or marketing
the power. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any excessive delay resulting from compliance with the provisions of Federal environmental laws or administrative
review by a Federal agency, pertaining to the Project, may extend the five year time period for a period equal to that
of the delay. In the event of litigation related to the proposed Project, the five year time period will be extended
for a period equal to that of the delay, provided such litigation was initiated by parties other than the selected potential
lessee(s) or its employees, officers, agents, assigns, shareholders, customers or persons or groups served by or
in privity with the potential lessee(s).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ronald Johnston, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
CUP Program Director, 
<!-- PJG 0012 frnewline -->
Department of the Interior.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31057 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;RK&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00090 </DOCNO>
<PARENT> FR941219-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Bureau of Land Management</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OR126&hyph;6332&hyph;00 G5&hyph;040]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Bal'diyaka Interpretive Center, OR; Intent To Prepare an Environmental Impact Statement
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Intent to Prepare an Environmental Impact Statement (EIS) and Notice of Scoping Meetings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to Section 102(2)(C) of the National Environmental Policy Act of 1969, the Bureau of Land Management, Coos
Bay District, will be directing the preparation of an EIS to be prepared by a third party contractor on the impacts of
the proposed construction of the Bal'diyaka Interpretive Center.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments will be accepted until January 10, 1995. Public scoping meetings will be held from 3 to 5 and 7 to 9 p.m.
on Monday, January 9, 1995, at BLM's Coos Bay Office, 1300 Airport Lane, North Bend, OR and from 3 to 5 and 7 to 9 p.m. on
Tuesday, January 10, 1995, at BLM's Eugene Office, 2890 Chad Drive, Eugene, OR. Additional briefing meetings will
be considered as appropriate.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments concerning issues to be addressed in the EIS should be addressed to: District Manager, Coos Bay District,
1300 Airport Lane, North Bend, OR 97459&hyph;2000, Attn: Bal'diyaka Project.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Daryl Albiston, Tioga Area Manager, Coos Bay District, 1300 Airport Lane, North Bend, OR 97459&hyph;2000, (503)
756&hyph;0100.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
BLM, in cooperation with the Confederated Tribes of Coos, Lower Umpqua &amp; Siuslaw, et al. is considering the construction
of an interpretive center to be located near the Cape Arago Lighthouse on Gregory Point in Coos County, OR (T. 26 S.,
R. 14 W., Sec. 4, Willamette Meridian). The center will be known as the Bal'diyaka Interpretive Center and could feature
the Native American history of the local tribes, as well as the historic use of this site by the U.S. Lifesaving Service
and the U.S. Coast Guard. The proposed action may consist of one or more new buildings to house the interpretive displays,
meeting rooms, offices, a new lighthouse, and related infrastructure needs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Potential issues include, but may not be limited to, vehicular access and parking; social and economic values; recreation;
impacts on cultural resources, traditional Native American resources, geology and mineral resources, visual resources,
soil, watershed, and vegetation resources.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The project area will encompass approximately 40 acres, while the area of consideration of impacts will be much larger
and include the communities of Coos Bay, Charleston, North Bend, as well as associated rural areas.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Consideration will be given to adjacent Federal and State administered lands as well as County and private lands and
the affect on local land use planning.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The specific location, design and arrangement is yet to be determined. Alternatives to be considered, other than
the No Action Alternative, are unknown at this time.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Bureau of Land Management's scoping process for the EIS will include: (1) Identification of issues to be addressed;
(2) Identification of viable alternatives; and (3) Notifying interested groups, individuals, and agencies so that
additional information concerning these can be obtained.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The scoping process will consist of this Federal Register Notice; a legal notice in local newspapers announcing the
scoping meetings; letters of invitation to participate in the scoping process; and a scoping meeting agenda which
further clarifies the proposed action, range of alternatives and previously identified significant issues being
considered, to be distributed to selected parties and available upon request.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Melvin Chase,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31159 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;33&hyph;P&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00091 </DOCNO>
<PARENT> FR941219-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[MT&hyph;920&hyph;05&hyph;1310&hyph;01&hyph;P; NDM 62731]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Proposed Reinstatement of Terminated Oil and Gas Lease NDM 62731</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the provisions of P.L. 97&hyph;451, a petition for reinstatement of oil and gas lease NDM 62731, Stark County,
North Dakota, was timely filed and accompanied by the required rental accruing from the date of termination.
<!-- PJG 0012 frnewline -->
No valid lease has been issued affecting the lands. The lessee has agreed to new lease terms for rentals and royalties
at rates of $5 per acre and 162/3 percent respectively. Payment of a $500 administration fee has been made.
<!-- PJG 0012 frnewline -->
Having met all the requirements for reinstatement of the lease as contained in Sec. 31 (d) and (e) of the Mineral Lands
Leasing Act of 1920 (30 U.S.C. 188), the Bureau of Land Management is proposing to reinstate the lease, effective as
of the date of termination, subject to the original terms and conditions of the lease, the increased rental and royalty
rates cited above, and reimbursement for cost of publication of this Notice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Karen J. Carroll,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Fluids Adjudication Section.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31160 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;DN&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00092 </DOCNO>
<PARENT> FR941219-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[AZ-020&hyph;05&hyph;1430&hyph;00; AZA&hyph;28350]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Intent To Prepare an Environmental Impact Statement Analyzing the Impacts of the Proposed Exchange of Approximately
5910 Acres of Public Land Near Kearny, Arizona and 640 Acres of Federal Mineral Estate Near Casa Grande, Arizona for
Other Private Lands of Equal Appraised Value in Central Arizona </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Interior, Bureau of Land Management.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of intent to prepare an environmental impact statement for the exchange of public lands near Kearny and Casa
Grande, Arizona.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice advises the public that the Bureau of Land Management intends to prepare an environmental impact statement
for the exchange of public lands near Kearny and Casa Grande, Arizona for private lands of equal value in central Arizona.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Identification of the geographic areas involved: The proposed land exchange involves approximately 6550 acres
of public lands currently managed by the Phoenix District, Bureau of Land Management that are located near Kearny
and Casa Grande, Arizona. 
<!-- PJG 0012 frnewline -->
2. The no action alternative and alternatives that consider various combinations of selected and offered lands will
be analyzed. 
<!-- PJG 0012 frnewline -->
3. General types of issues anticipated: The proposed land exchange involves issues related to the natural resource
values and uses of the public lands in question. These issues are expected to involve impacts on water resources, native
vegetation, riparian areas, wildlife, recreation, socioeconomic, public access, grazing allotments, county
tax base, minerals, and cultural resources. 
<!-- PJG 0012 frnewline -->
4. Disciplines to be represented and used to prepare the environmental impact statement: Hydrology, botany, wildlife,
recreation, realty, range, economics, geology, and archaeology. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The kind and extent of public participation: Public open houses/scoping meetings will be held at the following locations
and times: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Mesa Open House, January 30, 1995 4&hyph;8 p.m., Mesa Community and Conference Center, 263 North Center Street, Mesa,
Arizona (602) 644&hyph;2178 
<!-- PJG 0012 frnewline -->
Kearny Open House, January 31, 1995 5&hyph;9 p.m., Constitution Hall (Senior Citizen Center), 912 East Tilbury Drive,
Kearny, Arizona (602)363&hyph;5071.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Public input may be submitted during the public meeting or in writing to the address given in the section below. Public
comments will be accepted until February 14, 1995. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments concerning the environmental impact statement should be submitted to Bureau of Land Management,
Attn: Gail Acheson, Area Manager, Phoenix Resource Area, 2015 West Deer Valley Road, Phoenix, Arizona 85027. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Bill Ruddick, Bureau of Land Management, Phoenix District Office, 2015 West Deer Valley Road, Phoenix, Arizona 85027,
phone (602) 780&hyph;8090. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John R. Christensen,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31059 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;32&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00093 </DOCNO>
<PARENT> FR941219-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CO&hyph;076&hyph;1110&hyph;04] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Seasonal Road Closure for the Garvey Canyon Area </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Bureau of Land Management, Department of Interior
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Order of area, road winter use restriction.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This order, issued under the authority of 43 CFR 8364.1 and 43 CFR 8341.2(a), limits travel from December 1 to May 1 in
Garvey Canyon, 15 miles north of Fruita, Colorado to non-motorized means. The length of road with this additional
seasonal closure is approximately 1.5 miles, which is joined to the existing seasonal closure indicated in the Grand
Junction Resource Management Plan of 1987. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The affected public land is in the Grand Junction Resource Area, Grand Junction District, and is located in T. 8 S.,
R. 101 W., Sections 7 and 8, and T. 8 S., R. 102 W., Sec. 12, 6th Principal Meridian; Garfield County, Colorado.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The restriction shall be effective December 15, 1994 and remain until rescinded or modified by the Authorized Officer.

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The purpose of the seasonal closure is to significantly reduce human-induced stress on wintering deer and elk in an
area where costs in energy loss are particularly high due to the topography and the concentration of animals. The closure
affects about 1.5 miles of road in lower Garvey Canyon. A sign will be posted before the gate indicating the closure
season and the reason. Information including maps of the restricted area is available in the Resource Area Office
and District Office at the addresses shown below. Persons who are exempt from the restrictions include: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) Any Federal, State, or local officers engaged in fire, emergency, or law enforcement activities; (2) BLM employees
engaged in official duties; (3) Persons authorized to operate motorized vehicles within the restricted area, such
as natural gas well service people and permitted grazing operators.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PENALTIES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Violations of this restriction order are punishable by fines not to exceed $1,000 and/or imprisonment not to exceed
12 months.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUPPLEM>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Catherine Robertson, Area Manager, Grand Junction Resource Area, 2815 H Road, Grand Junction, CO 81506; (303) 244&hyph;3000.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Mark Morse, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Grand Junction District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31158 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;JB&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00094 </DOCNO>
<PARENT> FR941219-2-00058 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Fish and Wildlife Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Receipt of Application(s) for Permit</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following applicant has applied for a permit to conduct certain activities with endangered species. This notice
is provided pursuant to Section 10(c) of the Endangered Species Act of 1973, as amended (16 U.S.C. 1531, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
PRT&hyph;797125
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Applicant:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 Monte Carroll McDonald, Ogden Environmental &amp; Energy Services, Oak Ridge, Tennessee
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant requests a permit to include take activities for the American burying beetle (nicrophorus americanus)
for the purpose of scientific research and enhancement of propagation and survival of the species as prescribed by
Service recovery documents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
PRT&hyph;797129
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Applicant:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 Dr. James P. Collins, Chair, Department of Zoology, Arizona State University, Tempe, Arizona
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant requests a permit to include take activities for various endangered fish species that occur within
waters in Arizona, New Mexico, Texas, and Oklahoma for the purpose of scientific research and enhancement of propagation
and survival of the species as prescribed by Service recovery documents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
PRT&hyph;797127
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
Lt. Col. Gary Burroughs, District Engineer, USA Corps of Engineers, Albuquerque, NM
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant requests a permit to include take activities for various endangered fish, birds, and plants that occur
within Arizona and New Mexico for the purpose of scientific research and enhancement of propagation and survival
of the species as prescribed by Service recovery documents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
PRT&hyph;797128
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Applicant:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
 Dr. Paul R. Krausman, School of Renewable Natural Resources, University of Arizona, Tucson, Arizona
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant requests a permit to include take activities for the Sonoran pronghorn antelope (Antilocapra americana
sonoriensis) for the purpose of scientific research and enhancement of propagation and survival of the species as
prescribed by Service recovery documents.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written data or comments should be submitted to the Assistant Regional Director, Ecological Services, U.S. Fish
and Wildlife Service, P.O. Box 1306, Albuquerque, New Mexico 87103, and must be received by the Assistant Regional
Director within 30 days for the date of this publication.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Documents and other information submitted with this application are available for review, subject to the requirements
of the Privacy Act and Freedom of Information Act, by any party who submits a written request for a copy of such documents
to the above office within 30 days of the date of publication of this notice. (See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESS
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 above)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James A. Young,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director, Region 2, Albuquerque, New Mexico.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31058 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00095 </DOCNO>
<PARENT> FR941219-2-00059 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Record of Decision for Bayou Sauvage National Wildlife Refuge, Master Plan/Final Environmental Impact
Statement (FEIS), Orleans Parish, Louisiana</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Fish and Wildlife Service, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice makes available to the public a summary of the Record of Decision (ROD) for the final Master Plan/FEIS for
the Bayou Sauvage National Wildlife Refuge, located in Orleans Parish, Louisiana. Establishment of a 19,000-acre
refuge was authorized by Congress on July 28, 1986. As of 1993, the refuge contained approximately 22,800 acres under
the supervision of the Fish and Wildlife Service (Service). There is a potential for future expansion of the refuge
to include a total of approximately 30,000 acres. Federal funding for design, construction, and operation of the
refuge is provided through appropriations by Congress. Pursuant to the Council on Environmental Quality regulations
implementing the National Environmental Policy Act (NEPA) (40 CFR 1505.2), the Service issues this ROD upon consideration
of the FEIS prepared for the Proposed Action.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A Notice of Availability of the FEIS was published by the Environmental Protection Agency in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on September 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Factors influencing selection of the Preferred Alternative included: (1) Compliance with the purpose for which
the Refuge was established, (2) adherence to the goals, objectives, and policies established for the refuge, (3)
opinions of the public and commenting agencies, and (4) evaluation of the impacts of the four alternatives on the physical,
biological, and socioeconomic environments. The Preferred Alternative, referred to as Alternative 2, Comprehensive
Diverse Habitat Enhancement Alternative, contains a Management Program and a Facilities Program characterized
by the following elements:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Management Program:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
a. Habitat-Wildlife
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Habitat conservation for the five threatened and/or endangered species presently using the refuge.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Support for at least 60,000 wintering waterfowl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Control of nuisance animals and exotic plants, as needed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Freshwater fisheries habitat enhancement in leveed wetlands south of Interstate 10 (I&hyph;10).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Estuarine fisheries habitat enhancement in leveed wetlands north of I&hyph;10.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
b. Environmental Management
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Acquire all lands presently leased (i.e., The Conservation Fund and the city of New Orleans property).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Acquire additional lands from willing sellers in the refuge expansion zone.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;Tidal Wetlands Management_Uncontrolled Estuarine Habitat (Units 1, 2b, 6b, 7a, 7b, 8b).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Stabilize and enhance shore zone (Units 1, 7a, 7b)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Stabilize and enhance bank line (Units 7a, 7b, 6b)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Increase diversity of estuarine habitat types (brackish marsh; sand/shell beach; small, shallow waterbodies;
and protected lagoons with submerged aquatics, oyster reefs)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Leveed Wetlands Management_Controlled Fresh Habitat (Units 5, 6a, 9).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Enhance bottomland hardwood forest (Units 3, 5, 8a, 9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Reestablish fresh emergent vegetation in Units 5 and 6a
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Maintain scrub/shrub habitat for rookeries in Unit 6a
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Protect refuge facilities and infrastructure from flooding
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Leveed Wetlands Management_Controlled Fresh-Intermediate Habitat (Units 3, 4)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Enhance the quality of and maintain a maximum number of different habitats for the benefit of wildlife and the enjoyment
and education of the public
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Restore and maintain fresh-intermediate marsh vegetation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Protect refuge facilities and infrastructure from flooding
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Leveed Wetlands Management_Controlled Estuarine (Unit 2a)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Restore estuarine nursery habitat inside protection levee
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00096 </DOCNO>
<PARENT> FR941219-2-00059 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Facilities Program:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
a. User Groups
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Public (nonconsumptive, consumptive, special use, scientific research).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Protect and interpret archaeological sites
<!-- PJG 0012 frnewline -->
_Support fishing and nonconsumptive uses
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Service (administration, management, maintenance).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Enforce refuge regulations
<!-- PJG 0012 frnewline -->
_Close selected portions of refuge seasonally to protect migratory waterfowl and bald eagles from human disturbances
<!-- PJG 0012 frnewline -->
_Protect refuge facilities and infrastructure from flooding
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
b. Facilities Program
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;Visitor/Interpretive Center is southeast quadrant of I&hyph;10/Turtle Bayou interchange (Unit 3).
<!-- PJG 0012 frnewline -->
*&blank;Environmental Educational Center south of U.S. Highway No. 11 and U.S. Highway No. 90 intersection (Unit
5).
<!-- PJG 0012 frnewline -->
*&blank;Administration/Maintenance Center near southeast quadrant of the I&hyph;10/Michoud Boulevard interchange
(Unit 9).
<!-- PJG 0012 frnewline -->
*&blank;Trails and Trail Heads (Units 1, 2a, 3, 4, 5a, 8b, and 9).
<!-- PJG 0012 frnewline -->
Three other alternatives evaluated in detail included:
<!-- PJG 0012 frnewline -->
(1) No Build Alternative
<!-- PJG 0012 frnewline -->
(2) Minimal Diverse Habitat Enhancement
<!-- PJG 0012 frnewline -->
(3) Comprehensive Estuarine Habitat Enhancement
<!-- PJG 0012 frnewline -->
These alternatives were developed by the Service with input obtained from the public and review agencies during the
review and comment process. Issues raised in comments included, but are not limited to: Expansion of the refuge, hunting,
trapping, commercial fishing, public access, locations of visitor center, habitat management objectives, mosquito
control, and monitoring of management programs to achieve program objectives. All substantive issues raised during
the public and agency review process have been addressed to the satisfaction of the Service either through revisions
incorporated into the FEIS text or in responses contained in Section 9.0 of the FEIS. These responses are incorporated
by reference into the ROD. One comment was received on the FEIS.
<!-- PJG 0012 frnewline -->
Findings and Decision: Based upon a thorough analysis and consideration of the impacts identified in the FEIS, results
of the research and investigations conducted in conjunction with the Draft Environmental Impact Statement (DEIS)
and FEIS, comments received in connection with the public information hearings and review of the DEIS, public review
of management programs already approved for the refuge, and other relevant factors, including the purposes for which
the refuge was established by Congress and statutory and regulatory guidance for funding such projects, the Service
finds as follows:
<!-- PJG 0012 frnewline -->
(1) The preferred alternative is Alternative 2. Alternative 2 consists of the Management and Facilities Programs
discussed previously.
<!-- PJG 0012 frnewline -->
(2) The Preferred Alternative best fulfills the Public Use Goal for environmental education, wildlife and habitat
interpretation, wildlife/wildlands-oriented recreation, and scientific research.
<!-- PJG 0012 frnewline -->
(3) Consistent with economic, social, and other essential considerations, to the maximum extent practicable, potential
adverse environmental effects identified in the FEIS will be minimized or avoided by incorporating mitigative measures
as conditions of Federal funding approval and permit issuance. The potential impacts and mitigative measures are
described in Section 4.0 and 5.0 of the FEIS.
<!-- PJG 0012 frnewline -->
(4) Only 45 acres of jurisdictional wetlands, out of the presently supervised area of approximately 22,800 acres,
are estimated to be impacted by construction of facilities on the refuge. Specific details regarding mitigation
plans for site-specific projects will be developed on a case-by-case basis as part of the Section 404 permit process.
However, under the Preferred Alternative, habitat management measures implemented on other areas of the refuge
for the purpose of increasing the quality and quantity of emergent and submergent aquatic vegetation and scrub/shrub
vegetation are expected to be more than adequate to serve as mitigation for wetlands impacted by facility construction.
<!-- PJG 0012 frnewline -->
(5) The Preferred Alternative is designed to conserve and/or enhance existing habitat for the presently listed threatened
and endangered species using the refuge. No State or federally listed endangered or threatened species or their critical
habitats are known to be adversely affected by implementation of the Preferred Alternative.
<!-- PJG 0012 frnewline -->
(6) No historic properties listed in or eligible for listing in the National Register of Historic Places are know to
be adversely affected by implementation of the Preferred Alternative. Detailed cultural resources investigations
will be conducted for site-specific projects on a case-by-case basis as part of the Section 404 permit process.
<!-- PJG 0012 frnewline -->
(7) Statutory authority for the Service to fund and implement, and for the U.S. Army Corps of Engineers to permit, the
Preferred Alternative exists.
<!-- PJG 0012 frnewline -->
(8) The requirements of NEPA and the implementing regulations (40 CFR Parts 1500&hyph;1508) have been satisfied.
<!-- PJG 0012 frnewline -->
For further information, contact:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Name: Howard Poitevant
<!-- PJG 0012 frnewline -->
Address: 1010 Gause Blvd., Bldg. 936, Slidell, Louisiana 70458
<!-- PJG 0012 frnewline -->
Phone: 504/646&hyph;7555.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jerome M. Butler,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31044 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00097 </DOCNO>
<PARENT> FR941219-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Availability of an Environmental Assessment/Habitat Conservation Plan and Receipt of an Application for an Incidental
Take Permit for the Proposed Great Hills Reserve Subdivision Development, Austin, Travis County, TX</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agencyy: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Fish and Wildlife Service, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Americo Financial, Limited (Applicant) has applied to the U.S. Fish and Wildlife Service (Service) for an incidental
take permit pursuant to Section 10(a)(1)(B) of the Endangered Species Act (Act). The Applicant has been assigned
Permit Number PRT&hyph;782832. The requested permit, which is for a period not to exceed 10 years, would authorize
the incidental take of the endangered golden-cheeked warbler (Dendroica chrysoparia). The proposed take would
occur as a result of the construction and operation of a residential development on 294.15 acres, in two parcels, in
Austin, Travis County, Texas.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Service has prepared an Environmental Assessment/Habitat Conservation Plan (EA/HCP) for the incidental take
application. A determination of jeopardy to the species or a Finding of No Significant Impact (FONSI) will not be made
before 30 days from the date of publication of this notice. This notice is provided pursuant to Section 10(c) of the
Act and National Environmental Policy Act regulations (40 CFR 1506.6).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
dates: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments on the application and the EA/HCP should be received on or before January 18, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
addresses: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Persons wishing to review the application may obtain a copy by writing to the Assistant Regional Director, Ecological
Services, U.S. Fish and Wildlife Service, P.O. Box 1306, Albuquerque, New Mexico 87103. Persons wishing to review
the EA/HCP may obtain a copy by contacting Alma Barrera, Ecological Services Field Office, U.S. Fish and Wildlife
Service, 10711 Burnet Road, Suite 200, Austin, Texas 78758 (512/490&hyph;0063). Documents will be available for
public inspection by written request, by appointment only, during normal business hours (8:00 to 4:00) at the Southwest
Regional Office, Division of Endangered Species/Permits, U.S. Fish and Wildlife Service, P.O. Box 1306, Albuquerque,
New Mexico 87103, or the Ecological Services Field Office (9:00 to 4:30), U.S. Fish and Wildlife Service, 10711 Burnet
Road, Suite 200, Austin, Texas 78758. Written data or comments concerning the application and EA/HCP should be submitted
to the Acting Field Supervisor, Ecological Services Field Office, Austin, Texas (see ADDRESSES above). Please refer
to Permit Number PRT&hyph;782832 when submitting in comments.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Alma Barrera at the above Ecological Services Field Office.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
supplementary information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Section 9 of the Act prohibits the ``taking'' of endangered species such as the golden-cheeked warbler. However,
the Service, under limited circumstances, may issue permits to take endangered wildlife species incidental to,
and not the purpose of, otherwise lawful activities. Regulations governing permits for endangered species are at
50 CFR 17.22.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Applicant plans to build a residential subdivision in northwest Austin, Travis County, Texas. An EA/HCP has been
developed as mitigation of the incidental taking of the golden-cheeked warbler. The Applicant proposes to mitigate
the incidental take via dedicating approximately 440 acres of occupied golden-cheeked warbler habitat as a permanent
preserve, providing funding for the operation and management of the preserve lands, performing golden-cheeked
warbler studies on the project lands, and avoiding construction activities within warbler territories during the
breeding season. Details of the mitigation are provided in the EA/HCP for the Great Hills Reserve.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Applicant considered five alternatives but rejected four because they were not economically viable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James A. Young,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director, Region 2, Albuquerque, New Mexico.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31060 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00098 </DOCNO>
<PARENT> FR941219-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Park Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Urban Park and Recreation Recovery Program</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 National Park Service, U.S. Dept. of the Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of FY&hyph;1995 Grant Round_UPARR Rehabilitation and Innovation Grants. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This notice announces the availability of grant funds under the Rehabilitation and Innovation phases of the Urban
Park and Recreation Recovery (UPARR) Program and provides information on the application process including eligible
recipients and deadlines for submission of proposals.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 ``UPARR,'' Recreation Grants Division, National Park Service, Department of the Interior, P.O. Box 37127, Washington,
DC 20013&hyph;7127; (202) 343&hyph;3700.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 For Fiscal Year 1995, $7,486,000 is available for the funding of Rehabilitation and Innovation projects under the
Urban Park and Recreation Recovery Act of 1978 (Pub. L. 95&hyph;625). NPS will consider proposals for funding projects
with a dollar limit of $200,000 (Federal share of total project cost) under the Rehabilitation phase of the program
and projects with a dollar limit of $50,000 (Federal share) under the Innovation phase. No more than ten percent ($748,600)
of the total amount appropriated will go toward the funding of Innovation proposals. Preapplications must be received
by the appropriate NPS Regional Office by no later than April 17, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Rehabilitation grants will be targeted to rehabilitate existing neighborhood recreation areas and facilities
which have deteriorated to the point where health and safety are endangered or the community's range of quality recreation
service is impaired. Proposals must be designed to provide recreation services for residents within a specified
area identified by the applicant. Proposals may identify improvements at multiple sites or facilities, each of which
must be individually addressed. Grants may be used to remodel, rebuild, expand, or develop existing outdoor or indoor
recreation areas and facilities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Innovation grants may generally cover the costs of personnel, training, facilities, recreation equipment, supplies
or services associated with the development of cost-effective ideas, concepts, and approaches towards improving
facility design, operations, or programming for the delivery of recreation services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Innovation projects should contribute to a systems approach to recreation by linking recreation services with other
critical community programs such as housing, transportation, health and public safety, water quality, energy conservation,
crime prevention, etc. The project should demonstrate a concept that is untried, unique, and/or advances the state
of the art for recreation at the national, regional or local level. Interested jurisdictions are directed to 36 CFR
72.45 for more detailed discussion of fundable elements under the Innovation phase of the UPARR program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In response to widespread interest in programs that help prevent urban crime, 1995 grant awards will focus on, but
not be limited to, youth-at-risk approaches_for example, innovation programs that combine recreation with education,
counselling or mentoring activities aimed at teens and/or rehabilitation proposals that target facilities that
will supply key recreation opportunities for the target youth populations. Program participants may be aware that
a new category of UPARR grants, called ``At-Risk-Youth'' grants, was established as part of the 1994 Omnibus Crime
Bill. However, funding is not authorized for such grants before 1996. Consequently, the 1995 grant round will highlight
crime prevention in recreation programs, without being limited exclusively to such grants. Preparations are now
underway for administration of the new UPARR grants authorized in the Crime Bill should funding for these become available
in 1996 or subsequent years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligible Jurisdictions:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Urban jurisdictions as listed in 36 CFR part 72 appendix B will be eligible. Additional jurisdictions meeting the
criteria for eligibility described in 36 CFR part 72 appendix A, and having been approved as discretionary applicants
by NPS, may also compete. All applicants must have a Recovery Action Program (RAP) which has been approved by NPS within
the past five years, and all projects must be in accord with the priorities outlined in the approved RAPs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Grant Implementation and Timing:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Grantees must comply with all applicable Federal laws and regulations for the UPARR program, which include completion
of a final grant agreement within 120 days of a grant offer (based on NPS evaluation of preapplications submitted for
consideration). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Preapplication Requirements:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Local chief elected officials (mayors, etc.) applying for UPARR grants will be required to certify, in the preapplication,
that the grantee will comply with all requirements of the UPARR program. Applicants must also identify the type of
control they have over properties to be assisted. Additional requirements are outlined in the UPARR PREAPPLICATION
HANDBOOK (updated for 1995) available from the Regional Offices of NPS. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Matching Requirements: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
UPARR Rehabilitation and Innovation grants are awarded on a 70/30 (Federal/local) matching basis. As an incentive
for state involvement in the program, the Federal Government will match, dollar for dollar, state contributions
to the local share of the total project cost, up to 15 percent of the approved grant. The Federal share is limited to no
more than 85 percent of the approved grant cost and the overall dollar limitations established above for Rehabilitation
and Innovation grants, respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pass-Through Funding: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At the discretion of the applicant jurisdiction, grants may be transferred, in whole or in part, to independent general
or special purpose local governments, private nonprofit agencies or community groups, and county or regional park
authorities that provide recreation opportunities to the general population within the jurisdictional boundaries
of the applicant jurisdiction. In such situations, the applicant jurisdiction will bear full legal responsibility
and liability for passed-through funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Post-Completion Requirements: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Section 1010 of the UPARR Act of 1978, assisted properties may not be converted to other than public
recreation use without the prior approval of NPS and the replacement of the converted site or facility with one of reasonably
equivalent usefulness and location. This provision may not be applicable to funded Innovation projects depending
upon the nature of the assistance provided. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00099 </DOCNO>
<PARENT> FR941219-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested jurisdictions should consult their NPS Regional Office for further information including grant round
schedule dates and for technical assistance in applying for funding. The NPS Regional Offices are listed below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Mid-Atlantic 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chief, Planning &amp; Grants Assistance Division, National Park Service, 200 Chestnut Street_3rd Floor, Philadelphia,
PA 19106, 215&hyph;597&hyph;7995_CT, DC, DE, MA, MD, ME, NH, NJ, NY, PA, RI, VA, VT, WV 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Mid-West 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Assistant Regional Director for Recreation Assistance Programs, National Park Service, 1709 Jackson Street, Omaha,
NE 68102&hyph;2571, 402&hyph;221&hyph;3201_IA, IL, IN, KS, MI, MN, MO, NE, OH, WI 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Pacific Northwest 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chief, Recreation Programs Division, National Park Service, 909 First Avenue, Seattle, WA 98104&hyph;1060, 206&hyph;220&hyph;4083_AK,
ID, OR, WA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Rocky Mountain 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chief, Division of National Recreation Programs, National Park Service, P.O. Box 25287, Denver, CO 80225&hyph;0287,
303&hyph;969&hyph;2850_CO, MT, ND, SD, UT, WY 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Southeast 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chief, Grants Division, National Park Service, 75 Spring Street, 10th Floor, Atlanta, GA 30303, 404&hyph;331&hyph;2610_AL,
FL, GA, KY, MS, NC, PR, SC, TN, VI 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Southwest 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Assistant Regional Director for External Programs, National Park Service, P.O. Box 728, Santa Fe, NM 87501, 505&hyph;988&hyph;6705_AR,
LA, NM, OK, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Western 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chief, Grants Branch, Division of Planning, Grants and Environmental Quality, National Park Service, 600 Harrison
Street_Suite 600, San Francisco, CA 94107&hyph;1372, 415&hyph;744&hyph;3972_AS, AZ, CA, GU, HI, NV, CM.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
 15.919) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Title X, National Parks and Recreation Act of 1978, Pub.L. 95&hyph;625, 16 U.S.C. 2501&hyph;2514) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Michael P. Rogers,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief, Recreation Grants Division, National Park Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31042 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00100 </DOCNO>
<PARENT> FR941219-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF JUSTICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree Pursuant to the Comprehensive Environmental Response, Compensation and Liability Act</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Consistent with the policy set forth in Section 122(d)(2)(B) of the Comprehensive Environmental Response, Compensation
and Liability Act of 1980 as amended (``CERCLA''), 42 U.S.C. 9622(d)(2)(B), and the Department of Justice regulations
at 28 C.F.R. 50.7, notice is hereby given that on December 6, 1994 a proposed consent decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 The Boeing Company,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 C92&hyph;5369B, was lodged with the United States District Court for the Western District of Washington. The Consent
Decree resolves claims asserted by the United States, on behalf of the U.S. Environmental Protection Agency, against
the Boeing Company (``Boeing'') pursuant to Section 107 of CERCLA, 42 U.S.C. 9607, as well as a counterclaim by Boeing
for response costs incurred in connection with the Tacoma Channel/Well 12A/Time Oil Site (the ``Site'') in Tacoma,
Washington. The Consent Decree provides for payment of $2.3 million by Boeing and $7.7 million by the United States
to the Hazardous Substance Superfund.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department of Justice will receive, for a period of thirty (30) days from the date of this publication, comments
relating to the proposed consent decree. Comments should be addressed to the Assistant Attorney General for the Environment
and Natural Resources Division, Department of Justice, Washington, D.C. 20530, and should refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 The Boeing Company,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 DOJ Ref. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
90&hyph;11&hyph;3&hyph;566.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent decree may be examined at the Region 10 office of the Environmental Protection Agency, 7th Floor
Records Center, 1200 Sixth Avenue, Seattle, Washington 98101 and at the Consent Decree Library, 1120 G Street, N.W.,
4th Floor, Washington, D.C. (20005), 202&hyph;624&hyph;0892. A copy of the proposed consent decree may also be obtained
in person or by mail from the Consent Decree Library, 1120 G Street, N.W., 4th Floor, Washington, D.C. 20005. In requesting
a copy please refer to the referenced case and enclose a check in the amount of $3.25 (25 cents per page reproduction
costs), payable to the Consent Decree Library.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce S. Gelber,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31112 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00101 </DOCNO>
<PARENT> FR941219-2-00063 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree Pursuant to the Comprehensive Environmental Response, Compensation, and Liability Act
of 1980, as Amended</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Departmental policy, 28 C.F.R. 50.7 and pursuant to Section 122 of the Comprehensive Environmental
Response, Compensation and Liability Act (``CERCLA''), 42 U.S.C. 9622, notice is hereby given that a proposed Consent
Decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reeves Southeastern Corporation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civil Action No. 94&hyph;1752&hyph;CIV&hyph;T&hyph;24A, was lodged on November 2, 1994, with the United States
District Court for the Middle District of Florida, Tampa Division.
<!-- PJG 0012 frnewline -->
This case concerns the Reeves Southeastern Galvanizing (``SEG'') facility and the Reeves Southeastern Wire (``SEW'')
facility which are located along the north and south sides of State Road 574 in Tampa, and, together are known as the
Reeves Southeastern Corporation Superfund Site (the ``Site''). Pursuant to Sections 106 and 107 of the Comprehensive
Environmental Response, Compensation and Liability Act (``CERCLA''), 42 U.S.C. 9606 and 9607, the Complaint in
this action seeks recovery of all past and future costs incurred and to be incurred by the United States at the Site,
and injunctive relief for the Site, namely, implementation of remedies selected by EPA in Records of Decision (``ROD'')
for Operable Unit (``OU'') One, dated October 13, 1992, for OU two, dated September 9, 1993, and for OU three dated June
28, 1994. The ROD for OU One provides for excavation of contaminated soils and sediments at the SEW and SEG facilities,
backfilling of those excavated areas with clean fill, solidification and stabilization of contaminated soils and
sediments, disposal of the solidified material above the water table on the SEG facility and installation of a low
permeability cap over the solidified material. The ROD for OU Two requires that the surficial aquifer be monitored
for at least 21/2 years after the source control measures required in the Operable Unit One ROD have been completed.
If, after 21/2 years have expired, levels of contaminants of concern in the surficial aquifer have not been reduced
to a pre-determined targeted level, the surficial aquifer will have to be actively remediated through a pump and treat
system. If levels have attenuated to the target level, pump and treat will not be required at that time; however, monitoring
will continue. The ROD for OU Three requires sampling and monitoring of the North Wetland.
<!-- PJG 0012 frnewline -->
Defendant Reeves (the ``Settling Defendant'') has agreed in the proposed Consent Decree to pay the United States
$297,759 for past response costs incurred at the Site, as well as all future costs of overseeing the implementation
of the Remedial Actions of OU One, Two and Three. The Settling Defendant has also agreed to implement the remedy selected
by EPA for the Site.
<!-- PJG 0012 frnewline -->
The Department of Justice will receive, for a period of thirty (30) days from the date of this publication, comments
relating to the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General for the Environment
and Natural Resources Division, Department of Justice, Washington, D.C. 20530, and should refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reeves Southeastern Corporation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 DOJ Ref. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
90&hyph;11&hyph;2&hyph;897C.
<!-- PJG 0012 frnewline -->
The proposed Consent Decree may be examined at the office of the United States Attorney, Middle District of Florida,
500 Zack St. Room 410, Tampa, Florida 33602; the Office of the United States Environmental Protection Agency, Region
IV, 345 Courtland Street, N.E., Atlanta, Georgia; and at the Consent Decree Library, 1120 G Street, N.W., 4th Floor,
Washington, D.C. 20005, (202) 624&hyph;0892. A copy of the proposed Consent Decree Library, 1120 G Street, N.W.,
4th Floor, Washington, D.C. 20005. In requesting a copy, please refer to the referenced case and enclose a check in
the amount of $30.00 (25 cents per page reproduction costs), payable to the Consent Decree Library for a copy of the
Consent Decree with attachments or a check in the amount of $21.25, for a copy of the proposed Consent Decree without
those attachments.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce S. Gelber,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31113 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00102 </DOCNO>
<PARENT> FR941219-2-00064 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Lodging of Judgment by Consent Pursuant to the Clear Air Act</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Departmental policy, 28 CFR 50.7, notice is hereby given that on November 29, 1994, a proposed consent
decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ASARCO, Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civil Action No. CV&hyph;94&hyph;88&hyph;H&hyph;CCL, was lodged with the United States District Court for the
District of Montana, Helena Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed consent decree will resolve the United States' claims for violations of section 113(b) of the Clear Air
Act as amended, 42 U.S.C. 7413(b), and the requirements and prohibitions set forth in a permit issued to ASARCO, for
its plant in East Helena, Montana, pursuant to the State of Montana's State Implementation Plan.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department of Justice will receive comments relating to the proposed consent decree with ASARCO, Inc., for a period
of thirty (30) days from the date of this publication. Comments on the decree should be addressed to the Assistant Attorney
General, Environmental &amp; Natural Resources Division, U.S. Department of Justice, Washington DC. 20530, and
should refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ASARCO, Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civil Action No. CV&hyph;94&hyph;88&hyph;H&hyph;CCL, 
<!-- PJG 0012 frnewline -->
DOJ reference No. 90&hyph;5&hyph;2&hyph;1&hyph;1859.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A copy of the proposed consent decree may be examined at the Office of the United States Attorney, District of Montana,
Federal Building, Helena, Montana; the Region VIII office of the Environmental Protection Agency, 999 18th Street,
Denver, Colorado 80202; and the Consent Decree Library, 1120 G Street, NW. 4th Floor, Washington DC. 20005, (202&hyph;624&hyph;0892).
A copy of the proposed decree may be obtained in person or by mail from the Consent Decree Library, 1120 G Street, NW.,
4th Floor, Washington, DC. 20005. When requesting a copy of the proposed consent decree, please enclose a check in
the amount of $1.25 (twenty-five cents per page reproduction costs) payable to the ``Consent Decree Library.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce S. Gelber,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31145 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00103 </DOCNO>
<PARENT> FR941219-2-00065 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF LABOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Secretary's Task Force on Excellence in State and Local Government Through Labor-Management Cooperation: Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of the Secretary, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of public meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Secretary's Task Force on Excellence in State and Local Government Through Labor-Management Cooperation was
established in accordance with the Federal Advisory Committee Act (FACA) (Pub. L. 82&hyph;463)). Pursuant to Section
10(a) of FACA, this is to announce that the Task Force will meet at the time and place shown below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Time and Place
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The meeting will be held on Tuesday, January 10, from 9 a.m. to 4 p.m. and on Wednesday, January 11, from 9 a.m. to 3 p.m.
in Conference Room N&hyph;3437 B&hyph;D in the Department of Labor, 200 Constitution Avenue, NW, Washington, DC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Agenda
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At this meeting, the Task Force intends to hear testimony on and discuss the following topics: education, alternative
dispute resolution, demographics of the workforce, ways of defining excellence, and workplace attitudes towards
excellence, participation, and representation. The Task Force may also discuss future work plans, including the
desirability of scheduling meetings of working groups of Task Force Members at various locations around the country.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Public Participation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The meeting will be open to the public. Seating will be available on a first-come, first-served basis. Individuals
with disabilities wishing to attend should contact the Task Force to request appropriate accommodations. Individuals
or organizations wishing to submit written statements should send 20 copies on or before January 3 to Mr. Charles A.
Richards, Designated Federal Official, Secretary of Labor's Task Force on Excellence in State and Local Government
through Labor-Management Cooperation, U.S. Department of Labor, 200 Constitution Avenue, NW, Room S&hyph;2203,
Washington, DC 20210. These statements will be thoroughly reviewed and become part of the record.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For the purposes of this meeting, the Task Force is primarily interested in statements that address the topics mentioned
above under the heading ``Agenda.'' However, the Task Force continues to welcome submissions that address the questions
in the mission statement and the following eight general areas: (1) Finding Models, Ingredients, and Barriers to
Excellence and Labor-Management Cooperation and, as the following relate to promoting workplace cooperation and
excellence; (2) Bargaining and Related Institutions and Practices; (3) Conflict Resolution Skills, Practices,
and Institutions; (4) Legal and Regulatory Issues; (5) Financial Background, Financial Security, and Budget Systems;
(6) Affects of Civil Service; (7) Political and Electoral Considerations and Relationships; and (8) Providing a
Humane Work Environment.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. Charles A. Richards, Designated Federal Official, Secretary of Labor's Task Force on Excellence in State and
Local Government through Labor-Management Cooperation, U.S. Department of Labor, Room S&hyph;2203, Washington,
DC 20210, (202) 219&hyph;6231.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, DC this 14th day of December, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Robert B. Reich,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of Labor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31142 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;23&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00104 </DOCNO>
<PARENT> FR941219-2-00066 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Employment and Training Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Attestations Filed by Facilities Using Nonimmigrant Aliens as Registered Nurses </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Employment and Training Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Department of Labor (DOL) is publishing, for public 
<!-- PJG 0012 frnewline -->
information, a list of the following health care facilities that have submitted attestations (Form ETA 9029 and explanatory
statements) to one of four Regional Offices of DOL (Boston, Chicago, Dallas and Seattle) for the purpose of employing
nonimmigrant alien nurses. A decision has been made on these organizations' attestations and they are on file with
DOL.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Anyone interested in inspecting or reviewing the employer's attestation may do so at the employer's place of business.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Attestations and short supporting explanatory statements are also available for inspection in the U.S. Employment
Service, Employment and Training Administration, Department of Labor, Room N&hyph;4456, 200 Constitution Avenue,
N.W., Washington, D.C. 20210. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any complaints regarding a particular attestation or a facility's activities under that attestation, shall be filed
with a local office of the Wage and Hour Division of the Employment Standards Administration, Department of Labor.
The address of such offices are found in many local telephone directories, or may be obtained by writing to the Wage
and Hour Division, Employment Standards Administration, Department of Labor, Room 
<!-- PJG 0012 frnewline -->
S&hyph;3502, 200 Constitution Avenue, N.W., Washington, D.C. 20210.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Regarding the Attestation Process: Chief, Division of Foreign Labor Certifications, U.S. Employment Service.
Telephone: 202&hyph;219&hyph;5263 (this is not a toll-free number). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Regarding the Complaint Process: Questions regarding the complaint process for the H&hyph;1A nurse attestation
program will be made to the Chief, Farm Labor Program, Wage and Hour Division. Telephone: 202&hyph;219&hyph;7605
(this is not a toll-free number).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Immigration and Nationality Act requires that a health care facility seeking to use nonimmigrant aliens as registered
nurses first attest to the Department of Labor (DOL) that it is taking significant steps to develop, recruit and retain
United States (U.S.) workers in the nursing profession. The law also requires that these foreign nurses will not adversely
affect U.S. nurses and that the foreign nurses will be treated fairly. The facility's attestation must be on file with
DOL before the Immigration and Naturalization Service will consider the facility's H&hyph;1A visa petitions for
bringing nonimmigrant registered nurses to the United States. 26 U.S.C. 1101(a)(15)(H)(i)(a) and 1181(m). The
regulations implementing the nursing attestation program are at 20 CFR Parts 655, Subpart D, and 29 CFR Part 504, (January
6, 1994). The Employment and Training Administration, pursuant to 20 CFR 655.310(c), is publishing the following
list of facilities which have submitted attestations which have been accepted for filing and those which have been
rejected. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The list of facilities is published so that U.S. registered nurses, and other persons and organizations can be aware
of health care facilities that have requested foreign nurses for their staff. If U.S. registered nurses or other persons
wish to examine the attestation (on Form ETA 9029) and the supporting documentation, the facility is required to make
the attestation and documentation available. Telephone numbers of the facilities chief executive officer also
are listed to aid public inquiries. In addition, attestations and explanatory statements (but not the full supporting
documentation) are available for inspection at the address for the Employment and Training Administration set forth
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESSES 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
section of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If a person wishes to file a complaint regarding a particular attestation or a facility's activities under the 
<!-- PJG 0012 frnewline -->
attestation, such complaint must be filed at the address for the 
<!-- PJG 0012 frnewline -->
Wage and Hour Division of the Employment Standards Administration set forth in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESSES 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
section of this notice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, D.C., this 13th day of December 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John M. Robinson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Assistant Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00105 </DOCNO>
<PARENT> FR941219-2-00066 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,s200,xls40,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Division of Foreign Labor Certifications, Health Care Facility Attestations
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[FORM ETA&hyph;9029]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1CEO-Name/Facility Name/Address
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1State
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Action date
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 1
<!-- PJG 0012 frnewline -->
11/7/94 TO 11/13/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Denise Eaton, Babcock Artificial Kidney Center, 1055 Commonwealth Avenue, Boston, MA 02215, 042474787
<!-- PJG 007 0104 intable -->
MA
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215678 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Consuelo Vaca, Nurse Care Registry, Inc., 25&hyph;31 30th Road, Astoria, NY 11102, 718&hyph;204&hyph;8585
<!-- PJG 007 0104 intable -->
NY
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215687 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 1 
<!-- PJG 0012 frnewline -->
11/21/94 TO 11/27/94 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
David M. Cavalier, Keystone Nursing &amp; Rehabilitation, 44 Keystone Drive, Leominster, MA 01453, 508&hyph;537&hyph;9237
<!-- PJG 007 0104 intable -->
MA
<!-- PJG 007 0104 intable -->
11/22/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215812 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Joseph O'Grady, O'Grady-Peyton, Int'l, 470 Atlantic Avenue, Boston, MA 02210, 617&hyph;482&hyph;5655
<!-- PJG 007 0104 intable -->
MA
<!-- PJG 007 0104 intable -->
11/22/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215973 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Warren E. Gager, William B. Kessler Memorial Hosp., 600 S. White Horse Pike, Hammonton, NJ 08037&hyph;2099, 609&hyph;561&hyph;6700
<!-- PJG 007 0104 intable -->
NJ
<!-- PJG 007 0104 intable -->
11/22/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215841 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Elvie L. Labaro, Professional Health Care Agency, 31&hyph;14 Steinway St., Astoria, NY 11103, 718&hyph;454&hyph;5880
<!-- PJG 007 0104 intable -->
NY
<!-- PJG 007 0104 intable -->
11/22/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215969 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Michael Rodzenko, South Nassau Communities Hospital, 2445 Oceanside Road, Oceanside, NY 11572, 516&hyph;763&hyph;3930
<!-- PJG 007 0104 intable -->
NY
<!-- PJG 007 0104 intable -->
11/22/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_1/215840 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 10 
<!-- PJG 0012 frnewline -->
11/7/94 TO 11/13/94 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mattie Henderson, Downey Care Center, 13007 South Paramount Boulevard, Downey, CA 90242, 310&hyph;923&hyph;9301
<!-- PJG 007 0104 intable -->
CA
<!-- PJG 007 0104 intable -->
11/9/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_10/20592 ACTION_ACCEPTED 
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 10
<!-- PJG 0012 frnewline -->
11/14/94 TO 11/20/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Tim Howard, Community Hospital Medical Center, 6501 North 19th Avenue, Phoenix, AZ 85015, 602&hyph;844&hyph;4151
<!-- PJG 007 0104 intable -->
AZ
<!-- PJG 007 0104 intable -->
11/18/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_10/205955 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mario A. Juanengo, Exproserv Unlimited, 3435 Camino Del Rio South, Suite 307, San Diego, CA 92108, 619&hyph;563&hyph;5733
<!-- PJG 007 0104 intable -->
CA
<!-- PJG 007 0104 intable -->
11/16/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_10/206017 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
David Chen, Supernurse, 1316 Wilshire Boulevard, Suite 12, Los Angeles, CA 90017, 213&hyph;483&hyph;8388
<!-- PJG 007 0104 intable -->
CA
<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_10/205948 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 10 
<!-- PJG 0012 frnewline -->
11/28/94 TO 12/4/94 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ann C. Seisa, Vagthol's Residential Care Inc., 6537 Fountain Avenue, Los Angeles, CA 90028, 213&hyph;464&hyph;6067
<!-- PJG 007 0104 intable -->
CA
<!-- PJG 007 0104 intable -->
12/2/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_10/205970 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 5
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/7/94 TO 11/13/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Philip S. De Leon, Jr., Abington of Glenview (The), 3901 Glenview Road, Glenview, IL 60025, 708&hyph;729&hyph;0000

<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232970 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Fred Gantz, Ambassador Nursing Center, 4900 N. Bernard, Chicago, IL 60625, 312&hyph;583&hyph;7130
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232978 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Marvin Mermelstein, Balmoral Nursing Centre, Inc., 2055 West Balmoral Avenue, Chicago, IL 60625, 312&hyph;561&hyph;8661
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232975 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Nicholas A. Vangel, Butterfield Health Care, Inc., d/b/a Meadowbrook Manor 431 W., Remington Blvd., Bolingbrook,
IL 60440, 708&hyph;759&hyph;1112
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232980 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Jody Swearingen, Carle Foundation Hospital, 611 West Park, Urbana, IL 61801, 217&hyph;383&hyph;3311
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232971 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Amy Saltzman, Continental Care Center, 5336 N. Western, Chicago, IL 60625, 312&hyph;271&hyph;5600
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232985 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Jack Endeley, Danville Manor, ATTN: Don 1215 Holiday Drive, Danville, IL 61832, 217&hyph;443&hyph;4123
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232981 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Connie J. Hoselton, Heitage Manor Nursing Home, 900 N. Rutledge Street, Springfield, IL 62702, 217&hyph;789&hyph;0930
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232966 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Delores Prostek, LifeLink Corporation, 331 South York Road, Besenville, IL 60106, 708&hyph;766&hyph;3570
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232987 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Lourdes Cervantes, Methodist Hospital of Chicago, 5025 N. Paulina, Chicago, IL 60640, 312&hyph;271&hyph;9040
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232983 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Blaine Fox, Villas of Shannon, 418 South Ridge P.O. Box 86, Shannon, IL 64078, 815&hyph;864&hyph;2425
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232977 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Gary T. Johnson, Washington and Jane Smith Home, 2340 West 113th Place, Chicago, IL 60643, 312&hyph;779&hyph;8010
<!-- PJG 007 0104 intable -->
IL
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232967 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Grace Smith, Seton Hill Manor, Inc., 501 West Franklin Street, Baltimore, MD 21201, 410&hyph;837&hyph;4990
<!-- PJG 007 0104 intable -->
MD
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232986 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Heather A. Millar, Great Lakes Rehabilitation Hosp., 22401 Foster Winter Drive, Southfield, MI 48075, 810&hyph;569&hyph;1500
<!-- PJG 007 0104 intable -->
MI
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232965 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Noreen Trout, Home Care Network, Inc., 812 B East Franklin Street, Centerville, OH 45459, 800&hyph;538&hyph;4218
<!-- PJG 007 0104 intable -->
OH
<!-- PJG 007 0104 intable -->
11/8/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/232969 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 5
<!-- PJG 0012 frnewline -->
11/14/94 TO 11/20/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Edwin Zechman, Jr., Children's Hospital, 111 Michigan Avenue, N.W., Washington, DC 20010&hyph;2970, 202&hyph;884&hyph;5000

<!-- PJG 007 0104 intable -->
DC 
<!-- PJG 007 0104 intable -->
11/15/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233271 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Karen Cook, Hays Medical Center, 2220 Canterbury Drive, Hays, KS 67601, 913&hyph;628&hyph;7403 
<!-- PJG 007 0104 intable -->
KS 
<!-- PJG 007 0104 intable -->
11/16/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233353 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Aaron R. Jade, Bloomfield Hills Care Center, Inc., 50 W. Square Lake Rd., Bloomfield Hills, MI 48322, 810&hyph;338&hyph;0345

<!-- PJG 007 0104 intable -->
MI 
<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233360 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Betty Stone, Chippenham Medical Center, 7101 Jahnke Road, Richmond, VA 23225, 804&hyph;320-3911 
<!-- PJG 007 0104 intable -->
VA 
<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233367 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mariano C. Evangelista, Metro Employment &amp; Immig. Services, 3717 Columbia Pike, Suite 201, Arlington, VA 22204,
703&hyph;979&hyph;6253 
<!-- PJG 007 0104 intable -->
VA 
<!-- PJG 007 0104 intable -->
11/15/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233272 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Leah Rama, Premier Quality Care Services, Inc., 101 South Whiting St., Suite 113, Alexandria, VA 22304, 703&hyph;370&hyph;6900

<!-- PJG 007 0104 intable -->
VA 
<!-- PJG 007 0104 intable -->
11/16/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233349 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Armida Evangelista, Southern Medical Services, Inc., 3717 Columbia Pike, Suite 201, Arlington, VA 22204, 703&hyph;979&hyph;6253

<!-- PJG 007 0104 intable -->
VA 
<!-- PJG 007 0104 intable -->
11/16/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233350 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 5 
<!-- PJG 0012 frnewline -->
11/28/94 TO 12/4/94 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Joseph O'Grady, O'Grady-Peyton International USA, 470 Atlantic Avenue, Boston, MA 02210, 617&hyph;482&hyph;5655

<!-- PJG 007 0104 intable -->
MA 
<!-- PJG 007 0104 intable -->
11/21/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/233554 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 5 
<!-- PJG 0012 frnewline -->
11/21/94 TO 11/27/94 
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Carl Baker, King Bruwaert House, 6101 S. County Line Road, Burr Ridge, IL 60251, 708&hyph;323&hyph;2250 
<!-- PJG 007 0104 intable -->
IL 
<!-- PJG 007 0104 intable -->
12/1/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_5/234068 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Barbara Baxter, Medi-Search International, P.O. Box 60631&hyph;0882 240 East Lake Street, Suite 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
206, Chicago, IL 60631&hyph;0882, 708&hyph;941&hyph;8341 
<!-- PJG 007 0104 intable -->
IL 
<!-- PJG 007 0104 intable -->
12/1/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_5/234072 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Elaine Yarling, Mt. Sinai Hospital Medical Center, California Avenue at 15th St., Chicago, IL 60608, 312&hyph;257&hyph;6653

<!-- PJG 007 0104 intable -->
IL 
<!-- PJG 007 0104 intable -->
12/1/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_5/234014 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
William C. Langschied, Mariner Health Care of Fort Wayne, 4430 Elsdale Drive, Fort Wayne, IN 46835, 219&hyph;485&hyph;8157

<!-- PJG 007 0104 intable -->
IN 
<!-- PJG 007 0104 intable -->
12/1/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_5/234065 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Thomas G. Rau, Four Chaplains Convalescent Center, 28349 Joy Road, Westland, MI 48185, 313&hyph;261&hyph;9500

<!-- PJG 007 0104 intable -->
MI 
<!-- PJG 007 0104 intable -->
12/1/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_5/234067 ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 6
<!-- PJG 0012 frnewline -->
11/7/94 TO 11/13/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Isaac Mizrahi, El Ponce De Leon Convalescent Ctr., 335 SW 12 Avenue, Miami, FL 33130, 305&hyph;545&hyph;5417

<!-- PJG 007 0104 intable -->
FL 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222591 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Denton Crockett, Independent Home Health Services, 1020 Lakeview Road, Suite 200, Clearwater, FL 34616, 813&hyph;461&hyph;4481
<!-- PJG 007 0104 intable -->
FL 
<!-- PJG 007 0104 intable -->
11/10/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222659 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Isaac Mizrahi, Jackson Manor Nursing Home, Inc., 1861 NW 8 Avenue, Miami, FL 33136, 303&hyph;324&hyph;0280 
<!-- PJG 007 0104 intable -->
FL 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222590 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Isaac Mizrah, Snapper Creek Nursing Home, 9200 SW 87 Avenue, Miami, FL 33157, 305&hyph;271&hyph;1313 
<!-- PJG 007 0104 intable -->
FL 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222592 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. John P. Whitley, Louisiana State Penitentiary, Angola, LA 70712, 504&hyph;655&hyph;4411 
<!-- PJG 007 0104 intable -->
LA 
<!-- PJG 007 0104 intable -->
11/10/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222728 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Peggy L. Miller, Bermuda Village Retirement Center, 163 Stratford Ct., Suite 205, Winston-Salem, NC 27103, 910&hyph;998&hyph;6112

<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/10/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222663 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Robert HIll, Jr., Britthaven of Chapel Hill, 1716 Legion Road, Chapel Hill, NC 27514, 919&hyph;942&hyph;2280

<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222657 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Robert Hill, Jr., Britthaven of Kernersville, 728 Piney Grove Road, Kernersville, NC 27284, 910&hyph;556&hyph;4038

<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222656 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Randy L. Beaman, Carolina Retirement Services, Inc., 163 Stratford Court, Winston-Salem, NC 27103, 919&hyph;823&hyph;2799

<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222486 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Karen S. Daniel, Integrated Health Serv. of Raleigh, 3830 Blue Ridge Road, Raleigh, NC 27612, 919&hyph;781&hyph;4900

<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222479 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Jody Barnes, Orlando Memorial, 163 Stratford Court, Ste. 205, 407&hyph;423&hyph;1612 
<!-- PJG 007 0104 intable -->
NC 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222589 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Linda Ghaffari, Buenavista Retirement Center, 1501 West 7th Street, Clovis, NM 88101, 505&hyph;763&hyph;5335

<!-- PJG 007 0104 intable -->
NM 
<!-- PJG 007 0104 intable -->
11/10/94 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222662 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. James Jewell, Edinburg Colonial Manor, 1401 South 2nd Street, Edinburg, TX 78539, 210&hyph;383&hyph;4978 
<!-- PJG 007 0104 intable -->
TX 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222481 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Dean Fleet, Monahans Care Center, 1200 W. 15th St., Monahans, TX 79756, 915&hyph;943&hyph;3063 
<!-- PJG 007 0104 intable -->
TX 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222487 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. James Jewell, Pharr Nursing Home, Inc., 204 South Casa Road, Pharr, TX 78577, 210&hyph;787&hyph;2735 
<!-- PJG 007 0104 intable -->
TX 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222482 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Ben M. Durr, Uvalde Memorial Hospital, 1025 Garner Field Road, Uvalde, TX 78801, 210&hyph;278&hyph;6251 
<!-- PJG 007 0104 intable -->
TX 
<!-- PJG 007 0104 intable -->
11/7/94
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222485 ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Georgia Holmes, Wright Nursing Home, 328 West Mayfield, San Antonio, TX 78221, 210&hyph;924&hyph;5533 
<!-- PJG 007 0104 intable -->
TX 
<!-- PJG 007 0104 intable -->
11/7/94 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222480 ACTION_ACCEPTED 
<!-- PJG 007 0162 intable -->
s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 6
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11/14/94 TO 11/20/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Lawrence J. Centella, REN Centers of Alabama, Inc., 216 Marengo Street 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
1, Florence, AL 35630, 205&hyph;764&hyph;5050
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
AL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222821 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. Issac Mizrah, Arch Creek Nursing Home, Inc., 12505 N.E. 16 Avenue, North Miami, FL 33161, 305&hyph;891&hyph;1710
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222744 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Ms. Marie McLucas, Fountainhead Nsg. &amp; Convalescent, 390 NE 135th Street, North Miami, FL 33161 305&hyph;893&hyph;0660
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222823 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. C. Scott Campbell, Highlands Regional Medical Center, 3600 S. Highlands Avenue P.O. Drawer 2066, Sebring, FL
33871, 813&hyph;385&hyph;6101
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/18/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222824 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Ms. Maxcine Darville, Okeechobee Council on Aging, Inc., 230 South Barfield Highway, Pahokee, FL 33476&hyph;1867,
407&hyph;924&hyph;5561
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222745 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Carlos Milanes, Palm Springs General Hospital, 1475 W. 49th Street, Hialeah, FL 33012, 305&hyph;558&hyph;2500
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222747 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. Isaac Mizrah, Palmetto Extended Care Center, Inc., 7600 S.W. 8 Street, Miami, FL 33144, 305&hyph;324&hyph;0280
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222743 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. William Patterson, Palms of Pasadena Hospital, 1501 Pasadena Ave. South, St. Petersburg, FL 33707, 813&hyph;381&hyph;1000
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/16/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/223328 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. David Catlin, Parkway Regional Medical Center, 160 N.W. 170th Street, N. Miami bEACH, FL 33169, 305&hyph;651&hyph;1100
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222748 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
W.E. Steiger, Miss. Dept. of Corrections Medical, P.O. Box E Highway 49&hyph;W, Parchman, MS 38738 601&hyph;745&hyph;6611
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
MS
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222746 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. John T. Carlisle, Cumberland Co. Hospital System, Inc., 1638 Owen Drive P.O. Box 2000, Fayetteville, NC 28302&hyph;2000,
910&hyph;609&hyph;6646
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/18/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222825 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. Leo Redding, Hillhaven Rehab Center-Cape Coral, 163 Stratford Ct. Suite 205, Winston-Salem, NC 27103, 813&hyph;574&hyph;4434
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/18/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222826 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Mr. Ralph E. Beaty, Huntsville Memorial Hospital, 3000 I&hyph;45 P.O. Box 4001, Huntsville, TX 77340, 409&hyph;291&hyph;4521
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/17/94
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
ETA CONTROL NUMBER_6/222872 ACTION_ACCEPTED
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 6
<!-- PJG 0012 frnewline -->
11/21/94 to 11/27/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Roger Kirk, 
<!-- PJG 0012 frnewline -->
Bethesda Memorial Hospital, 
<!-- PJG 0012 frnewline -->
2815 S. Seacrest Blvd., 
<!-- PJG 0012 frnewline -->
Boynton Beach, FL 33435, 407&hyph;737&hyph;7733 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222975 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Ronald A. Cass, 
<!-- PJG 0012 frnewline -->
Hospital Staffing Services, Inc., 
<!-- PJG 0012 frnewline -->
6245 N. Federal Highway, Suite 500, 
<!-- PJG 0012 frnewline -->
Ft. Lauderdale, FL 33308, 305&hyph;771&hyph;0500 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223019 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Richard Lockaby, 
<!-- PJG 0012 frnewline -->
Madison Nursing Center, 
<!-- PJG 0012 frnewline -->
Rte. 3, Box 2310, 
<!-- PJG 0012 frnewline -->
Madison, FL 32340, 904&hyph;973&hyph;4880 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222847 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Emil P. Miller, 
<!-- PJG 0012 frnewline -->
Pinellas Community Hospital, 
<!-- PJG 0012 frnewline -->
7950 66th Street, North, 
<!-- PJG 0012 frnewline -->
Pinellas Park, FL 34665, 813&hyph;545&hyph;7300 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222910 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Derek Carissimi, 
<!-- PJG 0012 frnewline -->
Piedmont Hospital, 
<!-- PJG 0012 frnewline -->
1968 Peachtree Road, NW., 
<!-- PJG 0012 frnewline -->
Atlanta, GA 30309, 404&hyph;605&hyph;5000 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
GA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222909 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Fred E. Calcote, Jr., 
<!-- PJG 0012 frnewline -->
East Louisiana State Hospital, 
<!-- PJG 0012 frnewline -->
P.O. Box 498 Highway 10, 
<!-- PJG 0012 frnewline -->
Jackson, LA 70748, 504&hyph;634&hyph;2651 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
LA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222848 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Dudley Romero, 
<!-- PJG 0012 frnewline -->
Our Lady of Lourdes Reg. Med. Ctr., 
<!-- PJG 0012 frnewline -->
611 St. Landry Street, 
<!-- PJG 0012 frnewline -->
Lafayette, LA 70506, 318&hyph;231&hyph;2104 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
LA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222881 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. G. Wayne Shuler, 
<!-- PJG 0012 frnewline -->
Madison General Hospital, 
<!-- PJG 0012 frnewline -->
Highway 16 East, 
<!-- PJG 0012 frnewline -->
Canton, MS 39046, 601&hyph;859&hyph;1331 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
MS
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222845 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Ronnette Cox, 
<!-- PJG 0012 frnewline -->
Convalescent Center of Halifax, 
<!-- PJG 0012 frnewline -->
101 Carolina Ave., 
<!-- PJG 0012 frnewline -->
P.O. Drawer 432, 
<!-- PJG 0012 frnewline -->
Weldon, NC 27890, 919&hyph;536&hyph;4817 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NC
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222880 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Richard Powell, 
<!-- PJG 0012 frnewline -->
Dallas Nephrology Associates, 
<!-- PJG 0012 frnewline -->
3601 Swiss Avenue, 
<!-- PJG 0012 frnewline -->
Dallas, TX 75204, 214&hyph;956&hyph;8200 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222908 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Rene Gaviola, 
<!-- PJG 0012 frnewline -->
Midwest Rehab Center, 
<!-- PJG 0012 frnewline -->
4919 Shadowdale Drive, 
<!-- PJG 0012 frnewline -->
Houston, TX 77041, 713&hyph;937&hyph;3515 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/22/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/222907 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED
<!-- PJG 007 0162 intable -->
s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=2 -->
ETA REGION 6
<!-- PJG 0012 frnewline -->
11/28/94 to 12/04/94
<!-- PJG 007 0163 intable -->
0
<!-- PJG 007 0162 intable -->
s 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Judi L. Buxo, 
<!-- PJG 0012 frnewline -->
Harbour's Edge, 
<!-- PJG 0012 frnewline -->
401 East Linton Blvd., 
<!-- PJG 0012 frnewline -->
Delray Beach, FL 33483, 407&hyph;272&hyph;7979 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FL
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223190 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Bryan Batulis, 
<!-- PJG 0012 frnewline -->
Heritage Manor of Napoleonville, 
<!-- PJG 0012 frnewline -->
252 Highway 402, 
<!-- PJG 0012 frnewline -->
P.O. Box 669, 
<!-- PJG 0012 frnewline -->
Napoleonville, LA 70390, 504&hyph;369&hyph;6011 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
LA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223521 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Alivia Mitchell, 
<!-- PJG 0012 frnewline -->
Hacienda de Salud, 
<!-- PJG 0012 frnewline -->
3514 Leslie Road, 
<!-- PJG 0012 frnewline -->
Silver City, NM 88061, 505&hyph;388&hyph;3127 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NM
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223155 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. David Parmer, 
<!-- PJG 0012 frnewline -->
Baptist Hospital of Southeast TX, 
<!-- PJG 0012 frnewline -->
College &amp; 11th Street, 
<!-- PJG 0012 frnewline -->
Beaumont, TX 77704, 409&hyph;835&hyph;3187 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223191 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Mr. Nedro G. Parker, 
<!-- PJG 0012 frnewline -->
Health Network International, Inc., 
<!-- PJG 0012 frnewline -->
4506 LaBranch, 
<!-- PJG 0012 frnewline -->
Houston, TX 77004&hyph;4925, 713&hyph;522&hyph;2443 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223073 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=2 -->
Ms. Donna Wong, 
<!-- PJG 0012 frnewline -->
Total Life Care, 
<!-- PJG 0012 frnewline -->
105 Drew, 
<!-- PJG 0012 frnewline -->
Houston, TX 77006, 713&hyph;529&hyph;8922 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
12/1/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=2 -->
ETA CONTROL NUMBER_6/223074 
<!-- PJG 0012 frnewline -->
ACTION_ACCEPTED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;31137 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 4510&hyph;30&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00106 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=2 -->

<USBUREAU>Pension and Welfare Benefits Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=2 -->

<RINDOCK>[Application No. D&hyph;9834, et al.]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=2 -->
Proposed Exemptions; Alucobond Technologies, Incorporated Employees' Savings Plan, et al.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pension and Welfare Benefits Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed exemptions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document contains notices of pendency before the Department of Labor (the Department) of proposed exemptions
from certain of the prohibited transaction restriction of the Employee Retirement Income Security Act of 1974 (the
Act) and/or the Internal Revenue Code of 1986 (the Code).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Written Comments and Hearing Requests 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All interested persons are invited to submit written comments or request for a hearing on the pending exemptions,
unless otherwise stated in the Notice of Proposed Exemption, within 45 days from the date of publication of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Notice. Comments and request for a hearing should state: (1) the name, address, and telephone number of the person
making the comment or request, and (2) the nature of the person's interest in the exemption and the manner in which the
person would be adversely affected by the exemption. A request for a hearing must also state the issues to be addressed
and include a general description of the evidence to be presented at the hearing. A request for a hearing must also state
the issues to be addressed and include a general description of the evidence to be presented at the hearing.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 All written comments and request for a hearing (at least three copies) should be sent to the Pension and Welfare Benefits
Administration, Office of Exemption Determinations, Room N&hyph;5649, U.S. Department of Labor, 200 Constitution
Avenue NW., Washington, D.C. 20210. Attention: Application No. stated in each Notice of Proposed Exemption. The
applications for exemption and the comments received will be available for public inspection in the Public Documents
Room of Pension and Welfare Benefits Administration, U.S. Department of Labor, Room N&hyph;5507, 200 Constitution
Avenue NW., Washington, D.C. 20210. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice to Interested Persons 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice of the proposed exemptions will be provided to all interested persons in the manner agreed upon by the applicant
and the Department within 15 days of the date of publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Such notice shall include a copy of the notice of proposed exemption as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and shall inform interested persons of their right to comment and to request a hearing (where appropriate).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The proposed exemptions were requested in applications filed pursuant to section 408(a) of the Act and/or section
4975(c)(2) of the Code, and in accordance with procedures set forth in 29 CFR Part 2570, Subpart B (55 FR 32836, 32847,
August 10, 1990). Effective December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978 (43 FR 47713, 
<!-- PJG 0012 frnewline -->
October 17, 1978) transferred the authority of the Secretary of the Treasury to issue exemptions of the type requested
to the Secretary of Labor. Therefore, these notices of proposed exemption are issued solely by the Department. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applications contain representations with regard to the proposed exemptions which are summarized below. Interested
persons are referred to the applications on file with the Department for a complete statement of the facts and representations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Alucobond Technologies, Incorporated Employees' Savings Plan (the Plan) Located in St. Louis, Missouri; Proposed
Exemption
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9834]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2)
of the Code and in accordance with the procedures set forth in 29 CFR part 2570, subpart B (55 FR 32836, 32847, August
10, 1990). If the exemption is granted, the restrictions of sections 406(a), 406 (b)(1) and (b)(2) of the Act and the
sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1) (A) through
(E) of the Code shall not apply to (1) the proposed interest-free loan to the Plan (the Loan) by Alucobond Technologies,
Incorporated (the Employer), a party in interest with respect to the Plan, and (2) the Plan's potential repayment
of the Loan upon the receipt by the Plan of payments under Guaranteed Investment Contract No. CG01285A3A (the GIC)
issued by Executive Life Insurance Company (Executive Life); provided the following conditions are satisfied:

<!-- PJG 0012 frnewline -->
(A) No interest or expenses are paid by the Plan in connection with the proposed transaction; 
<!-- PJG 0012 frnewline -->
(B) The Loan will be repaid only out of amounts paid to the Plan by Executive Life, its successors, or any other responsible
third party; and 
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00107 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(C) Repayment of the Loan is waived with respect to the amount by which the Loan exceeds GIC proceeds. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Employer is a diversified manufacturer of aluminum composite panels, rigid foam P.V.C. panels and polystyrene
foamcore boards. The Employer has offices and/or production sites in St. Louis, Missouri; Benton, Kentucky and Richmond,
Indiana. The Plan is a profit sharing plan which includes a cash or deferred arrangement under section 401(k) of the
Code. As of December 31, 1993, the Plan had 93 participants and total assets of approximately $1,098,635. Participants
are currently entitled to direct the investment of their account balances among seven investment funds which are
managed by Scudder Investor Services, Inc. On February 12, 1988, prior to the implementation of participant direction,
The Boatmen's National Bank of St. Louis (the Bank),
<FOOTCITE>1</FOOTCITE>
 as trustee for the Plan, made the decision to invest a portion of the Plan's assets in a collective investment fund maintained
by the Bank and invested primarily in guaranteed investment contracts. The GIC is held as the sole asset of sub-fund
G&hyph;11 of the the collective investment fund. The GIC provided a rate of return of 8.65% per annum and a maturity
date of March 1, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Boatmen's Trust Company (Boatmen's) succeeded The Boatmen's National Bank of St. Louis as the Plan's trustee in 1990.

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. On April 11, 1991, Executive Life was placed into conservatorship by the Insurance Commissioner of the State of
California. The Employer represents that, pursuant to the conservatorship, payouts under the terms of Executive
Life's GICs were suspended.
<FOOTCITE>2</FOOTCITE>
 In February, 1994, Boatmen's, in its capacity as Plan trustee, elected to participate in the rehabilitation plan
for Executive Life. Although, through the rehabilitation process, the Plan has received $147,386.00 from Executive
Life, the amount of any additional payments to be received over the next several years is undetermined. Consequently,
Boatmen's has frozen that portion of participants' accounts which is attributable to the GIC. This freeze has prevented
Plan participants from exercising the rights they would normally have under the Plan to request distributions and
investment transfers with respect to amounts currently invested in the GIC.
<FOOTCITE>3</FOOTCITE>
 The Employer represents that the Loan would preserve the Plan's rights with respect to the GIC, give participants
and beneficiaries the ability to exercise their right to request investment transfers, and provide immediate liquidity
which would facilitate benefit distributions. The proposed Loan will be made in one lump-sum payment in the amount
of the maturity value
<FOOTCITE>4</FOOTCITE>
 of the GIC, plus post-maturity interest through the date of the Loan, credited at the rate paid on the Collective Employee
Benefit Trust Fund ``S'';
<FOOTCITE>5</FOOTCITE>
, less any amounts previously received pursuant to the rehabilitation process and the total amount of periodic advances
already made to the Plan. The Employer represents that the Loan is non-interest bearing and the Plan will not incur
any expenses in connection with the transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department notes that the decisions to acquire and hold the GIC are governed by the fiduciary responsibility requirements
of Part 4, Subtitle B, Title I of the Act. In this regard, the Department is not herein proposing relief for any violations
of Part 4 which may have arisen as a result of the acquisition and holding of the GIC issued by Executive Life. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Following the cessation of payments by Executive Life with respect to the GIC, the Employer made the decision to make
periodic advances to the Plan to permit the Plan to make distributions to participants and beneficiaries entitled
to distributions as a consequence of termination of employment. The applicant represents that, as of November, 1994,
the periodic advances to the Plan totaled approximately $50,618.00. The applicant also represents that the terms
of those periodic advances satisfy the conditions of PTE 80&hyph;26 (45 FR 28545, April 29, 1980). This conditional
class exemption permits a party in interest to make an interest-free loan to an employee benefit plan, and the repayment
of such loan. Specifically, the exemption states, in relevant part, that effective January 1, 1975, the restrictions
of section 406(a)(1)(B) and (D) and section 406(b)(2) of the Act and the taxes imposed by section 4975(a) and (b) of
the Code by reason of section 4975(c)(1)(B) and (D) of the Code, shall not apply to the lending of money from a party in
interest to an employee benefit plan, nor to the repayment of such loan in accordance with its terms, if no interest
or other fee is charged to the plan, the loan is unsecured, and the loan proceeds are used only for the payment of ordinary
operating expenses of the plan, including the payment of benefits in accordance with the terms of the plan.
<!-- PJG 0012 frnewline -->
In this proposed exemption the Department expresses no opinion as to whether the periodic advances satisfy the provisions
of PTE 80&hyph;26. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The maturity value is defined as the total amount deposited under the GIC, plus interest at the guaranteed interest
rate, through the date of maturity. The applicant represents that the maturity value is $297,210.76. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Employer represents that the annualized rate of return on the Collective Employee Benefit Trust Fund ``S'' for
the period from October 1, 1993 through September 30, 1994 was 4.0%. It is represented that, this fund, an investment
vehicle offered by Boatmen's Trust Company, invests in a diversified portfolio of money market instruments, such
as U.S. Treasury Bills, certificates of deposit, commercial paper, and demand notes, as well as other fixed-rate
and variable-rate fixed income securities. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Repayment of the Loan is limited to payments made to the Plan by or on behalf of Executive Life, or its successor, or
any other responsible third parties. No other assets of the Plan will be available for repayment of the Loan. If the
payments by or on behalf of Executive Life are not sufficient to fully repay the Loan, the Employer will have no recourse
against the Plan, or against any participants or beneficiaries of the Plan, for the unpaid amount. In the event that
GIC proceeds exceed the amount necessary to repay the Loan, the excess will be distributed to the Plan for the benefit
of participants and their beneficiaries. The Employer represents that it will maintain records of the proposed Loan
for a period of seven years, and such records will be open for inspection at all times by the Department or any Plan participant.

<!-- PJG 0012 frnewline -->
4. In summary, the applicant represents that the proposed transaction satisfies the criteria of section 408(a) of
the Act because: (1) The transaction will preserve the Plan's ability to allow participant-directed investment
re-allocations; (2) The Plan will not incur any expenses with respect to the transaction; (3) Repayment of the Loan
will be made only from amounts paid to the Plan by Executive Life, its successor, or any other third party; (4) If the
payments by or on behalf of Executive Life are not sufficient to fully repay the Loan, the Employer will have no recourse
against the Plan, or against any participants or beneficiaries of the Plan, for the unpaid amount; and (5) Repayment
of the Loan will be waived with respect to the amount by which the Loan exceeds the amount the Plan receives from GIC proceeds.

<!-- PJG 0012 frnewline -->
For Further Information Contact: Virginia J. Miller of the Department, telephone (202) 219&hyph;8971. (This is
not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00108 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Regency Marketing Corporation 
<!-- PJG 0012 frnewline -->
Restated Employees Profit Sharing 
<!-- PJG 0012 frnewline -->
Plan and Trust (the Plan) 
<!-- PJG 0012 frnewline -->
Located in West Bloomfield, Michigan; Proposed Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9763] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under section 4975(c)(2) of the Code and in accordance with the
procedures set forth in 29 CFR Part 2570, Subpart B (55 FR 32836, 32847, August 10, 1990). If the exemption is granted,
the sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1)(A) through
(E) of the Code, shall not apply to the proposed loan (the Loan) of $84,667 by the Plan to Frankenmuth Brewing Company
(Frankenmuth), a disqualified person with respect to the Plan.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Since Randall Heine and his wife, Paula Heine, are the only participants in the Plan, there is no jurisdiction under
Title I of the Act pursuant to 29 CFR 2510.3&hyph;3(b). However, there is jurisdiction under Title II of the Act pursuant
to section 4975 of the Code. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This proposed exemption is conditioned upon the following requirements: (a) the terms of the Loan are at least as favorable
to the Plan as those obtainable in an arm's length transaction with an unrelated party; 
<!-- PJG 0012 frnewline -->
(b) the Loan does not exceed twenty-five percent of the assets of the Plan at any time during the duration of the Loan;

<!-- PJG 0012 frnewline -->
(c) the Loan is secured by a first deed of trust on certain real property (the Property) which has been appraised by an
independent, qualified appraiser to ensure that the fair market value of the Property is at least 150 percent of the
amount of the Loan; 
<!-- PJG 0012 frnewline -->
(d) the fair market value of the Property remains at least equal to 150 percent of the outstanding balance of the Loan
throughout the duration of the Loan; 
<!-- PJG 0012 frnewline -->
(e) the Plan trustees determine on behalf of the Plan that the Loan is in the best interests of the Plan and protective
of the Plan's participants and beneficiaries; and 
<!-- PJG 0012 frnewline -->
(f) the Plan trustees monitor compliance with the terms and conditions of the Loan throughout the duration of the transaction,
taking any action necessary to safeguard the Plan's interest, including foreclosure on the Property in the event
of default. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Regency Marketing Corporation (Regency) established the Plan on July 1, 1976. On February 1, 1986, the Plan was
frozen due to the dissolution of Regency. Regency was a Michigan corporation engaged as a broker of dairy and other
related products. As of June 30, 1993, the Plan had total assets of $1,892,429. Randall Heine and his wife, Paula Heine,
are the only participants in the Plan. Mr. and Mrs. Heine are the trustees of the Plan (the Trustees) and have sole investment
discretion with regard to the Plan's assets. The Trustees represent that there will be no new participants in the Plan.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00109 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Heine is the majority shareholder of Frankenmuth, a Michigan corporation with its principal place of business
in Frankenmuth, Michigan. Frankenmuth manufactures beer and ale both under its own labels as well as under private
labels. 
<!-- PJG 0012 frnewline -->
2. The Trustees request an administrative exemption from the Department to permit the Loan to Frankenmuth under the
terms and conditions described herein. Frankenmuth proposes to use the loan proceeds towards purchasing the Property
which will be used for Frankenmuth's administrative offices. 
<!-- PJG 0012 frnewline -->
3. The Loan will be in a principal amount of $84,667. The applicant states that at no time will the amount of the Loan represent
more than twenty-five percent of the Plan's total assets. The Loan will be secured by a first deed of trust on the Property,
which consists of a 1,250 square foot improved commercial building and the underlying land. The Property is located
at 435 South Main Street, Frankenmuth, Michigan. The deed of trust will be duly recorded in Saginaw County to reflect
the Plan's security interest in the Property. In addition, Frankenmuth will insure the Property against casualty
loss and designate the Plan as the loss payee of such insurance. 
<!-- PJG 0012 frnewline -->
4. The Loan will have a ten-year term and will be evidenced by a promissory note (the Note). The Note will require Frankenmuth
to make monthly payments of principal and interest which will be fully amortized over the ten-year term. Interest
will accrue on the Loan at 11.5 percent per annum. The Plan will not be required to pay any commissions, fees or other
expenses in connection with the Loan. 
<!-- PJG 0012 frnewline -->
As a condition of the proposed exemption, the terms and conditions of the Loan must be at least as favorable to the Plan
as those which the Plan could obtain in dealing at arm's length with an unrelated party. In this regard, NBD Bank, N.A.
(NBD), an unrelated entity in Troy, Michigan, states in a letter, dated September 22, 1994, that NBD would make a secured
loan of 
<!-- PJG 0012 frnewline -->
$84,667 for an initial term of five years with a fifteen-year amortization schedule allowing for a balloon payment
at the end of the fifth year. At the end of the first five years, NBD would approve a new five-year note with a ten-year
amortization schedule. At the end of the tenth year, NBD would then approve 
<!-- PJG 0012 frnewline -->
a five-year note with a five-year amortization schedule. Interest would accrue within a range of 9.25 percent to 11.5
percent per annum, fixed or floating. In addition, NBD states that it would charge Frankenmuth a loan fee of one percent
or $846. Accordingly, the applicants represent that Frankenmuth will pay a loan fee of $846 to the Plan at the inception
of the Loan. 
<!-- PJG 0012 frnewline -->
5. The Property was appraised by Lewis H. Weiss of Weiss Appraisal Service (Weiss), an appraisal firm located in Frankenmuth,
Michigan. Mr. Weiss is a licensed real estate appraiser in Michigan and has ten years of experience appraising all
types of property. Mr. Weiss represents that both he and Weiss are independent of, and unrelated to, Frankenmuth and
the Trustees. 
<!-- PJG 0012 frnewline -->
Mr. Weiss placed a fair market value of $127,000 as of August 23, 1994. Mr. Weiss utilized the market data approach of
valuation by using comparable sales of commercial buildings located on the same street as the Property. 
<!-- PJG 0012 frnewline -->
6. The Trustees state that the terms of the Loan compare favorably with the terms of similar transactions between untreated
parties and would be a better than arm's length transaction as evidenced by the terms offered by NBD (see Item 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5 above). The Trustees represent, that from the Plan's perspective, the terms of the Loan are better than the terms
offered by NBD because the Loan allows the Plan to receive higher monthly payments at an interest rate of 11.5 percent
over a ten- year period rather than at a fixed or floating rate between 9.25 and 11.5 percent over a fifteen-year period.
The Trustees represent that they believe that the Loan is in the best interests of the Plan and its participants and
beneficiaries as an investment for the Plan's portfolio. The Trustees further represent that they will monitor the
Loan throughout its entire duration and will take any appropriate action necessary to protect the interests of the
Plan and its participants and beneficiaries, including a foreclosure on the Property in the event of default. The
Trustees will monitor the Property to ensure that the Loan remains secured by collateral worth at least 150 percent
of the Loan at all times. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00110 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. In summary, the applicant represents that the proposed transaction will satisfy the statutory criteria for an
exemption under section 408(a) of the Act because: 
<!-- PJG 0012 frnewline -->
(a) the terms of the Loan will be at least as favorable to the Plan as those obtainable in an arm's length transaction
with an unrelated party; 
<!-- PJG 0012 frnewline -->
(b) the Loan will not exceed twenty-five percent of the assets of the Plan at any time during the duration of the Loan;

<!-- PJG 0012 frnewline -->
(c) the Loan will be secured by a first deed of trust on certain real property (the Property) which has been appraised
by an independent, qualified appraiser to ensure that the fair market value of the Property is at least 150 percent
of the amount of the Loan; 
<!-- PJG 0012 frnewline -->
(d) the fair market value of the Property will remain at least equal to 150 percent of the outstanding balance of the
Loan throughout the duration of the Loan; 
<!-- PJG 0012 frnewline -->
(e) the Trustees have determined on behalf of the Plan that the Loan is in the best interest of the Plan and protective
of the Plan's participants and beneficiaries; and 
<!-- PJG 0012 frnewline -->
(f) the Trustees will monitor compliance with the terms and conditions of the Loan throughout the duration of the transaction,
taking any action necessary to safeguard the Plan's interest, including foreclosure on the Property in the event
of default. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice to Interested Persons 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since Mr. and Mrs. Heine are the only participants in the Plan, it has been determined that there is no need to distribute
the notice of proposed exemption to interested persons. Comments are due within thirty days after publication of
this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->
For Further Information Contact: Kathryn Parr of the Department, telephone (202) 219&hyph;8971. (This is not a toll-free
number). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00111 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Clarence E. Coker, Jr. and the Clarendon Family Practice, PA Employee Retirement Plan (the Plan) Located in Manning,
South Carolina; Proposed Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9736] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2)
of the Code and in accordance with the procedures set forth in 
<!-- PJG 0012 frnewline -->
29 C.F.R. Part 2570, Subpart B (55 FR 32836, 32847, August 10, 1990.) If the exemption is granted, the restrictions
of sections 406(a), 406(b)(1) and (b)(2) of the Act and the sanctions resulting from the application of section 4975
of the Code, by reason of section 4975(c)(1)(A) through (E) of the Code, shall not apply to the proposed sale of approximately
eight acres of unimproved land (the Land) by the Plan to Dr. Clarence E. Coker, Jr., (Dr. Coker), a party in interest
with respect to the Plan; provided that the following conditions are satisfied: 
<!-- PJG 0012 frnewline -->
(a) the proposed sale will be a one-time cash transaction; 
<!-- PJG 0012 frnewline -->
(b) the Plan will receive the higher of: (1) the original acquisition cost
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
; or (2) the current fair market value plus a certain premium related to the adjacency of the Land to other real property
owned by Dr. Coker, established at the time of the sale by an independent qualified appraiser; and 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The original acquisition cost is determined as follows: (original purchase price + aggregate real estate taxes)
^ aggregate rental income = original acquisition cost. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) the Plan will pay no expenses associated with the sale. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Plan is a defined contribution plan that was established January 1, 1974. The Plan has 13 participants, and as
of December 31, 1993, the Plan's total assets were $755,525.96. The sponsor of the Plan is Clarendon Family Practice,
PA (the Employer), which is a South Carolina subchapter ``C'' corporation engaged in family practice medicine. The
Plan's trustee is Dr. Coker who is also the sole shareholder of the Employer. 
<!-- PJG 0012 frnewline -->
2. On May 18, 1982, the Plan purchased the Land for $41,700 from Marian K. Thames, an unrelated third party in a one-time
cash transaction. The applicant represents that at the time of initial acquisition, the Land represented 19.9% of
the Plan's total assets. The Land consists of 8.34 acres of vacant land and is located adjacent to other property owned
by Dr. Coker, individually. The applicant represents that since 1982 the Land has been rented for approximately $400
a year to W. D. Harrington, a neighboring farmer who is unrelated to the Plan and the Employer, as grazing land for animals.
The aggregate rental income received by the Plan for the period 1982&hyph;1994 is $5,200. It is represented that the
Land has not been used by a party in interest since it was originally acquired by the Plan. Furthermore, the Land is not
encumbered by any debt. 
<!-- PJG 0012 frnewline -->
3. Dr. Coker in his trustee capacity, upon the advise of a certain certified public accountant, made the original decision
to acquire the Land as a long-term Plan investment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 With respect to the Land, the aggregate real estate taxes for the period 1983&hyph;1993 were $153.45. In this regard,
the original acquisition cost (the Original Acquisition Cost) to the Plan for the Land is $36,653.45. The Original
Acquisition Cost was determined as follows $41,700 (original purchase price) + $153.45 (aggregate real estate taxes)
^ $5,200 (aggregate rental income) = $36,653.45. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department expresses no opinion as to whether the Plan's acquisition and holding of the Land violated any provision
of part 4 of title I of the Act. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. The Land was appraised on February 11, 1994 (the Appraisal) by W. Burke Watson, Jr., an independent real estate appraiser
certified in the State of South Carolina (Mr. Watson). Mr. Watson relied on the direct sales comparison method and
estimated that as of February 11, 1994, the fair market value of the Land was $12,500. On July 28, 1994, in an update to
the Appraisal, Mr. Burke stated that adjacency of the Land to other property owned by Dr. Coker merits a premium (the
Premium) above the fair market value of approximately $500 per acre, which yields a new purchase price of $17,680 to
Dr. Coker in this transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00112 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Dr. Coker proposes to purchase the Land from the Plan in a one-time cash transaction. It is represented that as of
December 31, 1993, the Land represented 1.7 percent of the Plan's assets. The applicant represents that the Land has
been depreciating steadily over the years, but that this depreciation became evident to Dr. Coker in 1987. As such,
after conferring with the Plan's consultants and administrators in 1991, Dr. Coker decided that he should sell the
Land because of its steady depreciation and because of its illiquidity. Accordingly, the Land has been listed for
sale with an independent real estate broker from October 1991 to January 1992, but there was no willing buyer. Therefore,
it is represented that the proposed transaction is in the best interest and protective of the Plan because the transaction
will divest the Plan of an asset that has greatly depreciated in value since original acquisition, and will enable
the Plan to invest in vehicles with a higher return. The transaction is protective of the Plan because as a result of
the sale the Plan will receive the higher of: a) the Original Acquisition Cost; or b) the current fair market value plus
the Premium as established at the time of the sale by an independent qualified appraiser. Furthermore, the applicant
represents that any amounts received by the Plan as a result of the proposed transaction, which are in excess of the
fair market value of the Land will be treated as a contribution to the Plan, but that this contribution will not exceed
limitations of section 415 of the Internal Revenue Code. 
<!-- PJG 0012 frnewline -->
6. In summary, the applicant represents that the transaction satisfies the statutory criteria of section 408(a)
of the Act and section 4975(c)(2) of the Code because: 
<!-- PJG 0012 frnewline -->
(a) the proposed sale will be a one-time cash transaction; 
<!-- PJG 0012 frnewline -->
(b) the Plan will receive the higher of: 1) the Original Acquisition Cost; or 2) the current fair market value plus the
Premium as established at the time of the sale by an independent qualified appraiser; and 
<!-- PJG 0012 frnewline -->
(c) the Plan will pay no expenses associated with the sale. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tax Consequences of Transaction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Treasury has determined that if a transaction between a qualified employee benefit plan and its
sponsoring employer (or an affiliate thereof) results in the plan either paying less or receiving more than fair market
value, such excess may be considered to be a contribution by the sponsoring 
<!-- PJG 0012 frnewline -->
employer to the plan, and therefore must be examined under the 
<!-- PJG 0012 frnewline -->
applicable provisions of the Internal Revenue Code, including 
<!-- PJG 0012 frnewline -->
sections 401(a)(4), 404 and 415.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
For Further Information Contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ekaterina A. Uzlyan of the Department at (202) 219&hyph;8883. (This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
American Express Incentive Savings Plan (the Plan) 
<!-- PJG 0012 frnewline -->
Located in New York, New York; Proposed Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9813] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2)
of the Code and in accordance with the procedures set forth in 
<!-- PJG 0012 frnewline -->
29 C.F.R. Part 2570, Subpart B (55 F.R. 32836, 32847, August 10, 1990). If the exemption is granted the restrictions
of sections 406(a), 406 (b)(1) and (b)(2) of the Act and the sanctions resulting from the application of section 4975
of the Code, by reason of sections 4975(c)(1) (A) through (E) of the Code, shall not apply to (1) the proposed extensions
of credit (the Loans) to the Plan by American Express Company (the Employer), the sponsor of the Plan with respect to
two guaranteed investment contracts (the GICs) issued by Confederation Life Insurance Company (Confederation);
(2) the Plan's potential repayment of the Loans; and (3) the potential purchase of the GICs from the Plan by the Employer
for cash; provided the following conditions are satisfied: 
<!-- PJG 0012 frnewline -->
(A) All terms and conditions of such transactions are no less favorable to the Plan than those which the Plan could obtain
in arm's-length transactions with unrelated parties; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00113 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(B) No interest and/or expenses are paid by the Plan in connection with the transactions; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(C) The proceeds of the Loans are used solely in lieu of payments due from Confederation with respect to the GICs; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(D) Repayment of the Loans will be restricted to the GIC Proceeds, defined as the cash proceeds obtained by the Plan
from or on behalf of Confederation with respect to the GICs; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(E) Repayment of the Loans will be waived to the extent that the Loans exceed the GIC Proceeds; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(F) In any sale of the GICs to the Employer, the Plan will receive a purchase price which is no less than the fair market
value of the GICs as of the sale date, and no less than the GICs' accumulated book value, defined as the total principal
deposits plus accrued interest at the rates guaranteed by the GICs, less previous withdrawals and any Loans made pursuant
to this exemption, as of the sale date. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Plan is a defined contribution 401(k) plan which provides for individual participant accounts (the Accounts)
and participant-directed investment of the Accounts. The Plan is sponsored by American Express Company (the Employer),
a New York public corporation engaged in diversified travel and financial services. The trustee of the Plan is the
IDS Trust Company (the Trustee), a wholly-owned subsidiary of IDS Financial Corporation, which is wholly owned by
the Employer. The Accounts are invested at the directions of individual Plan participants among nine investment
funds, one of which is the ISP Income Fund (the Income Fund), which invests in, among other things, guaranteed investment
contracts issued by insurance companies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Among the assets in the Income Fund are two guaranteed investment contracts (the GICs) issued by Confederation
Life Insurance Company (Confederation), a Canadian corporation doing business in the United States through branches
in Michigan and Georgia. Contract 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
62516 was issued to the Plan by Confederation effective June 28, 1991, upon an initial principal deposit of $10 million,
and it provides for simple annual interest at the rate of 8.72 percent, with a maturity date of June 27, 1996. Contract

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
62764 was issued effective June 1, 1993 upon an initial principal deposit of $5 million and it provides for simple annual
interest at the rate of 6.06 percent, with a maturity date of June 30, 1998. Both GICs are single-deposit non-participating
contracts which allow the Plan to make benefit-responsive withdrawals (the Withdrawals) to fund benefit payments,
investment fund transfers, hardship withdrawals and participant loans (collectively, the Withdrawal Events).
The terms of the GICs provide that interest at the interest rates guaranteed by each GIC (the Contract Rates) will be
credited to the Plan daily, and if the amount of interest earned exceeds the amount of Withdrawals, the difference
will be paid annually (the Interest Payments) on the anniversary of a date specified by each GIC for such Interest Payments.
Conversely, if the amount of Withdrawals exceeds the amount of interest earned during the year, no anniversary Interest
Payment is made. Upon each GIC's maturity date, Confederation is obligated to make a final cash payment to the Plan
(the Maturity Payment) in the amount of the GIC's principal plus interest at the Contract Rate, less previous Withdrawals
(the Maturity Value). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The Employer represents that on August 11, 1994, the Canadian insurance regulatory authorities placed Confederation
into a liquidation and winding-up process, and on August 12, 1994, the insurance authorities of the State of Michigan
commenced legal action to place the U.S. operations of Confederation into a rehabilitation proceeding. As a result
of these actions, the Withdrawals and Interest Payments with respect to the GICs have been suspended.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Employer represents that it cannot be determined accurately whether, to what extent, or at what time the Withdrawals
and Interest Payments will be resumed. The Employer desires to alleviate the Plan's participants of the risks associated
with continued investment in the GICs, to prevent any losses of the Income Fund's investments in the GIC, and to provide
the Plan with the cash which otherwise would have been provided by the Withdrawals and Interest Payments. Accordingly,
the Employer proposes to make the Loans to the Plan from time to time in the amounts due the Plan under the GICs as Withdrawals
and Interest Payments. Upon the stated maturity date of each GIC, the Employer intends either (1) to purchase each
GIC from the Plan (the Sale), or, alternatively, (2) to make a Loan to the Plan in the amount of the GIC's Maturity Value,
depending upon the circumstances prevailing at such time. The Employer is requesting an exemption to permit these
transactions under the terms and conditions described herein. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 The Department notes that the decisions to acquire and hold the GICs are governed by the fiduciary responsibility
requirements of Part 4, Subtitle B, Title I of the Act. In this proposed exemption, the Department is not proposing
relief for any violations of Part 4 which may have arisen as a result of the acquisition and holding of the GICs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The Loans and their repayment, and any potential sale of the GICs to the Employer will be made pursuant to a written
agreement (the Agreement) between the Trustee and the Employer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Loans: Under the Agreement, the Employer agrees to make the Loans over the remaining terms of the GICs at such times
and in such amounts as required to enable the Income Fund to fully fund the Withdrawal Events and to fully realize the
Interest Payments, in lieu of the same amounts which otherwise would be paid to the Plan by Confederation as Withdrawals
and Interest Payments. Accordingly, the amount of each Loan will be determined on the basis of the GIC's principal
plus interest at the Contract Rate, less previous Withdrawals, as of the date of the Loan. Each Loan will also be reduced
by any amounts actually received by the Plan, with respect to the particular Withdrawal Event or Interest Payment
due, from Confederation or any other party making payment with respect to Confederation's obligations under the
GICs. In addition to the Loans in lieu of Withdrawals and Interest Payments, the Agreement authorizes the Employer,
as an alternative to purchasing the GICs (as described below in section 4) to make a final Loan with respect to each GIC
upon the GIC's Maturity Date in the amount of the GIC's Maturity Value. Any final Loan upon the maturity of each GIC will
be made within thirty days of the Maturity Date in the amount of the GIC's Maturity Value plus post-maturity interest
as described in section 4 below. The Employer will receive no interest or fees for any of the Loans, and the Plan will
incur no expenses related to the Loans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Repayments: The Agreement provides that the repayments of the Loans (the Repayments) with respect to each GIC
are restricted to the cash amounts, if any, which the Plan receives with respect to the GIC from Confederation, any
state insurance guaranty funds, any successor to Confederation, or any other third party making payments with respect
to Confederation's obligations under the GICs (collectively, the GIC Proceeds). The GIC Proceeds available to make
the Repayments also include, in the event of any purchase of either GIC, as described below, the purchase price of the
GIC (the Purchase Price). In this regard, in the event of any such sale of a GIC, Repayments of Loans with respect to that
GIC will be accomplished by crediting the total amount of outstanding Loans against the Purchase Price. In any event,
to the extent the Loans exceed total GIC Proceeds, the Repayments will be waived. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00114 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. With respect to the maturity of each GIC, the Agreement enables the Employer to retain the flexibility to decide
upon each GIC's maturity whether to make a final Loan in the amount of the Maturity Value, if not paid when due by or on
behalf of Confederation, or to purchase the GIC from the Plan. The Employer represents that it is unclear under current
conditions whether the purchase of the two GICs by the Employer would jeopardize the ability of the Plan and/or the
Employer to successfully assert rights to protection under the insurance guaranty fund laws of the various states.
The Employer is concerned that, if the two GICs are transferred from the Plan prior to resolution of issues related
to guaranty fund protection, various state guaranty fund associations may deny the full range of protection which
would have been conferred on the Plan and its participants through such insurance guaranty laws. For these reasons,
the Employer would like to wait until the maturity date of each GIC to determine whether to purchase the GIC from the
Plan or to make a Loan to the Plan in the amount of the GIC's Maturity Value. The Agreement requires the Employer to make
its decision with respect to the maturity of each GIC, and to consummate the Loan or purchase transaction, within thirty
business days after the maturity date of each GIC, during which the GIC's Maturity Value will earn interest (Post-Maturity
Interest) at the prevailing 30-day U.S. Treasury bill rate, from the date of maturity to the date of the loan or purchase.
In the event the Employer chooses to purchase either of the GICs, the purchase price will be cash in the amount of the
GIC's Maturity Value plus Post-Maturity Interest. The Plan will not incur any expenses related to any sale of the GICs.
In the event the Employer chooses to make a final Loan upon the Maturity of each GIC, each Loan will be in the amount of
the GIC's Maturity Value plus Post-Maturity Interest. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. In summary, the Employer represents that the proposed transactions satisfy the criteria of section 408(a) of the
Act for the following reasons: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The transactions will enable the Plan to recover all amounts due with respect to the GICs; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The Loans will enable the Plan to resume the ability to fund benefit payments, participant loans, hardship withdrawals,
and investment fund transfers within the Plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Repayment of the Loans will be restricted to the GIC Proceeds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The Repayments will be waived to the extent the Loans exceed the GIC Proceeds; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) No interest and/or expenses will be incurred by the Plan with respect to any of the transactions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information contact: Ron Willett of the Department, telephone (202) 219&hyph;8881. (This is not a toll-free
number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00115 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Bermo, Inc. Profit Sharing Plan and Trust (the Plan), Located in Circle Pines, Minnesota; Proposed Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9826] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act, and section
4975(c)(2) of the Code and in accordance with the procedures set forth in 29 CFR part 2570, subpart B (55 FR 32836, 32847,
August 10, 1990). If the exemption is granted, the restrictions of sections 406(a), 406 (b)(1) and (b)(2) of the Act
and the sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1) (A) through
(E) of the Code, shall not apply to the proposed series of loans (the Loans), originated within a five year period, by
the Plan to Bermo, Inc. (the Employer), a party in interest with respect to the Plan, provided that the following conditions
are met: 
<!-- PJG 0012 frnewline -->
(a) The total amount of outstanding Loans shall not exceed 25 percent of the Plan's total assets at any time during the
transaction; 
<!-- PJG 0012 frnewline -->
(b) All terms and conditions of the Loans are at least as favorable to the Plan as those which the Plan could obtain in
an arm's length transaction with an unrelated third party; 
<!-- PJG 0012 frnewline -->
(c) Each Loan will be: (1) for a maximum term of forty-eight months fully amortized and payable in equal monthly installments
of principal and interest, (2) the Loan proceeds shall be used exclusively by the Employer to purchase new equipment
(the Equipment) used by the Employer in the course of its business, (3) collateralized by the Equipment and other assets
owned by the Employer such that at all times each Loan will be collateralized in an amount equal to at least 200% of the
outstanding balance of such Loan, (4) equal to no more than 80% of the purchase price of the Equipment financed, and
(5) guaranteed personally by Fred Berdass, the principal shareholder of the Employer. 
<!-- PJG 0012 frnewline -->
(d) The value of the collateral offered by the Employer will be determined by a qualified independent appraiser; 
<!-- PJG 0012 frnewline -->
(e) Prior to the granting of each Loan, an independent qualified fiduciary determines, on behalf of the Plan, that
each Loan is feasible and in the best interests of the Plan and protective of the Plan and its participants and beneficiaries;

<!-- PJG 0012 frnewline -->
(f) The independent fiduciary will conduct a review of the terms and conditions of the exemption and the Loans, including
the applicable interest rate, the sufficiency of the collateral, the financial condition of the Employer and compliance
with the 25 percent of the Plan asset maximum total Loan amount prior to approving each disbursement under the Loan
agreement; 
<!-- PJG 0012 frnewline -->
(g) The independent fiduciary will monitor the terms and conditions of the exemption and the loans; and 
<!-- PJG 0012 frnewline -->
(h) The independent fiduciary is authorized to take whatever action is appropriate to protect the Plan's rights throughout
the duration of the exemption and throughout the duration of any Loan granted pursuant to this exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00116 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Temporary Nature of Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The exemption, if granted, is temporary and will expire five years from the date of the publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of the Final Grant of the proposed exemption. Subsequent to the expiration of this exemption, the Plan may hold any
Loans originated during this five year period until the Loans are repaid or otherwise terminated. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Plan is defined contribution plan having 63 participants and total assets of $4,621,936 as of September 39,
1995. Richfield Bank &amp; Trust Company of Richfield, Minnesota serves as the Plan's trustee (the Trustee). 
<!-- PJG 0012 frnewline -->
2. The Employer is a closely held corporation engaged in the metal-stamping business. The shareholders of the Employer
are Fred P. Berdass and members of his family. In the regular course of its business, the Employer purchases equipment
for its operations. The Employer maintains its principal place of business in Circle Pines, Minnesota. 
<!-- PJG 0012 frnewline -->
3. The Department granted two previous exemptions (Prohibited Transaction Exemption (PTE) 82&hyph;9, 47 FR 2431,
January 15, 1982 and PTE 87&hyph;77, 52 FR 29905, August 12, 1987) to permit loans (the Exempt Loans) by the Plan to the
Employer. Under the terms of the exemption, the Plan could make loans on a recurring basis to the Employer for a period
of five years. The proceeds from the Exempt Loans were used by the Employer for the purchases of machinery and equipment.
Each Exempt Loan was collateralized by specific equipment and assets owned by the Employer. The maximum length of
any Exempt Loan was 48 months, and the interest rate was one percent above the prime rate. The balance on total Exempt
Loans did not exceed 25 percent of the fair market value of the Plan's assets. An independent fiduciary acted on behalf
of the Plan and certified that each Exempt Loan was an appropriate investment for the Plan. 
<!-- PJG 0012 frnewline -->
The Trustee has confirmed that all payments of principal Loans were received by the Trustee on a timely basis and each
Exempt Loan was paid in full in accordance with the terms of PTE 82&hyph;9 and PTE 87&hyph;77. 
<!-- PJG 0012 frnewline -->
4. The Plan now proposes to make a series of Loans over a five year period to the Employer. The proceeds from the Loans
will be used by the Employer to purchase the Equipment. Each Loan will be collateralized by a promissory note and security
agreement which provide the Plan with a first lien on the Equipment. In addition, the Loan will be collateralized by
specific equipment or assets which are owned by the Employer. At all times each Loan will be collateralized in an amount
at least equal to 200 percent of the outstanding balance of such loan. The amount of each Loan will not exceed 80% of the
purchase price of the Equipment excluding tax and transportation. In addition, Mr. Berdass will personally guarantee
each Loan. 
<!-- PJG 0012 frnewline -->
The maximum length of any Loan will be 48 months and will have an interest rate of at least one percent above the prevailing
prime rate of interest of the Trustee which is the prevailing interest rate earned on similar loans made by the Trustee
to unrelated third parties. The outstanding Loan balance will not exceed 25 percent of the market value of the assets
of the Plan. The Employer will adequately insure the Equipment and all other collateral against fire and all other
relevant hazards with the Plan being named beneficiary of the insurance. 
<!-- PJG 0012 frnewline -->
4. Lake Elmo Bank, of Lake Elmo, Minnesota (the Bank) will serve as the independent fiduciary with respect to the proposed
Loans. The Bank represents that it is qualified to act as an independent fiduciary with respect to the Loan transactions
and that is understands that its responsibility as an ERISA fiduciary. In addition, the Bank represents that it has
no pre-existing relationship with the Employer nor with Mr. Berdass, and that the income derived from the Employer
and related parties, including the income derived from serving in the capacity of independent fiduciary will not
exceed 1% of the Bank's gross income. 
<!-- PJG 0012 frnewline -->
5. In its capacity as independent fiduciary, the Bank represents that it will determine the appropriateness and suitability
of each Loan prior to the consummation of each Loan transaction. In this regard, the Bank will review the independent
appraisals of the Equipment and the assets pledged to secure the Loans and confirm the sufficiency of such appraisals.
The Bank states that the Loans are appropriate investments for the Plan and are in the best interests of the Plan's participants
and beneficiaries and are protective of their interests. The Bank further states that the terms of the Loans are at
least equal to terms available between the Plan and an unrelated third party. The Bank represents that it will enforce
the terms of the Loan including, but not limited to, making demand for timely payment, bringing suit or other appropriate
process against the Employer in the event of default and monitoring the performance of each Loan. In addition, the
Bank has examined Mr. Berdass's personal financial statements and is assured that as guarantor of the Loans, Mr. Berdass
will continue to have the financial stability to personally assure the repayment of all Loans granted pursuant to
the proposed exemption. 
<!-- PJG 0012 frnewline -->
6. In summary, the applicant represents that the proposed transaction meets the statutory criteria for an exemption
under section 408(a) of the Act because: (a) the rate of return to the Plan on the Loans will equal the prevailing rate
earned on similar loans made by the Trustee; (b) the Plan's interests with respect to the Loans will be represented
by an independent fiduciary who will monitor the Loans as well as the conditions of the exemption, and will take all
appropriate actions necessary to safeguard the best interests of the Plan; (c) the Plan's independent fiduciary
has reviewed the terms and conditions of the proposed exemption and has determined that the Loans are in the best interest
of the Plan's participants and beneficiaries; (d) The independent fiduciary will review and approve each Loan prior
to making any disbursements; (e) the Loans will at all times be secured by the Equipment and other assets of the Employer
which will be valued at not less than 200% of the Loan; (f) the aggregate balance of the outstanding loans will not exceed
25% of the value of the Plan's assets; and (g) the proposed exemption will be of a temporary nature, not to exceed five
years. 
<!-- PJG 0012 frnewline -->
For Further Information Contact: Allison K. Padams of the Department, telephone (202) 219&hyph;8971. (This is not
a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00117 </DOCNO>
<PARENT> FR941219-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
General Information 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The attention of interested persons is directed to the following: 
<!-- PJG 0012 frnewline -->
(1) The fact that a transaction is the subject of an exemption under section 408(a) of the Act and/or section 4975(c)(2)
of the Code does not relieve a fiduciary or other party in interest of disqualified person from certain other provisions
of the Act and/or the Code, including any prohibited transaction provisions to which the exemption does not apply
and the general fiduciary responsibility provisions of section 404 of the Act, which among other things require a
fiduciary to discharge his duties respecting the plan solely in the interest of the participants and beneficiaries
of the plan and in a prudent fashion in accordance with section 404(a)(1)(b) of the act; nor does it affect the requirement
of section 401(a) of the Code that the plan must operate for the exclusive benefit of the employees of the employer maintaining
the plan and their beneficiaries; 
<!-- PJG 0012 frnewline -->
(2) Before an exemption may be granted under section 408(a) of the Act and/or section 4975(c)(2) of the Code, the Department
must find that the exemption is administratively feasible, in the interests of the plan and of its participants and
beneficiaries and protective of the rights of participants and beneficiaries of the plan; 
<!-- PJG 0012 frnewline -->
(3) The proposed exemptions, if granted, will be supplemental to, and not in derogation of, any other provisions of
the Act and/or the Code, including statutory or administrative exemptions and transitional rules. Furthermore,
the fact that a transaction is subject to an administrative or statutory exemption is not dispositive of whether the
transaction is in fact a prohibited transaction; and 
<!-- PJG 0012 frnewline -->
(4) The proposed exemptions, if granted, will be subject to the express condition that the material facts and representations
contained in each application are true and complete, and that each application accurately describes all material
terms of the transaction which is the subject of the exemption.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, DC, this 14th day of December, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ivan Strasfeld, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director of Exemption Determinations, Pension and Welfare Benefits 
<!-- PJG 0012 frnewline -->
Administration, U.S. Department of Labor. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31086 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00118 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Prohibited Transaction Exemption 94&hyph;84; Exemption Application No. D&hyph;9801, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Grant of Individual Exemptions; Alex. Brown &amp; Sons, Incorporated, et al. </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pension and Welfare Benefits Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Grant of Individual Exemptions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document contains exemptions issued by the Department of Labor (the Department) from certain of the prohibited
transaction restrictions of the Employee Retirement Income Security Act of 1974 (the Act) and/or the Internal Revenue
Code of 1986 (the Code). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notices were published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of the pendency before the Department of proposals to grant such exemptions. The notices set forth a summary of facts
and representations contained in each application for exemption and referred interested persons to the respective
applications for a complete statement of the facts and representations. The applications have been available for
public inspection at the Department in Washington, D.C. The notices also invited interested persons to submit comments
on the requested exemptions to the Department. In addition the notices stated that any interested person might submit
a written request that a public 
<!-- PJG 0012 frnewline -->
hearing be held (where appropriate). The applicants have represented that they have complied with the requirements
of the notification to interested persons. No public comments and no requests for a hearing, unless otherwise stated,
were received by the Department. 
<!-- PJG 0012 frnewline -->
The notices of proposed exemption were issued and the exemptions are being granted solely by the Department because,
effective December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978 (43 FR 47713, October 17, 1978) transferred
the authority of the Secretary of the Treasury to issue exemptions of the type proposed to the Secretary of Labor. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Statutory Findings 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 408(a) of the Act and/or section 4975(c)(2) of the Code and the procedures set forth in 29
CFR Part 2570, Subpart B (55 FR 32836, 32847, August 10, 1990) and based upon the entire record, the Department makes
the following findings: 
<!-- PJG 0012 frnewline -->
(a) The exemptions are administratively feasible;
<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) They are in the interests of the plans and 
<!-- PJG 0012 frnewline -->
their participants and beneficiaries; and 
<!-- PJG /ITAG -->

<!-- PJG QTAG 01 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) They are protective of the rights of the 
<!-- PJG 0012 frnewline -->
participants and beneficiaries of the plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Alex. Brown &amp; Sons, Incorporated (ABS) Located in Baltimore, Maryland 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;84; Exemption Application No. D&hyph;9801] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
I. Transactions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Effective August 12, 1994, the restrictions of 
<!-- PJG 0012 frnewline -->
sections 406(a) and 407(a) of the Act and the taxes imposed by section 4975(a) and (b) of the Code by reason of section
4975(c)(1)(A) through (D) of the Code shall not apply to the following transactions involving trusts and certificates
evidencing interests therein: 
<!-- PJG 0012 frnewline -->
(1) The direct or indirect sale, exchange or transfer of certificates in the initial issuance of certificates between
the sponsor or underwriter and an employee benefit plan when the sponsor, servicer, trustee or insurer of a trust,
the underwriter of the certificates representing an interest in the trust, or an obligor is a party in interest with
respect to such plan; 
<!-- PJG 0012 frnewline -->
(2) The direct or indirect acquisition or disposition 
<!-- PJG 0012 frnewline -->
of certificates by a plan in the secondary market for such certificates; and 
<!-- PJG 0012 frnewline -->
(3) The continued holding of certificates acquired by a plan pursuant to subsection I.A.(1) or (2). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00119 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding the foregoing, section I.A. does not provide an exemption from the restrictions of sections 406(a)(1)(E),
406(a)(2) and 407 for the acquisition or holding of a certificate on behalf of an Excluded Plan by any person who has
discretionary authority or renders investment advice with respect to the assets of that Excluded Plan.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section I.A. provides no relief from sections 406(a)(1)(E), 406(a)(2) and 407 for any person rendering investment
advice to an Excluded Plan within the meaning of section 3(21)(A)(ii) and regulation 29 CFR 2510.3&hyph;21(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
B. Effective August 12, 1994, the restrictions of sections 406(b)(1) and 406(b)(2) of the Act and the taxes imposed
by section 4975 (a) and (b) of the Code by reason of section 4975(c)(1)(E) of the Code shall not apply to: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The direct or indirect sale, exchange or 
<!-- PJG 0012 frnewline -->
transfer of certificates in the initial issuance of certificates between the sponsor or underwriter and a plan when
the person who has discretionary authority or renders investment advice with respect to the investment of plan assets
in the certificates is (a) an obligor with respect to 5 percent or less of the fair market value of obligations or receivables
contained in the trust, or (b) an affiliate of a person described in (a); if: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) the plan is not an Excluded Plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) solely in the case of an acquisition of certificates in connection with the initial issuance of the certificates,
at least 50 percent of each class of certificates in which plans have invested is acquired by persons independent of
the members of the Restricted Group and at least 50 percent of the aggregate interest in the trust is acquired by persons
independent of the Restricted Group; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) a plan's investment in each class of certificates does not exceed 25 percent of all of the certificates of that
class outstanding at the time of the acquisition; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) immediately after the acquisition of the 
<!-- PJG 0012 frnewline -->
certificates, no more than 25 percent of the assets of a plan with respect to which the person has discretionary authority
or 
<!-- PJG 0012 frnewline -->
renders investment advice are invested in certificates 
<!-- PJG 0012 frnewline -->
representing an interest in a trust containing assets sold or 
<!-- PJG 0012 frnewline -->
serviced by the same entity.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For purposes of this paragraph B.(1)(iv) only, an entity will not be considered to service assets contained in a trust
if it is merely a subservicer of that trust; 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For purposes of this exemption, each plan participating in a commingled fund (such as a bank collective trust fund
or insurance company pooled separate account) shall be considered to own the same proportionate undivided interest
in each asset of the commingled fund as its proportionate interest in the total assets of the commingled fund as calculated
on the most recent preceding valuation date of the fund. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) The direct or indirect acquisition or disposition of certificates by a plan in the secondary market for such certificates,
provided that the conditions set forth in paragraphs B.(1) (i), (iii) and (iv) are met; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The continued holding of certificates acquired by a plan pursuant to subsection I.B. (1) or (2). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Effective August 12, 1994, the restrictions of sections 406(a), 406(b) and 407(a) of the Act, and the taxes imposed
by section 4975 (a) and (b) of the Code by reason of section 4975(c) of the Code, shall not apply to transactions in connection
with the servicing, management and operation of a trust, provided: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) such transactions are carried out in accordance 
<!-- PJG 0012 frnewline -->
with the terms of a binding pooling and servicing arrangement; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) the pooling and servicing agreement is provided 
<!-- PJG 0012 frnewline -->
to, or described in all material respects in the prospectus or private placement memorandum provided to, investing
plans before they purchase certificates issued by the trust.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In the case of a private placement memorandum, such memorandum must contain substantially the same information that
would be disclosed in a prospectus if the offering of the certificates were made in a registered public offering under
the Securities Act of 1933. In the Department's view, the private placement memorandum must contain sufficient information
to permit plan fiduciaries to make informed investment decisions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding the foregoing, section I.C. does not provide an exemption from the restrictions of section 406(b)
of the Act or from the taxes imposed by reason of section 4975(c) of the Code for the receipt of a fee by a servicer of the
trust from a person other than the trustee or sponsor, unless such fee constitutes a ``qualified administrative fee''
as defined in section III.S. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00120 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D. Effective August 12, 1994, the restrictions of sections 406(a) and 407(a) of the Act, and the taxes imposed by sections
4975(a) and (b) of the Code by reason of sections 4975(c)(1)(A) through (D) of the Code, shall not apply to any transactions
to which those restrictions or taxes would otherwise apply merely because a person is deemed to be a party in interest
or disqualified person (including a fiduciary) with respect to a plan by virtue of providing services to the plan (or
by virtue of having a relationship to such service provider described in section 3(14)(F), (G), (H) or (I) of the Act
or section 4975(e)(2)(F), (G), (H) or (I) of the Code), solely because of the plan's ownership of certificates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
II. General Conditions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. The relief provided under Part I is available only if the following conditions are met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The acquisition of certificates by a plan is on terms (including the certificate price) that are at least as favorable
to the plan as they would be in an arm's-length transaction with an unrelated party; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The rights and interests evidenced by the certificates are not subordinated to the rights and interests evidenced
by other certificates of the same trust; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The certificates acquired by the plan have received a rating at the time of such acquisition that is in one of the
three highest generic rating categories from either Standard &amp; Poor's Corporation (S&amp;P's), Moody's Investors
Service, Inc. (Moody's), Duff &amp; Phelps Inc. (D &amp; P) or Fitch Investors Service, Inc. (Fitch); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The trustee is not an affiliate of any member of the Restricted Group. However, the trustee shall not be considered
to be an affiliate of a servicer solely because the trustee has succeeded to the rights and responsibilities of the
servicer pursuant to the terms of a pooling and servicing agreement providing for such succession upon the occurrence
of one or more events of default by the servicer; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) The sum of all payments made to and retained by the underwriters in connection with the distribution or placement
of certificates represents not more than reasonable compensation for underwriting or placing the certificates;
the sum of all payments made to and retained by the sponsor pursuant to the assignment of obligations (or interests
therein) to the trust represents not more than the fair market value of such obligations (or interests); and the sum
of all payments made to and retained by the servicer represents not more than reasonable compensation for the servicer's
services under the pooling and servicing agreement and reimbursement of the servicer's reasonable expenses in connection
therewith; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) The plan investing in such certificates is an ``accredited investor'' as defined in Rule 501(a)(1) of 
<!-- PJG 0012 frnewline -->
Regulation D of the Securities and Exchange Commission under the Securities Act of 1933. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Neither any underwriter, sponsor, trustee, servicer, 
<!-- PJG 0012 frnewline -->
insurer, or any obligor, unless it or any of its affiliates has discretionary authority or renders investment advice
with respect to the plan assets used by a plan to acquire certificates, shall be denied the relief provided under Part
I, if the provision of subsection II.A.(6) above is not satisfied with respect to acquisition or holding by a plan of
such certificates, provided that (1) such condition is disclosed in the prospectus or private placement memorandum;
and (2) in the case of a private placement of certificates, the trustee obtains a representation from each initial
purchaser which is a plan that it is in compliance with such condition, and obtains a covenant from each initial purchaser
to the effect that, so long as such initial purchaser (or any transferee of such initial purchaser's certificates)
is required to obtain from its transferee a representation regarding compliance with the Securities Act of 1933,
any such transferees 
<!-- PJG 0012 frnewline -->
will be required to make a written representation regarding compliance with the condition set forth in subsection
II.A.(6) above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
III. Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this exemption: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. ``Certificate'' means: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) a certificate_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) that represents a beneficial ownership 
<!-- PJG 0012 frnewline -->
interest in the assets of a trust; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) that entitles the holder to pass-through 
<!-- PJG 0012 frnewline -->
payments of principal, interest, and/or other payments made with respect to the assets of such trust; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) a certificate denominated as a debt instrument_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) that represents an interest in a Real Estate Mortgage Investment Conduit (REMIC) within the meaning of section
860D(a) of the Internal Revenue Code of 1986; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) that is issued by and is an obligation of a trust; 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
with respect to certificates defined in (1) and (2) above for which ABS or any of its affiliates is either (i) the sole
underwriter or the manager or co-manager of the underwriting syndicate, or (ii) a selling or placement agent. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this exemption, references to ``certificates representing an interest in a trust'' include certificates
denominated as debt which are issued by a trust. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. ``Trust'' means an investment pool, the corpus of which is held in trust and consists solely of: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) either 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) secured consumer receivables that bear 
<!-- PJG 0012 frnewline -->
interest or are purchased at a discount (including, but not 
<!-- PJG 0012 frnewline -->
limited to, home equity loans and obligations secured by shares issued by a cooperative housing association); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00121 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) secured credit instruments that bear interest 
<!-- PJG 0012 frnewline -->
or are purchased at a discount in transactions by or between business entities (including, but not limited to, qualified
equipment notes secured by leases, as defined in section III.T); 
<!-- PJG 0012 frnewline -->
(c) obligations that bear interest or are 
<!-- PJG 0012 frnewline -->
purchased at a discount and which are secured by single-family residential, multi-family residential and commercial
real property (including obligations secured by leasehold interests on commercial real property); 
<!-- PJG 0012 frnewline -->
(d) obligations that bear interest or are 
<!-- PJG 0012 frnewline -->
purchased at a discount and which are secured by motor vehicles or equipment, or qualified motor vehicle leases (as
defined in section III.U); 
<!-- PJG 0012 frnewline -->
(e) ``guaranteed governmental mortgage pool 
<!-- PJG 0012 frnewline -->
certificates,'' as defined in 29 CFR 2510.3&hyph;101(i)(2); 
<!-- PJG 0012 frnewline -->
(f) fractional undivided interests in any of the 
<!-- PJG 0012 frnewline -->
obligations described in clauses (a)-(e) of this section B.(1); 
<!-- PJG 0012 frnewline -->
(2) property which had secured any of the obligations 
<!-- PJG 0012 frnewline -->
described in subsection B.(1); 
<!-- PJG 0012 frnewline -->
(3) undistributed cash or temporary investments made 
<!-- PJG 0012 frnewline -->
therewith maturing no later than the next date on which distributions are to be made to certificateholders; and 
<!-- PJG 0012 frnewline -->
(4) rights of the trustee under the pooling and 
<!-- PJG 0012 frnewline -->
servicing agreement, and rights under any insurance policies, third-party guarantees, contracts of suretyship
and other credit support arrangements with respect to any obligations described in subsection B.(1). 
<!-- PJG 0012 frnewline -->
Notwithstanding the foregoing, the term ``trust'' does not include any investment pool unless: (i) the investment
pool consists only of assets of the type which have been included in other investment pools, (ii) certificates evidencing
interests in such other investment pools have been rated in one of the three highest generic rating categories by S&amp;P's,
Moody's, D &amp; P, or Fitch for at least one year prior to the plan's acquisition of certificates pursuant to this exemption,
and (iii) certificates evidencing interests in such other investment pools have been purchased by investors other
than plans for at least one year prior to the plan's acquisition of certificates pursuant to this exemption. 
<!-- PJG 0012 frnewline -->
C. ``Underwriter'' means: 
<!-- PJG 0012 frnewline -->
(1) ABS; 
<!-- PJG 0012 frnewline -->
(2) any person directly or indirectly, through one or 
<!-- PJG 0012 frnewline -->
more intermediaries, controlling, controlled by or under common control with ABS; or 
<!-- PJG 0012 frnewline -->
(3) any member of an underwriting syndicate or selling 
<!-- PJG 0012 frnewline -->
group of which ABS or a person described in (2) is a manager or co-manager with respect to the certificates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. ``Sponsor'' means the entity that organizes a trust by depositing obligations therein in exchange for certificates.

<!-- PJG 0012 frnewline -->
E. ``Master Servicer'' means the entity that is a party to the pooling and servicing agreement relating to trust assets
and is fully responsible for servicing, directly or through subservicers, the assets of the trust. 
<!-- PJG 0012 frnewline -->
F. ``Subservicer'' means an entity which, under the supervision of and on behalf of the master servicer, services
loans contained in the trust, but is not a party to the pooling and servicing agreement. 
<!-- PJG 0012 frnewline -->
G. ``Servicer'' means any entity which services loans contained in the trust, including the master servicer and any
subservicer. 
<!-- PJG 0012 frnewline -->
H. ``Trustee'' means the trustee of the trust, and in the case of certificates which are denominated as debt instruments,
also means the trustee of the indenture trust. 
<!-- PJG 0012 frnewline -->
I. ``Insurer'' means the insurer or guarantor of, or 
<!-- PJG 0012 frnewline -->
provider of other credit support for, a trust. Notwithstanding the foregoing, a person is not an insurer solely because
it holds securities representing an interest in a trust which are of a class subordinated to certificates representing
an interest in the same trust. 
<!-- PJG 0012 frnewline -->
J. ``Obligor'' means any person, other than the insurer, that is obligated to make payments with respect to any obligation
or receivable included in the trust. Where a trust contains qualified motor vehicle leases or qualified equipment
notes secured by leases, ``obligor'' shall also include any owner of property subject to any lease included in the
trust, or subject to any lease securing an obligation included in the trust. 
<!-- PJG 0012 frnewline -->
K. ``Excluded Plan'' means any plan with respect to which any member of the Restricted Group is a ``plan sponsor'' within
the meaning of section 3(16)(B) of the Act. 
<!-- PJG 0012 frnewline -->
L. ``Restricted Group'' with respect to a class of certificates means: 
<!-- PJG 0012 frnewline -->
(1) each underwriter; 
<!-- PJG 0012 frnewline -->
(2) each insurer; 
<!-- PJG 0012 frnewline -->
(3) the sponsor; 
<!-- PJG 0012 frnewline -->
(4) the trustee; 
<!-- PJG 0012 frnewline -->
(5) each servicer; 
<!-- PJG 0012 frnewline -->
(6) any obligor with respect to obligations or receivables included in the trust constituting more than 5 percent
of the aggregate unamortized principal balance of the assets in the trust, determined on the date of the initial issuance
of certificates by the trust; or 
<!-- PJG 0012 frnewline -->
(7) any affiliate of a person described in (1)&hyph;(6) 
<!-- PJG 0012 frnewline -->
above. 
<!-- PJG 0012 frnewline -->
M. ``Affiliate'' of another person includes: 
<!-- PJG 0012 frnewline -->
(1) Any person directly or indirectly, through one 
<!-- PJG 0012 frnewline -->
or more intermediaries, controlling, controlled by, or under common control with such other person; 
<!-- PJG 0012 frnewline -->
(2) Any officer, director, partner, employee, 
<!-- PJG 0012 frnewline -->
relative (as defined in section 3(15) of the Act), a brother, a 
<!-- PJG 0012 frnewline -->
sister, or a spouse of a brother or sister of such other 
<!-- PJG 0012 frnewline -->
person; and 
<!-- PJG 0012 frnewline -->
(3) Any corporation or partnership of which such 
<!-- PJG 0012 frnewline -->
other person is an officer, director or partner. 
<!-- PJG 0012 frnewline -->
N. ``Control'' means the power to exercise a controlling 
<!-- PJG 0012 frnewline -->
influence over the management or policies of a person other than 
<!-- PJG 0012 frnewline -->
an individual. 
<!-- PJG 0012 frnewline -->
O. A person will be ``independent'' of another person only 
<!-- PJG 0012 frnewline -->
if: 
<!-- PJG 0012 frnewline -->
(1) such person is not an affiliate of that other 
<!-- PJG 0012 frnewline -->
person; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00122 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) the other person, or an affiliate thereof, is not a fiduciary who has investment management authority or renders

<!-- PJG 0012 frnewline -->
investment advice with respect to any assets of such person. 
<!-- PJG 0012 frnewline -->
P. ``Sale'' includes the entrance into a forward delivery 
<!-- PJG 0012 frnewline -->
commitment (as defined in section Q below), provided: 
<!-- PJG 0012 frnewline -->
(1) The terms of the forward delivery commitment 
<!-- PJG 0012 frnewline -->
(including any fee paid to the investing plan) are no less favorable to the plan than they would be in an arm's length
transaction with an unrelated party; 
<!-- PJG 0012 frnewline -->
(2) The prospectus or private placement memorandum is provided to an investing plan prior to the time the plan enters

<!-- PJG 0012 frnewline -->
into the forward delivery commitment; and 
<!-- PJG 0012 frnewline -->
(3) At the time of the delivery, all conditions of 
<!-- PJG 0012 frnewline -->
this exemption applicable to sales are met. 
<!-- PJG 0012 frnewline -->
Q. ``Forward delivery commitment'' means a contract for the 
<!-- PJG 0012 frnewline -->
purchase or sale of one or more certificates to be delivered at an agreed future settlement date. The term includes
both mandatory contracts (which contemplate obligatory delivery and acceptance of the certificates) and optional
contracts (which give one party the right but not the obligation to deliver certificates to, or demand delivery of
certificates from, the other party). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
R. ``Reasonable compensation'' has the same meaning as that 
<!-- PJG 0012 frnewline -->
term is defined in 29 CFR 2550.408c-2. 
<!-- PJG 0012 frnewline -->
S. ``Qualified Administrative Fee'' means a fee which meets 
<!-- PJG 0012 frnewline -->
the following criteria: 
<!-- PJG 0012 frnewline -->
(1) the fee is triggered by an act or failure to act 
<!-- PJG 0012 frnewline -->
by the obligor other than the normal timely payment of amounts 
<!-- PJG 0012 frnewline -->
owing in respect of the obligations; 
<!-- PJG 0012 frnewline -->
(2) the servicer may not charge the fee absent the act 
<!-- PJG 0012 frnewline -->
or failure to act referred to in (1); 
<!-- PJG 0012 frnewline -->
(3) the ability to charge the fee, the circumstances 
<!-- PJG 0012 frnewline -->
in which the fee may be charged, and an explanation of how the fee is calculated are set forth in the pooling and servicing
agreement; and 
<!-- PJG 0012 frnewline -->
(4) the amount paid to investors in the trust will 
<!-- PJG 0012 frnewline -->
not be reduced by the amount of any such fee waived by the servicer. 
<!-- PJG 0012 frnewline -->
T. ``Qualified Equipment Note Secured By A Lease'' means an 
<!-- PJG 0012 frnewline -->
equipment note: 
<!-- PJG 0012 frnewline -->
(1) which is secured by equipment which is leased; 
<!-- PJG 0012 frnewline -->
(2) which is secured by the obligation of the lessee 
<!-- PJG 0012 frnewline -->
to pay rent under the equipment lease; and 
<!-- PJG 0012 frnewline -->
(3) with respect to which the trust's security 
<!-- PJG 0012 frnewline -->
interest in the equipment is at least as protective of the rights of the trust as the trust would have if the equipment
note were secured only by the equipment and not the lease. 
<!-- PJG 0012 frnewline -->
U. ``Qualified Motor Vehicle Lease'' means a lease of a motor vehicle where: 
<!-- PJG 0012 frnewline -->
(1) the trust holds a security interest in the lease; 
<!-- PJG 0012 frnewline -->
(2) the trust holds a security interest in the leased 
<!-- PJG 0012 frnewline -->
motor vehicle; and 
<!-- PJG 0012 frnewline -->
(3) the trust's security interest in the leased motor 
<!-- PJG 0012 frnewline -->
vehicle is at least as protective of the trust's rights as the trust would receive under a motor vehicle installment
loan contract. 
<!-- PJG 0012 frnewline -->
V. ``Pooling and Servicing Agreement'' means the agreement or agreements among a sponsor, a servicer and the trustee
establishing a trust. In the case of certificates which are denominated as debt instruments, ``Pooling and Servicing
Agreement'' also includes the indenture entered into by the trustee of the trust issuing such certificates and the
indenture trustee. 
<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on October 25, 1994 at 59 FR 53674.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This exemption is effective for transactions occurring on or after August 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Gary Lefkowitz of the Department, telephone (202) 219&hyph;8881. (This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00123 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
The Masters, Mates and Pilots Pension Plan (The Pension Plan) and Individual Retirement Account Plan (the IRAP; together,
the Plans) Located in Linthicum Heights, Maryland 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;85; Exemption Application Nos. D&hyph;9618 and D&hyph;9619] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The restrictions of sections 406(a), 406(b)(1) and (b)(2) and 407(a) of the Act and the sanctions resulting from the
application of section 4975 of the Code, by reason of section 4975(c)(1)(A) through (E) of the Code, shall not apply
to the continued holding by the Plans of their shares of stock (the Stock) in American Heavy Lift Shipping Company,
provided that: 
<!-- PJG 0012 frnewline -->
(a) the Plans' independent fiduciary has determined that the Plans' holding of the Stock is appropriate for the Plans
and in the best interests of the Plans' participants and beneficiaries; and (b) the Plans' independent fiduciary
continues to monitor the Plans' holding of the Stock and determines at all times that such transaction remains in the
best interests of the Plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on October 25, 1994 at 59 FR 53682.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
TEMPORARY NATURE OF EXEMPTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This exemption is effective until the later of: (1) December 31, 1995, or (2) December 31, 1996 provided another application
for exemption is filed with the Department prior to December 31, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Gary H. Lefkowitz of the 
<!-- PJG 0012 frnewline -->
Department, telephone (202) 219&hyph;8881. (This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00124 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Bank of California, N.A.; Located in San Francisco, California 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;86; 
<!-- PJG 0012 frnewline -->
Exemption Application No. D&hyph;9240] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Section I_Exemption for In-Kind Transfer of Assets 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The restrictions of section 406(a) and section 406(b) of the Act and the sanctions resulting from the application
of section 4975 of the Code by reason of section 4975(c)(1) (A) through (F) shall not apply, effective November 12,
1993, to the in-kind transfer to any diversified open-end investment company (the Fund or Funds) registered under
the Investment Company Act of 1940 to which the Bank of California, N.A. or any of its affiliates (collectively, the
Bank) serves as investment adviser and may provide other services of the assets of various employee benefit plans
(the Plan or Plans) that are either held in certain collective investment funds (the CIF or CIFs) maintained by the
Bank or otherwise held by the Bank as trustee, investment manager, or in any other capacity as fiduciary on behalf of
the Plans, in exchange for shares of such Funds; provided that the following conditions are met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) A fiduciary (the Second Fiduciary) who is acting on behalf of each affected Plan and who is independent of and unrelated
to the Bank, as defined in paragraph (g) of section III below, receives advance written notice of the in-kind transfer
of assets of the Plans or the CIFs in exchange for shares of the Fund and the disclosures described in paragraph (g) of
section II below; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) On the basis of the information described in paragraph (g) of section II below, the Second Fiduciary authorizes
in writing the in-kind transfer of assets of the Plans in exchange for shares of the Funds, the investment of such assets
in corresponding portfolios of the Funds, and the fees received by the Bank in connection with its services to the Fund.
Such authorization by the Second Fiduciary to be consistent with the responsibilities, obligations, and duties
imposed on fiduciaries by Part 4 of Title I of the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) No sales commissions are paid by the Plans in connection with the in-kind transfers of asset of the Plans or the CIFs
in exchange for shares of the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) All or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of the assets of the Plans held in the CIFs or all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of the assets of the Plans held by the Bank in any capacities as fiduciary on behalf of such Plans are transferred
in-kind to the Funds in exchange for shares of such Funds, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The Plans or the CIFs receive shares of the Funds that have a total net asset value equal in value to the assets of the
Plans or the CIFs exchanged for such shares on the date of transfer; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) The current market value of the assets of the Plans or the CIFs to be transferred in-kind in exchange for shares is
determined in a single valuation performed in the same manner and at the close of business on the same day, using independent
sources in accordance with the procedures set forth in Rule 17a&hyph;7(b) (Rule 17a&hyph;7) under the Investment
Company Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement, and
the procedures established by the Funds pursuant to Rule 17a&hyph;7 for the valuation of such assets. Such procedures
must require that all securities for which a current market price cannot be obtained by reference to the last sale price
for transactions reported on a recognized securities exchange or NASDAQ be valued based on an average of the highest
current independent bid and lowest current independent offer, as of the close of business on the Friday preceding
the weekend of the Plan or CIF transfers determined on the basis of reasonable inquiry from at least three sources that
are broker-dealers or pricing services independent of the Bank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) Not later than thirty (30) days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange
for shares of the Funds, the Bank sends by regular mail to the Second Fiduciary, who is acting on behalf of each affected
Plan and who is independent of and unrelated to the Bank, as defined in paragraph (g) of section III below, a written
confirmation that contains the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) the identity of each of the assets that was valued for purposes of the transaction in accordance with Rule 17a&hyph;7(b)(4)
under the Investment Company Act of 1940; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00125 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) the price of each of the assets involved in the transaction; and 
<!-- PJG 0012 frnewline -->
(3) the identity of each pricing service or market maker consulted in determining the value of such assets; and 
<!-- PJG 0012 frnewline -->
(h) For all conversion transactions that occur after the date of this exemption, the Bank, no later than ninety (90)
days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange for shares of the Funds,
will send by regular mail to the Second Fiduciary, who is acting on behalf of each affected Plan and who is independent
of and unrelated to the Bank, as defined in paragraph (g) of section III below, a written confirmation that contains
the following information: 
<!-- PJG 0012 frnewline -->
(1) the number of CIF units held by each affected Plan immediately before the conversion (and the related per unit value
or the aggregate dollar value of the units transferred); and 
<!-- PJG 0012 frnewline -->
(2) the number of shares in the Funds that are held by each affected Plan following the conversion (and the related per
share net asset value or the aggregate dollar value of the shares received). 
<!-- PJG 0012 frnewline -->
(i) The conditions set forth in paragraphs (d), (e), (f), (o), (p), (q) and (r) of section II below are satisfied; 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Section II_Exemption for Receipt of Fees From Funds 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the exemption is granted, effective November 12, 1993, the restrictions of section 406(a) and section 406(b) of
the Act and the sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1)
(A) through (F) of the Code shall not apply to the receipt of fees by the Bank from the Funds for acting as the investment
adviser, custodian, sub-administrator, and other service provider for the Funds in connection with the investment
in the Funds by the Plans for which the Bank acts as a fiduciary provided that: 
<!-- PJG 0012 frnewline -->
(a) No sales commissions are paid by the Plans in connection with purchases or sales of shares of the Funds and no redemption
fees are paid in connection with the sale of such shares by the Plans to the Funds; 
<!-- PJG 0012 frnewline -->
(b) The price paid or received by the Plans for shares in the Funds is the net asset value per share, as defined in paragraph
(e) of section III, at the time of the transaction and is the same price which would have been paid or received for the
shares by any other investor at that time; 
<!-- PJG 0012 frnewline -->
(c) The Bank, its affiliates, and officers or directors have not and will not purchase from or sell to any of the Plans
shares of any of the Funds; 
<!-- PJG 0012 frnewline -->
(d) The combined total of all fees received by the Bank for the provision of services to the Plans, and in connection
with the provision of services to any of the Funds in which the Plans may invest, are not in excess of ``reasonable compensation''
within the meaning of section 408(b)(2) of the Act; 
<!-- PJG 0012 frnewline -->
(e) The Bank does not receive any fees payable, pursuant to Rule 12b&hyph;1 under the Investment Company Act of 1940
(the 12b&hyph;1 Fees) in connection with the transactions; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00126 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(f) The Plans are not sponsored by the Bank; 
<!-- PJG 0012 frnewline -->
(g) A Second Fiduciary who is acting on behalf of a Plan and who is independent of and unrelated to the Bank, as defined
in paragraph (g) of section III below, receives in advance of the investment by a Plan in any of the Funds a full and detailed
written disclosure of information concerning such Fund including, but not limited to: 
<!-- PJG 0012 frnewline -->
(1) a current prospectus for each portfolio of each of the Funds in which such Plan is considering investing, 
<!-- PJG 0012 frnewline -->
(2) a statement describing the fees for investment management, investment advisory, or other similar services,
any fees for secondary services (Secondary Services), as defined in paragraph (h) of section III below, and all other
fees to be charged to or paid by the Plan and by such Funds to the Bank, including the nature and extent of any differential
between the rates of such fees, 
<!-- PJG 0012 frnewline -->
(3) the reasons why the Bank may consider such investment to be appropriate for the Plan, 
<!-- PJG 0012 frnewline -->
(4) a statement describing whether there are any limitations applicable to the Bank with respect to which assets of
a Plan may be invested in the Funds, and, if so, the nature of such limitations; and 
<!-- PJG 0012 frnewline -->
(5) upon request of the Second Fiduciary, a copy of the proposed exemption and/or a copy of the final exemption. 
<!-- PJG 0012 frnewline -->
(h) On the basis of the information described in paragraph (g) of this section II, the Second Fiduciary authorizes
in writing: (1) The investment of assets of the Plans in shares of the Fund, in connection with the transaction set forth
in section II; (2) the investment portfolios of the Funds in which the assets of the Plans may be invested; and (3) the
fees received by the Bank in connection with its services to the Funds; such authorization by the Second Fiduciary
to be consistent with the responsibilities, obligations, and duties imposed on fiduciaries by Part 4 of Title I of
the Act; 
<!-- PJG 0012 frnewline -->
(i) The authorization, described in paragraph (h) of this section II, is terminable at will by the Second Fiduciary
of a Plan, without penalty to such Plan. Such termination will be effected by the Bank selling the shares of the Fund
held by the affected Plan within one business day following receipt by the Bank, either by mail, hand delivery, facsimile,
or other available means at the option of the Second Fiduciary, of the termination form (the Termination Form), as
defined in paragraph (i) of section III below, or any other written notice of termination; provided that if, due to
circumstances beyond the control of the Bank, the sale cannot be executed within one business day, the Bank shall have
one additional business day to complete such sale; 
<!-- PJG 0012 frnewline -->
(j) Plans do not pay any plan-level investment management fees, investment advisory fees, or similar fees to the Bank
with respect to any of the assets of such Plans which are invested in shares of any of the Funds. This condition does not
preclude the payment of investment advisory fees or similar fees by the Funds to the Bank under the terms of an investment
advisory agreement adopted in accordance with section 15 of the Investment Company Act of 1940 or other agreement
between the Bank and the Funds; 
<!-- PJG 0012 frnewline -->
(k) In the event of an increase in the rate of any fees paid by the Funds to the Bank regarding any investment management
services, investment advisory services, or fees for similar services that the Bank provides to the Funds over an existing
rate for such services that had been authorized by a Second Fiduciary, in accordance with paragraph (h) of this section
II, the Bank will, at least thirty (30) days in advance of the implementation of such increase, provide a written notice
(which may take the form of a proxy statement, letter, or similar communication that is separate from the prospectus
of the Fund and which explains the nature and amount of the increase in fees) to the Second Fiduciary of each of the Plans
invested in a Fund which is increasing such fees. Such notice shall be accompanied by the Termination Form, as defined
in paragraph (i) of section III below; 
<!-- PJG 0012 frnewline -->
(l) In the event of an addition of a Secondary Service, as defined in paragraph (h) of section III below, provided by
the Bank to the Fund for which a fee is charged or an increase in the rate of any fee paid by the Funds to the Bank for any Secondary
Service, as defined in paragraph (h) of section III below, that results either from an increase in the rate of such fee
or from the decrease in the number or kind of services performed by the Bank for such fee over an existing rate for such
Secondary Service which had been authorized by the Second Fiduciary of a Plan, in accordance with paragraph (h) of
this section II, the Bank will at least thirty (30) days in advance of the implementation of such additional service
for which a fee is charged or fee increase, provide a written notice (which may take the form of a proxy statement, letter,
or similar communication that is separate from the prospectus of the Fund and which explains the nature and amount
of the additional service for which a fee is charged or the nature and amount of the increase in fees) to the Second Fiduciary
of each of the Plans invested in a Fund which is adding a service or increasing fees. Such notice shall be accompanied
by the Termination Form, as defined in paragraph (i) of section III below. 
<!-- PJG 0012 frnewline -->
(m) The Second Fiduciary is supplied with a Termination Form at the times specified in paragraphs (k), (l), and (n)
of this section II, which expressly provides an election to terminate the authorization, described above in paragraph
(h) of this section II, with instructions regarding the use of such Termination Form including statements that: 
<!-- PJG 0012 frnewline -->
(1) the authorization is terminable at will by any of the Plans, without penalty to such Plans. Such termination will
be effected by the Bank selling the shares of the Fund held by the Plans requesting termination within one business
day following receipt by the Bank, either by mail, hand delivery, facsimile, or other available means at the option
of the Second Fiduciary, of the Termination Form or any other written notice of termination; provided that if, due
to circumstances beyond the control of the Bank, the sale of shares of such Plans cannot be executed within one business
day, the Bank shall have one additional business day to complete such sale; and 
<!-- PJG 0012 frnewline -->
(2) failure by the Second Fiduciary to return the Termination Form on behalf of a Plan will be deemed to be an approval
of the additional Secondary Service for which a fee is charged or increase in the rate of any fees, if such Termination
Form is supplied pursuant to paragraphs (k) and (l) of this section II, and will result in the continuation of the authorization,
as described in paragraph (h) of this section II, of the Bank to engage in the transactions on behalf of such Plan; 
<!-- PJG 0012 frnewline -->
(n) The Second Fiduciary is supplied with a Termination Form, annually during the first quarter of each calendar year,
beginning with the first quarter of the calendar year that begins after the date the grant of this exemption is published
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and continuing for each calendar year thereafter; provided that the Termination Form need not be supplied to the Second
Fiduciary, pursuant to paragraph (n) of this section II, sooner than six months after such Termination Form is supplied
pursuant to paragraphs (k) and (l) of this section II, except to the extent required by said paragraphs (k) and (l) of
this section II to disclose an additional Secondary Service for which a fee is charged or an increase in fees; 
<!-- PJG 0012 frnewline -->
(o)(1) With respect to each of the Funds in which a Plan invests, the Bank will provide the Second Fiduciary of such Plan:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00127 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(A) at least annually with a copy of an updated prospectus of such Fund; 
<!-- PJG 0012 frnewline -->
(B) upon the request of such Second Fiduciary, with a report or statement (which may take the form of the most recent
financial report, the current statement of additional information, or some other written statement) which contains
a description of all fees paid by the Fund to the Bank; and 
<!-- PJG 0012 frnewline -->
(2) With respect to each of the Funds in which a Plan invests, in the event such Fund places brokerage transactions with
the Bank, the Bank will provide the Second Fiduciary of such Plan at least annually with a statement specifying: 
<!-- PJG 0012 frnewline -->
(A) the total, expressed in dollars, brokerage commissions of each Fund's investment portfolio that are paid to the
Bank by such Fund; 
<!-- PJG 0012 frnewline -->
(B) the total, expressed in dollars, of brokerage commissions of each Fund's investment portfolio that are paid by
such Fund to brokerage firms unrelated to the Bank; 
<!-- PJG 0012 frnewline -->
(C) the average brokerage commissions per share, expressed as cents per share, paid to the Bank by each portfolio of
a Fund; and 
<!-- PJG 0012 frnewline -->
(D) the average brokerage commissions per share, expressed as cents per share, paid by each portfolio of a Fund to brokerage
firms unrelated to the Bank; 
<!-- PJG 0012 frnewline -->
(p) All dealings between the Plans and any of the Funds are on a basis no less favorable to such Plans than dealings between
the Funds and other shareholders holding the same class of shares as the Plans; 
<!-- PJG 0012 frnewline -->
(q) The Bank maintains for a period of six (6) years the records necessary to enable the persons, as described in paragraph
(r) of section II below, to determine whether the conditions of this exemption have been met, except that: 
<!-- PJG 0012 frnewline -->
(1) a prohibited transaction will not be considered to have occurred if, due to circumstances beyond the control of
the Bank, the records are lost or destroyed prior to the end of the six (6) year period, and 
<!-- PJG 0012 frnewline -->
(2) no party in interest, other than the Bank, shall be subject to the civil penalty that may be assessed under section
502(i) of the Act, or to the taxes imposed by section 4975(a) and (b) of the Code, if the records are not maintained, or
are not available for examination as required by paragraph (r) of section II below; 
<!-- PJG 0012 frnewline -->
(r)(1) Except as provided in paragraph (r)(2) of this section II and notwithstanding any provisions of subsection
(a)(2) and (b) of section 504 of the Act, the records referred to in paragraph (q) of section II above are unconditionally
available at their customary location for examination during normal business hours by_
<!-- PJG 0012 frnewline -->
(i) Any duly authorized employee or representative of the Department or the Internal Revenue Service; 
<!-- PJG 0012 frnewline -->
(ii) Any fiduciary of each of the Plans who has authority to acquire or dispose of shares of any of the Funds owned by such
a Plan, or any duly authorized employee or representative of such fiduciary; and 
<!-- PJG 0012 frnewline -->
(iii) Any participant or beneficiary of the Plans or duly authorized employee or representative of such participant
or beneficiary; 
<!-- PJG 0012 frnewline -->
(2) None of the persons described in paragraph (r)(1)(ii) and (r)(1)(iii) of section II shall be authorized to examine
trade secrets of the Bank, or commercial or financial information which is privileged or confidential. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Section III_Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this exemption, 
<!-- PJG 0012 frnewline -->
(a) The term ``Bank'' means The Bank of California, N.A. and any affiliate of the Bank, as defined in paragraph (b) of
this section III. 
<!-- PJG 0012 frnewline -->
(b) An ``affiliate'' of a person includes: 
<!-- PJG 0012 frnewline -->
(1) Any person directly or indirectly through one or more intermediaries, controlling, controlled by, or under common
control with the person; 
<!-- PJG 0012 frnewline -->
(2) any officer, director, employee, relative, or partner in any such person; and 
<!-- PJG 0012 frnewline -->
(3) Any corporation or partnership of which such person is an officer, director, partner, or employee. 
<!-- PJG 0012 frnewline -->
(c) The term ``control'' means the power to exercise a controlling influence over the management or policies of a person
other than an individual; 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00128 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) The term ``Fund or Funds'' means any diversified open-end investment company or companies registered under the
Investment Company Act of 1940 for which the Bank serves as investment adviser, and may also provide custodial or other
services as approved by such Funds; 
<!-- PJG 0012 frnewline -->
(e) The term, ``net asset value'' means the amount for purposes of pricing all purchases and sales calculated by dividing
the value of all securities, determined by a method as set forth in a Fund's prospectus and statement of additional
information, and other assets belonging to each of the portfolios in such Fund, less the liabilities charged to each
portfolio, by the number of outstanding shares. 
<!-- PJG 0012 frnewline -->
(f) The term, ``relative,'' means a ``relative'' as that term is defined in section 3(15) of the Act (or a ``member of
the family'' as that term is defined in section 4975(e)(6) of the Code), or a brother, a sister, or a spouse of a brother
or a sister. 
<!-- PJG 0012 frnewline -->
(g) The term, ``Second Fiduciary,'' means a fiduciary of a plan who is independent of and unrelated to the Bank. For
purposes of this exemption, the Second Fiduciary will not be deemed to be independent of and unrelated to the Bank if:

<!-- PJG 0012 frnewline -->
(1) Such Second Fiduciary directly or indirectly controls, is controlled by, or is under common control with the Bank;

<!-- PJG 0012 frnewline -->
(2) Such Second Fiduciary, or any officer, director, partner, employee, or relative of such Second Fiduciary is an
officer, director, partner, or employee of the Bank (or is a relative of such persons); 
<!-- PJG 0012 frnewline -->
(3) Such Second Fiduciary directly or indirectly receives any compensation or other consideration for his or her
own personal account in connection with any transaction described in this exemption. 
<!-- PJG 0012 frnewline -->
If an officer, director, partner, or employee of the Bank (or a relative of such persons), is a director of such Second
Fiduciary, and if he or she abstains from participation in (i) the choice of the Plan's investment manager/advisor,
(ii) the approval of any purchase or sale by the Plan of shares of the Funds, and (iii) the approval of any change of fees
charged to or paid by the Plan, in connection with any of the transactions described in sections I and II above, then
paragraph (g)(2) of section III above, shall not apply. 
<!-- PJG 0012 frnewline -->
(h) The term, ``Secondary Service,'' means a service, other than an investment management, investment advisory,
or similar service, which is provided by the Bank to the Funds, including but not limited to custodial, accounting,
brokerage, administrative, or any other service. 
<!-- PJG 0012 frnewline -->
(i) The term, ``Termination Form,'' means the form supplied to the Second Fiduciary, at the times specified in paragraphs
(k), (l), and (n) of section II above, which expressly provides an election to the Second Fiduciary to terminate on
behalf of the Plans the authorization, described in paragraph (h) of section II. Such Termination Form may be used
at will by the Second Fiduciary to terminate such authorization without penalty to the Plans and to notify the Bank
in writing to effect such termination by selling the shares of the Fund held by the Plans requesting termination within
one business day following receipt by the Bank, either by mail, hand delivery, facsimile, or other available means
at the option of the Second Fiduciary, of written notice of such request for termination; provided that if, due to circumstances
beyond the control of the Bank, the sale cannot be executed within one business day, the Bank shall have one additional
business day to complete such sale.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The exemption is effective retroactively, as of November 12, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Written Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the Notice of Proposed Exemption (the Notice), the Department invited all interested persons to submit written
comments and requests for a hearing on the proposed exemption within sixty (60) days of the date of the publication
of the Notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on August 17, 1994. All comments and requests for hearing were due by October 17, 1994. 
<!-- PJG 0012 frnewline -->
During the comment period, the Department received no requests for a hearing. However, the Department did receive
a comment letter from the applicant, dated October 17, 1994. The comment from the applicant requested certain modifications
and clarifications of the conditions of the exemption and certain corrections of the language of the Summary of Facts
and Representation in the Notice. The applicant's comments are as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00129 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
First, the Bank requests modification of the language in Section I(f). This section provides in relevant part that,

<!-- PJG 0012 frnewline -->
The value of the assets of the Plans or the CIFs to be transferred in-kind 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
and the net asset value of the Funds receiving those assets 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
in exchange for shares is determined in a single valuation performed in the same manner and at the close of business
on the same day, in accordance with the procedures set forth in Rule 17a&hyph;7(b) (Rule 17a&hyph;7) under the Investment
Company Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
(Emphasis added). In this regard, the Bank indicated that the valuation procedures described in Rule 17a&hyph;7
were used to value the CIF securities transferred to the Funds in the ``conversion'' transaction that occurred on
November 12, 1993, for which retroactive relief has been requested. Further, in connection with the determination
of the net asset value of the Funds' shares to be transferred to the CIFs in that transaction, the trustees of the HighMark
Group (HighMark) decided to use Rule 17a&hyph;7 procedures to value certain securities held in the portfolios of
the Funds in cases where those securities were the same as the securities being transferred to the Funds by the CIFs.
However, it is represented that Rule 17a&hyph;7 procedures were not used to determine the value of other securities
held in the Fund portfolios where those securities were not the same as those held by the CIFs. The values of such other
Fund securities were instead determined pursuant to procedures permitted under the Investment Company Act and normally
followed by HighMark in determining net asset value. The Bank maintains that it did not intend as a condition of the
exemption that Rule 17a&hyph;7 valuation procedures be used to determine the value of all of the Fund's assets for
purposes of ascertaining the number of shares to be issued in connection with a conversion. The Bank believes that
the best approach is to require both parties to a conversion (e.g., a CIF and a Fund) to use the same procedures to value
any securities that are held by both parties, but that compliance with the valuation requirements of Rule 17a&hyph;7
should be required only with respect to securities held by a party (such as a CIF) that is not a registered investment
company. In the opinion of the Bank, this would provide assurance that assets transferred in a conversion transaction
are priced appropriately without interfering with the procedures normally employed by a registered investment
company in determining its net asset value. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In this regard, the Department believes that the most important consideration is that the value of the securities
transferred by the Plan or the CIF into the Fund equal the value of the units of the Fund received in exchange for such
securities by the Plan. Accordingly, we believe that the securities transferred must be valued under the same procedures
by both the transferee and transferor entity (e.g. a CIF and a Fund). In response to the comment, the Department has
reviewed its policies concerning valuation in these types of transactions and has decided to implement the following
changes. The word, ``are,'' before the word, ``value,'' should be deleted and the language of Section I(e) amended
to read as follows: ``The Plans or the CIFs receive shares of the Funds that 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
have a total net asset 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
value equal in value to the assets of the Plans or the CIFs exchanged for such shares 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
on the date of transfer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.'' (The New language is italicized). 
<!-- PJG 0012 frnewline -->
The Department concurs with the applicant's request that Section I(f) be amended by deleting the phrase, ``and the
net asset value of the Funds receiving those assets,'' from the language quoted above to provide that Rule 17a&hyph;7
procedures are required to value only assets being transferred to a Fund, and not the assets of the Fund itself. In this
connection, the Department has amended the language of Section I(f) to read as follows: ``The 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
current market 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
value of the assets of the Plans or the CIFs to be transferred in-kind in exchange for shares is determined in a single
valuation performed in the same manner and at the close of business on the same day, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
using independent sources 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
in accordance with the procedures set forth in Rule 17a&hyph;7(b) (Rule 17a&hyph;7) under the Investment Company
Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
and the procedures established by the Funds pursuant to Rule 17a&hyph;7 for the valuation of such assets. Such procedures
must require that all securities for which a current market price cannot be obtained by reference to the last sale price
for transactions reported on a recognized securities exchange or NASDAQ be valued based on an average of the highest
current independent bid and lowest current independent offer, as of the close of business on the Friday preceding
the weekend of the Plan or CIF transfers determined on the basis of reasonable inquiry from at least three sources that
are broker-dealers or pricing services independent of the Bank. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(The new language is italicized). 
<!-- PJG 0012 frnewline -->
The Bank in another comment requests a modification of the language of Section II(i) and the parallel language in Section
II(m)(1) and Section III(i). The language in these sections requires the Bank to sell Fund shares within one business
day after receipt by the Bank, either by mail, hand delivery, facsimile, or other available means of the Termination
Form or any other written notice from the Second Fiduciary terminating its authorization of investments in the Fund.
The language of these sections provides that if due to circumstances beyond the control of the Bank, the sale cannot
be executed within one business day, the Bank shall have one additional business day to complete such sale. The Bank
believes that the circumstances that may prevent the Bank from completing a sale within one business day (e.g., natural
disaster) may, as a practical matter, also prevent completion of such sale by the second day. Accordingly, the Bank
suggests that the language be amended to make clear that a prohibited transaction will not be considered to have occurred
in such circumstances, if the Bank, due to circumstances that could not be reasonably foreseen by the Bank, is further
prevented from completing the sale by the end of the additional business day. 
<!-- PJG 0012 frnewline -->
The Department believes that the two business day requirement provides ample opportunity for the Bank to execute
sales of shares in the Funds, even in the event circumstances arise which could not reasonably have been foreseen by
the Bank. Accordingly, the Department does not believe that the modification proposed by the Bank would be in the interest
of the Plans, and has determined not to revise the exemption in this manner. 
<!-- PJG 0012 frnewline -->
The Bank also requested a clarification of the scope of relief provided by Section II of the proposed exemption. In
this regard, the language of Section II, as published in the Notice, provides relief from ``the sanctions resulting
from the application of section 4975 of the Code by reason of section 4975(c)(1) (D) through (F) of the Code.'' The Bank
believes that the reference to section 4975(c)(1)(D) is a typographical error and requests that the exemption be
corrected to include relief from section 4975(c)(1) (A) through (F) of the Code in order to conform with the scope of
relief provided to other applicants for substantially similar transactions. The Department concurs and has amended
the exemption accordingly. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00130 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Bank also commented on section I wherein it is stated that the Plans involved in the transaction are Plans for which
the Bank serves as trustee, investment manager, or in any other capacity as fiduciary on behalf of the Plan, and on section
II wherein it is stated that the Plans involved in the transaction are Plans for which the Bank serves as fiduciary.
The Bank states that although its original application referred to Plans for which it exercised investment discretion,
it wishes to note for the record that it also serves Plans in other fiduciary capacities that do not involve the exercise
of investment responsibility. In this regard, in addition to the representations contained in paragraph 2 of the
Notice, as of the time of the application, the Bank had custody of approximately $2.5 billion in assets from approximately
1,500 plans for which the Bank does not exercise investment responsibility. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In response to this comment, the Department acknowledges this additional information. However, the Department
wishes to reiterate that it is not granting relief for transactions afforded relief by Section 404(c) of the Act nor
relief for transactions involving any plan sponsored by the Bank or its affiliates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Bank in its comment letter also requests further modifications and updates to the language of the Summary of Facts
and Representations, as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Specifically, the Bank requests that representations at pages 42293 through 42294 in Notice be changed to reflect
the fact that HighMark now has eleven (11) portfolios, having established in November 1993, four (4) new non-money
market portfolios, namely the Growth Fund, the Income &amp; Growth Fund, the Balanced Fund, and the Government Bond
Fund, and having merged the Special Growth Equity and Growth Funds in May 1994. It is further represented that the Bank
continues to serve as investment adviser, sub-administrator, sub-transfer agent and custodian, but does not serve
as sub-accountant to HighMark. The Department notes that this additional information will be included in the record
of the exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Bank also requests clarification of the language of the fourth sentence of paragraph 3 of the Summary of Facts and
Representation, as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. In this regard, the Bank wishes to confirm that the exemption does not preclude the Bank from relying on any other available
exemption (e.g., Prohibited Transaction Class Exemption 84&hyph;24 or Prohibited Transaction Class Exemption
77&hyph;4), if the terms and conditions of such exemptions are satisfied and if the Bank deems it appropriate to do
so in a given situation. The Department concurs in this comment, but expresses no opinion regarding the availability
of those exemptions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Bank also comments that the first sentence of paragraph 5 of the Summary of Facts and Representations in the Notice
could be read to suggest that the Bank believes that in-kind transfers of the type covered by Section I of the exemption
are not covered by Prohibited Transaction Class Exemption 77&hyph;4. While the Bank represents that it intends to
follow the requirements of Section I of the exemption in connection with such in-kind transfers, the Bank reiterates
that its position was and is that such transfers also are within the scope of Prohibited Transaction Class Exemption
77&hyph;4. The Department notes that it has formally expressed its view on this issue. Specifically, the Department
has concluded that the relief provided by Prohibited Transaction Class Exemption 77&hyph;4 is unavailable for the
purchase of shares in mutual funds other than for cash. (See footnote 3 in Advisory Opinion 94&hyph;35A, dated November
3, 1994). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Finally, the Bank wishes to update in three particulars the description of the Bank's automated ``sweep'' service
described in the Summary of Facts and Representations, as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. In this regard, language in the first paragraph in paragraph 14 of the Notice indicates that purchases and sales of
shares in any of the Funds by the Plans may also occur in connection with daily automated cash ``sweep'' arrangements,
but that agreement to such an arrangement is not a condition for the Plan otherwise choosing to invest in shares of the
Fund, nor will the reverse be required. The Bank maintains that the meaning of the phrase, ``nor will the reverse be
required'' is unclear. It is the Bank's position that, in the exercise of its business judgment regarding the structure
and characteristics of any sweep services it may wish to offer, it may choose to limit investment vehicles made available
under any sweep program to shares of a designated Fund. The Department notes that the sentence in which the phrase,
``nor will the reverse be required,'' appeared was intended to mean that Plans may participate in automated cash ``sweep''
arrangements involving the Funds without being required to invest other plan assets in shares of the Funds and that
Plans may invest in the Funds without being required also to participate in automated cash ``sweep'' arrangements
offered by the Bank. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second, the Bank wishes to correct a representation in the second paragraph of paragraph 14 of the Notice which states,
in part, that ``all of the Plans served by the Bank had elected to participate in automated cash ``sweep'' arrangements
with HighMark.'' According to the Bank, this representation should read that ``substantially all'' of the Plans
served by the Bank had elected to participate in automated cash ``sweep'' arrangements with HighMark. The Department
concurs and incorporates this information into the exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Third, the Bank seeks clarification of the second sentence of the third paragraph of paragraph 14 of the Notice. In
the opinion of the Bank, the sentence could be read to suggest that the ``sweep'' program for a given Plan may involve
investments in more than one of the HighMark money market portfolios at the same time. The Bank represents that while
a Plan may choose from among several such portfolios of HighMark, the ``sweep'' arrangement for a given Plan involves
automatic investments in shares of only one such portfolio at a time. The Department concurs and incorporates the
information on the ``sweep'' program into the exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
After giving full consideration to the entire record, including the written comment from the Bank, the Department
has decided to grant the exemption, as described and concurred in above. In this regard, the comment letter submitted
by the Bank to the Department has been included as part of the public record of the exemption application. The complete
application file, including all supplemental submissions received by the Department, is made available for public
inspection in the Public Documents Room of the Pension Welfare Benefits Administration, Room N&hyph;5638, U.S.
Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption refer to the notice of proposed exemption published on Wednesday, August 17, 1994, at 59 FR 42289. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Angelena C. Le Blanc of the Department, telephone (202) 219&hyph;8883 (this is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00131 </DOCNO>
<PARENT> FR941219-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
General Information 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The attention of interested persons is directed to the following: 
<!-- PJG 0012 frnewline -->
(1) The fact that a transaction is the subject of an exemption under section 408(a) of the Act and/or section 4975(c)(2)
of the Code does not relieve a fiduciary or other party in interest or disqualified person from certain other provisions
to which the exemptions does not apply and the general fiduciary responsibility provisions of section 404 of the Act,
which among other things require a fiduciary to discharge his duties respecting the plan solely in the interest of
the participants and beneficiaries of the plan and in a prudent fashion in accordance with section 404(a)(1)(B) of
the Act; nor does it affect the requirement of section 401(a) of the Code that the plan must operate for the exclusive
benefit of the employees of the employer maintaining the plan and their beneficiaries; 
<!-- PJG 0012 frnewline -->
(2) These exemptions are supplemental to and not in derogation of, any other provisions of the Act and/or the Code,
including statutory or administrative exemptions and transactional rules. Furthermore, the fact that a transaction
is subject to an administrative or statutory exemption is not dispositive of whether the transaction is in fact a prohibited
transaction; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
(3) The availability of these exemptions is subject to the express condition that the material facts and representations
contained in each application accurately describes all material terms of the transaction which is the subject of
the exemption. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, D.C., this 14th day of December, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ivan Strasfeld, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director of Exemption Determinations 
<!-- PJG 0012 frnewline -->
Pension and Welfare Benefits 
<!-- PJG 0012 frnewline -->
Administration, 
<!-- PJG 0012 frnewline -->
U.S. Department of Labor. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31087 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00132 </DOCNO>
<PARENT> FR941219-2-00069 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NATIONAL AERONAUTICS AND SPACE ADMINISTRATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Notice (94&hyph;102)]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Fiscal Year 1994 Report of Closed Meeting Activities of Advisory Committees
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Aeronautics and Space Administration (NASA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability of reports.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to the Federal Advisory Committee Act, Public Law 92&hyph;463, the NASA advisory committees that held closed
or partially closed meetings. Copies of the reports have been filed and are available for public inspection at the
Library of Congress, Federal Advisory Committee Desk, Washington, DC 20540; and the National Aeronautics and Space
Administration, Headquarters Information Center, Washington, DC 20546. The names of the committees are: NAC NASA/NIH
Advisory Committee on Biomedical and Behavioral Research; NAC Space Science Advisory Committee; NAC Life and Microgravity
Sciences and Applications Advisory Committee.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mechthild E. Peterson, Code JMC, National Aeronautics and Space Administration, Washington, DC 20546 (202&hyph;358&hyph;1306).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Timothy M. Sullivan,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Advisory Committee Management Officer, National Aeronautics and Space Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31073 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7510&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00133 </DOCNO>
<PARENT> FR941219-2-00070 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. 50&hyph;282 and 50&hyph;306]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Northern States Power Company; Withdrawal of Application for Amendments to Facility Operating Licenses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The U.S. Nuclear Regulatory Commission (the Commission) has granted the request of Northern States Power Company
(the licensee) to withdraw its July 13, 1992, application for proposed amendments to Facility Operating License
Nos. DPR&hyph;42 and DPR&hyph;60 for the Prairie Island Nuclear Generating Plant, Unit Nos. 1 and 2, respectively,
located in Goodhue County, Minnesota.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendments would have revised the facility technical specifications to clarify the applicability
of the requirements for containment closure during refueling and to clarify the requirements for operability and
load testing of the fuel handling cranes. The Commission had previously issued a Notice of Consideration of Issuance
of Amendments published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on August 5, 1992 (57 FR 34588). However, by letter dated July 5, 1994, the licensee withdrew the proposed changes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further details with respect to this action, see the application for amendment dated July 13, 1992, and the licensee's
letter dated July 5, 1994, which withdrew the application for license amendment. The above documents are available
for public inspection at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington,
DC, and at the local public document room located at the Minneapolis Public Library, Technology and Science Department,
300 Nicollet Mall, Minneapolis, Minnesota 54401.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated at Rockville, Maryland, this 7th day of December 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Nuclear Regulatory Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sheri R. Peterson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Project Manager, Project Directorate III&hyph;I, Division of Reactor Projects&hyph;III/IV, Office of Nuclear
Reactor Regulation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31072 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00134 </DOCNO>
<PARENT> FR941219-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[IA 94&hyph;035]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>In the Matter of Rex Allen Werts (Also Known As: Michael Allen Hunter); Order Prohibiting Involvement in NRC-Licensed
Activities and Unescorted Access (Effective Immediately)</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Rex Allen Werts (Also Known As: Michael Allen Hunter) was employed by Power Plant Maintenance, Inc., (PPM) a contractor
of the Carolina Power and Light Company (CP&amp;L or Licensee), from March 24, 1993 until his unescorted access was
revoked on July 26, 1993. Licensee is the holder of License Nos. DPR&hyph;62 and DPR&hyph;71 issued by the Nuclear
Regulatory Commission (NRC or Commission) pursuant to 10 CFR Part 50 on December 27, 1974 and November 12, 1976, respectively.
The licenses authorize the operation of the Brunswick Nuclear Plant in accordance with the conditions specified
therein. The facility is located on the Licensee's site in Southport, North Carolina.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On March 24, 1993, Mr. Werts was granted unescorted access to the Brunswick Nuclear Plant, based in part on representations
he made on an access authorization application, dated March 11, 1993, which he submitted to Power Plant Maintenance,
Inc., (PPM), a contractor of the Licensee. In the application, Mr. Werts falsely represented himself as Michael Allen
Hunter and stated that he had not been arrested or convicted of any criminal offense. In addition, Mr. Werts failed
to correct that information after he was granted unescorted access and continued to hold that status on the basis of
his false identity. The Licensee submitted fingerprint cards completed by Mr. Werts to the Federal Bureau of Investigation
(FBI) and subsequently was informed that Mr. Werts (alias Mr. Hunter) had a record of arrests, convictions, and imprisonments
prior to 1990.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on the above, Mr. Werts engaged in deliberate misconduct in violation of 10 CFR 50.5(a)(2) which prohibits any
employee of a licensee or licensee contractor from deliberately submitting to the licensee or licensee's contractor
information the employee knows to be incomplete or inaccurate in some respect material to the NRC. Information concerning
an individual's true identity and criminal history is material in that it is used by the Licensee to make determinations
relative to the grant or denial access authorization. If the Licensee has been given accurate information regarding
Mr. Werts' criminal record the Licensee would not have granted unescorted access to Mr. Werts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The NRC must be able to rely on the Licensee, its contractors, and licensee and contractor employees to comply with
NRC requirements, including the requirement to provide information that is complete and accurate in all material
respects. Mr. Werts' actions have raised serious concerns as to whether he can be relied upon to comply with NRC requirements
and to provide complete and accurate information to the NRC or NRC licensees in the future.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Consequently, I lack the requisite reasonable assurance that nuclear safety activities can be conducted in compliance
with the Commission's requirements and that the health and safety of the public would be protected if Mr. Werts were
permitted at this time to be involved in the performance of licensed activities or were permitted unescorted access
to protected or vital areas of NRC-licensed facilities. Therefore, the public health, safety and interest require
that Mr. Werts be prohibited from being involved in the performance of activities licensed by the NRC and be prohibited
from obtaining unescorted access for a period of three years from the date of this Order. For a period of five years from
the date of this Order, Mr. Werts is required to inform the NRC of his acceptance of employment with any employer whose
operations he knows or has reason to believe involve NRC-licensed activities. Furthermore, pursuant to 10 CFR 2.202,
I find that the significance of the deliberate misconduct described above is such that the public health, safety and
interest require that this Order be immediately effective.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, pursuant to sections 103, 161b, 161i, 182 and 186 of the Atomic Energy Act of 1954, as amended, and the
Commission's regulations in 10 CFR 2.202, 10 CFR 50.5, and 10 CFR 150.20, It is hereby ordered, effective immediately,
that:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. For a three-year period from the date of this Order, Mr. Rex Allen Werts is prohibited from engaging in activities
licensed by the NRC and is prohibited from obtaining unescorted access to protected and vital areas of facilities
licensed by the NRC. For the purposes of this Order, licensed activities include the activities licensed or regulated
by: (1) NRC; (2) an Agreement State, limited to the Licensee's conduct of activities within NRC jurisdiction pursuant
to 10 CFR 150.20; and (3) an Agreement State where the licensee is involved in the distribution of products that are
subject to NRC jurisdiction.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00135 </DOCNO>
<PARENT> FR941219-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
B. For a five-year period from the date of this Order, Mr. Werts is required to provide notice to the Director, Office
of Enforcement, U.S. Nuclear Regulatory Commission, Washington, DC 20555, of his acceptance of employment with
any employer whose operations he knows or has reason to believe involve NRC-licensed activities.
<!-- PJG 0012 frnewline -->
The Director, Office of Enforcement, may, in writing, relax or rescind any of the above conditions upon demonstration
by Mr. Werts of good cause.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with 10 CFR 2.202, Mr. Werts must, and any other person adversely affected by this Order may, submit an
answer to this Order, and may request a hearing on this Order, within 20 days of the date of this Order. The answer may
consent to this Order. Unless the answer consents to this Order, the answer shall, in writing and under oath or affirmation,
specifically admit or deny each allegation or charge made in this Order and shall set forth the matters of fact and law
on which Mr. Werts or other person adversely affected relies and the reasons as to why the Order should not have been
issued. Any answer or request for a hearing shall be submitted to the Secretary, U.S. Nuclear Regulatory Commission,
ATTN: Chief, Docketing and Services Section, Washington, DC 20555. Copies also shall be sent to the Director, Office
of Enforcement, U.S. Nuclear Regulatory Commission, Washington, DC 20555, to the Assistant General Counsel for
Hearings and Enforcement at the same address, to the Regional Administrator, Region II, U.S. Nuclear Regulatory
Commission, 101 Marietta St. NW., Atlanta, Georgia 30323, and to Mr. Werts, if the answer or hearing request is by a
person other than Mr. Werts. If a person other than Mr. Werts requests a hearing, that person shall set forth with particularity
the manner in which his interest is adversely affected by this Order and shall address the criteria set forth in 10 CFR
2.714(d).
<!-- PJG 0012 frnewline -->
If a hearing is requested by Mr. Werts or a person whose interest is adversely affected, the Commission will issue an
Order designating the time and place of any hearing. If a hearing is held, the issue to be considered at such hearing
shall be whether this Order should be sustained.
<!-- PJG 0012 frnewline -->
Pursuant to 10 CFR 2.202(c)(2)(i), Mr. Werts, or any other person adversely affected by this Order, may, in addition
to demanding a hearing, at the time the answer is filed or sooner, move the presiding officer to set aside the immediate
effectiveness of the Order on the ground that the Order, including the need for immediate effectiveness, is not based
on adequate evidence but on mere suspicion, unfounded allegations, or error.
<!-- PJG 0012 frnewline -->
In the absence of any request for a hearing, the provisions specified in Section IV above shall be final 20 days from
the date of this Order without further order or proceedings. An answer or a request for a hearing shall not stay the immediate
effectiveness of this order.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated at Rockville, Maryland this 12th day of December 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Nuclear Regulatory Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James L. Milhoan,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Executive Director for Nuclear Reactor Regulation, Regional Operations and Research.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31070 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00136 </DOCNO>
<PARENT> FR941219-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Thermal Hydraulic Phenomena; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The ACRS Subcommittee on Thermal Hydraulic Phenomena will hold a meeting on January 10, 1995, Room T&hyph;2B3, 11545
Rockville Pike, Rockville, Maryland.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The entire meeting will be open to public attendance, with the exception of a portion that may be closed to discuss General
Electric Nuclear Energy (GENE) proprietary information pursuant to [5 U.S.C. 552b(c)(4)].
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for the subject meeting shall be as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tuesday, January 10, 1995_8:30 a.m. Until the Conclusion of Business
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee will review the NRC staff Safety Evaluation Report pertaining to the adequacy of the technical approach
to the GENE Test and Analysis Programs being conducted in support of the Simplified Boiling Water Reactor (SBWR) design
certification. The purpose of this meeting is to gather information, analyze relevant issues and facts, and to formulate
proposed positions and actions, as appropriate, for deliberation by the full Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oral statements may be presented by members of the public with the concurrence of the Subcommittee Chairman; written
statements will be accepted and made available to the Committee. Electronic recordings will be permitted only during
those portions of the meeting that are open to the public, and questions may be asked only by members of the Subcommittee,
its consultants, and staff. Persons desiring to make oral statements should notify the cognizant ACRS staff engineer
named below five days prior to the meeting, if possible, so that appropriate arrangements can be made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
During the initial portion of the meeting, the Subcommittee, along with any of its consultants who may be present,
may exchange preliminary views regarding matters to be considered during the balance of the meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Subcommittee will then hear presentations by and hold discussions with representatives of the NRC staff, GENE,
their consultants, and other interested persons regarding this review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further information regarding topics to be discussed, whether the meeting has been cancelled or rescheduled, the
Chairman's ruling on requests for the opportunity to present oral statements and the time allotted therefor can be
obtained by contacting the cognizant ACRS staff engineer, Mr. Paul A. Boehnert (telephone 301/415&hyph;8065) between
7:30 a.m. and 4:15 p.m. (EST). Persons planning to attend this meeting are urged to contact the above named individual
on the working day prior to the meeting to be advised of any potential changes in the proposed agenda, etc., that may
have occurred.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sam Duraiswamy, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Nuclear Reactors Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31068 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00137 </DOCNO>
<PARENT> FR941219-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Westinghouse Standard Plant Designs; Meeting
</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The ACRS Subcommittee on Westinghouse Standard Plant Designs will hold a meeting on January 11, 1995, Room T&hyph;2B3,
11545 Rockville Pike, Rockville, Maryland.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The entire meeting will be open to public attendance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for the subject meeting shall be as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wednesday, January 11, 1995_8:30 a.m. Until the Conclusion of Business
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee will begin review of the NRC staff Draft Safety Evaluation Report (DSER) for the Westinghouse AP600
design. The purpose of this meeting is to gather information, analyze relevant issues and facts, and to formulate
proposed positions and actions, as appropriate, for deliberation by the full Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oral statements may be presented by members of the public with the concurrence of the Subcommittee Chairman; written
statements will be accepted and made available to the Committee. Electronic recordings will be permitted only during
those portions of the meeting that are open to the public, and questions may be asked only by members of the Subcommittee,
its consultants, and staff. Persons desiring to make oral statements should notify the cognizant ACRS staff engineer
named below five days prior to the meeting, if possible, so that appropriate arrangements can be made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
During the initial portion of the meeting, the Subcommittee, along with any of its consultants who may be present,
may exchange preliminary views regarding matters to be considered during the balance of the meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Subcommittee will then hear presentations by and hold discussions with representatives of the NRC staff, Westinghouse,
their consultants, and other interested persons regarding this review.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further information regarding topics to be discussed, whether the meeting has been cancelled or rescheduled, the
Chairman's ruling on requests for the opportunity to present oral statements and the time allotted therefore can
be obtained by contacting the cognizant ACRS staff engineer, Mr. Noel F. Dudley (telephone 301/415&hyph;6888) between
7:30 a.m. and 4:15 p.m. (EST). Persons planning to attend this meeting are urged to contact the above named individual
on the working day prior to the meeting to be advised of any potential changes in the proposed agenda, etc., that may
have occurred.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sam Duraiswamy,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Nuclear Reactors Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31067 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00138 </DOCNO>
<PARENT> FR941219-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Planning and Procedures; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The ACRS Subcommittee on Planning and Procedures will hold a meeting on January 11, 1995, Room T&hyph;2B1, 11545 Rockville
Pike, Rockville, Maryland.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to
5 U.S.C. 552b(c) (2) and (6) to discuss organizational and personnel matters that relate solely to internal personnel
rules and practices of ACRS, and matters the release of which would constitute a clearly unwarranted invasion of personal
privacy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for the subject meeting shall be as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wednesday, January 11, 1995_2:00 p.m. Until the Conclusion of Business
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee will discuss proposed ACRS activities and related matters. Also, it will discuss status of the appointment
of members to the ACRS. The purpose of this meeting is to gather information, analyze relevant issues and facts, and
to formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oral statements may be presented by members of the public with the concurrence of the Subcommittee Chairman; written
statements will be accepted and made available to the Committee. Electronic recordings will be permitted only during
those portions of the meeting that are open to the public, and questions may be asked only by members of the Subcommittee,
its consultants, and staff. Persons desiring to make oral statements should notify the cognizant ACRS staff person
named below five days prior to the meeting, if possible, so that appropriate arrangements can be made. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further information regarding topics to be discussed, the scheduling of sessions open to the public, whether the
meeting has been cancelled or rescheduled, the Chairman's ruling on requests for the opportunity to present oral
statements, and the time allotted therefor can be obtained by contacting the cognizant ACRS staff person, Dr. John
T. Larkins (telephone: 301/415&hyph;7360) between 7:30 a.m. and 4:15 p.m. (EST). Persons planning to attend this
meeting are urged to contact the above named individual on the working day prior to the meeting to be advised of any changes
in schedule, etc., that may have occurred. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sam Duraiswamy,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Nuclear Reactors Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31066 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00139 </DOCNO>
<PARENT> FR941219-2-00075 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>OFFICE OF MANAGEMENT AND BUDGET</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Budget Analysis Branch; Final Sequestration Report</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Management and Budget.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Transmittal of Final Sequestration Report to the President and Congress.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to Section 254(b) of the Balanced Budget and Emergency Deficit Control Act of 1985, as amended, the Office
of Management and Budget hereby reports that it has submitted its Final Sequestration Report to the President, the
Speaker of the House of Representatives, and the President of the Senate.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ellen Balis, Budget Analysis Branch_202/395&hyph;4574.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John B. Arthur,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;30750 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3110&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00140 </DOCNO>
<PARENT> FR941219-2-00076 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>SECURITIES AND EXCHANGE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Issuer Delisting; Notice of Application To Withdraw From Listing and Registration; (Cavalier Homes, Inc., Common
Stock, $.10 Par Value) File No. 1&hyph;9792</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cavalier Homes, Inc. (``Company'') has filed an application with the Securities and Exchange Commission (``Commission''),
pursuant to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and Rule 12d2&hyph;2(d) promulgated thereunder,
to withdraw the above specified security (``Security'') from listing and registration on the American Stock Exchange,
Inc. (``Amex.'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reasons alleged in the application for withdrawing the security from listing and registration include the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
According to the Company, in addition to being listed on the Amex, its common stock is listed on the New York Stock Exchange,
Inc. (``NYSE''). The Company's common stock commenced trading on the NYSE at the opening of business on December 5,
1994 and concurrently therewith such securities were suspended from trading on the Amex.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In making the decision to withdraw its common stock from listing on the Amex, the Company considered the direct and
indirect costs and expenses attendant on maintaining the dual listing of its securities on the NYSE and on the Amex.
The Company does not see any particular advantage in the dual trading of its common stock and believes that dual listing
would fragment the market for its security.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any interested person may, on or before January 5, 1995 submit by letter to the Secretary of the Securities and Exchange
Commission, 450 Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether the application has been
made in accordance with the rules of the exchanges and what terms, if any, should be imposed by the Commission for the
protection of investors. The Commission, based on the information submitted to it, will issue an order granting the
application after the date mentioned above, unless the Commission determines to order a hearing on the matter.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31101 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00141 </DOCNO>
<PARENT> FR941219-2-00077 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Issuer Delisting; Notice of Application To Withdraw From Listing and Registration; (Advanced Environmental Recycling
Technologies, Inc., Class A Common Stock, $.01 Par Value) File No. 1&hyph;10367</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Advanced Environmental Recycling Technologies, Inc. (``Company'') has filed an application with the Securities
and Exchange Commission (``Commission''), pursuant to Section 12(d) of the Securities Exchange Act of 1934 (``Act'')
and Rule 12d2&hyph;2(d) promulgated thereunder, to withdraw the above specified security (``Security'') from
listing and registration on the Boston Stock Exchange, Inc. (``BSE'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reasons alleged in the application for withdrawing the Security from listing and registration include the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Due to the limited number of transactions in the Company's stock on the BSE, the Company can no longer justify the time
and expense required to continue listing its securities on that exchange.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any interested person may, on or before January 5, 1995 submit by letter to the Secretary of the Securities and Exchange
Commission, 450 Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the application has been made
in accordance with the rules of the exchanges and what terms, if any, should be imposed by the Commission for the protection
of investors. The Commission, based on the information submitted to it, will issue an order granting the application
after the date mentioned above, unless the Commission determines to order a hearing on the matter.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31100 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00142 </DOCNO>
<PARENT> FR941219-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Rel. No. IC&hyph;20764; File No. 812&hyph;9116]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Federal Kemper Life Assurance Company, et al.</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Securities and Exchange Commission (the ``SEC'' or the ``Commission'').
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of application for exemption under the Investment Company Act of 1940 (the ``1940 Act'').
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICANTS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Kemper Life Assurance Company (``FKLA''), FKLA Variable Separate Account (the ``Separate Account''),
any other separate account established in the future (``Future Accounts'') by FKLA or an affiliated life insurance
company to support certain scheduled premium, single premium, or flexible premium variable life insurance contracts
issued by FKLA or an affiliated life insurance company (the ``Contracts''), and Kemper Financial Services, Inc.
(``KFS'').
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
RELEVANT 1940 ACT SECTIONS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Order requested under Section 6(c) of the 1940 Act for exemptions from Section 27(c)(2) of the 1940 Act and Rules 6e-2(c)(4)(v)
and 6e-3(T)(c)(4)(v) thereunder.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY OF APPLICATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Applications seek an order to permit them to deduct from premiums received under the Contracts an amount that is reasonable
in relation to the increased federal income tax burden resulting from the receipt of such premiums in connection with
the Contracts.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
FILING DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The application was filed on July 19, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
HEARING OR NOTIFICATION OF HEARING:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 An order granting the application will be issued unless the Commission orders a hearing. Interested persons may request
a hearing on this application by writing to the Secretary of the SEC and serving Applicants with a copy of the request,
personally or my mail. Hearing requests must be received by the Commission by 5:30 p.m. on January 6, 1995 and should
be accompanied by proof of service on Applicants in the form of an affidavit or, for lawyers, a certificate of service.
Hearing requests should state the nature of the interest, the reason for the request, and the issues contested. Persons
may request notification of a hearing by writing to the Secretary of the SEC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Secretary, Securities and Exchange Commission, 450 Fifth Street NW., Washington, D.C. 20549. Applicants, 1 Kemper
Drive, Long Grove, Illinois 60049.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Wendy Finck Friedlander, Senior Attorney, at (202) 942&hyph;0670, Office of Insurance Products, Division of Investment
Management.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Following is a summary of the application. The complete application is available for a fee from the Commission's Public
Reference Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applicants' Representations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. FKLA, a stock life insurance company organized under the laws of Illinois, is the depositor of the Separate Account.
FKLA offers life insurance and annuity products and is admitted to do business in the District of Columbia and in all
states except New York. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The Separate Account was established under Illinois law as a separate account of FKLA. The Separate Account, registered
under the 1940 Act as a unit investment trust, will fund the Contracts issued by FKLA. The Contracts will be registered
under the Securities Act of 1933. The Kemper Investors Fund (the ``Fund''), a registered open-end management investment
company, will serve as the underlying investment medium for the Separate Account.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. KFS, a registered broker-dealer under the Securities Exchange Act of 1934, is the principal underwriter for the
Contracts, and will be the principal underwriter of any other variable life insurance policies funded through the
Separate Account or any Future Account (``Future Contracts'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The Contracts are flexible premium individual variable life insurance policies. Applicants represent that the
Contracts will be issued in reliance on Rule 6e&hyph;3(T)(b)(13)(i)(B) under the 1940 Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. FLKA will deduct a charge of 1.00% of each premium payment under the Contracts to cover a portion of FKLA's estimated
cost for higher federal corporate income tax liability resulting from changes made to the Internal Revenue Code of
1986 (``Code'') by the Omnibus Budget Reconciliation Act of 1990 (``OBRA''), affecting the treatment of deferred
acquisition costs. The requested order also would permit the deduction of up to 1.25% of each premium payment under
Future Contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00143 </DOCNO>
<PARENT> FR941219-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. OBRA amended the Code by, among other things, enacting Section 848 thereof. Section 848 changed how a life insurance
company must compute its itemized deductions from gross income for federal income tax purposes. Section 848 requires
an insurance company to capitalize and amortize, over a period of ten years, part of the company's general expenses
for the current year. Under prior law, these general expenses were deductible in full from the current year's gross
income.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. The amount of deductions that must be capitalized and amortized over ten years, rather than deducted in the year
incurred, is based on ``net premiums'' received in connection with certain types of insurance contracts. Section
848 of the Code defines ``net premium'' for a type of contract as gross premiums received by the insurance company on
the contracts minus return premiums and premiums paid by the insurance company for reinsurance of its obligations
under such contracts. Applicants state that the effect of Section 848 is to accelerate the realization of income from
insurance contracts covered by that Section, and, accordingly, the payment of taxes on the income generated by those
contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. The amount of general deductions that must be capitalized depends upon the type of contract to which the premiums
received relate and varies according to a schedule set forth in Section 848. Applicants represent that the Contracts
are ``specified insurance contracts'' that fall into the category of life insurance contracts, and, under Section
848, 7.7% of the year's net premiums received must be capitalized and amortized.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Applicants represent that the increased tax burden resulting from Section 848 may be quantified as follows. For
each $10,000 of net premiums received under the Contracts in a given year, Section 848 requires FKLA to capitalize
$770 (7.7% of $10,000) and $38.50 of this $770 may be deducted in the current year. This leaves $731.50 ($770 minus $38.50)
subject to taxation at the corporate tax rate of 35% which results in FKLA owing $256.03 (.35 &times; $731.50) more
in taxes for the current year than would have been owed prior to OBRA. This current increase in federal income tax will
be partially offset by deductions that will be allowed during the next ten years as a result of amortizing the remainder
of the $770 ($77 in each of the following nine years and $38.50 in the tenth year).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. In FKLA's business judgment, a discount rate of 8% is appropriate for use in calculating the present value of the
increased future tax deductions resulting from the amortization described above. Applicants state that FKLA seeks
an after tax rate of return on the investment of its capital in excess of 15%. To the extent that capital must be used by
FKLA to meets its increased federal tax burden under Section 848 resulting from the receipt of premiums, such capital
is not available to FKLA for investment. Thus, Applicants argue, the cost of capital used to satisfy FKLA's increased
federal income tax burden under Section 848 is, in essence, FKLA's after tax rate of return on capital; and, accordingly,
the rate of return on capital is appropriate for use in this present value calculation. To the extent that the 8% discount
rate is lower than FKLA's actual targeted rate of return, Applicants submit that a measure of comfort is provided that
the calculation of FKLA's increased tax burden attributable to the receipt of premiums will continue to be reasonable
over time, even if the corporate tax rate applicable to FKLA is reduced, or its targeted rate of return is lowered.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. In determining the after tax rate of return used in arriving at this discount rate, Applicants state that a number
of factors were considered, including: market interest rates; FKLA's anticipated long term growth rate; the risk
level for this type of business; inflation; and available information about the rates of return obtained by other
life insurance companies. FKLA represents that such factors are appropriate factors to consider in determining
FKLA's cost of capital. Applicants state that FKLA first projects its future growth rate based on the anticipated
sales, the current interest rates, the inflation rate, acceptable risk levels, the amount of capital that FKLA can
provide to support such growth, and industry practice. FKLA then uses the anticipated growth rate and the other factors
enumerated above to set a rate of return on capital that equals or exceeds this rate of growth. Of these other factors,
market interest rates, the acceptable risk levels and the inflation rate receive significantly more weight than
information about the rates of return obtained by other companies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00144 </DOCNO>
<PARENT> FR941219-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
12. Applicants state that FKLA seeks to maintain a ratio of capital to assets that is established based on its judgment
of the risks represented by various components of its assets and liabilities. Applicants state that maintaining
the ratio of capital to assets is critical to offering competitively priced products and, as to FKLA, to maintaining
a competitive rating from various rating agencies. Consequently, Applicants state that FKLA's capital should grow
at least at the same rate as do its assets.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. Using a corporate federal income tax rate of 35% and assuming a discount rate of 8%, the present value of the federal
income tax effect of the increased deductions allowable in the following 10 years, which partially offsets the increased
federal income tax burden, comes to $174.60. The effect of Section 848 on the Contracts is, therefore, an increased
federal income tax burden with a present value of $81.43 for each $10,000 of net premiums, i.e., $256.03 minus $174.60.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14. State premium taxes are deductible in computing federal income taxes. Thus, FKLA does not incur incremental federal
income tax when it passes on state premium taxes to owners of the Contracts. Conversely, federal income taxes are not
deductible in computing FKLA's federal income taxes. To compensate FKLA fully for the impact of Section 848, therefore,
it would be necessary to allow FKLA to impose an additional charge that would make it whole not only for the $81.43 additional
federal income tax burden attributable to Section 848 but also for the federal income tax on the additional $81.43
itself. This federal income tax can be determined by dividing $81.43 by the complement of the 35% federal corporate
income tax rate, i.e., 65%, resulting in an additional charge of $125.28 for each $10,000 of net premiums, or 1.25%.
However, FKLA currently intends to deduct 1.00% of each premium payment under the Contracts, which is less than its
increased federal corporate income tax burden. FKLA reserves the rights to increase the charge and to deduct up to
1.25% of each premium payment of Future Contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
15. Based on prior experience, FKLA expects that all of its current and future deductions will be fully taken. Applicants
represent that the maximum 1.25% charge, and the current 1.00% charge, to be deducted pursuant to the relief requested,
are reasonably related to their increased federal income tax burden under Section 848, taking into account the capitalization
and amortization permitted by Section 848, and the use by FKLA of a discount rate of 8% in computing the future deductions
resulting from such capitalization and amortization, such rate being lower than, but assumed for these purposes
to be the equivalent of, FKLA's cost of capital.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. While the application states that FKLA believes that a charge of 1.00% of premium payments would reimburse it for
the impact of Section 848 (as currently written) on FKLA's federal income tax liabilities, the application also states,
however, that FKLA believes that it will have to increase this charge if any future change in, or interpretation of
Section 848, or any successor provision, results in an increased federal income tax burden due to the receipt of premiums.
Such an increase could result from a change in the corporate federal income tax rate, a change in the 7.7% figure, a change
in the categorization of specified insurance contracts, or a change in the amortization period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 Applicants' Legal Analysis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Applicants request an order to the Commission pursuant to Section 6(c) exempting them from the provisions of Section
27(c)(2) of the 1940 Act, and Rules 6e&hyph;2(c)(4)(v) and 6e&hyph;3(T)(c)(4)(v) thereunder, to the extent necessary
to permit deductions to be made from premium payments received in connection with the Contracts. The deductions would
be in an amount that is reasonable in relation to the increased federal income tax burden related to the receipt of such
premiums. Applicants further request an exemption from Rules 6e&hyph;2(c)(4) and 6e&hyph;3(T)(c)(4) under the
1940 Act to premit the proposed deductions to be treated as other than ``sales load'' for the purposes of Section 27
of the 1940 and the exemptions from various provisions of that Section found in Rules 6e&hyph;2 and 6e&hyph;3(T).
<!-- PJG 0012 frnewline -->
2. Section 6(c) of the 1940 Act provides, in pertinent part, that the Commission may by order upon application, conditionally
or unconditionally exempt any person, security or transaction from any provision of the 1940 Act if and to the extent
that such exemption is necessary or appropriate in the public interest and consistent with the protection of investors
and the purposes fairly intended by the policy and the provisions of the 1940 Act.
<!-- PJG 0012 frnewline -->
3. Section 27(c)(2) of the 1940 Act prohibits the sale of periodic payment plan certificates unless the proceeds of
all payments (except such amounts as are deducted for sales load) are held under an indenture or agreement containing
in substance the provisions required by Sections 26(a)(2) and 26(a)(3) of the 1940 Act. Certain provisions of Rules
6e&hyph;2 and 6e&hyph;3(T) provide a range of exemptive relief for the offering of variable life insurance policies
such as the Contracts.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00145 </DOCNO>
<PARENT> FR941219-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Rule 6e&hyph;2(c)(4)(v) defines ``sales load'' charged on any payment as the excess of the payment over certain
specified charges and adjustments, including ``a deduction approximately equal to state premium taxes''. Rule
6e&hyph;3(T)(c)(4)(v) defines ``sales load'' charged during a contract period as the excess of any payments made
during the period over the sum of certain specified charges and adjustments, including ``a deduction for and approximately
equal to state premium taxes.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Applicants submit that the deduction for federal income tax charges, proposed to be deducted in connection with
the Contracts, should be treated as other than sales load, as is a state premium tax charge, for purposes of the 1940
Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Applicants argue that the requested exemptions from Rules 6e&hyph;2(c)(4) and 6e&hyph;3(c)(4) are necessary
in connection with Applicant's reliance on certain provisions of Rules 6e&hyph;2(b)(13) and 6e&hyph;3(T)(b)(13),
which provide exemptions from Sections 27(a)(1) and 27(h)(1) of the 1940 Act. Issuers and their affiliates may only
rely on Rules 6e&hyph;2(b)(13)(i) or 6e&hyph;3(T)(b)(13)(i) if they meet the respective Rule's alternative limitations
on sales load as defined in Rule 6e&hyph;2(c)(4) or Rule 6e&hyph;3(T)(c)(4). Applicants state that, depending upon
the load structure of a particular Contract, these alternative limitations may not be met if the deduction for the
increase in an issuer's federal tax burden is included in sales load. Although a deduction for an insurance company's
increased federal tax burden does not fall squarely within any of the specified charges or adjustments which are excluded
from the definition of ``sales load'' in Rules 6e&hyph;2(c)(4) and 6e&hyph;3(T)(c)(4), Applicants state that they
have found no public policy reason for including them in ``sales load.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. The public policy that underlies Rules 6e&hyph;2(b)(13)(i) and 6e&hyph;3(T)(b)(13)(i), like that which underlies
Sections 27(a)(1) and 27(h)(1) of the 1940 Act, is to prevent excessive sales loads from being charged in connection
with the sale of periodic payment plan certificates. Applicants submit that the treatment of a federal income tax
charge attributable to premium payments as sales load would not in any way further this legislative purpose because
such a deduction has no relation to the payment of sales commissions or other distribution expenses. Applicants state
that the Commission has concurred with this conclusion by excluding deductions for state premium taxes from the definition
of ``sales load'' in Rules 6e&hyph;2(c)(4) and 6e&hyph;3(T)(c)(4).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Applicants assert that the source for the definition of ``sales load'' found in the Rules supports this analysis.
Applicants state that the Commission's intent in adopting such provisions was to tailor the general terms of Section
2(a)(35) of the 1940 Act to variable life insurance contracts. Just as the percentage limits of Sections 27(a)(1)
and 27(h)(1) depend on the definition of ``sales load'' in Section 2(a)(35) for their efficacy, the percentage limits
in Rules 6e&hyph;2(b)(13)(i) and 6e&hyph;3(T)(b)(13)(i) depend on Rules 6e&hyph;2(c)(4) and 6e&hyph;3(T)(c)(4),
respectively, which do not depart, in principle, from Section 2(a)(35).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Section 2(a)(35) excludes deductions from premiums for ``issue taxes'' from the definition of ``sales load''
under the 1940 Act. Applicants submit that this suggests that it is consistent with the policies of the 1940 Act to exclude
from the definition of ``sales load'' in Rules 6e&hyph;2 and 6e&hyph;3(T) deductions made to pay an insurance company's
costs attributable to its tax obligations. Section 2(a)(35) also excludes administrative expenses or fees that
are ``not properly chargeable to sales or promotional activities.'' Applicants argue that this suggests that the
only deductions intended to fall within the definition of ``sales load'' are those that are properly chargeable to
such activities. Because the proposed deductions will be used to compensate FKLA for its increased federal income
tax burden attributable to the receipt of premiums, and are not properly chargeable to sales or promotional activities,
this language in Section 2(a)(35) is another indication that not treating such deductions as ``sales load'' is consistent
with the policies of the 1940 Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00146 </DOCNO>
<PARENT> FR941219-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10. Applicants assert that the terms of the relief requested with respect to Contracts to be issued through the Separate
Account or through Future Accounts are consistent with the standards enumerated in Section 6(c) of the 1940 Act. Without
the requested relief, Applicants would have to request and obtain exemptive relief for each Future Contract. Applicants
state that such additional requests for exemptive relief would present no issues under the 1940 Act not already addressed
in this request for exemptive relief.
<!-- PJG 0012 frnewline -->
11. Applicants assert that the requested relief is appropriate in the public interest because it would promote competitiveness
in the variable life insurance market by eliminating the need for Applicants to file redundant exemptive applications,
thereby reducing administrative expenses and maximizing efficient use of resources. The delay and expense involved
in having to seek repeated exemptive relief would impair the ability of Applicants to take advantage fully of business
opportunities as those opportunities arise. Additionally, Applicants state that the requested relief is consistent
with the purposes of the 1940 Act and the protection of investors for the same reasons. If Applicants were required
to seek exemptive relief repeatedly with respect to the same issues addressed in this application, investors would
not receive any benefit or additional protection thereby and might be disadvantaged as a result of increased overhead
expenses for Applicants.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conditions for Relief
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Applicants represent that FKLA will monitor the reasonableness of the charge to be deducted pursuant to the requested
exemptive relief.
<!-- PJG 0012 frnewline -->
2. Applicants represent that the registration statement for each Contract under which the charge referenced in paragraph
one of this section is deducted will : (i) Disclose the charge; (ii) explain the purpose of the charge; and (iii) state
that the charge is reasonable in relation to the increased federal income tax burden under Section 848 of the Code resulting
from the receipt of premiums.
<!-- PJG 0012 frnewline -->
3. Applicants represent that the registration statement for each Contract under which the charge referenced in paragraph
one of this section is deducted will contain as an exhibit an actuarial opinion as to: (i) The reasonableness of the
charge in relation to the increased federal income tax burden under Section 848 resulting from the receipt of premiums;
(ii) the reasonableness of the after tax rate of return that is used in calculating such charge; and (iii) the appropriateness
of the factors taken into account in determining the after tax rate of return.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants submit that, for the reasons and upon the facts set forth above, the requested exemptions from Section
27(c)(2) of the 1940 Act, and Rules 6e&hyph;2(c)(4)(v) and 6e&hyph;3(T)(c)(4)(v) thereunder, to permit the deduction
of up to 1.25% of premium payments under the Contracts meet the standards in Section 6(c) of the 1940 Act. In this regard,
Applicants assert that granting the relief requested in the application would be appropriate in the public interest
and consistent with the protection of investors and the purposes fairly intended by the policy and provisions of the
1940 Act.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Investment Management, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31041 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00147 </DOCNO>
<PARENT> FR941219-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Rel. No. IC&hyph;20765; File No. 812&hyph;9110]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Providentmutual Life and Annuity Company of America</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Securities and Exchange Commission (``SEC'' or the ``Commission'').
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Application for an order under the Investment Company Act of 1940 (the ``1940 Act'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
APPLICANTS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Providentmutual Life and Annuity Company of America (``Providentmutual''), Providentmutual Variable Life Separate
Account (the ``Account''), and PML Securities Company (``PML''). (Providentmutual, the Account, and PML shall
be referred to herein collectively as ``Applicants.'')
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
RELEVANT 1940 ACT SECTIONS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Order requested under Section 6(c) of the 1940 Act for exemptions from Section 27(c)(2) of the 1940 Act and Rule 6e&hyph;3(T)(c)(4)(v)
thereunder.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY OF APPLICATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Applicants seek an order permitting them and other separate accounts that Providentmutual may establish in the future
to support flexible premium variable life insurance contracts (the ``future accounts'') to deduct from premium
payments received an amount that is reasonable in relation to Providentmutual's increased federal tax burden resulting
from the application of Section 848 of the Internal Revenue Code of 1986, as amended.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
FILING DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
July 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
HEARING OR NOTIFICATION OF HEARING:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 An order granting the application will be issued unless the Commission order a hearing. Interested persons may request
a hearing on this application by writing to the Secretary of the SEC and serving Applicants with a copy of the request,
personally or by mail. Hearing requests must be received by the SEC by 5:30 p.m. on January 6, 1995, and should be accompanied
by proof of service on Applicants in the form of an affidavit or, for lawyers, by certificate. Hearing requests should
state the nature of the interest, the reason for the request, and the issues contested. Persons may request notification
of a hearing by writing to the Secretary of the SEC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Secretary, SEC, 450 Fifth Street, N.W., Washington, D.C. 20549. Applicants, Providentmutual Life and Annuity Company
of America, 1600 Market Street, Philadelphia, Pennsylvania 19103.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Patrice M. Pitts, Attorney, at (202) 942&hyph;0670, Office of Insurance Products, Division of Investment Management.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Following is a summary of the application. The complete application is available for a fee from the Public Reference
Branch of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applicants' Representations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Providentmutual, a stock life insurance company incorporated under the name of Washington Square Life Insurance
Company in the Commonwealth of Pennsylvania in 1958 and redomiciled as a Delaware insurance company in December 1992,
is a wholly-owned subsidiary of Provident Mutual Life Insurance Company of Philadelphia (``Provident Mutual Life''),
a mutual insurance company chartered by the Commonwealth of Pennsylvania in 1865. Providentmutual currently is
licensed to transact life insurance business in 48 states and the District of Columbia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. For purposes of the 1940 Act, Providentmutual is depositor and sponsor of the Account (and would be the depositor
and sponsor of any future accounts) as those terms have been interpreted by the Commission with respect to variable
life insurance company separate accounts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Providentmutual currently is developing a new flexible premium adjustable variable life insurance contract
(the ``Contract'') which includes the ``tax burden charge'' identified above and as explained more fully below.
Providentmutual also anticipates that it would include such a charge in future flexible premium variable life insurance
contracts (``future contracts'') that it may develop.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The Contract and any future contracts issued by Providentmutual may be supported by the Account or any future accounts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00148 </DOCNO>
<PARENT> FR941219-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. The Account was established by Providentmutual as a separate investment account under Delaware law on June 30,
1994, as a funding vehicle for variable life insurance contracts. The Account will be registered under the 1940 Act
as a unit investment trust. The Account will be divided into subaccounts, each of which will invest exclusively in
the shares of a designated investment portfolio of a specified open-end management investment company registered
under the 1940 Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Under Delaware law, amounts allocated to the Account are owned by Providentmutual. To the extent provided under
the Contract, however, that portion of the assets of the Account equal to the reserves and other Contract liabilities
pertaining to the Account shall not be chargeable with liabilities arising out of any other business Providentmutual
may conduct. The income, gains and losses, realized and unrealized, from the assets allocated to the Account are credited
to or charged against the Account without regard to other income, gains or losses of Providentmutual. The Account
is, and any future account will be, a ``separate account,'' as defined by Rule 0&hyph;1(e) under the 1940 Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. PML is an indirect wholly-owned subsidiary of Provident Mutual Life Insurance Company of Philadelphia. PML acts
as principal underwriter, as defined in the 1940 Act, of the variable life insurance contracts supported by the Account.
PML is registered as a broker-dealer under the Securities Exchange Act of 1934, and is a member of the National Association
of Securities Dealers, Inc. Applications for the Contracts and future contracts will be solicited by registered
representatives of PML, or other broker-dealers having selling agreements will PML, who are licensed by applicable
state insurance authorities to sell flexible premium variable life insurance contracts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. In the Omnibus Budget Reconciliation Act of 1990, Congress amended the Internal Revenue Code of 1986 (the ``Code'')
by, among other things, enacting Section 848 thereof. Section 848 changed the federal income taxation of life insurance
companies by requiring them to capitalize and amortize over a period of ten years part of their general expenses for
the current year. Under prior law, these expenses were deductible in full from the current year's gross income. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. The amount of expenses that must be capitalized and amortized under Section 848 is generally determined with reference
to premiums for certain categories of life insurance and other contracts (``specified contracts''). Thus, for each
specified contract, an amount of expenses must be capitalized and amortized equal to a percentage of the current year's
net premiums (i.e., gross premiums minus return premiums and reinsurance premiums) for that contract. The percentage
varies, depending on the type of specified contract in question, according to a schedule set forth in Section 848(c)(1).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. Although framed in terms of requiring a portion of a life insurance company's general expenses to be capitalized
and amortized, Section 848 in effect accelerates the realization of income from specified contracts for federal
income tax purposes and, therefore, the payment of taxes on the income generated by those contracts. When the time
value of money is taken into account, this has the economic consequence of increasing the tax burden borne by the insurance
company that is attributable to such contracts. Because the amount of general deductions that must be capitalized
and amortized is measured by premiums paid for specified contracts, an increased tax burden results from the receipt
of those premiums. In this respect, the impact of Section 848 can be compared with that of a state premium tax. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. The Contract and any future contracts to which the ``tax burden charge'' will be applied are among the specified
contracts. They fall into the category of life insurance contracts for which the percentage of net premiums that determines
the amount of otherwise currently deductible general expenses to be capitalized and amortized with respect to such
contracts is 7.7 percent. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. The increased tax burden resulting from the applicability of Section 848 to every $10,000 of net premiums received
may be quantified as follows. In the year when the premiums are received, Providentmutual's general deductions are
reduced by $731.50_i.e., an amount equal to (a) 7.7 percent of $10,000, or $770, minus (b) one-half year's portion
of the ten-year amortization, or $38.50. Using a 35 percent corporate tax rate, this works out to an increase in tax
for the current year of $256.03. This reduction will be partially offset by increased deductions that will be allowed
during the next ten years as a result of amortizing the remainder of the $770_$77 in each of the following nine years,
and $38.50 in the tenth year. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. To the extent and capital must be used by Providentmutual to satisfy its increased federal tax burden under Section
848 resulting from the receipt of premiums, such profits are not available to Providentmutual for investment. Accordingly
Providentmutual submits that its targeted rate of return is appropriate for use in this present value calculation.
Because it seeks an after tax rate of return of 9.3 percent on its invested capital
<FOOTCITE>1</FOOTCITE>
 Providentmutual submits that a discount rate of at least 9.3 percent is appropriate for use in calculating the present
value of its future tax deductions resulting from the amortization described above. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In determining its cost of capital, Providentmutual considered a number of factors. Providentmutual first projected
its future growth rate based on sales projects, current interest rates, the inflation rate, and the amount of capital
that it can provide to support such growth. Providentmutual then used the anticipated growth rate and other factors
(such as market interest rates, Providentmutual's anticipated long-term growth rate, the risk level for this type
of business that is acceptable to Providentmutual, inflation and available information about the rates of return
obtained by other insurance companies) to set a rate of return on capital that equals or exceeds this rate of growth.
(Of these other factors, market interest rates, the acceptable risk level and the inflation rate receive significantly
more weight than information about the rates of return obtained by other insurance companies.) Providentmutual
represents that these are appropriate factors for Providentmutual to consider in determining its cost of capital.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Providentmutual also took into account the ratio of surplus to assets that it seeks to maintain. Providentmutual
represents that maintaining the ratio of surplus to assets is critical to maintaining a competitive rating from various
rating agencies and to offering competitively priced products (i.e., sufficient dividends on outstanding contracts
and competitive pricing on newly offered contracts). Consequently, Providentmutual asserts that its surplus must
grow at least at the same rate as its assets. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
14. Using a corporate tax rate of 35 percent, and assuming a discount rate of 9.3 percent, the present value of the tax
effect of the increased deductions allowable in the following ten years comes to $165.16. Because this amount partially
offsets the increased tax burden, applying Section 848 to the specified contracts imposes an increased tax burden
on Providentmutual equal to a present value of $90.87 (i.e., $256.03 minus $165.16) for each $10,000 of net premiums.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00149 </DOCNO>
<PARENT> FR941219-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
15. Because state premium taxes are deductible when computing federal income taxes, Providentmutual does not incur
incremental income tax when it passes on state premium taxes to contract owners. In contrast, federal income taxes
are 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
not 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
tax-deductible when computing Providentmutual's federal income taxes. Therefore, to offset fully the impact of
Section 848, Providentmutual must impose an additional charge that would make it whole not only for the $90.87 additional
tax burden attributable to Section 848, but also for the tax on the additional $90.87 itself. This additional charge
can be computed by dividing $90.87 by the complement of the 35 percent federal corporate income taxe rate (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
65 percent), resulting in an additional charge of $139.80 for each $10,000 of net premiums, or 1.40 percent of net premiums.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. Tax deductions are of value to Providentmutual only to the extent that it has sufficient gross income to fully utilize
the deductions. Based on its prior experience, Providentmutual submits that it can reasonably expect to have sufficient
taxable income in future years to utilize all deferred acquisition cost deductions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
17. Providentmutual submits that a charge of 1.25 percent of premium payments would reimburse it for the impact of
Section 848 (as currently written) on its federal tax liabilities. Providentmutual represents that a 1.25 percent
charge is reasonably related to its increased tax burden under Section 848, taking into account the benefit to Providentmutual
of the amortization permitted by Section 848, and the use by Providentmutual of a 9.3 percent discount rate in computing
the future deductions resulting from such amortization, such rate being the equivalent of Providentmutual's cost
of capital.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
18. Providentmutual asserts that it would have to increase the 1.25 percent charge if future changes in, or interpretations
of, Section 848 or any successor provision result in a further increased tax burden resulting from the receipt of premiums.
Such an increase could result from a change in the corporate tax rate, a change in the 7.7 percent figure, or a change
in the amortization period. The Contract and any future contracts issued by Providentmutual will reserve the right
to increase or decrease the 1.25 percent charge in response to future changes in, or interpretations of, Section 848
or any successor provision that increase or decrease Providentmutual's tax burden.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applicant's Legal Analysis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Section 6(c) of the 1940 Act provides, in relevant part, that the Commission, by order upon application, may exempt
any person, security or transaction (or any class or classes of persons, securities or transactions) from provisions
of the 1940 Act or any rules thereunder, if and to the extent that the exemption is necessary or appropriate in the public
interest and consistent with the protection of investors and the purposes fairly intended by the policy and provisions
of the 1940 Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Applicants request an order of the Commission pursuant to Section 6(c) of the 1940 Act, exempting them from the provisions
of Section 27(c)(2) of the 1940 Act and Rule 6e&hyph;3(T)(c)(4)(v) thereunder to the extent necessary to permit Applicants
to deduct from premium payments received in connection with the Contracts and any future contracts an amount that
is reasonable in relation to Providentmutual's increased federal tax burden created by its receipt of such premium
payments. The deduction would not be treated as sales load.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Relief From Provisions of Section 27(c)(2) and Rule 6e&hyph;3(T)(c)(4)(v)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Section 2(a)(35) of the 1940 Act defines ``sales load'' as the difference between the price of a security offered
to the public and that portion of the proceeds from its sale which is received and invested or held for investment by
the issuer (or in the case of a unit investment trust, by the depositor or trustee), less any portion of such difference
deducted for trustees's or custodian's fees, insurance premiums, issue taxes, or administrative expenses or fees
which are not properly chargeable to sales or promotional activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Section 27(c)(2) of the 1940 Act prohibits a registered investment company or a depositor or underwriter for such
company from making any deduction from purchase payments made under periodic payment plan certificates other than
a deduction for sales load. Sections 27(a) (1) and 27(h)(1) of the 1940 Act, in effect, limit sales loads on periodic
payment plan certificates to 9 percent of total payments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Paragraph (a) of Rule 6e&hyph;3(T) requires that a separate account (such as the Account or any future accounts)
that issues flexible premium variable life insurance contracts, its principal underwriter and its depositor, comply
with all provisions of the 1940 Act and rules thereunder applicable to a registered investment company issuing periodic
payment plan certificates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Paragraph (b) of Rule 6e&hyph;3(T) provides numerous limited conditional exemptions from most such provisions
and rules in connection with the offer, sale and administration of flexible premium variable life insurance contracts.
For example, among other things, Rule 6e&hyph;3(T)(b)(13)(iii)(E) provides relief from Section 27(c)(2) of the
1940 Act to the extent necessary to permit the deduction of certain charges other than sales load, including ``[t]he
deduction of premium or other taxes imposed by any state or other governmental entity.'' Applicants request the relief
from Section 27(c)(2) sought in this application only to preclude the possibility that a charge related to the increased
burden resulting from Section 848 of the Code is not covered by the exemption provided by Rule 6e&hyph;3(T)(b)(13)(iii)(E).
Applicants submit that the public policy reasons underlying Rule 6e&hyph;3(T)(b)(13)(iii)(E) provide support
for the exemption from Section 27(c)(2) requested herein. In this regard, Applicants note that the Commission previously
has issued orders granting substantially similar relief to that requested by Applicants, including an order to Providentmutual's
corporate parent under nearly identical circumstances.
<FOOTCITE>2</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Provident Mutual Life Insurance Company, Investment Company Act Release Nos. 19552 (July 1, 1993) and 19519 (June
4, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Applicants represent that the requested exemption is necessary if they are to rely on Rule 6e&hyph;3(T)(b)(13)(i)
under the 1940 Act, which provides critical exemptions from Sections 27(a)(1) and 27(h)(1) thereof. Applicants
note that issuers and their affiliates may rely on Rule 6e&hyph;3(T)(b)(13)(i) only if they meet its alternative
limits that apply to ``sales load,'' as defined in rule 6e&hyph;3(T)(c)(4). Rule 6e&hyph;3(T)(c)(4) defines ``sales
load'' during a contract period as the excess of any payments made during that period over certain specified charges
and adjustments, including a deduction for and approximately equal to state premium taxes. Applicants represent
that a ``tax burden charge'' such as the one Providentmutual proposes to deduct does not fall squarely into any of the
itemized categories of charges or adjustments. Applicants note that a literal reading of Rule 6e&hyph;3(T)(c)(4)
arguably does not exclude such a ``tax burden charge'' from sales load.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00150 </DOCNO>
<PARENT> FR941219-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
6. Applicants maintain, however, that there is no public policy reason why a ``tax burden charge'' designed to cover
the expense of federal taxes should be treated as sales load or otherwise be subject to the sales load limits of Rule
6e&hyph;3(T). Applicants also assert that nothing in the administrative history of Rule 6e&hyph;3(T) (or, for that
matter, in the administrative history of Rule 6e&hyph;2, its predecessor rule) suggests that the Commission intended
to treat tax charges as sales load.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Applicants assert that the public policy that underlies Rule 6e&hyph;3T(b)(13)(i), like that which underlies
Sections 27(a)(1) and 27(h)(1), is to prevent excessive sales loads from being charged in connection with the sale
of periodic payment plan certificates. Applicants submit that the treatment of a ``tax burden charge'' attributable
to the receipt of purchase payments as sales load would in no way further this legislative purpose because such a deduction
has no relation to the payment of sales commissions or other distribution expenses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Applicants assert that the genesis of Rule 6e&hyph;3T(c)(4) supports this analysis. in this regard, Applicants
note that Section 2(a)(35) of the 1940 Act provides a scale against which the percent limits of Sections 27(a)(1) and
27(h)(1) thereof may be measured. Applicants submit that the Commission's intent in adopting Rule 6e&hyph;3T(c)(4)
was to tailor the general terms of Section 2(a)(35) to flexible premium variable life insurance contracts in order,
among other things, to facilitate verification by the Commission of compliance with the sales load limits set forth
in Rule 6e&hyph;3T(b)(13)(i). Applicants submit that Rule 6e&hyph;3T(c)(4) does not depart, in principal, from
Section 2(a)(35), and that both Section 2(a)(35) and Rule 6e&hyph;3T(c)(4) define ``sales load'' derivatively.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Applicants further assert that Section 2(a)(35) clearly excludes from the definition of ``sales load'' under
the 1940 Act deductions from purchase payments for ``issue taxes.'' Applicants submit that the exclusion of charges
for expenses attributable to federal taxes from sales load (as defined in Section 2(a)(35)) is consistent with the
protection of investors and the purposes intended by the policies and provisions of the 1940 Act. By extension, Applicants
submit, it is equally consistent to exclude such charges, including the ``tax burden charge'' described above, from
the definition of ``sales load'' in Rule 6e&hyph;3T(c)(4).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. Applicants submit that the reference in Section 2(a)(35) to administrative expenses or fees that are ``not properly
chargeable to sales or promotional activities'' suggests that the only charges or deductions intended to fall within
the definition of ``sales load'' are those that 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
are
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 properly chargeable to such activities. Because the proposed ``tax burden charge'' will be used to pay costs attributable
to Providentmutual's federal tax liabilities, and such costs are not properly chargeable to sales or promotional
activities, Applicants assert that the language of Section 2(a)(35) is another indication that not treating the
proposed ``tax burden charge'' as sales load is consistent with the purposes intended by the policies and provisions
of the 1940 Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. Applicants state that the specification of only state premium taxes in Rule 6e&hyph;3T(c)(4)(v) probably is
an historical accident, related to the fact that the Section 848 tax burden attributable to the receipt of premiums
did not exist when Rule 6e&hyph;3T was initially adopted in 1984 and amended in 1987. Applicants note that nothing
in the administrative history of Rule 6e&hyph;3(T) suggests that the exclusion from the definition of ``sales load''
of deductions for tax liabilities attributable to the amount of premium payments received was tried to the type of
government entity imposing such taxes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00151 </DOCNO>
<PARENT> FR941219-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
12. For these reasons, Applicants assert that deducting a charge from variable life insurance contract premium payments
for an insurer's tax burdens attributable to its receipt of such payments and excluding that charge from sales load
is appropriate in the public interest and consistent with the protection of investors and the purposes fairly intended
by the policy and provisions of the 1940 Act. Applicants submit that this is because such a charge is for a legitimate
expense of the insurer and is not designed to cover sales and distribution expenses. Applicants note that, in adopting
Rule 6e&hyph;3(T) and its analog, Rule 63&hyph;2, which applies to schedule premium variable life insurance contracts,
the Commission considered similar deductions for tax burdens in respect of premium taxes. In each case, the Commission
permitted deductions for such taxes to be made and to be treated as other than sales load. Applicants submit that the
propriety of a charge for an insurer's tax burden attributable to premium payments received is the same whether such
burden arises under state or federal law.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Request for ``Class Relief''
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Applicants note that the relief sought herein applies to existing Accounts as well as to future accounts that Providentmutual
may establish to support flexible premium variable life insurance contracts. Such future accounts may be established
as additional investment options under previously issued contracts. Such future accounts may be established as
additional investment options under previously issued contracts that have a ``tax burden charge'' or as investment
options for new contracts that may have a ``tax burden charge.''
<!-- PJG 0012 frnewline -->
2. Applicants submit that because the terms of any exemption sought for the future accounts to permit the deduction
of a ``tax burden charge'' would be substantially identical to those in this application, any additional requests
for exemptive relief for the future accounts would present no issues under the 1940 Act that have not already been addressed
in this application. Applicants note, however, that unless the ``class relief'' requested herein is granted, Providentmutual
would have to request and obtain exemptive relief for each future account to the extent required. For the reasons set
forth below, Applicants assert that the requested exemptions are appropriate in the public interest and are consistent
with the protection of investors and the purposes intended by the policy and provisions of the 1940 Act.
<!-- PJG 0012 frnewline -->
3. Applicants submit that the requested ``class relief'' would promote competitiveness in the variable life insurance
market by eliminating the need for Providentmutual to file redundant exemptive applications, thereby reducing
its administrative expenses and maximizing the efficient use of its resources. Applicants submit that the delay
and expense involved in having repeatedly to seek the same exemptions would impair Providentmutual's ability to
effectively take advantage of business opportunities as they arise.
<!-- PJG 0012 frnewline -->
4. Applicants further submit that owners of Contracts and future contracts would receive no benefit or additional
protection if Providentmutual were required repeatedly to seek Commission orders with respect to the same issues
addressed in this application; indeed, they might be disadvantaged as a result of Providentmutual's increased overhead
expenses.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conditions for Relief
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Applicants agree to comply with the following conditions for relief:
<!-- PJG 0012 frnewline -->
a. Providentmutual will monitor the reasonableness of the 1.25 percent charge.
<!-- PJG 0012 frnewline -->
b. The registration statement for the Contract and for any future contracts under which the 1.25 percent charge is
deducted will include: (i) disclosure of the charge; (ii) disclosure explaining the purpose of the charge; and (iii)
a statement that the charge is reasonable in relation to Providentmutual's increased tax burden as a result of applying
Section 848 of the Code.
<!-- PJG 0012 frnewline -->
c. Providentmutual also will include an exhibit to the registration statement for the Contract and for any other variable
life insurance contract under which the 1.25 percent charge is deducted an actuarial opinion as to: (i) the reasonableness
of the charge in relation to Providentmutual's increased tax burden as a result of Section 848 of the Code; (ii) the
reasonableness of the after tax rate of return used in calculating the charge; and (iii) the appropriateness of the
factors taken into account by Providentmutual in determining the after tax rate of return.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants submit that for the reasons and upon the facts set forth above, the requested exemptions from Section 27(c)(2)
of the 1940 Act and Rule 6e&hyph;3(T)(c)(4)(v) thereunder to permit the deduction of 1.25 percent of premium payments
under the Contracts and any future contracts meet the standards of Section 6(c) of the 1940 Act. In this regard, Applicants
assert that granting the requested relief would be appropriate in the public interest and consistent with the protection
of investors and the purposes fairly intended by the policy and provisions of the 1940 Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Investment Management, under delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31102 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00152 </DOCNO>
<PARENT> FR941219-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;35084; International Series Release No. 756; File No. SR&hyph;Amex&hyph;94&hyph;54]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Notice of Filing and Immediate Effectiveness of Proposed Rule Change by the American
Stock Exchange, Inc. Relating to the Listing of Options on the Amex Airline Index </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''), 15 U.S.C. 78s(b)(1), notice is hereby
given that on December 7, 1994, the American Stock Exchange, Inc. (``Amex'' or ``Exchange'') filed with the Securities
and Exchange Commission (``Commission'') the proposed rule change as described in Items I, II, and III below, which
Items have been prepared by the Exchange. The Commission is publishing this notice to solicit comments on the proposed
rule change from interested persons. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange proposes to trade options on The Amex Airline Index (``Index''), a new stock index developed by the Amex
based on airline industry stocks (or ADRs thereon) which are traded on the Amex, the New York Stock Exchange, Inc. (``NYSE''),
or are national market system (``Nasdaq/NMS'') securities traded through Nasdaq. In addition, the Amex proposes
to amend Rule 901C, Commentary .01 to reflect that 90% of the Index's numerical index value will be accounted for by
stocks that meet the current criteria and guidelines set forth in Rule 915. The text of the proposed rule change is available
at the Office of the Secretary, the Amex, and at the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In its filing with the Commission, the Amex included statements concerning the purpose of and basis for the proposed
rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has
prepared summaries, set forth in Section (A), (B), and (C) below, of the most significant aspects of such statements.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
(A)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=3 -->
 Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The Amex has developed a new industry-specific index called The Amex Airline Index, based entirely on shares of widely-held
airline industry stocks or American Depository Receipts (``ADRs'') which are exchange listed or are Nasdaq/NMS
securities.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 It is intended that the Amex list standardized option contracts on the newly developed Index. The Exchange is filing
this proposal pursuant to Rule 901C, Commentary .02, which provides for the commencement of trading of options on
the Index thirty days after the filing date, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 30 days after December 7, 1994. The Exchange represents that the proposal satisfies all the criteria set forth in Commentary
.02 to Rule 901C and the Commission's order approving that rule as outlined below.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The component securities of the Index are AMR Corp., British Airways PLC (ADR), Southwest Airlines; UAL Corporation,
Delta Air Lines Inc., KLM Royal Dutch Air, Alaska Airgroup Inc., Continental Airlines Inc. (Class B), Northwest Airlines
Corporation, and USAir Group. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 34157 (June 3, 1994), 59 FR 30062 (June 10, 1994) (``Generic Index Approval Order'').

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Eligibility Standards for Index Components
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Commentary .02 to Amex Rule 901C, the Amex represents that all of the component securities of the Index
are listed on the NYSE or are Nasdaq/NMS securities, each of the component securities has a minimum market capitalization
of at least $75 million,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and each has a monthly trading volume of at least one million shares per month over each of the six months preceding the
filing of this proposal. In addition, all of the component securities in the Index have standardized options traded
on them and thus have met the initial eligibility criteria for standardized options trading set forth in Amex Rule
915. One component (USAir Group), however, has traded below $5 during two of the last six months. While it is not known
at this point whether options on USAir Group will eventually be delisted, the Index would still satisfy the criteria
set forth in Commentary .02 to Rule 901C because as a result of each quarterly rebalancing, at least 90% of the value
of the Index and at least 80% of the total number of components will meet the standards set forth in Rule 915.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In the case of ADRs, this represents market value as measured by total world-wide shares outstanding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00153 </DOCNO>
<PARENT> FR941219-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As a result of the ``equal dollar-weighting'' calculation methodology,
<FOOTCITE>4</FOOTCITE>
 no individual component stock in the Index represents more than 25% of the weight of the Index following each quarterly
rebalancing. Additionally, the top five highest weighted stocks in the Index do not constitute more than 60% of the
weight of the Index. Finally, because the sole ADR component of the Index (British Airways PLC) has standardized options
trading on it, the Index also satisfies the criteria that no more than 20% of the weight of the Index can be composed of
non-options eligible foreign securities (including ADRs).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 discussion of Index calculation, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
infra.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Maintenance of the Index
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange will maintain the Index so that (1) the total number of component securities will not increase or decrease
by more than 331/3% from the number of components in the proposed Index (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 10) and in no event will the Index have less than nine components; (2) component stocks constituting the top 90% of
the Index by weight, must have a minimum market capitalization of $75 million and the component stocks constituting
the bottom 10% of the Index, by weight, must have a minimum market capitalization of $50 million; (3) the monthly trading
volume of each component security shall be at least 500,000 shares, provided, however, that components accounting
in aggregate for no more than 10% of the Index, by weight, shall have a monthly trading volume of at least 400,000 shares;
and (4) the Index shall satisfy the criteria that no single component will represent more than 25% of the weight of the
Index and that the five highest weighted component shall represent no more than 60% of the weight of the Index, as of
each quarterly rebalancing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Exchange shall not open for trading any additional option series should the Index fail to satisfy any of the maintenance
criteria set forth above unless such failure is determined by the Exchange not to be significant and the Commission
concurs in that determination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Index Calculation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Index is calculated using an ``equal dollar-weighting'' methodology designed to ensure that each of the component
securities is represented in an approximately ``equal'' dollar amount in the Index. The Exchange believes that this
method of calculation is important since even among the largest companies in the airline industry there is great disparity
in market value. For example, although the stocks included in the Index represent many of the most highly capitalized
companies in the airline industry, the five most highly capitalized companies in the airline industry currently
represent approximately 80% of the aggregate market value of the Index. It has been the Exchange's experience that
options on market value weighted indexes dominated by relatively few component stocks are less useful to investors
because the index will tend to represent those few components and not the broader target sector that the index is designed
to represent.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following is a description of how the equal dollar-weighting calculation method works. As of the market close
on October 21, 1994, a portfolio of airline securities was established representing an investment of $10,000 in the
stock (or ADR) (rounded to the nearest whole share) of each of the companies in the Index. The value of the Index equals
the current market value (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 based on U.S. primary market prices) of the sum of the assigned number of shares of each of the securities in the Index
portfolio divided by the Index divisor. The Index divisor was initially determined to yield the benchmark value of
200.00 at the close of trading on October 21, 1994. Each quarter thereafter, following the close of trading on the third
Friday of January, April, July, and October, the Index portfolio will be adjusted by changing the number of whole shares
of each component security so that each company is again represented in ``equal'' dollar amounts. The Exchange has
chosen to rebalance following the close of trading on the quarterly expiration cycle because it allows an option contract
to be held for up to three months without a change in the Index portfolio while at the same time, maintaining the equal
dollar-weighting feature of the Index. If necessary, a divisor adjustment is made at the rebalancing to ensure continuity
of the Index's value. The newly adjusted portfolio becomes the basis for the Index's value on the first trading day
following the quarterly adjustment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00154 </DOCNO>
<PARENT> FR941219-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As noted above, the number of shares of each component security in the Index portfolio remains fixed between quarterly
reviews except in the event of certain types of corporate actions such as the payment of a dividend other than an ordinary
cash dividend, a stock distribution, stock split, reverse stock split, rights offering, distribution, reorganization,
recapitalization, or similar event with respect to the component securities. In a merger or consolidation of an issuer
of a component security, if the stock or ADR remains in the Index, the number of shares of that security in the portfolio
may be adjusted, to the nearest whole share, to maintain the component's relative weight in the Index at the level immediately
prior to the corporate action. In the event of a stock or ADR replacement, the average dollar value of the remaining
portfolio components will be calculated and that amount invested in the security of the new component, to the nearest
whole share. In all cases, the divisor will be adjusted, if necessary, to ensure Index continuity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Amex will calculate and maintain the Index, and pursuant to Exchange Rule 901C(b) may at any time or from time to
time substitute securities, or adjust the number of securities included in the Index based on changing conditions
in the airline industry. In the event, however, that the Exchange determines to increase the number of Index components
to greater than thirteen or to reduce the number of components to fewer than nine, the Exchange will submit a 19b&hyph;4
filing to the Commission. In selecting securities to be included in the Index, the Exchange will be guided by a number
of factors including market value of outstanding shares, trading activity, and adherence to Rule 901C, Commentary
.02. Similar to other stock index values published by the Exchange, the value of the Index will be calculated continuously
and disseminated every 15 seconds over the Consolidated Tape Association's Network B.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Expiration and Settlement
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed options on the Index are European-style,
<FOOTCITE>5</FOOTCITE>
 and cash-settled. The Exchange's standard option trading hours (9:30 a.m. to 4:10 p.m. Eastern Standard Time) will
apply to Index options. The options on the Index will expire on the Saturday following the third Friday of the expiration
month (``Expiration Friday''). The last trading day in an Index option series will normally be the second to last business
day preceding the Saturday following Expiration Friday (normally a Thursday). Trading in expiring Index options
will cease at the close of trading on the last trading day.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
European-style options may only be exercised during a specified time period immediately prior to expiration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange plans to list Index options series with expirations in the three near-term calendar months and in the
two additional calendar months in the January cycle. In addition, longer term option series having up to thirty-six
months to expiration may be traded. In lieu of such long-term options based on the full-value of the Index, the Exchange
may instead list long-term, reduced-value put and call options based on one tenth (1/10th) of the Index's full value.
In either event, the interval between expiration months for either a full-value of reduced-value long-term Index
option will not be less than six months. The trading of any long-term Index options would be subject to the same rules
which govern the trading of all the Exchange's index options, including sales practice rules, margin requirements,
and floor trading procedures. Position limits on reduced-value long-term Index options will be equivalent to the
position limits for regular (full-value) Index options and would be aggregated with such options. For example, if
the position limit for the full-value options on the Index is 10,500 contracts on the same side of the market, then the
position limit for the reduced-value options will be 105,000 contracts on the same side of the market and positions
in reduced-value Index options will be aggregated with positions in full-value Index options.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The exercise settlement value for all of the expiring Index options will be calculated based upon the primary exchange
regular way opening sale prices for the component securities. In the case of Nasdaq/NMS securities, the first reported
sale price will be used. If any component security does not open for trading on its primary market on the last day before
expiration, then the prior day's last sale price will be used in the exercise settlement value calculation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Exchange Rules Applicable to Stock Index Options
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Amex Rules 900C through 980C will apply to the trading of option contracts based on the Index. These rules cover issues
such as surveillance, exercise prices, and position limits. Surveillance procedures currently used to monitor
trading in each of the Exchange's other index options will also be used to monitor trading in options on the Index. The
Index is deemed to be a Stock Index Option under Rule 901C(a) and a Stock Index Industry Group under Rule 900C(b)(1).
With respect to Rule 903C(b), the Exchange proposes to list near-the-money (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
strike prices within ten points above or below the current Index value) option series on the Index at 21/2 intervals
only when the value of the Index is below 200 points. In addition, the Exchange expects that the review required by Rule
904C(c) will result in a position limit of 10,500 contracts with respect to options on this Index.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Amex represents that the proposed rule change is consistent with Section 6(b) of the Act in general and furthers
the objectives of Section 6(b)(5)
<FOOTCITE>6</FOOTCITE>
 in particular in that it will permit trading in options based on the Amex Airline Index pursuant to rules designed to
prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, to foster
cooperation and coordination with persons engaged in facilitating transactions in securities, and to remove impediments
to and perfect the mechanism of a free and open market and a national market system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. &sect;78f(b)(5) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00155 </DOCNO>
<PARENT> FR941219-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
(B) Self-Regulatory Organization's Statement on Burden on Competition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange does not believe that the proposed rule change will impose any burden on competition.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
(C) Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No written comments were solicited or received with respect to the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Because the foregoing proposed rule change complies with the standards set forth in the Generic Index Approval Order,
it has become effective pursuant to Section 19(b)(3)(A) of the Act. Pursuant to the Generic Index Approval Order,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the Exchange may not list Amex Airline Index options for trading prior to 30 days after December 7, 1994, the date the
proposed rule change was filed with the Commission. At any time within 60 days of the filing of the proposed rule change,
the Commission may summarily abrogate the rule change if it appears to the Commission that such action is necessary
or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes
of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See supra 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
note 2.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Solicitation of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street, N.W., Washington, D.C. 20549. Copies of the submission, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. &sect;552, will be available for inspection and copying at the Commission's
Public Reference Section, 450 Fifth Street, N.W., Washington, D.C. 20549. All submissions should refer to File No.
SR&hyph;Amex&hyph;94&hyph;54 and should be submitted by January 9, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31039 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00156 </DOCNO>
<PARENT> FR941219-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;35079; File No. SR&hyph;MSRB&hyph;94&hyph;13]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Municipal Securities Rulemaking Board; Order Approving a Proposed Rule Change
Relating to Depository Eligibility of New Issue Municipal Securities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On August 17, 1994, the Municipal Securities Rulemaking Board (``MSRB'') filed with the Securities and Exchange
Commission (``Commission'') a proposed rule change (File No. SR&hyph;MSRB&hyph;94&hyph;13) pursuant to Section
19(b)(1) of the Securities Exchange Act of 1934 (``Act'').
<FOOTCITE>1</FOOTCITE>
 Notice of the proposal was published on September 6, 1994, in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to solicit comments on the proposed rule change.
<FOOTCITE>2</FOOTCITE>
 Eleven comment letters were received.
<FOOTCITE>3</FOOTCITE>
 For reasons discussed below, the Commission is approving the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 34607 (August 26, 1994), 59 FR 46075.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Ten of the comment letters were received by the MSRB prior to publication of the notice. Letters from Gregory P. Vitt,
Vice President, Cashier Department, A.G. Edwards &amp; Sons, Inc., to Judith A. Somerville, MSRB (May 1, 1994) (``A.G.
Edwards letter''); Walter J. Roesch, President, The Cashiers' Association of Wall Street, Inc., to Judith Somerville,
MSRB (June 2, 1994) (``Cashiers letter''); John J. Flynn, Senior Vice President, Fleet Securities, to Judith Somerville,
Uniform Practice Specialist (``Specialist''), MSRB (June 23, 1994) (``Fleet letter''); Edward C. Brisotti, Vice
President, Operations Division, Goldman, Sachs &amp; Co., to Judith Somerville, Specialist, MSRB (May 18, 1994)
(``Goldman letter''); Jill M. Considine, President, New York Clearing House, to Judith Somerville, Specialist,
MSRB (May 27, 1994) (``NYCH letter''); George Brakatselos, Vice President, Public Securities Association, to Judith
Somerville, Specialist, MSRB (July 5, 1994) (``PSA letter''); Bruce L. Vernon, President, and Thomas Sargant, Vice
President, The Regional Municipal Operations Association, to Judith Somerville, MSRB (May 23, 1994, and September
23, 1994) (``RMOA letters''); Marc E. Lackritz, President, Securities Industry Association, to Judith Somerville,
Uniform Practice Specialist, MSRB (June 16, 1994) (``SIA letter''); Duane H. Thieme, Treasurer, Summers &amp; Company,
Inc., to Judith Somerville, Specialist, MSRB (May 20, 1994) (``Summers letter''); and Nicholas M. Ricciardi, Assistant
Vice President, Dean Witter Discover and Co., Dean Witter Reynolds, Inc., to Judith Somerville, Specialist, MSRB
(May 27, 1994) (``Dean Witter letter'').
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change amends MSRB Rule G&hyph;34 to require generally that dealers acquiring new issue municipal
securities apply for depository eligibility. This amendment is designed to facilitate the movement of municipal
securities to a three business day (``T+3'') settlement time frame.
<FOOTCITE>4</FOOTCITE>
 Because interdealer and institutional customer transactions are settled on a delivery vs. payment or receipt vs.
payment (``DVP/RVP'') basis, it is critical that the delivery of securities be made in a timely manner on the settlement
date. The physical delivery of securities certificates, however, is relatively time-consuming and inefficient
as compared to book-entry delivery through a securities depository. A shortened settlement cycle will provide dealers,
institutional customers, and their clearing agents with less time to deal with the processing requirements and inevitable
problems that arise in connection with transportation, delivery, and acceptance of physical securities certificates.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
On October 6, 1993, the Commission adopted Rule 15c6&hyph;1 under the Act which establishes three business days after
the trade date (``T+3'') instead of five business days (``T+5'') as the standard settlement timeframe for most broker-dealer
transactions. The rule becomes effective June 7, 1995. Securities Exchange Act Release Nos. 33023 (October 6, 1993),
58 FR 52891 and 34952 (November 9, 1994), 59 FR 59137. Although municipal securities were not included within the scope
of Rule 15c6&hyph;1, the Commission did request that MSRB provide a plan for implementing T+3 settlement in the municipal
securities market. In response, MSRB submitted to the Commission its 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Report of the Municipal Securities Rulemaking Board on T+3 Settlement for the Municipal Securities Market (March
17, 1994) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
(``T+3 Report''). The T+3 Report detailed changes in operational practices and regulatory actions that will be needed
in the municipal securities market in a T+3 environment. The T+3 Report discussed the need to increase the number of
securities made depository eligible in order to minimize the use of physical securities certificates to settle interdealer
and institutional customer transactions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MSRB Rules G&hyph;12(f)(ii) and G&hyph;15(d)(iii) require essentially all interdealer and institutional customer
transactions be settled by book-entry when the securities involved in the transactions are listed as eligible for
deposit in a depository. The proposed rule change facilitates book-entry settlement of transactions in municipal
securities by requiring, with limited exceptions, that dealers that acquire new issue municipal securities apply
for depository eligibility.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the proposed rule change, brokers, dealers, and municipal securities dealers are required to apply for depository
eligibility within one business day of the date of sale of a new issue municipal security.
<FOOTCITE>5</FOOTCITE>
 The proposed rule change exempts (1) issues not meeting the eligibility criteria of all depositories that accept
municipal securities for deposit and (2) issues maturing in sixty days or less. The proposed rule change also provides
an exemption until July 1, 1996, for issues under $1 million in par value.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For competitively sold issues, the date of award from the issuer is considered the date of sale. For negotiated issues,
the date of execution of the contract to purchase the securities from the issuer is considered the date of sale.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MSRB has asked that the proposed rule change become effective sixty days from the date of approval. Therefore, the
proposed rule change will be effective on February 7, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00157 </DOCNO>
<PARENT> FR941219-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In March 1994, MSRB requested comment on a draft of the amendment to Rule G&hyph;34 (``Draft Amendment''). The Draft
Amendment included exemptions for issues not meeting the criteria set by depositories for eligibility and for new
issues under $1 million in par value. MSRB received eleven comment letters in response to the draft amendments.
<FOOTCITE>6</FOOTCITE>
 The comments generally supported the MSRB's proposal. Five commenters felt that the proposed rule change could facilitate
T+3 settlement.
<FOOTCITE>7</FOOTCITE>
 Two commenters noted that settlement through a depository was more efficient and provided greater cost savings than
settlement with physical certificates.
<FOOTCITE>8</FOOTCITE>
 Some commenters, however, suggested modifications to the draft amendments. In response to these comments, the MSRB
amended their proposal prior to filing the proposed rule change with the Commission.
<FOOTCITE>9</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Comment letters are set forth 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 3.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Dean Witter letter, Cashiers letter, NYCH letter, PSA letter, and SIA letter.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cashiers letter and Goldman letter.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The MSRB amended the proposed rule to require that the application to a depository be made within one business day of
the date of sale of the issue instead of ten days prior to closing. The MSRB also added the exemption for issues maturing
in sixty days or less.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Exemption Until July 1, 1996, for Issues Under $1 Million in Par Value
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Draft Amendment included exemptive language for issues under $1 million in par value.
<FOOTCITE>10</FOOTCITE>
 Nine commenters urged the MSRB to include issues under $1 million in par value within the scope of the rule with most
citing the need for increased settlement efficiencies offered by book-entry when T+3 becomes effective.
<FOOTCITE>11</FOOTCITE>
 Two commenters noted that ultimately all issues should be included within the scope of the rule but suggested a temporary
exemption for small issues because of their belief that some underwriters of small issues may need time to adjust their
procedures for book-entry distribution.
<FOOTCITE>12</FOOTCITE>
 Only the Summers letter stated that a permanent exemption for small issues should be included. In response to these
comments, the MSRB amended its proposal prior to filing with the Commission to include issues under $1 million in par
value but to provide a temporary exemption for such issues until July 1, 1996.
<FOOTCITE>13</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This exemption was included because some dealers believed physical settlements should be permissible for small
issues with limited distribution.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A.G. Edwards letter, Cashiers letter, Dean Witter letter, Fleet letter, Goldman letter, NYCH letter, PSA letter,
RMOA letters, and SIA letter.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Dean Witter and NYCH letters.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Four commenters suggested that a reduction in depository application fees would reduce the need for an exemption
for small issues. A.G. Edwards letter, RMOA letters, Summers letter, and NYCH letter.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00158 </DOCNO>
<PARENT> FR941219-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Other Suggested Exemptions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Summers letter suggested exempting municipal leases municipal notes, and municipal bonds sold to nondepository
participants. The MSRB rejected this suggestion, stating that it was not aware of any reason that these types of securities
should be treated differently than other municipal securities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and
regulations thereunder and particularly with the requirements of Section 15B(b)(2)(C).
<FOOTCITE>14</FOOTCITE>
 Section 15B(b)(2)(C) requires that the rules of the MSRB be designed to foster cooperation and coordination with
persons engaged in regulating, clearing, settling, and facilitating transactions in municipal securities. The
proposed rule change meets this requirement by creating a more efficient, safe, and cohesive environment for the
transfer of municipal securities.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78o&hyph;4(b)(2)(C) (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By requiring dealers acquiring new issue municipal securities to apply for depository eligibility, the proposal
will help to ensure that the great majority of new issue municipal securities are made depository eligible. As a result,
the number of interdealer and institutional customer transactions that must be settled by book-entry under MSRB
Rules G&hyph;12(f)(ii) and G&hyph;15(d)(iii) should increase greatly. By increasing the number of book-entry
settlements and by limiting the number of physical deliveries that occur, the rule will enhance the efficiency of
the clearance and settlement of municipal securities. As a consequence, a safer environment in which to facilitate
transactions in municipal securities will exist. The proposed rule change also facilitates the conversion to T+3
settlement of municipal securities and thus promotes cooperation and coordination with persons engaged in regulating,
clearing, and settling municipal securities.
<!-- PJG 0012 frnewline -->
The Commission believes that the limited exemption for issues under $1 million in par value adequately addresses
the concerns of the commenters. The PSA noted that almost 20% of the new issues in 1992 would have been eligible for the
small issue exemption. The Commission believes that it is important that the vast majority of securities be made depository
eligible. There are concerns, however, that underwriters of smaller issues may not be prepared for book-entry distribution.
The Commission believes that the temporary exemption will give underwriters of smaller issues an opportunity to
adapt to book-entry distribution while establishing a definite date by which smaller issues must be made depository
eligible.
<!-- PJG 0012 frnewline -->
The Commission also agrees with the MSRB's determination not to exempt municipal leases, municipal notes, and municipal
bonds sold to nondepository participants. The Commission believes that every effort should be made to make as many
types of municipal securities depository eligible as practicable.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the foregoing, the Commission finds that the proposal is consistent with the requirements of the Act
and particularly with Section 15B(b)(2)(C) of the Act and the rules and regulations thereunder.
<!-- PJG 0012 frnewline -->
It is therefore ordered, pursaunt to Section 19(b)(2) of the Act, that the proposed rule change (File No. SR&hyph;MSRB&hyph;94&hyph;13)
be, and hereby is, approved and will become effective February 7, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>15</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1994).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31040 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00159 </DOCNO>
<PARENT> FR941219-2-00082 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;35089; File No. SR&hyph;Phlx&hyph;94&hyph;58]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Notice of Filing of Proposed Rule Change by the Philadelphia Stock Exchange, Inc.,
Relating to its Rule 229 Governing Execution of PACE Orders</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''), 15 U.S.C. 78s(b)(1), notice is hereby
given that on December 1, 1994, the Philadelphia Stock Exchange, Inc. (``Phlx'' or ``Exchange'') filed with the Securities
and Exchange Commission (``Commission'') the proposed rule change as described in Items I, II and III below, which
Items have been prepared by the self-regulatory organization. On December 12, 1994, the Exchange filed with the Commission
Amendment No. 1 to the proposed rule change.
<FOOTCITE>1</FOOTCITE>
 The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 letter from William W. Uchimoto, Vice President and General Counsel, Phlx, to Glen Barrentine, Senior Counsel, SEC,
dated December 12, 1994. Amendment No. 1 made certain clarifying changes to the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Philadelphia Stock Exchange, Inc., pursuant to Rule 19b&hyph;4 of the Act, proposes to amend the Supplementary
Material section to its Rule 229 respecting the Philadelphia Stock Exchange Automated Communication and Execution
System (``PACE''). The text of the proposed rule change is as follows [new text is italicized; deleted text is bracketed]:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Rule 229
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;*&blank;* Supplementary Material
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
*&blank;*&blank;* Execution of Market Orders
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.05&blank;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Subject to Supplementary Material Section .07,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 all round-lot market orders up to 500 shares 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
and PRL market orders up to 599 shares
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<FOOTCITE>2</FOOTCITE>
 will be [executed automatically upon entry into the system; provided, however,]
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 stopped at the PACE Quote
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<FOOTCITE>3</FOOTCITE>
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
at the time of entry into the system (``Stop Price'') and be subject to a delay of up to 15 seconds from being executed
in order to receive an opportunity for price improvement. If such market order is not executed within the 15 second
window, the order will be automatically executed at the Stop Price. If the PACE Quote at the time of order entry into
the system reflects a 1/8 point spread between the best bid and offer, that order will be executed immediately without
the 15 second delay. Subject to these procedures,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the specialist may voluntarily agree to execute round-lot [and PRL] market orders of a size greater than 500 shares

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
and PRL market orders of a size greater than 599 shares
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 [automatically] upon entry into the system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The term ``PRL'' means a combined round-lot and odd-lot order. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Phlx Rule 229.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The term ``Pace Quote'' means the best bid/ask quote among the American, Boston, Cincinnati, Chicago, New York, Pacific,
or Philadelphia stock exchanges, or the Intermarket Trading System/Computer Assisted Execution System quote,
as appropriate. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Phlx Rule 229.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.07(a)&blank;Member organizations which enter market orders (round-lots up to 500 shares and PRL's up to 599 shares)
after the opening may elect to have such orders executed (i) [automatically on the PACE Quote] 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
in accordance with the procedures set forth in Supplementary Material Section .05
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or, (ii) if such execution price would be outside the New York market high-low range for the day manually at or within
the New York market high-low range of the day.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In its filing with the Commission, the self-regulatory organization included statements concerning the purpose
of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text
of these statements may be examined at the places specified in Item IV below. The self-regulatory organization has
prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Purpose
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of the proposed rule change is to provide for an enhancement to PACE by providing Phlx specialists the opportunity
to effect price improvement for market orders in securities sent through PACE when the spread between the PACE Quote,
which reflects the consolidated national best bid and offer, exceeds 1/8 point in any PACE eligible security. The
proposed rule change provides for an automatic stop of such orders and a fifteen second execution delay, allowing
a Phlx specialist to manually provide for price improvement equal to or better than the stock price.
<FOOTCITE>4</FOOTCITE>
 Specifically, all round-lot market orders of up to 500 shares and all combined round-lot and odd-lot orders of up to
599 shares will be stopped at the PACE Quote at the time of entry into PACE (stopped at the best bid for sell orders; at
the best ask for buy orders) and shall be subject to a delay of up to fifteen seconds from being executed in order to provide
an opportunity for price improvement by the Phlx specialist. If a particular market order is not executed within fifteen
seconds, the order will be automatically executed by the system at the stop price. If the PACE Quote at the time of order
entry reflects a spread between the best bid and offer of 1/8 point, PACE market orders shall be system executed immediately.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Accordingly to the Phlx, the proposed rule change does not apply to limit orders, including marketable limit orders,
because such orders are executed manually and, therefore, already have an opportunity for price improvement. Telephone
conversation between William W. Uchimoto, Vice President and General Counsel, Phlx, and Glen Barrentine, Senior
Counsel, SEC, on December 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00160 </DOCNO>
<PARENT> FR941219-2-00082 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
2. Statutory Basis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The Exchange believes that the proposed rule change is consistent with Section 6(b) of the Securities Exchange Act
of 1934 in general and Section 6(b)(5) in particular in that it is designed to foster cooperation and coordination
with persons engaged in facilitating transactions in securities and to protect investors and the public interest.
Additionally, the proposed system enhancement and rule change are consistent with the mandate of Section 11A(a)(1)(C)(iv)
of the Act respecting ``[t]he practicability of brokers executing investors' orders in the best market.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Self-Regulatory Organization's Statement on Burden on Competition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The Exchange does not believe that the proposed rule change will impose any inappropriate burden on competition.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received from Members, Participants
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The Exchange has neither solicited nor received written comments on the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Within 35 days of the publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or within such longer period (i) as the Commission may designate up to 90 days of such date if it finds such longer period
to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents,
the Commission will:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) By Order approve the proposed rule change, or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) Institute proceedings to determine whether the proposed rule change should be disapproved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
IV. Solicitation of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit written data, views and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street, N.W., Washington, D.C. 20549. Copies of the submission, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copy at the Commission's Public
Reference Section, 450 Fifth Street, N.W., Washington, D.C. 20549. Copies of such filing will also be available for
inspection and copying at the principal office of the Phlx. All submissions should refer to File No. SR&hyph;Phlx&hyph;94&hyph;58
and should be submitted by January 9, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31103 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00161 </DOCNO>
<PARENT> FR941219-2-00083 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF STATE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2132]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Renewal of the Overseas Schools Advisory Council
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of State is renewing the Overseas Schools Advisory Council to provide a formal channel for regular
consultation and advice from U.S. corporations and foundations regarding American-sponsored overseas schools.
The Under Secretary for Management has determined that the committee is necessary and in the public interest.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Members of the committee will be appointed by the Assistant Secretary for Administration. The Committee will follow
the procedures prescribed by the Federal Advisory Committee Act (FACA). Meetings will be open to the public unless
a determination is made in accordance with the FACA Section 10(d), 5 U.S.C. 552(b) (1) and (4) that a meeting or a portion
of the meeting should be closed to the public. Notice of each meeting will be provided in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at least 15 days prior to the meeting date.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information, contact Dr. Ernest N. Mannino, Executive Secretary of the committee at 703&hyph;875&hyph;7800.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ernest N. Mannino,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Secretary, Overseas Schools Advisory Council.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31115 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;24&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00162 </DOCNO>
<PARENT> FR941219-2-00084 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2134]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Renewal of the Advisory Committee on Private International Law </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is renewing the Charter of the Secretary of State's Advisory Committee on Private International Law
for two years. The Committee advises the Department on matters concerning the harmonization of private law at the
international level. Private law harmonization is normally achieved by preparation of conventions, model national
laws, legal guides and other materials. This work is undertaken by organizations such as the United Nations Commission
on International Trade Law (UNCITRAL), the Hague Conference on Private International Law, the International Institute
for the Unification of Private Law (UNIDROIT), the Specialized Conference on Private International Law of the Organization
of American States (OAS), the International Chamber of Commerce and others. The Committee reviews projects under
way by the above-referenced organizations or others that may be involved. When appropriate, specialized Study Groups
of the Committee are formed to provide technical advice on particular topics. The Under Secretary for Management
has determined that continuation of the Committee is necessary and in the public interest. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Members of the Committee are appointed by the Legal Adviser, who serves as Chair of the Committee, on the basis of nominations
by national legal organizations. Participation in the work of the Committee and its Study Groups is open to any interested
and qualified person or organization. The Committee follows the procedures of the Federal Advisory Committee Act,
its meetings are open to the public, and notice of each meeting will be provided in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and to any individual or organization requesting such notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information on the Committee or the private international law projects that it currently reviews, contact
Harold Burman, Committee Executive Director at (202) 653&hyph;9852, fax (202) 653&hyph;9854, or by writing to the
Office of the Legal Adviser (L/PIL), 2100 K Street, NW_Suite 501, Washington, DC 20037&hyph;7180. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Peter H. Pfund, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Legal Adviser. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31116 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00163 </DOCNO>
<PARENT> FR941219-2-00085 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2135]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Renewal of the Shipping Coordinating Committee</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of State is renewing the Shipping Coordinating Committee to solicit the view of interested members
of the public and government agencies on maritime policy issues, for the guidance of U.S. delegations to international
meetings on these matters. The Under Secretary for Management has determined that the committee is necessary and
in the public interest.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Membership includes representatives from the maritime industry, labor unions, environmental groups and government
bureaus and agencies. The Committee will follow the procedures prescribed by the Federal Advisory Committee Act
(FACA). Meetings will be open to the public unless a determination is made in accordance with the FACA Section 10(d),
5 U.S.C. 552(b) (1) and (4) that a meeting or a portion of the meeting should be closed to the public. Notice of each meeting
will be provided in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
at least 15 days prior to the meeting date.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information, contact Marie Murray, Executive Secretary of the Committee or Stephen Miller at (202) 647&hyph;6961.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles A. Mast,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Shipping Coordinating Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31117 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;07&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00164 </DOCNO>
<PARENT> FR941219-2-00086 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2128] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Shipping Coordinating Committee, Subcommittee on Ship Design and Equipment and Associated Bodies; Notice of Meeting
</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Shipping Coordinating Committee (SCC) will conduct an open meeting at 9:30 AM on Friday, January 6, 1995, in Room
2415, at U.S. Coast Guard Headquarters, 2100 Second Street SW., Washington, DC 20593&hyph;0001. The purpose of the
meeting is to finalize preparations for the Thirty-eighth session of the Subcommittee on Ship Design and Equipment
(DE 38) and associated bodies of the International Maritime Organization (IMO) which is scheduled for January 23&hyph;27,
1995, at the IMO Headquarters in London. The purpose of the meeting is to discuss the papers received and the draft U.S.
positions for DE 38.
<!-- PJG 0012 frnewline -->
Among other things, the items of particular interest are:
<!-- PJG 0012 frnewline -->
a. Safety of passenger submersible craft;
<!-- PJG 0012 frnewline -->
b. Development of safety standards for combined pusher tug-barges;
<!-- PJG 0012 frnewline -->
c. Guidelines for safe ocean towing;
<!-- PJG 0012 frnewline -->
d. Guidelines for the design and operation of passenger ships to the needs of elderly and disabled persons;
<!-- PJG 0012 frnewline -->
e. Use of compressed air systems for buoyancy;
<!-- PJG 0012 frnewline -->
f. Ventilation of vehicle decks during loading and unloading;
<!-- PJG 0012 frnewline -->
g. Matters related to the prevention of oil pollution;
<!-- PJG 0012 frnewline -->
h. Matters relating to ship structures, including hull stress monitoring devices, corrosion protection for ballast
tanks, and access to tank and ballast space structures;
<!-- PJG 0012 frnewline -->
i. Structural aspects of the on board use of composite materials;
<!-- PJG 0012 frnewline -->
j. Requirements for ships intended for polar waters;
<!-- PJG 0012 frnewline -->
k. Revision of the Code of Safety for Diving Systems;
<!-- PJG 0012 frnewline -->
l. Review of existing ships' safety standards; and
<!-- PJG 0012 frnewline -->
m. Guidelines on standard calculation methods for anchor positioning systems for Mobile Offshore Drilling Units
(MODUs).
<!-- PJG 0012 frnewline -->
The IMO Subcommittees work to develop international agreements, guidelines, and standards for the marine industry.
In most cases, these international agreements, guidelines, and standards form the basis for national standards/regulations
and class society rules. The U.S. Safety of Life at Sea (SOLAS) Working Group supports the U.S. Representative to the
IMO Subcommittee in developing the U.S. position on those issues raised at the IMO Subcommittee meetings. Because
of the impact on domestic regulations through development of these international guidelines, standards, and regulations,
the U.S. SOLAS Working Group serves as an excellent forum for the U.S. maritime industry to express their ideas. All
shipping companies, shipyards, design firms, naval architects, marine engineers, and consultants are encouraged
to send representatives to participate in the development of U.S. positions on those issues affecting your maritime
industry and remain abreast of all activities ongoing within the IMO.
<!-- PJG 0012 frnewline -->
Members of the public may attend this meeting up to the seating capacity of the room. Interested persons may seek information
by writing: CDR Jim Stamm, U.S. Coast Guard Headquarters, Commandant (G&hyph;MTH), Room 1218, 2100 Second Street
SW., Washington, DC 20593&hyph;0001 or by calling: (202) 267&hyph;2206.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles A. Mast,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Shipping Coordinating Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31118 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;07&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00165 </DOCNO>
<PARENT> FR941219-2-00087 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2129] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Shipping Coordinating Committee, Subcommittee for the Prevention of Marine Pollution; Notice of Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee for the Prevention of Marine Pollution (SPMP), a subcommittee of the Shipping Coordinating Committee,
will conduct an open meeting on January 12, 1995, 9:30 AM in Room 2415 of U.S. Coast Guard Headquarters, 2100 Second
Street SW., Washington, D.C.
<!-- PJG 0012 frnewline -->
The purpose of this meeting will be to report on the thirty-sixth session of the Marine Environment Protection Committee
(MEPC 36) of the International Maritime Organization (IMO) held from October 31&hyph;November 4, 1994. The Coast
Guard has held similar meetings prior to MEPC sessions. To facilitate public involvement and provide additional
time for the public to review issues addressed at MEPC sessions, the Coast Guard feels an additional public meeting
shortly after an MEPC session is needed. The U.S. delegation to MEPC 36 will report on the activities of the session.
<!-- PJG 0012 frnewline -->
The major items for discussion will be the following:
<!-- PJG 0012 frnewline -->
a. Prevention of oil pollution. Work progress on the guidelines for implementation of Regulations 13F and 13G to Annex
I of The International Convention for the Prevention of Pollution from Ships (MARPOL 73/78). This includes guidelines
for structural and operational requirements for existing ships, equivalencies for double-hulls for new ships,
and guidelines for enhanced inspections.
<!-- PJG 0012 frnewline -->
b. Implementation of the International Convention on Oil Pollution Preparedness, Response and Cooperation (OPRC).
An IMO working group addressed topics such as guidelines for the use and application of dispersants and the redraft
of the contingency planning portion of the IMO Oil Pollution Manual.
<!-- PJG 0012 frnewline -->
c. Follow-up action to the United Nations Conference on Environment and Development (UNCED). An MEPC working group
examined IMO's role in implementation of UNCED and discussed the results of a correspondence group on use of the precautionary
principle.
<!-- PJG 0012 frnewline -->
d. Unwanted aquatic organisms in ballast water. A working group discussed a possible technical annex to MARPOL 73/78
to prevent the introduction of exotic species through discharge of ballast water.
<!-- PJG 0012 frnewline -->
e. Enforcement of Pollution Conventions. A working group considered refuse recordkeeping amendments to Annex V
of MARPOL 73/78 proposed by the United States.
<!-- PJG 0012 frnewline -->
f. The future work program of the U.S. in preparation for MEPC 37 scheduled for September, 1995.
<!-- PJG 0012 frnewline -->
Members of the public may attend the meeting up to the seating capacity of the room.
<!-- PJG 0012 frnewline -->
For further information or documentation pertaining to the SPMP meeting, contact Lieutenant Commander Ray Perry,
U.S. Coast Guard Headquarters (G&hyph;MEP&hyph;3), 2100 Second Street, S.W., Washington, D.C. 20593&hyph;0001,
Telephone: (202) 267&hyph;0423.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles A. Mast,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Shipping Coordinating Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31119 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;07&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00166 </DOCNO>
<PARENT> FR941219-2-00088 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice 2130]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Shipping Coordinating Committee, Subcommittee on Safety of Life at Sea, Working Group on Radiocommunications;
Notice of Meetings</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Working Group on Radiocommunications of the Subcommittee on Safety of Life at Sea will conduct open meetings at
9:30 AM on Thursday, January 12, and Thursday, February 16, 1995. These meetings will be held in the Department of Transportation
Headquarters Building, 400 Seventh Street SW., Washington, DC 20950. The purpose of these meetings is to discuss
the papers received and the draft U.S. positions in preparation for the 41st Session of the International Maritime
Organization (IMO) Subcommittee on Radiocommunications which is scheduled for early 1996, at the IMO headquarters
in London, England.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Among other things, the item of particular interest is:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_The implementation of the Global Maritime Distress and Safety System (GMDSS).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Members of the public may attend these meetings up to the seating capacity of the rooms. Interested persons may seek
information, including meeting room numbers, by writing: Mr. Ronald J. Grandmaison, U.S. Coast Guard Headquarters,
Commandant (G-TTM), Room 6311, 2100 Second Street SW., Washington, DC 20593&hyph;0001 or by calling: (202) 267&hyph;1389.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles A. Mast,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Shipping Coordinating Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31120 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;07&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00167 </DOCNO>
<PARENT> FR941219-2-00089 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Order Adjusting International Cargo Rate Flexibility Level </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Policy Statement PS&hyph;109, implemented by Regulation ER&hyph;1322 of the Civil Aeronautics Board and adopted
by the Department, established geographic zones of cargo pricing flexibility within which certain cargo rate tariffs
filed by carriers would be subject to suspension only in extraordinary circumstances. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Standard Foreign Rate Level (SFRL) for a particular market is the rate in effect on April 1, 1982, adjusted for the
cost experience of the carriers in the applicable ratemaking entity. The first adjustment was effective April 1,
1983. By Order 94&hyph;10&hyph;8, the Department established the currently effective SFRL adjustments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In establishing the SFRL for the two-month period beginning December 1, 1994, we have projected non-fuel costs based
on the year ended September 30, 1994 data, and have determined fuel prices on the basis of the latest available experienced
monthly fuel cost levels as reported to the Department. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
By Order 94&hyph;12&hyph;16 cargo rates may be adjusted by the following adjustment factors over the April 1, 1982
level: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=38 g=1 f=1 -->
Atlantic 
<!-- PJG 0114 ellipses -->
1.1665 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Western Hemisphere 
<!-- PJG 0114 ellipses -->
1.1136 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pacific 
<!-- PJG 0114 ellipses -->
1.3878 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For further information contact: Keith A. Shangraw (202) 366- 2439. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Department of Transportation: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Patrick V. Murphy, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Assistant Secretary for Aviation and International Affairs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31097 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;62&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00168 </DOCNO>
<PARENT> FR941219-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket 37554]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Order Adjusting the Standard Foreign Fare Level Index </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 41509(e) of Title 49 of the United States Code requires that the Department, as successor to the Civil Aeronautics
Board, establish a Standard Foreign Fare Level (SFFL) by adjusting the SFFL base periodically by percentage changes
in actual operating costs per available seat-mile (ASM). Order 80&hyph;2&hyph;69 established the first interim
SFFL, and Order 94&hyph;10&hyph;7 established the currently effective two-month SFFL applicable through November
30, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In establishing the SFFL for the two-month period beginning December 1, 1994, we have projected non-fuel costs based
on the year ended September 30, 1994 data, and have determined fuel prices on the basis of the latest available experienced
monthly fuel cost levels as reported to the Department. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
By Order 94&hyph;12&hyph;15 fares may be increased by the following adjustment factors over the October 1979 level:

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=38 g=1 f=1 -->
Atlantic 
<!-- PJG 0114 ellipses -->
1.3877 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Latin America 
<!-- PJG 0114 ellipses -->
1.4122 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pacific 
<!-- PJG 0114 ellipses -->
1.7834 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Canada 
<!-- PJG 0114 ellipses -->
1.4994 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For further information contact: Keith A. Shangraw (202) 366&hyph;2439. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Department of Transportation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Dated: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Patrick V. Murphy,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Assistant Secretary for Aviation and International Affairs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31098 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;62&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00169 </DOCNO>
<PARENT> FR941219-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Aviation Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Proposed Advisory Circular 21&hyph;20B; Supplier Surveillance Procedures</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA) DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces the availability of proposed Advisory Circular (AC) 21&hyph;20B, Supplier Surveillance
Procedures, for review and comments. The proposed AC 21&hyph;20B provides information and guidance concerning
an acceptable means, but not the only means, of demonstrating compliance with the requirements of the Federal Aviation
Regulations (FAR) Part 21, Certification Procedures for Products and Parts.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments submitted must identify the proposed AC 21&hyph;20B File Number A&hyph;230&hyph;94&hyph;018, and be
received by March 21, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of the proposed AC 21&hyph;20B can be obtained from and comments may be returned to the following: Department
of Transportation, Federal Aviation Administration, Aircraft Certification Service, Production and Airworthiness
Certification Division, Policy and Procedures Branch, AIR&hyph;230, 800 Independence Avenue SW., Washington,
DC 20591.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Randy Courtney, Federal Aviation Administration, Production and Airworthiness Certification Division, Policy
and Procedures Branch, AIR&hyph;230, Room 815, 800 Independence Avenue SW., Washington, DC 20591, at telephone
number (202) 267&hyph;8361.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The proposed AC 21&hyph;20B provides information and guidance concerning surveillance of suppliers to U.S. production
approval holders (PAH) by the PAH and the Federal Aviation Administration. Further, this AC includes procedures
which supplement bilateral airworthiness agreements pertaining to certification of components manufactured
outside the United States.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested persons are invited to comment on the proposed AC 21&hyph;20B, listed in this notice, by submitting such
written data, views, or arguments, as they desire, to the aforementioned specified address. All communications
received on or before the closing date for comments, specified above, will be considered by the Director of the Aircraft
Certification Service before issuing the final AC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments received on the proposed AC 21&hyph;20B may be examined before or after the comment closing date in Room 815,
FAA Headquarters Building (FOB&hyph;10A), 800 Independence Avenue, S.W., Washington, DC 20591, between 8:00 a.m.
and 4:00 p.m. on weekdays, except Federal holidays.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Issued in Washington, DC on November 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
Joyce A. Eaton,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Acting Manager, Production and Airworthiness Certification Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;31085 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00170 </DOCNO>
<PARENT> FR941219-2-00092 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=2 -->

<USBUREAU>Federal Railroad Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=2 -->

<RINDOCK>[FRA General Docket No. H&hyph;94&hyph;6; Notice No. 2] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=2 -->
Public Hearing Involving Remotely Controlled Locomotives 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Railroad Administration (FRA), Department of Transportation (DOT).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of revised date of public hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On November 18, 1994, FRA published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 (59 FR 59826) a notice regarding a test program of rail operations involving use of remotely controlled locomotives.
An informal hearing to discuss the test program was scheduled for January 11, 1995. Due to conflicts with other scheduled
FRA public proceedings, FRA is rescheduling the public hearing to Thursday, February 23, 1995 at 9:30 a.m., in Room
2230, 400 Seventh Street, S.W., Washington, D.C. 20590. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments received by March 3, 1995 will be considered before final action is taken. All comments received will be available
for examination during regular working hours in Room 8201, Nassif Building, 400 Seventh Street, S.W., Washington,
D.C. 20590.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, D.C. on December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce M. Fine 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31150 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;06&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00171 </DOCNO>
<PARENT> FR941219-2-00093 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Transit Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket 94&hyph;B] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Third Party Contracting Guidelines Circular Revision 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Transit Administration, DOT. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Extension of comment period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On September 7, 1994, the Federal Transit Administration (FTA) issued a notice announcing that the FTA was revising
Circular 4220.1B: Third Party Contracting Guidelines. Specifically, this notice announced the availability of
the draft circular for review and solicited comments from interested parties on the proposed changes. FTA is extending
the comment period to allow interested parties additional time to review the draft circular and to comment on the proposed
revisions. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before January 18, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 All requests for the draft circular should be addressed to Carolyn Thompson, Third Party Contract Review Division,
Federal Transit Administration, 400 Seventh Street, S.W., Room 7405, Washington, DC 20590. Comments on the Circular
should be submitted to the FTA Docket Clerk, same address, Room 9316. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Carolyn Thompson, Procurement Analyst, Third Party Contract Review Division, Federal Transit Administration,
202&hyph;366&hyph;5470. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Current contracting guidance for FTA grantees is contained in FTA Circular 4220.1B, ``Third Party Contracting Guidelines,''
dated May 5, 1988, revised February 5, 1990. FTA is revising the Circular to incorporate new provisions included in
the Intermodal Surface Transportation Efficiency Act of 1991 (Pub. L. 102&hyph;240, October 28, 1991) and to reflect
a more current contracting policy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The original comment period ended on November 7, 1994. FTA is extending the comment period for an additional 30 days,
in order to allow interested parties adequate time to review the draft circular and formulate their comments. The
comment period will now end January 18, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: December 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Gordon J. Linton, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31082 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;57&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00172 </DOCNO>
<PARENT> FR941219-2-00094 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Highway Traffic Safety Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 92&hyph;50; Notice 3]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Autokraft Ltd; Receipt of Application for Renewal of 
<!-- PJG 0012 frnewline -->
Temporary Exemption From Motor Vehicle Safety Standard No. 208 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Autokraft Limited of Weybridge, Surrey, England, has applied for a renewal of NHTSA Exemption No. 92&hyph;6, exempting
its AC MkIV until January 1, 1995, from compliance with paragraph S4.1.4 of Federal Motor Vehicle Safety Standard
No. 208 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Occupant Crash Protection
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The basis of the application is that compliance would cause substantial economic hardship to a manufacturer that
has tried to comply with the standard in good faith. 
<!-- PJG 0012 frnewline -->
Notice of receipt of the application is published in accordance with agency regulations on the subject (49 CFR Part
555) and does not represent any judgment of the agency on the merits of the application. 
<!-- PJG 0012 frnewline -->
Autokraft was granted NHTSA Exemption No. 92&hyph;6 on December 21, 1992 (57 FR 60563). The reader is referred to that
notice for further information about the company and its initial compliance efforts. The exemption from S4.1.4 of
Standard No. 208 will expire on January 1, 1995. Because the application for renewal of the exemption was filed ``not
later than 60 days before the termination date'' (in this instance, October 27, 1994), the termination date is stayed
until the Administrator has acted upon the application (49 CFR 555.8(e)). 
<!-- PJG 0012 frnewline -->
The applicant seeks a further two-year exemption for its AC Mark IV passenger car, of which it has produced 15 in the
year preceding the filing of its application. Although the company had projected sales of 150 units in the United States
in the years 1992&hyph;94, in fact, there have been only seven sales. According to its application, Autokraft ``has
continued the process of researching and developing the installation of a driver and passenger side airbag system''
but ``we have been unable to achieve the fitting of a suitable system mainly due to the chassis design being based upon
a classic 1960's design and not easily adaptable to suit air bag installation.'' The delay is also due to ``the project
having insufficient funds generated by sales and available for completing the development.'' 
<!-- PJG 0012 frnewline -->
Autokraft has concluded that the adaptation of an existing automatic restraint system is the only viable alternative.
Its continuation of compliance efforts has given it ``significant knowledge into the areas of vehicle modification,
computer simulation, design rough road testing and low, medium and high speed crash testing.'' Complicating its
efforts is the need to use a different engine and transmission after October 1, 1995, and the possible effect that this
will have upon compliance. It estimates the cost to achieve conformance would be $550,000, achievable by spreading
these costs during the exemption period. Autokraft reports losses totalling 3,308,243 Pounds Sterling (approximately
$5,624,000 at a rate of $1.70/1) for the years 1992&hyph;93, and projects a further loss for 1994. 
<!-- PJG 0012 frnewline -->
The company argues that an exemption would be in the public interest and consistent with the objectives of motor vehicle
safety because it meets all applicable EEC standards, and all U.S. Federal motor vehicle safety standards with the
exception of the automatic restraint requirements of Standard No. 208 (its 3-point driver and passenger restraints
meet the previous requirements). The production of the car makes available to the public ``at a realistic price''
a replica of the original AC Cobra vehicle produced from the original AC Cobra tooling, manufactured during the 1960's
predominantly for the American market. Autokraft is in the process of finalizing a U.S. distribution agreement and
will show the car at the North American International Auto Show in Detroit in January 1995. 
<!-- PJG 0012 frnewline -->
The applicant believes that it will comply with Standard No. 208 six months before January 1, 1997, when the 2-year
extension of its exemption that it has requested would expire. 
<!-- PJG 0012 frnewline -->
Interested persons are invited to submit comments on the application described above. Comments should refer to Docket
No. 92&hyph;50; Notice 3, and be submitted to: Docket Section, National Highway Traffic Safety Administration,
room 5109, 400 Seventh St. SW, Washington, DC 20590. It is requested but not required that 10 copies be submitted. 
<!-- PJG 0012 frnewline -->
All comments received before the close of business on the comment closing date indicated below will be considered,
and will be available for examination in the docket at the above address both before and after that date. To the extent
possible, comments filed after the closing date will also be considered. Notice of final action on the petition will
be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pursuant to the authority indicated below. 
<!-- PJG 0012 frnewline -->
Comment closing date: January 18, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. 30113; delegations of authority at 49 CFR 1.50 and 501.8. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: December 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barry Felrice, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31081 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00173 </DOCNO>
<PARENT> FR941219-2-00095 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94&hyph;65; Notice 2] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>General Motors Corporation; Decision That </DOCTITLE>
<!-- PJG 0012 frnewline -->
Noncompliance With Standard No. 108 is Inconsequential to Safety 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Motors Corporation (GM) of Warren, Michigan, determined that some of its vehicles failed to comply with 49
CFR 571.108, Federal Motor Vehicle Safety Standard (FMVSS) No. 108, ``Lamps, Reflective Devices, and Associated
Equipment,'' and filed an appropriate report pursuant to 49 CFR Part 573, ``Defect and Noncompliance Reports.''
GM also applied to be exempted from the notification and remedy requirements of 49 U.S.C. Chapter 301 - ``Motor Vehicle
Safety'' on the basis that the noncompliance is inconsequential to motor vehicle safety. 
<!-- PJG 0012 frnewline -->
Notice of receipt of the application was published on July 29, 1994, and an opportunity afforded for comment (59 FR
38660). This notice grants the application. 
<!-- PJG 0012 frnewline -->
Figure 10 of FMVSS No. 108, referenced at S5.1.1.27(a)(3), lists the photometric requirements for center high-mounted
stop lamps (CHMSLs). GM produced two different vehicle populations which do not meet the photometric requirements
of Figure 10. The first population of vehicles, approximately 23,695 Cadillac Deville and Deville Concours produced
between the start of the 1994 model year and November 19, 1993, had their CHMSLs ``framed'' in the rear window by a 27
mm high opening in the blackout paint at the lower edge of the rear window. A vertical shift in the installed position
of the rear window, compounded by build variation, caused the painted frame around the CHMSL on each of these vehicles
to obscure the photometric performance at the 5D line. 
<!-- PJG 0012 frnewline -->
The second population of vehicles, approximately 65,403 Cadillac Deville and Deville Concours produced between
November 19, 1993, and May 4, 1994, has a narrower painted ``frame'' around the CHMSL in the rear window. The painted
frame width was reduced due to an engineering change by 5 mm to a width of 22 mm. The shift in installed position and build
variation noted above obscured the 5D line on some of these vehicles. Other vehicles within this second population
had the 10U line obscured as a result of build variation. In no case were both the 5D and 10U lines obscured. 
<!-- PJG 0012 frnewline -->
GM supported its application for inconsequential noncompliance as discussed below. GM also submitted diagrams
and tables in support which are available for review in the NHTSA docket. According to GM: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
GM performed a dimensional analysis on a 51-vehicle sample to determine where the paint opening on the rear glass was
in relation to the CHMSL. (Note that no CHMSL could be obscured at both the top and bottom by the paint line.) For those
vehicles with the CHMSL obscured at the bottom of the lamp, the analysis, which approximates a normal distribution,
indicated that 1.5 percent of the entire population of vehicles, or approximately 1,336 vehicles, could experience
sufficient obscuration to render the vehicles out of compliance with FMVSS 108, with a 4.6 mm worst case infringement
at the bottom of the CHMSL. However, a photometric test conducted on a CHMSL with a 4.6 mm mask at the bottom of the lamp
established that for the test points that fell on and below horizontal, i.e., for the points on the H and 5D lines, photometric
output exceeded FMVSS 108 requirements by an average of 75 percent. *&blank;*&blank;* Even on the 5D line, all five
test points were within 20 percent of FMVSS 108, with the worst performance at 5D&hyph;5R, where the tested value was
23.0 candela, or 82 percent of the 25.0 candela requirement. 
<!-- PJG 0012 frnewline -->
As for those vehicles with the CHMSL obscured at the top of the lamp, the sample suggests that 15 percent of the second
population described above, or 9,810 vehicles, could be obscured to the point that they would fail to comply with FMVSS
108, with a worst case infringement at the top of the CHMSL of 4.5 mm. However, a photometric test on a CHMSL with a 4.5
mm mask at the top of the lamp demonstrated that while test values on the 10U line fall below required levels, the lamp
provides approximately 75 percent more light output above horizontal (at the 5U and 10U lines combined) than required
by FMVSS 108. (Photometric output of the obscured lamp as a whole approximated 33 percent more than FMVSS 108 requirements.)
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->
To determine the extent of the noncompliance for those vehicles obscured at the top of the CHMSL, GM plotted data from
a series of photometric tests of 10U-V (the worst performing test point), with varying degrees of obscuration, against
performance to the FMVSS 108 requirement. The result approximates a linear function of obscuration versus photometric
output, and suggests that subject CHMSLs obscured less than 3.07 mm will fall within 20 percent of the values listed
in FMVSS 108 *&blank;*&blank;*. Applying the distribution determined from GM's 51-vehicle sample to that, approximately
76 percent, or 7,456 of the 9,810 vehicles described above, will provide photometric output within 20 percent of the
FMVSS 108 requirements at 10U. 
<!-- PJG 0012 frnewline -->
As acknowledged in NHTSA's notices granting other similar Petitions for Determination of Inconsequential Noncompliance,
a change in luminous intensity of approximately 25 percent is required before the human eye can detect a difference
between two lamps. (See, e.g., Notice granting Petition by Subaru of America (56 Fed. Reg. 59971); and Notice granting
Petition by Hella, Inc. (55 Fed. Reg. 37601, at 37602).) Given this, the 7,456 vehicles obscured less than 3.07 mm at
the top of the CHMSL, as well as the 1,336 vehicles obscured at the bottom of the lamp, do not compromise motor vehicle
safety since the noncompliance is imperceptible to the naked eye and the overall light at the outer zones (H &amp; 5D;
5U &amp; 10U) exceeds the FMVSS requirements. 
<!-- PJG 0012 frnewline -->
Although the degradation in light output for the 2,354 remaining vehicles would likely be discernible in a subjective
side-by-side comparison with a conforming lamp, visible light is still emitted at the 10U line. Moreover, GM's photometric
analysis indicates that even with a worst case obscuration of the 10U line, the 16 candela required light output at
10U-V is supplied at 8U-V. Given that and the location of the CHMSL on the subject vehicles, these CHMSLs perform their
intended function in a manner virtually indistinguishable from CHMSLs on other vehicles that fully comply with FMVSS
108, as demonstrated below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00174 </DOCNO>
<PARENT> FR941219-2-00095 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The specified range of required photometric output for CHMSLs from 10U to 5D was developed from SAE J186a and is presumably
intended to allow manufacturers latitude in locating CHMSLs for the myriad of vehicle designs, while assuring that
sufficient light is available to signal drivers of following vehicles. For example, the 10U photometric angle helps
to assure that drivers of large vehicles (such as medium and heavy duty trucks), perceive a preceding vehicle's CHMSL
signal, regardless of the size of that vehicle or the CHMSL's mounting location. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 However, the Cadillac CHMSL is mounted relatively high in relation to other passenger vehicles on the road, and is
located in the passenger compartment, not on the deck lid. Therefore, the light emitted from the Cadillac CHMSL at
the upward-most photometric angles is not as critical as light at those same angles emitted from vehicles with CHMSLs
located rearward and closer to the ground. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 To illustrate this point, GM compared the Cadillac CHMSL to the CHMSL on the Mazda Miata. The Miata sits comparatively
low to the ground, and its CHMSL is mounted low on the deck lid. After determining that the 16 candela photometric output
required by FMVSS 108 at 10U-V is provided by the Cadillac CHMSL with a worst case intrusion at 8U, GM overlaid the mounting
location and 10U line of the Mazda Miata on a drawing of the Cadillac CHMSL and 8U line, placing the rear of the vehicles
at the same location *
<!-- PJG 0060 hspace -->
&blank;9*
<!-- PJG 0060 hspace -->
&blank;9*. The result shows that the 8U and 10U lines cross 37.4 feet behind the vehicles and 9.3 feet above the ground;
until that point, the Cadillac CHMSL provides more light to the extreme up positions than does the fully compliant
Miata CHMSL. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 GM then overlaid on the drawing of the Cadillac and Miata CHMSLs the average eye ellipse location for heavy duty trucks
(cab over) and medium duty trucks, which are 7.7 feet and 6.8 feet from ground, respectively *
<!-- PJG 0060 hspace -->
&blank;9*
<!-- PJG 0060 hspace -->
&blank;9*. The fact that these eye-ellipse locations fall well below the 9.3 feet intersection point of the Cadillac
CHMSL 8U line and the Miata CHMSL 10U line demonstrates that the Cadillac CHMSL provides sufficient usable light to
all following drivers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 That is, because GM designed the subject vehicles with a high and forward CHMSL mounting location, drivers sitting
at the highest positions from the road will see the photometric output intended by the Standard for the upward-most
angles, regardless of (worst case) obscuration of the lamp. The Cadillac CHMSL actually provides a greater area of
visible light than a vehicle with a fully compliant lamp that is mounted lower and rearward. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 There are vehicles with fully compliant CHMSLs, at mounting locations approximating that of the Cadillac, that cast
more light in the upper extreme areas behind the vehicle. However, *
<!-- PJG 0060 hspace -->
&blank;9*
<!-- PJG 0060 hspace -->
&blank;9* a compliant CHMSL (mounted at the same location as the Cadillac CHMSL) will provide only an additional triangular
area six feet in length and eleven inches high of potentially usable light, starting 20 feet behind the vehicle. This
small area is only visible to drivers of the largest vehicles. Given that and negligible decrease of light emitted
by the Cadillac CHMSL, GM believes that the Cadillac CHMSL will perform its intended function effectively identical
to fully compliant CHMSLs mounted at the same location. Furthermore, as demonstrated above, the Cadillac CHMSL provides
more light at the extreme up angles than other fully compliant CHMSLs mounted lower and rearward. These factors, together
with the small number of Cadillacs involved, support GM's belief that the CHMSLs at issue here will not have an adverse
affect on motor vehicle safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The CHMSLs otherwise meet all FMVSS 108 requirements, and the photometric output of the stop lamps, which are supplemented
by the CHMSL, far exceeds FMVSS 108 minimum requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 GM is not aware of any accidents, injuries, owner complaints or field reports related to this issue. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 General Motors believes that the noncompliance that results from a small obstruction of the CHMSL by blackout paint
on the rear window is inconsequential as it relates to motor vehicle safety. In consideration of the foregoing, General
Motors petitions that it be exempted from the recall and remedy provisions of the Act for this specific noncompliance
with FMVSS 108. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 No comments were received on the application.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=11 g=1 f=1 -->
In presenting its arguments, GM has separated its noncomplying vehicles into two categories, those in which the diminished
luminous intensity of the CHMSL might be discernible, and those in which it might pass unnoticed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 The noncompliance that is most likely to have a consequential effect on safety is the degradation in light output that
``would likely be discernible in a subjective side-by-side comparison with a conforming light.'' This appears to
occur only in vehicles where compliance along the 10U line is affected. GM argues that, in the worst case, there is full
compliance along a hypothetical 8U line, and that ``visible light is still emitted at the 10U line.'' Thus, the effect
on safety of a diminished luminous intensity in the two degrees between 8U and 10U must be considered. GM has pointed
out the obvious, that the mounting height of the CHMSL is not standardized among vehicles, and that factor, in addition
to the differing eye height of following drivers and the angle of approach, results in an infinite number of perceptions.
The result of this is that, in some instances, the noncompliant Cadillac CHMSL ``actually provides a greater area
of visible light'' than a complying CHMSL ``that is mounted lower and rearward.'' With respect to the two-degree area
of noncompliance, a complying lamp ``will provide only an additional triangular area six feet in length and eleven
inches high of potentially usable light, starting 20 feet behind the vehicle.'' Terming this a ``small area,'' GM
submits that it ``is only visible to drivers of the largest vehicles.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 NHTSA reviews noncompliances involving performance failures with special concern, and it has done so here. But it
has concluded that GM has met this concern with respect to the possible effect of this specific noncompliance upon
motor vehicle safety, and has decided that it does not affect safety in a consequential manner. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00175 </DOCNO>
<PARENT> FR941219-2-00095 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
With respect to the remaining noncompliances, those that might not be discernible to the naked eye, GM cites NHTSA's
previous grants of inconsequentiality petitions based upon the agency's conclusion that a change in luminous intensity
of approximately 25 percent must occur before the human eye can discern a difference. Three-quarters of GM's noncompliant
lamps probably are said to have a noncompliance in luminous intensity that does not exceed 20 percent of Figure 10's
specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 GM has correctly noted NHTSA's position on the effect of deviations in luminous intensity. Additional support for
that position has been provided in a recent report ``Driver Perception of Just-Noticeable Differences of Automotive
Signal Lamp Intensities'' (DTNH22&hyph;92&hyph;D&hyph;07002) which found that 25 percent is a reasonable criterion
for use in inconsequentiality decisions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Accordingly, the applicant has met its burden of persuasion that the noncompliance herein described is inconsequential
to safety, and General Motors Corporation is hereby exempted from the notification requirements of 49 U.S.C. 30118
and the remedy requirements of 49 U.S.C. 30120.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
(49 U.S.C. 30118, 30120; delegations of authority at 49 CFR 1.50 and NHTSA Order 800&hyph;2)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barry Felrice, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Rulemaking. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31089 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00176 </DOCNO>
<PARENT> FR941219-2-00096 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94&hyph;77; Notice 2]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Decision That Nonconforming 1988 Volvo 740 Sedans Are Eligible for Importation </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Highway Traffic Safety Administration (NHTSA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of decision by NHTSA that nonconforming 1988 Volvo 740 Sedans are eligible for importation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces the decision by NHTSA that 1988 Volvo 740 Sedans not originally manufactured to comply with
all applicable Federal motor vehicle safety standards are eligible for importation into the United States because
they are substantially similar to a vehicle originally manufactured for importation into and sale in the United States
and certified by its manufacturer as complying with the safety standards (the U.S.-certified version of the 1988
Volvo 740 Sedan), and they are capable of being readily altered to conform to the standards. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This decision is effective as of the date of its publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ted Bayler, Office of Vehicle Safety Compliance, NHTSA (202&hyph;366&hyph;5306).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under 49 U.S.C. &sect;30141(a)(1)(A) (formerly section 108(c)(3)(A)(i) of the National Traffic and Motor Vehicle
Safety Act (the Act)), a motor vehicle that was not originally manufactured to conform to all applicable Federal motor
vehicle safety standards shall be refused admission into the United States unless NHTSA has decided that the motor
vehicle is substantially similar to a motor vehicle originally manufactured for importation into and sale in the
United States, certified under 49 U.S.C. &sect;30115 (formerly section 114 of the Act), and of the same model year
as the model of the motor vehicle to be compared, and is capable of being readily altered to conform to all applicable
Federal motor vehicle safety standards. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Petitions for eligibility decisions may be submitted by either manufacturers or importers who have registered with
NHTSA pursuant to 49 CFR Part 592. As specified in 49 CFR 593.7, NHTSA publishes notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of each petition that it receives, and affords interested persons an opportunity to comment on the petition. At the
close of the comment period, NHTSA decides, on the basis of the petition and any comments that it has received, whether
the vehicle is eligible for importation. The agency then publishes this decision in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Western Cascade of Seattle Washington (Registered Importer R&hyph;94&hyph;023) petitioned NHTSA to decide whether
1988 Volvo 740 Sedans are eligible for importation into the United States. NHTSA published notice of the petition
on September 27, 1994 (59 FR 49281) to afford an opportunity for public comment. The reader is referred to that notice
for a thorough description of the petition. No comments were received in response to the notice. Based on its review
of the information submitted by the petitioner, NHTSA has decided to grant the petition. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Vehicle Eligibility Number for Subject Vehicles 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The importer of a vehicle admissible under any final decision must indicate on the form HS&hyph;7 accompanying entry
the appropriate vehicle eligibility number indicating that the vehicle is eligible for entry. VSP 87 is the vehicle
eligibility number assigned to vehicles admissible under this decision. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Final Determination 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, on the basis of the foregoing, NHTSA hereby decides that a 1988 Volvo 740 Sedan not originally manufactured
to comply with all applicable Federal motor vehicle safety standards is substantially similar to a 1988 Volvo 740
Sedan originally manufactured for importation into and sale in the United States and certified under 49 U.S.C. 30115,
and is capable of being readily altered to conform to all applicable Federal motor vehicle safety standards. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. 30141(a)(1)(A) and (b)(1); 49 CFR 593.8; delegations of authority at 49 CFR 1.50 and 501.8. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: December 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William A. Boehly,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Enforcement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31013 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00177 </DOCNO>
<PARENT> FR941219-2-00097 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4718 -->

<!-- PJG STAG 4718 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 242&blank;/&blank;Monday, December 19, 1994&blank;/&blank;Sunshine Act Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 242
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Monday, December 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
U.S. CONSUMER PRODUCT SAFETY COMMISSION
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
10:00 a.m., Tuesday, December 20, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
LOCATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Room 420, East West Towers, 4330 East West Highway, Bethesda, Maryland.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Open to the public.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
MATTERS TO BE CONSIDERED:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Protocol Revisions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The staff will brief the Commission on a final rule revising the child-resistant packaging test protocols under the
Poison Prevention Packaging Act.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For a recorded message containing the latest agenda information, call (301) 504&hyph;0709.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR ADDITIONAL INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Sadye E. Dunn, Office of the Secretary, 4330 East West Highway, Bethesda, MD 20207 (301) 504&hyph;0800.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sadye E. Dunn,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31243 Filed 12&hyph;15&hyph;94; 2:55 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6355&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00178 </DOCNO>
<PARENT> FR941219-2-00098 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
DEFENSE NUCLEAR FACILITIES SAFETY BOARD 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to the provisions of the ``Government in the Sunshine Act'' (5 U.S.C. 552b), notice is hereby given of the
following meeting of the Board: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
9:00 a.m., December 23, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Board Conference Room, Suite 700, 625 Indiana Avenue, N.W., Washington, D.C. 20004.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Closed. Exemption 3. Portions of the meeting may also be closed under Exemption 1 and Exemption 9. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Board will discuss a possible Recommendation to the Secretary of Energy pertaining to DOE's adherence to health
and safety orders and requirements during the period in transition to rulemaking.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Robert M. Andersen, General Counsel, Defense Nuclear Facilities Safety Board, 625 Indiana Avenue NW, Suite 700,
Washington, DC 20004, (202) 208&hyph;6387.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Board specifically reserves its right to further schedule and otherwise regulate the course of the hearing, to
recess, reconvene, postpone or adjourn the hearing, conduct further reviews, and otherwise exercise its power under
the Atomic Energy Act of 1954, as amended.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 15, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John T. Conway,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31185 Filed 12&hyph;15&hyph;94; 2:51 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;KD&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00179 </DOCNO>
<PARENT> FR941219-2-00099 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
NATIONAL TRANSPORTATION SAFETY BOARD 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
9:30 a.m., Tuesday, December 20, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Board Room, 
<!-- PJG 0012 frnewline -->
5th Floor, 
<!-- PJG 0012 frnewline -->
490 L'Enfant Plaza, S.W., 
<!-- PJG 0012 frnewline -->
Washington, D.C. 20594. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Open. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
6502_Recommendations to 37 States, Puerto Rico &amp; District of Columbia: A Lower Blood Alcohol Concentration
for All Drivers 
<!-- PJG 0012 frnewline -->
6213A_Marine Accident Report: Explosion and Fire on Board The U.S. Tankship OMI CHARGER, Galveston, Texas, October
9, 1993 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
NEWS MEDIA CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Telephone: (202) 382&hyph;0660.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FOR MORE INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bea Hardesty, (202) 382&hyph;6525. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bea Hardesty, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Federal Register Liaison Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31170 Filed 12&hyph;15&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7533&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00180 </DOCNO>
<PARENT> FR941219-2-00100 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Monday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
December 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part II
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Reader Aids
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Cumulative List of Public Laws
<!-- PJG 0012 frnewline -->
103d Congress, Second Session
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 242&blank;/&blank;Monday, December 19, 1994&blank;/&blank;Reader Aids
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=52 g=1 f=1 -->
CUMULATIVE LIST OF PUBLIC LAWS
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This is the cumulative list of public laws for the 103d Congress, Second Session. The List of Public Laws will resume
when bills are enacted into public law during the 104th Congress, First Session, which convenes on January 4, 1995.
Any comments may be addressed to the Director, Office of the Federal Register, Washington, DC 20408.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 4,L0,tp0,p9,8/8,g1,t1,xs45,r290,xs65,xs30 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Public Law
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Title
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Approved
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1108 Stat.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
103&hyph;211
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making emergency supplemental appropriations for the fiscal year ending September 30, 1994, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 12, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;212
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal Building and United States Courthouse located at 402 East State Street in Trenton, New Jersey,
as the ``Clarkson S. Fisher Federal Building and United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
43
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;213
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located at 525 Griffin Street in Dallas, Texas, as the ``A. Maceo Smith Federal Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
44
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;214
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located at 100 East Fifth Street in Cincinnati, Ohio, as the ``Potter Stewart United
States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
45
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;215
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse located in Houma, Louisiana, as the ``George Arceneaux, Jr., United States
Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
46
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;216
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse under construction at 611 Broad Street, in Lake Charles, Louisiana, as
the ``Edwin Ford Hunter, Jr., United StatesCourthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
47
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;217
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the month of March 1994 as ``Irish-American Heritage Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Feb. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
48
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;218
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Technology-Related Assistance for Individuals With Disabilities Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 9, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
50
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;219
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Everglades National Park Protection and Expansion Act of 1989, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 9, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
98
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;220
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 23, United States Code, to permit the use of funds under the highway bridge replacement and rehabilitation
program for seismic retrofit of bridges, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 17, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
100
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;221
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the week beginning April 11, 1994, as ``National Public Safety Telecommunicators Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 24, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
101
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;222
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating March 25, 1994, as ``Greek Independence Day: A National Day of Celebration of Greek and American Democracy''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 24, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
102
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;223
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To proclaim March 20, 1994, as ``National Agriculture Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 24, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
103
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;224
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate March 20 through March 26, 1994, as ``Small Family Farm Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 24, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
105
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;225
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Food Stamp Program Improvements Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
106
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;226
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Workforce Restructuring Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
111
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;227
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Goals 2000: Educate America Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
125
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;228
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To temporarily extend certain provisions of the Marine Mammal Protection Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mar. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
281
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;229
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating March 23, 1994, as ``Education and Sharing Day, U.S.A.''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
282
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;230
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Developmental Disabilities Assistance and Bill of Rights Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
284
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;231
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To extend certain compliance dates for pesticide safety training and labeling requirements
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
333
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;232
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To reauthorize and amend the National Fish and Wildlife Foundation Establishment Act, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
336
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;233
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Multifamily Housing Property Disposition Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
342
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;234
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 To redesignate the Federal building located at 380 Trapelo Road in Waltham, Massachusetts, as the ``Frederick C.
Murphy Federal Center''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
380
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;235
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To extend until July 1, 1998, the exemption from ineligibility based on a high default rate for certain institutions
of higher education
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 28, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
381
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;236
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Foreign Relations Authorization Act, Fiscal Years 1994 and 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
382
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;237
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To suspend temporarily the duty on the personal effects of participants in, and certain other individuals associated
with, the 1994 World Cup Soccer Games, the 1994 World Rowing Championships, the 1995 Special Olympics World Games,
the 1996 Summer Olympics, and the 1996 Paralympics
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
530
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;238
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Marine Mammal Protection Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Apr. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
532
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;239
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
School-to-Work Opportunities Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
568
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;240
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 38, United States Code, to extend eligibility for burial in national cemeteries to persons who have
20 years of service creditable for retired pay as members of a reserve component of the Armed Forces and to their dependents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
609
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;241
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse under construction in Denver, Colorado, as the ``Byron White United States
Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
610
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;242
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Rio Grande Designation Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
611
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;243
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize appropriations for the Coastal Heritage Trail Route in the State of New Jersey, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
613
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;244
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Providing for the appointment of Frank Anderson Shrontz as a citizen regent of the Board of Regents of the Smithsonian
Institution
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
614
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;245
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 Providing for the appointment of Manuel Luis Ibanez as a citizen regent of the Board of Regents of the Smithsonian Institution
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
615
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;246
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the week of May 2 through May 8, 1994, as ``Public Service Recognition Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
616
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;247
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To make certain technical corrections, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
618
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;248
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Farmers Home Administration Improvement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
619
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;249
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located at 711 Washington Street in Boston, Massachusetts, as the ``Jean Mayer
Human Nutrition Research Center on Aging''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
620
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;250
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the President to proclaim September 1994 as ``Classical Music Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
621
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;251
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating May 1, 1994, through May 7, 1994, as ``National Walking Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
622
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;252
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Human Services Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 18, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
623
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;253
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Clear Creek County, Colorado, Public Lands Transfer Act of 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
674
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;254
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Arson Prevention Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
679
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;255
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for a land exchange between the Secretary of Agriculture and Eagle and Pitkin Counties in Colorado, and
for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
684
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;256
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located at 600 Camp Street in New Orleans, Louisiana, as the ``John Minor Wisdom
United States Court of Appeals Building'', and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
690
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;257
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate June 6, 1994, as ``D-Day National Remembrance Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
691
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;258
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating May 11, 1994, as ``Vietnam Human Rights Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
692
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;259
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Freedom of Access to Clinic Entrances Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
694
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;260
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Airport Improvement Program Temporary Extension Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
698
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;261
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To extend the time period for compliance with the Nutrition Labeling and Education Act of 1990 for certain food products
packaged prior to August 8, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
705
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;262
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize appropriations for the National Historical Publications and Records Commission for fiscal years 1994,
1995, 1996, and 1997
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
706
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;263
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To make certain technical corrections
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
707
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;264
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the week of June 12 through 19, 1994, as ``National Men's Health Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
May 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
710
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;265
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Post Office building located at 401 E. South Street in Jackson, Mississippi, as the ``Medgar Wiley
Evers Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
712
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;266
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 11, District of Columbia Code, and Part C of title IV of the District of Columbia Self-Government and
Governmental Reorganization Act to remove gender-specific references
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
713
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;267
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Child Safety Protection Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
722
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;268
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the District of Columbia Spouse Equity Act of 1988 to provide for coverage of the former spouses of judges of
the District of Columbia courts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 28, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
730
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;269
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 11, D.C. Code, to clarify that blind individuals are eligible to serve as jurors in the Superior Court
of the District of Columbia
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 28, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
731
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;270
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Independent Counsel Reauthorization Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
June 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
732
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;271
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Board of Veterans' Appeals Administrative Procedures Improvement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
740
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;272
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To revise, codify, and enact without substantive change certain general and permanent laws, related to transportation,
as subtitles II, III, and V-X of title 49, United States Code, ``Transportation'', and to make other technical improvements
in the Code
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
745
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;273
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located at 601 East 12th Street in Kansas City, Missouri, as the ``Richard Bolling
Federal Building'' and the United States Courthouse located at Ninth and Locust Streets, in Kansas City, Missouri,
as the ``Charles Evans Whittaker United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1402
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;274
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse located in Bridgeport, Connecticut, as the ``Brien McMahon Federal Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1403
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;275
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making supplemental appropriations for the Department of Housing and Urban Development for the fiscal year ending
September 30, 1994, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1404
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;276
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for the imposition of temporary fees in connection with the handling of complaints of violations of the
Perishable Agricultural Commodities Act, 1930
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1406
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;277
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To extend the Export Administration Act of 1979
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1407
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;278
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating July 16 through July 24, 1994, as ``National Apollo Anniversary Observance''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 20, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1408
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;279
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
John F. Kennedy Center Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 21, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1409
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;280
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To remove certain restrictions from a parcel of land owned by the city of North Charleston, South Carolina, in order
to permit a land exchange, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1418
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;281
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Twin Falls County Landfill Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1420
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;282
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Small Business Act to increase the authorization for the development company program, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1422
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;283
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Legislative Branch Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
July 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1423
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;284
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the plaza to be constructed on the Federal Triangle property in Washington, DC, as the ``Woodrow Wilson
Plaza''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1448
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;285
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building located on St. Croix, Virgin Islands, as the ``Almeric L. Christian Federal Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1449
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;286
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To require certain payments made to victims of Nazi persecution to be disregarded in determining eligibility for
and the amount of benefits or services based on need
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1450
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;287
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building and United States courthouse in Lubbock, Texas, as the ``George H. Mahon Federal
Building and United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1453
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;288
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse located at 940 Front Street in San Diego, California, and the Federal building
attached to the courthouse as the ``Edward J. Schwartz Courthouse and Federal Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1454
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;289
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Federal building and United States courthouse located at  100 East Houston Street in Marshall, Texas,
as the ``Sam B. Hall, Jr. Federal Building and United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1455
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;290
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide that the National Education Commission on Time and Learning shall terminate on September 30, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1456
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;291
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating May 29, 1995, through June 6, 1995, as a ``Time for the National Observance of the Fiftieth Anniversary
of World War II''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1457
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;292
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Winter Run Chinook Salmon Captive Broodstock Act of 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1458
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;293
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating August 2, 1994, as ``National Neighborhood Crime Watch Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1459
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;294
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate August 1, 1994, as ``Helsinki Human Rights Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1460
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;295
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the transfer of naval vessels to certain foreign countries
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 12, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1462
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;296
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Social Security Independence and Program Improvements Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 15, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1464
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;297
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Telemarketing and Consumer Fraud and Abuse Prevention Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1545
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;298
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
General Aviation Revitalization Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 17, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1552
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;299
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Recognizing the American Academy in Rome, as American overseas center for independent study and advanced research,
on the occasion of the 100th anniversary of its founding
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 18, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1555
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;300
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse under construction in St. Louis, Missouri, as the ``Thomas F. Eagleton
United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1557
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;301
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To proclaim the week of October 16 through October 22, 1994, as ``National  Character Counts Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1558
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;302
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Indian Dams Safety Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1560
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;303
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
District of Columbia Justice Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1564
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;304
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
King Holiday and Service Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1565
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;305
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Aviation Administration Authorization Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1569
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;306
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making appropriations for foreign operations, export financing, and related programs for the fiscal year ending
September 30, 1995, and making supplemental appropriations for such programs for the fiscal year ending September
30, 1994, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1608
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;307
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Military Construction Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1659
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;308
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating December 7 of each year as ``National Pearl Harbor Remembrance Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1669
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;309
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating October 1994 as ``Italian-American Heritage and Culture Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1670
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;310
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To direct the Administrator of General Services to acquire by transfer the Old U.S. Mint in San Francisco, California,
and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1672
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;311
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Hazardous Materials Transportation Act to authorize appropriations for fiscal years 1994, 1995, 1996,
and 1997, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1673
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;312
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Trade Commission Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1691 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;313
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Farmington Wild and Scenic River Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1699
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;314
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
George Washington National Forest Mount Pleasant Scenic Area Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1703
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;315
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To redesignate the postal facility located at 2100 North 13th Street in Reading, Pennsylvania, as the ``Gus Yatron
Postal Facility''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1706
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;316
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Energy and Water Development Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1707
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;317
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making appropriations for the Departments of Commerce, Justice, and State, the Judiciary, and related agencies
programs for the fiscal year ending September 30, 1995, and making supplemental appropriations for these departments
and agencies for the fiscal year ending September 30, 1994, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1724
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;318
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Northern Great Plains Rural Development Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1781
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;319
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the week beginning on November 20, 1994 and ending on November 26, 1994, as ``National Family Caregivers
Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1790
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;320
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating September 16, 1994, as ``National POW/MIA Recognition Day'' and authorizing display of the National
League of Families POW/MIA flag
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1791
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;321
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Commemorative Works Act, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Aug. 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1793
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;322
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Violent Crime Control and Law Enforcement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1796
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;323
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To restore Federal services to the Pokagon Band of Potawatomi Indians
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 21, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2152
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;324
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Little Traverse Bay Bands of Odawa Indians and the Little River Band of Ottawa Indians Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 21, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2156 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;325
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Riegle Community Development and Regulatory Improvement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2160
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;326
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To reduce the restrictions on lands conveyed by deed under the Act of June 8, 1926
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 23, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2297
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;327
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Departments of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act,
1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 28, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2298
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;328
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Riegle-Neal Interstate Banking and Branching Efficiency Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 29, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2338
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;329
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Treasury, Postal Service and General Government Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2382
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;330
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Agricultural, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2435
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;331
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Department of Transportation and Related Agencies Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2471
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;332
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Department of the Interior and Related Agencies Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2499
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;333
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2539
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;334
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making appropriations for the government of the District of Columbia and other activities chargeable in whole or
in part against the revenues of said District for the fiscal year ending September 30, 1995, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2576
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;335
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Making appropriations for the Department of Defense for the fiscal year ending September 30, 1995, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sept. 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2599
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;336
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the building located at 41&hyph;42 Norre Gade in Saint Thomas,  Virgin Islands, for the period of time
during which it houses operations of the United States Postal Service, as the Alvaro de Lugo Post Office; and to amend
title 39, United States Code, to make applicable with respect to the United States Postal Service certain exclusionary
authority relating to the treatment of reemployed annuitants under the civil service retirement laws, and forother
purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 3, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2661
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;337
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
National Defense Authorization Act for Fiscal Year 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 5, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2663
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;338
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the facility of the United States Postal Service located at 401 South Washington Street in Chillicothe,
Missouri, as the ``Jerry L. Litton United States Post Office Building'', and to authorize travel and transportation
expenses for certain Federal career appointees, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3114
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;339
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Guam Excess Lands Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3116
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;340
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Junior Duck Stamp Conservation and Design Program Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3119
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;341
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 220 South 40th Avenue in Hattiesburg, Mississippi,
as the ``Roy M. Wheat Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3122
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;342
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 1601 Highway 35 in Middletown, New Jersey, as the ``Candace
White Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3123
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;343
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 9630 Estate Thomas in Saint Thomas, Virgin Islands,
as the ``Aubrey C. Ottley Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3124
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;344
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
American Indian Religious Freedom Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3125
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;345
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
President John F. Kennedy Assassination Records Collection Extension Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3128
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;346
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 To direct the Secretary of the Interior to convey to the City of Imperial Beach, California, approximately 1 acre of
land in the Tijuana Slough National Wildlife Refuge
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3131
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;347
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate October 1994 as ``Crime Prevention Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3132
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;348
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Vegetable Ink Printing Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3133
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;349
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Plant Variety Protection Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;350
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Piscataway Park Expansion Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3146
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;351
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To express the sense of the Congress in Commemoration of the 75th anniversary of Grand Canyon National Park
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 8, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3147
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;352
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for the continuation of certain fee collections for the expenses of the Securities and Exchange Commission
for fiscal year 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3148
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;353
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Uniformed Services Employment and Reemployment Rights Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3149
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;354
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Crop Insurance Reform and Department of Agriculture Reorganization Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3178
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;355
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Acquisition Streamlining Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3243
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;356
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Government Management Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3410
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;357
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Act entitled ``An Act to provide for the extension of certain Federal benefits, services, and assistance
to the Pascua Yaqui Indians of Arizona, and for other purposes''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3418
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;358
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 Child Abuse Accountability Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3420
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;359
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Intelligence Authorization Act for Fiscal Year 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3423
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;360
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse to be constructed at 907 Richland Street in Columbia, South Carolina, as
the ``Matthew J. Perry, Jr. United States Courthouse''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3462
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;361
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the second Sunday in October of 1994 as ``National Children's Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3463
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;362
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To establish the fourth Sunday of July as ``Parents' Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3465
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;363
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating the week beginning October 16, 1994, as ``National Penny Charity Week''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3466
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;364
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Saguaro National Park Establishment Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3467
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;365
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Arizona Wilderness Land Title Resolution Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3469
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;366
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate 1994 as ``The Year of Gospel Music''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3472
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;367
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate October 1994 as ``National Breast Cancer Awareness Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3473
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;368
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating 1995 the ``Year of the Grandparent''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 14, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3475
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;369
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Satellite Home Viewer Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 18, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3477
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;370
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate October 19, 1994, as ``National Mammography Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 18, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3483
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;371
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Petroleum Marketing Practices Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3484
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;372
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for an investigation of the whereabouts of the United States citizens and others who have been missing from
Cyprus since 1974
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3487
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;373
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Payment Reauthorization Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3488
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;374
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize appropriations for carrying out the Earthquake Hazards Reduction Act of 1977 for fiscal years 1995 and
1996
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3492
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;375
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
North American Wetlands Conservation Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3494
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;376
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Farm Credit System Agricultural Export and Risk Management Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3497
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;377
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mohegan Nation of Connecticut Land Claims Settlement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3501
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;378
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the transfer of naval vessels to certain foreign countries
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3508
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;379
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating the months of March 1995 and March 1996 as ``Irish-American Heritage Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3510
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;380
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Providing for temporary extension of the application of the final paragraph of section 10 of the Railway Labor Act
with respect to the dispute between the Soo Line Railroad Company and certain of its employees
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3512
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;381
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
African Conflict Resolution Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 19, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3513
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;382
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Improving America's Schools Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 20, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3518
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;383
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Full Faith and Credit for Child Support Orders Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 20, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4063
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;384
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Native American Veterans' Memorial Establishment Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4067
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;385
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To redesignate the Post Office building located at 1000 Lamar Street in Wichita Falls, Texas, as the ``Graham B. Purcell,
Jr. Post Office Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4069
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;386
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 3000 Veterans Drive in Saint Thomas, Virgin Islands,
as the ``Arturo R. Watlington, Sr. Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4070
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;387
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Social Security Domestic Employment Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4071
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;388
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Federal Employees Family Friendly Leave Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4079
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;389
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Unlisted Trading Privileges Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4081
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;390
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To grant the Consent of the Congress to the Kansas and Missouri Metropolitan Culture District Compact
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4085
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;391
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Rhinoceros and Tiger Conservation Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4094
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;392
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Jobs Through Trade Expansion Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4098
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;393
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Water Bank Extension Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4105
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;394
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Bankruptcy Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4106
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;395
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Providing for the convening of the First Session of the One Hundred Fourth Congress
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4152
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;396
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Animal Medicinal Drug Use Clarification Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4153
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;397
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Payments In Lieu of Taxes Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4156
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;398
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Lincoln County, Montana, Lands Transfer Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4162
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;399
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Indian Lands Open Dump Cleanup Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4164
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;400
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
United States-Mexico Border Health Commission Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4169
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;401
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Pension Annuitants Protection Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4172
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;402
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Aleutian and Pribilof Islands Restitution Act to increase authorization for appropriation to compensate
Aleut villages for church property lost, damaged, or destroyed during World War II
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4174
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;403
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Small Business Administration Reauthorization and Amendments Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4175
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;404
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the Warren B. Rudman United States Courthouse, the Jamie L. Whitten Federal Building, and the William
H. Natcher Federal Building and United States Courthouse
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4206
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;405
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Courthouse in Detroit, Michigan, as the ``Theodore Levin Courthouse'', and for other
purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4208
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;406
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Energy Policy and Conservation Act Amendments Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4209
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;407
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Sheep Promotion, Research, and Information Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4210
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;408
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To recognize the achievements of radio amateurs, and to establish support for such amateurs as national policy
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4228
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;409
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FEGLI Living Benefits Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4230
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;410
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To redesignate the Post Office building located at 600 Princess Anne Street in Fredericksburg, Virginia, as the ``Samuel
E. Perry Post Office Building''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4235
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;411
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Independent Safety Board Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4236
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;412
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
American Indian Trust Fund Management Reform Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4239
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;413
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Indian Self-Determination Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4250
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;414
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 18, United States Code, to make clear a telecommunications carrier's duty to cooperate in the interception
of communications for law enforcement purposes, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4279
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;415
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To make certain technical amendments relating to the State Department Basic Authorities Act of 1956, the United States
Information and Educational Exchange Act of 1948, and other provisions of law
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4299
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;416
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Immigration and Nationality Technical Corrections Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4305
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;417
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Dietary Supplement Health and Education Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4325
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;418
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Veterans' Compensation Cost-of-Living Adjustment Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4336
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;419
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Civil Rights Commission Amendments Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4338
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;420
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 Judicial Amendments Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4343
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;421
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Base Closure Community Redevelopment and Homeless Assistance Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4346
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;422
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Approving the location of a Thomas Paine Memorial and a World War II Memorial in the Nation's Capital
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4356
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;423
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Regarding United States policy toward Haiti
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 25, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4358
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;424
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To reauthorize the Office of Special Counsel, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 29, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4361
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;425
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Defense Department Overseas Teachers Pay and Personnel Practices Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4369
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;426
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the Secretary of the Interior to negotiate agreements for the use of Outer Continental Shelf sand, gravel,
and shell resources
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4371
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;427
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To ensure that timber-dependent communities adversely affected by the Forest Plan for a Sustainable Economy and
a Sustainable Environment qualify for loans and grants from the Rural Development Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4373
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;428
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the Export-Import Bank of the United States to provide financing for the export of nonlethal defense
articles and defense services the primary end use of which will be for civilian purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4375
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;429
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To codify without substantive change recent laws related to transportation and to improve the United States Code
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4377
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;430
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Census Address List Improvement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4393
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;431
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Ocean Pollution Reduction Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4396 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;432
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Social Security Act Amendments of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4398
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;433
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate certain lands in the California Desert as wilderness, to establish the Death Valley and Joshua Tree National
Parks, to establish the Mojave National Preserve, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4471
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;434
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for the settlement of the water rights claims of the Yavapai-Prescott Indian Tribe in Yavapai County, Arizona,
and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Oct. 31, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4526
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;435
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To make certain technical corrections, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4566
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;436
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Confederated Tribes of the Colville Reservation Grand Coulee Dam Settlement Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4577
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;437
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To make technical improvements in the United States Code by amending provisions to reflect the current names of congressional
committees
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4581
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;438
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
International Antitrust Enforcement Assistance Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4597
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;439
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Central Midwest Interstate Low-Level Radioactive Waste Compact Amendments Consent Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4607
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;440
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize appropriations for high-speed rail transportation, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4615
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;441
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States courthouse located at 231 West Lafayette Street in Detroit, Michigan, as the ``Theodore
Levin United States Courthouse'' and to designate the postal facility located at 1401 West Fort Street in Detroit,
Michigan, as the ``George W. Young Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4629
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;442
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend title 18, United States Code, with respect to certain crimes relating to Congressional medals of honor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4630
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;443
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To amend the Omnibus Budget Reconciliation Act of 1993 to permit the prompt sharing of timber sale receipts of the Forest
Service and the Bureau of Land Management
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4631
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;444
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Crow Boundary Settlement Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4632
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;445
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To provide for the acceptance by the Secretary of Education of applications submitted by the local educational agency
serving the Window Rock Unified School District, Window Rock, Arizona, under section 3 of the Act of September 30,
1950 (Public Law 874, 81st Congress) for fiscal years 1994 and 1995
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4644
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;446
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Veterans' Benefits Improvements Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4645
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;447
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
International Narcotics Control Corrections Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4691
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;448
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Healthy Meals for Healthy Americans Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4699
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;449
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To establish the Quinebaug and Shetucket Rivers Valley National Heritage Corridor in the State of Connecticut, and
for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4752
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;450
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To expand the boundaries of the Red Rock Canyon National Conservation Area
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4766
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;451
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
National Maritime Heritage Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4769
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;452
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Veterans Health Programs Extension Act of 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4783
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;453
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the building located at 216 Coleman Avenue in Waveland, Mississippi, for the period of time during which
it houses operations of the United States Postal Service, as the ``John Longo, Jr. Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4790
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;454
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
 To provide for the annual publication of a list of federally recognized Indian tribes, and for other purposes
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4791
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;455
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the building located at 100 Vester Gade, in Cruz Bay, Saint Thomas, Virgin Islands, for the period of time
which it houses operations of the United States Postal Service, as the ``Ubaldina Simmons Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4797
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;456
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 115 North Chester in Ruleville, Mississippi, as the
``Fannie Lou Hamer Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4798
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;457
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To award a congressional gold medal to Rabbi Menachem Mendel Schneerson
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4799
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;458
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 301 West Lexington Street in Independence, Missouri,
as the ``William J. Randall Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4801
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;459
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the United States Post Office building located at 103&hyph;104 Estate Richmond in Saint Croix, Virgin
Islands, as the ``Wilbert Armstrong Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4802
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;460
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To designate the building located at 4021 Laclede in St. Louis, Missouri, for the period of time during which it houses
operations of the United States Postal Service, as the ``Marian Oldham Post Office''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4803
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;461
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To direct the Secretary of the Interior to make technical corrections to maps relating to the Coastal Barrier Resources
System, and to authorize appropriations to carry out the Coastal Barrier Resources Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4804
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;462
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating the month of November in each of the calendar years 1993 and 1994 as ``National American Indian Heritage
Month''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4805
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;463
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating January 16, 1995, as ``National Good Teen Day''
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Nov. 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4807
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;464
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Designating September 17, 1994, as ``Constitution Day''
<!-- PJG 007 0104 intable -->
Nov. 9, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4808
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
103&hyph;465
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Uruguay Round Agreements Act
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Dec. 8, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4809 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The text of laws may be ordered in individual pamphlet form (referred to as ``slip laws'') from the Superintendent
of Documents, U.S. Government Printing Office, Washington, DC 20402 (phone, 202&hyph;512&hyph;2470). Some laws
may not yet be available for purchase.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00181 </DOCNO>
<PARENT> FR941219-2-00100 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Monday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
December 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of the Interior
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Fish and Wildlife Service
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Notice of Availability-Planning and Management Chapter of the Service Manual; Notice 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 242&blank;/&blank;Monday, December 19, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF THE INTERIOR</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Fish and Wildlife Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Notice of Availability_Planning and Management Chapter of the Service Manual
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Fish and Wildlife Service, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Part 602 of the Service Manual concerning planning and management has been prepared. This chapter will provide guidance
for comprehensive management planning for all lands, waters, and interests of the National Wildlife Refuge System.
This guidance will be applicable to the full range of planning needs that reflect an ecosystem approach to land management
and provides a clear statement of the desired future conditions of units that comprise the National Wildlife Refuge
System (NWRS). The purpose of this Notice is to allow the public the opportunity to comment on the content of the chapter.
The chapter is available for review by writing for a copy at the address listed below under the heading 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments will be accepted on or before February 17, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of the planning and management chapter may be obtained and comments regarding such chapter received at: U.S.
Fish and Wildlife Service, 1849 C Street, NW, Attention: Pete Jerome, MS 670 ARLSQ, Washington, DC 20240.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</ADDRESS>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR941219-2-00182 </DOCNO>
<PARENT> FR941219-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pete Jerome, at the address listed under the heading 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
; telephone: 703&hyph;358&hyph;2043.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The planning and management chapter has been developed with Regional input over a period of several months. The Directorate
has reviewed the chapter for consistency with Regional goals and the mission of the Service. The chapter ensures consistency
with the National Environmental Policy Act (NEPA), including the Draft ``Refuges 2003'' Plan/Environmental Impact
Statement (March 1993_to be completed in 1995), and the Service's Ecosystem Approach to Fish and Wildlife Conservation
(March 1994) and associated National Implementation Guidance (June 1994). The major objectives of comprehensive
management planning, as outlined in the chapter, are: (1) To ensure that management of NWRS lands reflects policies
and goals of the NWRS and the purposes for which each was established; (2) to ensure that all units contribute to the
conservation of biological diversity and to the structure and function of the ecosystem in which they are located;
(3) to provide a clear statement of the desired future conditions of the planning unit as it should be when system and
individual unit purposes are accomplished; (4) to provide a systematic process to aid decision making by identifying
opportunities, issues, and concerns; collecting, organizing, and analyzing information; and developing and considering
a range of management alternatives; (5) to aid in determining the compatibility of uses on Service units; (6) to ensure
that other Service programs, other agencies, and the public have opportunities to participate in management decision
making for each Service unit; (7) to provide a uniform basis for budget requests for operational, maintenance, and
capital development programs that accomplish unit and NWRS purposes; (8) to provide a basis for monitoring progress
and evaluating plan implementation; (9) to identify unit objectives and management strategies leading to their
achievement; and (10) to provide long-term continuity in unit management.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
George T. Frampton, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Fish and Wildlife and Parks. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;31030 Filed 12&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>
Z
<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<!-- PJG ITAG l=39 g=1 f=1 -->
&blank;
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



